Radical cystectomy

treatment - Surgery

Radical cystectomy is …
instance of (P31):
medical conceptQ111796709

External links are
P673eMedicine ID448623
P4235PatientsLikeMe treatment IDradical-cystectomy

Reverse relations

main subject (P921)
Q44386807"Never events": Centers for Medicare and Medicaid Services complications after radical cystectomy
Q45989119"The devil is in the details": randomized trial of robotic versus open radical cystectomy.
Q46423726'Successful' chemo- and radiotherapy prior to radical cystectomy does not necessarily correlate with clinical course in small cell carcinoma of the bladder
Q569284891213 THE EVALUATION OF THE LEARNING CURVE ASSOCIATED WITH ROBOTIC RADICAL CYSTECTOMY: INITIAL 100 CASES
Q5312660918 F-fluorodeoxyglucose positron emission tomography-computed tomography for preoperative lymph node staging in patients undergoing radical cystectomy for bladder cancer: a prospective study.
Q4614892025-year experience in the management of invasive bladder cancer by radical cystectomy
Q9334933430-day readmission after radical cystectomy: Identifying targets for improvement using the phases of surgical care
Q702750934,000 RAD preoperative irradiation followed by prompt radical cystectomy for invasive bladder carcinoma: a prospective study of patient tolerance and pathologic downstaging
Q5692849182 COST ANALYSIS OF ROBOTIC-ASSISTED RADICAL CYSTECTOMY VERSUS OPEN RADICAL CYSTECTOMY UTILIZING A PROSPECTIVE, RANDOMIZED COHORT
Q8895615190-Day Mortality after Radical Cystectomy for Bladder Cancer: Prognostic Factors in a Multicenter Case Series
Q4050873490-Day complication rate in patients undergoing radical cystectomy with enhanced recovery protocol: a prospective cohort study
Q50193856A Case of Secondary Extramammary Paget's Disease Aroundthe Cutaneous Stoma after Radical Cystectomy
Q92045177A Comparative Propensity-Score Matched Analysis of Perioperative Outcomes of Intracorporeal versus Extracorporeal Urinary Diversion after Robot-Assisted Radical Cystectomy: Results from the International Robotic Cystectomy Consortium
Q98990592A Meta-analysis of Radical Radiotherapy or Radical Cystectomy for Patients with Bladder Cancer Muscle Invaded
Q40196162A Model to Optimize Followup Care and Reduce Hospital Readmissions after Radical Cystectomy.
Q37053761A Multi-Center International Study Assessing the Impact of Differences in Baseline Characteristics and Perioperative Care Following Radical Cystectomy
Q40702603A Multi-Institutional Analysis of Outcomes of Patients with Clinically Node Positive Urothelial Bladder Cancer Treated with Induction Chemotherapy and Radical Cystectomy
Q90747869A Population-based Study of Ureteroenteric Strictures After Open and Robot-assisted Radical Cystectomy
Q38893318A Prospective Randomized Trial of the Effects of Early Enteral Feeding after Radical Cystectomy
Q47301928A Prospective, Randomized, Clinical Trial on the Effects of a Valveless Trocar on Respiratory Mechanics During Robotic Radical Cystectomy: A Pilot Study.
Q101053854A Qualitative Assessment of Patient Satisfaction with Radical Cystectomy for Bladder Cancer at a Single Institution: How Can We Improve?
Q55311343A Retrospective Study Comparing Surgical and Early Oncological Outcomes between Intracorporeal and Extracorporeal Ileal Conduit after Laparoscopic Radical Cystectomy from a Single Center.
Q90686086A Retrospective Study of Patients Undergoing Radical Cystectomy and Receiving Peri-Operative Naloxegol or Alvimopan: Comparison of Length of Stay
Q49793011A Simplified Frailty Index to Predict Outcomes After Radical Cystectomy.
Q41484110A Single-centre Early Phase Randomised Controlled Three-arm Trial of Open, Robotic, and Laparoscopic Radical Cystectomy (CORAL).
Q91024100A Systematic Review and Meta-analysis of Delay in Radical Cystectomy and the Effect on Survival in Bladder Cancer Patients
Q97893038A Systematic Review and Meta-analysis of Variant Histology in Urothelial Carcinoma of the Bladder Treated with Radical Cystectomy
Q73235865A case of urethral recurrence found 15 years after radical cystectomy
Q72606701A classification after radical cystectomy of patients with bladder cancer associated with schistosomiasis
Q39424758A clinicopathologic study of gynecologic organ involvement at radical cystectomy for bladder cancer.
Q42671705A comparative study between open and laparoscopic approach in radical cystectomy with orthotopic ileal neobladder
Q34417428A comparative study of fast-track versus [corrected] conventional surgery in patients undergoing laparoscopic radical cystectomy and ileal conduit diversion: Chinese experience
Q99713739A comparison between limited bowel preparation and comprehensive bowel preparation in radical cystectomy with ileal urinary diversion: a systematic review and meta-analysis of randomized controlled trials
Q42621069A comparison of early complications between open and robot-assisted radical cystectomy
Q39451070A comparison of preliminary oncologic outcome and postoperative complications between patients undergoing either open or robotic radical cystectomy
Q83709768A contemporary standard for morbidity and outcome after radical cystectomy
Q38054266A contemporary update on pathology standards for bladder cancer: transurethral resection and radical cystectomy specimens
Q57253190A cost-effectiveness modeling study of robot-assisted (RARC) versus open radical cystectomy (ORC) for bladder cancer to inform future research
Q46676805A critical analysis of perioperative mortality from radical cystectomy.
Q80442089A delay in radical cystectomy of >3 months is not associated with a worse clinical outcome
Q81037386A delay in radical cystectomy of >3 months is not associated with a worse clinical outcome
Q82229800A delay in radical cystectomy of >3 months is not associated with a worse clinical outcome
Q90225546A delay ≥8 weeks to neoadjuvant chemotherapy before radical cystectomy increases the risk of upstaging
Q34225949A double-blind randomized controlled clinical trial to assess the effect of Doppler optimized intraoperative fluid management on outcome following radical cystectomy
Q42644348A dual-centre, cohort comparison of open, laparoscopic and robotic-assisted radical cystectomy.
Q44428810A feasibility study of peritoneum preservation in radical cystectomy with extraperitonealization of orthotopic neobladder for invasive high-grade bladder cancer: a preliminary analysis
Q36642888A fourteen-year review of radical cystectomy for transitional cell carcinoma demonstrating the usefulness of the concept of lymph node density.
Q37641597A greater number of dissected lymph nodes is associated with more favorable outcomes in bladder cancer treated by radical cystectomy: a meta-analysis
Q41705006A low psoas muscle volume correlates with a longer hospitalization after radical cystectomy
Q30938056A meta-analysis of randomised trials suggests a survival benefit for combined radiotherapy and radical cystectomy compared with radical radiotherapy for invasive bladder cancer: are these data relevant to modern practice?
Q57220010A missing silk strip during laparoscopic radical cystectomy and bilateral nephroureterectomy
Q36029574A model to predict the outcome of the bilharzial bladder cancer patient after radical cystectomy
Q54940104A multicenter round robin test of PD-L1 expression assessment in urothelial bladder cancer by immunohistochemistry and RT-qPCR with emphasis on prognosis prediction after radical cystectomy.
Q77608295A multicenter study of the morbidity of radical cystectomy in select elderly patients with bladder cancer
Q80063768A multimodal perioperative plan for radical cystectomy and urinary intestinal diversion: effects, limits and complications of early artificial nutrition
Q40237184A new concept for early recovery after surgery for patients undergoing radical cystectomy for bladder cancer: results of a prospective randomized study
Q100511762A new index (A/G) associated with early complications of radical cystectomy and intestinal urinary diversion
Q93077664A new modification of tubeless cutaneous ureterostomy following radical cystectomy
Q45179878A new prognostic model for cancer-specific survival after radical cystectomy including pretreatment thrombocytosis and standard pathological risk factors
Q69026348A new radical cystectomy for advanced or multifocal urinary bladder cancer
Q91826049A new ureteroileal anastomosis technique in modified ileal orthotopic bladder substitution after radical cystectomy
Q30981992A nomogram predicting the cancer-specific mortality in patients eligible for radical cystectomy evaluating clinical data and neoadjuvant cisplatinum-based chemotherapy
Q38817683A nonrandomized, prospective, clinical study on the impact of circulating tumor cells on outcomes of urothelial carcinoma of the bladder patients treated with radical cystectomy with or without adjuvant chemotherapy
Q94683799A novel prevention bundle to reduce incisional infections after radical cystectomy
Q38596001A novel risk stratification model, involving preoperative lymphocyte-monocyte ratio and standard pathological factors, for overall survival in patients with bladder cancer undergoing radical cystectomy
Q39623533A novel risk stratification to predict local-regional failures in urothelial carcinoma of the bladder after radical cystectomy
Q100695669A perioperative management to reduce rate of urinary tract infection for patient underwent radical cystectomy with ileal conduit diversion
Q43188531A phase II trial of neoadjuvant erlotinib in patients with muscle-invasive bladder cancer undergoing radical cystectomy: clinical and pathological results.
Q83877649A plea for a uniform surveillance schedule after radical cystectomy
Q85319597A plea for uniform terminology for patients with urothelial carcinoma treated with chemotherapy prior to radical cystectomy: induction versus neoadjuvant chemotherapy
Q43847642A population-based competing-risks analysis of the survival of patients treated with radical cystectomy for bladder cancer
Q73738131A predictive model of survival after radical cystectomy for carcinoma of the bladder
Q33641978A preliminary oncologic outcome and postoperative complications in patients undergoing robot-assisted radical cystectomy: Initial experience
Q33904099A prospective evaluation of surgical outcomes of laparoscopic transperitoneal radical cystectomy/anterior pelvic exenteration: our surgical technique and experience
Q37594340A prospective randomised controlled trial of laparoscopic vs open radical cystectomy for bladder cancer: perioperative and oncologic outcomes with 5-year follow-upT Lin et al.
Q40325970A prospective randomized multicenter study of Turkish Society of Urooncology comparing two different mechanical bowel preparation methods for radical cystectomy.
Q48342930A prospective randomized pilot study evaluating an ERAS protocol versus a standard protocol for patients treated with radical cystectomy and urinary diversion for bladder cancer.
Q46001051A randomized trial of radical cystectomy versus radical cystectomy plus cisplatin, vinblastine and methotrexate chemotherapy for muscle invasive bladder cancer.
Q43780702A randomized trial of robot-assisted laparoscopic radical cystectomy
Q36314809A reported 20-gene expression signature to predict lymph node-positive disease at radical cystectomy for muscle-invasive bladder cancer is clinically not applicable.
Q60552864A retrospective analysis of incidence and its associated risk factors of upper urinary tract recurrence following radical cystectomy for bladder cancer with transitional cell carcinoma: the significance of local pelvic recurrence and positive lymph n
Q37124229A retrospective evaluation of preoperative anemia in patients undergoing radical cystectomy for muscle-invasive urothelial urinary bladder cancer, with or without neoadjuvant chemotherapy
Q72151816A simple ileal substitute bladder after radical cystectomy: experience with a modification of the Studer pouch
Q43684222A stage specific approach to tumor surveillance after radical cystectomy for transitional cell carcinoma of the bladder
Q41893474A standardized protocol for identifying and counting lymph nodes harvested by pelvic lymph node dissection at the time of radical cystectomy
Q35071431A study of the morbidity, mortality and long-term survival following radical cystectomy and radical radiotherapy in the treatment of invasive bladder cancer in Yorkshire
Q81473808A study of the morbidity, mortality and long-term survival following radical cystectomy and radical radiotherapy in the treatment of invasive bladder cancer in Yorkshire
Q90750289A systematic review and meta-analysis comparing the outcomes of open and robotic assisted radical cystectomy
Q52569036A systematic review and meta-analysis of lymphovascular invasion in patients treated with radical cystectomy for bladder cancer.
Q38938343A systematic review and meta-analysis of quality of life outcomes after radical cystectomy for bladder cancer
Q37839415A systematic review and meta-analysis of the relationship between hospital/surgeon volume and outcome for radical cystectomy: an update for the ongoing debate
Q50165363A systematic review and meta-analysis on the oncological long-term outcomes after trimodality therapy and radical cystectomy with or without neoadjuvant chemotherapy for muscle-invasive bladder cancer
Q47325390A systematic review of exercise and psychosocial rehabilitation interventions to improve health-related outcomes in patients with bladder cancer undergoing radical cystectomy
Q73924520A technique of transrectal ultrasound guided transperineal percutaneous drainage of pelvic abscess after radical cystectomy
Q33431065A thorough pelvic lymph node dissection in presence of positive margins associated with better clinical outcomes in radical cystectomy patients
Q51373293A three-centre experience of orthotopic neobladder reconstruction after radical cystectomy: initial results.
Q51564304A three-centre experience of orthotopic neobladder reconstruction after radical cystectomy: initial results.
Q82933310A three-centre experience of orthotopic neobladder reconstruction after radical cystectomy: revisiting the initial experience, and results in 104 patients
Q47102708AB011. Laparoscopic radical cystectomy, modified Wallace ileal conduit retrospectively.
Q46633375AB014. Laparoscopic radical cystectomy and intracorporeal orthotopic ileal neobladder with bilateral isoperistaltic afferent limbs: initial experience.
Q47123038AB044. Application of rapid bowel rehabilitation programme in radical cystectomy and ileal neobladder.
Q45785451AB045. Extended lymphadenectomy versus non-extended lymphadenectomy in radical cystectomy for bladder cancer: a meta-analysis.
Q45785425AB047. Clinic therapeutic effect of sigmoid orthotopic neobladder after radical cystectomy.
Q46631309AB053. Laparoscopic pelvic lymph node dissection during radical cystectomy: strategy and clinical outcomes.
Q46632349AB054. An improved technique for bladder cancer: pure laparoscopic radical cystectomy with orthotopic U-shape ileal neobladder using titanium staples.
Q45785022AB066. Sensitivity of initial biopsy or transurethral resection of bladder tumor(s) for detecting histological variants on radical cystectomy.
Q45784691AB103. Overexpression of RNF2 is an independent predictor of outcome in patients with urothelial carcinoma of the bladder underwent radical cystectomy.
Q46631813AB117. Analysis of perioperative outcome and complications following radical cystectomy: a single center retrospective study of 1,212 patients in two decades.
Q46627403AB117. Laparoscopic versus open radical cystectomy for elderly patients over 75-year-old: a single center comparative analysis.
Q46631938AB120. Early radical cystectomy in BCG naive pathological non-muscle invasive bladder cancer: results from a retrospective study with 164 cases.
Q45786241AB129. Clinical analysis about 21 cases of different urinary diversion after radical cystectomy
Q45784493AB172. Laparoscopic radical cystectomy and intracorporeal orthotopic ileal neobladder with bilateral isoperistaltic afferent limbs: initial experience.
Q47855073ABO Blood Group and Rhesus Factor Are Not Associated with Outcomes After Radical Cystectomy for Non-metastatic Urothelial Carcinoma of the Bladder
Q98293781ASO Author Reflections: Prognostic Nutritional Index-A Simple Evaluation that May Help Reduce the Risk of Postoperative Pulmonary Complications in Radical Cystectomy
Q49709096Abdominal Sacrocolpopexy for Repair of Pelvic Organ Prolapse After Radical Cystectomy
Q54719358Absence of Tumor on Repeat Transurethral Resection of Bladder Tumor Does Not Predict Final Pathologic T0 Stage in Bladder Cancer Treated with Radical Cystectomy.
Q92352730Accuracy of American College of Surgeons National Surgical Quality Improvement Program Universal Surgical Risk Calculator in Predicting Complications Following Robot-Assisted Radical Cystectomy at a National Comprehensive Cancer Center
Q70794101Accuracy of computer tomography in urinary bladder cancer. Study of 74 patients following radical cystectomy
Q53059423Accuracy of urethral frozen section during radical cystectomy for bladder cancer.
Q91396152Accurate Quantification of Residual Cancer Cells in Pelvic Washing Reveals Association with Cancer Recurrence Following Robot-Assisted Radical Cystectomy
Q87346801Accurate determination of the pathological stage with gross dissection protocol for radical cystectomy
Q41255492Acute Kidney Injury After Radical Cystectomy for Bladder Cancer is Associated with Chronic Kidney Disease and Mortality
Q95941418Acute Kidney Injury following Enhanced Recovery after Surgery (ERAS) in Patients Undergoing Radical Cystectomy
Q50159822Acute acalculous cholecystitis after radical cystectomy
Q46671308Acute acalculous cholecystitis after radical cystectomy: a report of two cases.
Q64991350Acute kidney injury following radical cystectomy and urinary diversion: predictors and associated morbidity.
Q80760148Acute normovolemic hemodilution for radical retropubic prostatectomy and radical cystectomy
Q59649561Adenocarcinoma Versus Urothelial Carcinoma of the Urinary Bladder: Comparison Between Pathologic Stage at Radical Cystectomy and Cancer-specific Mortality
Q46840883Adherence to surveillance guidelines after radical cystectomy: a population-based analysis
Q79919302Adjustable continence therapy for the treatment of urinary incontinence after radical cystectomy and orthotopic neobladder in women
Q40610039Adjuvant Chemotherapy After Radical Cystectomy for Urothelial Bladder Cancer: Outcome and Prognostic Factors for Survival in a French Multicenter, Contemporary Cohort
Q35856850Adjuvant Chemotherapy Correlates with Improved Survival after Radical Cystectomy in Patients with pT3b (Macroscopic Perivesical Tissue Invasion) Bladder Cancer
Q38610028Adjuvant Chemotherapy vs Observation for Patients With Adverse Pathologic Features at Radical Cystectomy Previously Treated With Neoadjuvant Chemotherapy.
Q47231814Adjuvant Radiotherapy Use by US Radiation Oncologists After Radical Cystectomy for Muscle-invasive Bladder Cancer
Q47393991Adjuvant Sandwich Chemotherapy Plus Radiotherapy vs Adjuvant Chemotherapy Alone for Locally Advanced Bladder Cancer After Radical Cystectomy: A Randomized Phase 2 Trial
Q44789122Adjuvant chemotherapy after radical cystectomy for bladder cancer: a comparative study using inverse-probability-of-treatment weighting
Q40860545Adjuvant chemotherapy following radical cystectomy
Q73139168Adjuvant chemotherapy for non-organ confined disease after radical cystectomy
Q87091388Adjuvant chemotherapy is associated with decreased mortality after radical cystectomy for locally advanced bladder cancer
Q97877838Adjuvant chemotherapy is ineffective in patients with bladder cancer and variant histology treated with radical cystectomy with curative intent
Q64979120Adjuvant chemotherapy versus observation after radical cystectomy in patients with node-positive bladder cancer.
Q33396809Adjuvant chemotherapy with cisplatin and gemcitabine versus chemotherapy at relapse in patients with muscle-invasive bladder cancer submitted to radical cystectomy: an Italian, multicenter, randomized phase III trial
Q38218163Adjuvant cisplatin-based combined chemotherapy for lymph node (LN)-positive urothelial carcinoma of the bladder (UCB) after radical cystectomy (RC): a retrospective international study of >1500 patients
Q43806537Adjuvant polychemotherapy of nonorgan-confined bladder cancer after radical cystectomy revisited: long-term results of a controlled prospective study and further clinical experience
Q53721312Adjuvant radiotherapy after radical cystectomy and ileal orthotopic neobladder.
Q36338035Adjuvant radiotherapy after radical cystectomy for muscle-invasive bladder cancer: A retrospective multicenter study
Q33630045Adjuvant radiotherapy after radical cystectomy for patients with muscle invasive bladder cancer: a phase II trial.
Q55064633Adjuvant treatment following radical cystectomy for muscle-invasive urothelial carcinoma and variant histologies: Is there a role for radiotherapy?
Q88555461Adopting Enhanced Recovery Programmes in Radical Cystectomy: Can We Afford Not To?
Q68215944Advanced Bladder Cancer (Stages pT3b, pT4a, pN1 and pN2): Improved Survival after Radical Cystectomy and 3 Adjuvant Cycles of Chemotherapy. Results of a Controlled Prospective Study
Q79369638Advanced age is associated with poorer bladder cancer-specific survival in patients treated with radical cystectomy
Q38640776Adverse Pathology After Neoadjuvant Chemotherapy and Radical Cystectomy: The Role of Adjuvant Chemotherapy.
Q46332516Age and body mass index are independent risk factors for the development of postoperative paralytic ileus after radical cystectomy
Q44989449Age and bupivacaine plasma concentrations following radical cystectomy.
Q93170984Age and sex have no impact on expression levels of markers of immune cell infiltration and immune checkpoint pathways in patients with muscle-invasive urothelial carcinoma of the bladder treated with radical cystectomy
Q84883989Age ≥ 80 years is independently associated with survival outcomes after radical cystectomy: results from the Canadian Bladder Cancer Network Database
Q40219984Age, American Society of Anesthesiologists physical status classification and Charlson score are independent predictors of 90-day mortality after radical cystectomy
Q43662823Age, tumour stage, and preoperative serum albumin level are independent predictors of mortality after radical cystectomy for treatment of bladder cancer in Hong Kong Chinese
Q57238997Age-adjusted Charlson comorbidity score is associated with treatment decisions and clinical outcomes for patients undergoing radical cystectomy for bladder cancer
Q39939847Aggregate lymph node metastasis diameter and survival after radical cystectomy for invasive bladder cancer
Q51729078Air embolism during radical cystectomy with ileal conduit urinary diversion.
Q60907292Alexis Wound Retractor for Radical Cystectomy: A Safe and Effective Method for Retraction
Q38434405Alvimopan accelerates gastrointestinal recovery after radical cystectomy: a multicenter randomized placebo-controlled trial
Q64246701Alvimopan for post-radical cystectomy ileus: what should we know?
Q85501098Alvimopan for prevention of postoperative paralytic ileus in radical cystectomy patients: a cost-effectiveness analysis
Q24186081Alvimopan for recovery of bowel function after radical cystectomy
Q49357124Alvimopan for recovery of bowel function after radical cystectomy
Q36360289Alvimopan for recovery of bowel function after radical cystectomy.
Q37057032Alvimopan in an Enhanced Recovery Program Following Radical Cystectomy
Q91730541Alvimopan is Associated with a Reduction in Length of Stay and Hospital Costs for Patients Undergoing Radical Cystectomy
Q84390151Alvimopan provides rapid gastrointestinal recovery without nasogastric tube decompression after radical cystectomy and urinary diversion
Q91342763Alvimopan usage increasing following radical cystectomy
Q44342565Alvimopan, a peripherally acting μ-opioid receptor antagonist, is associated with reduced costs after radical cystectomy: economic analysis of a phase 4 randomized, controlled trial
Q36285089An Evaluation of the Timing of Surgical Complications Following Radical Cystectomy: Data From the American College of Surgeons National Surgical Quality Improvement Program
Q58594897An Update in Enhanced Recovery Following Radical Cystectomy
Q36710334An analysis of preoperative delays prior to radical cystectomy for bladder cancer in Quebec
Q37319815An audit of early complications of radical cystectomy using Clavien-Dindo classification
Q88116203An easily applicable single condition-based mortality index for patients undergoing radical prostatectomy or radical cystectomy
Q56928484An evaluation of adjuvant chemotherapy eligibility rates among patients undergoing radical cystectomy
Q67971124An ileal neobladder for a female patient after a radical cystectomy to ensure voiding from the urethra: a case report
Q40664979An improved technique for bladder cancer: Pure laparoscopic radical cystectomy with orthotopic U-shape ileal neobladder using titanium staples
Q33941669Analgesic opioid dose is an important indicator of postoperative ileus following radical cystectomy with ileal conduit: experience in the robotic surgery era.
Q77949463Analysis of early complications after radical cystectomy: results of a collaborative care pathway
Q39839417Analysis of early complications of robotic-assisted radical cystectomy using a standardized reporting system.
Q37685561Analysis of gender differences in early perioperative complications following radical cystectomy at a tertiary cancer center using a standardized reporting methodology
Q46532844Analysis of histopathological prognostic factors in patients who underwent radical cystectomy in cancer of the bladder
Q42625988Analysis of intracorporeal compared with extracorporeal urinary diversion after robot-assisted radical cystectomy: results from the International Robotic Cystectomy Consortium.
Q45292570Analysis of isolated bacteria and short-term antimicrobial prophylaxis with tazobactam-piperacillin (1:4 ratio) for prevention of postoperative infections after radical cystectomy
Q40750987Analysis of life-threatening complications during perioperative period in patients undergoing radical cystectomy with orthotopic neobladder
Q87444365Analysis of open and intracorporeal robotic assisted radical cystectomy shows no significant difference in recurrence patterns and oncological outcomes
Q82742274Analysis of prognostic factors in patients with transitional cell carcinoma of the bladder treated with radical cystectomy
Q46611293Analysis of radical cystectomy and urinary diversion complications with the Clavien classification system in an Italian real life cohort
Q51290828Analysis of sex differences in cancer-specific survival and perioperative mortality following radical cystectomy: results of a large German multicenter study of nearly 2500 patients with urothelial carcinoma of the bladder.
Q92591908Analysis of surgeon biometrics during open and robotic radical cystectomy with electromyography and motion capture analysis
Q39578304Analysis of the perioperative and five-year oncological outcome of two hundred cases of open radical cystectomy: a single center experience
Q38064344Anatomic basis of radical cystectomy and orthotopic urinary diversion in female patients
Q50781326Anatomic robot-assisted radical cystectomy.
Q46298528Anatomic study of pelvic urethra in women: value of its conservation in radical cystectomy
Q44582202Anesthesia and perioperative care in radical cystectomy
Q48921514Anesthesia management of laparoscopic radical cystectomy and orthotopic bladder surgery with a robotic-assisted surgical system
Q78816405Antegrade extraperitoneal approach to radical cystectomy and ileal neobladder
Q91666707Anterior enterocele: a cause of recurrent prolapse after radical cystectomy
Q87757107Anterior fascial fixation does not reduce the parastomal hernia rate after radical cystectomy and ileal conduit
Q60920106Anterior versus posterior approach laparoscopic radical cystectomy: a retrospective analysis
Q97556708Appendiceal conduit: A novel technique to be applied after radical cystectomy: A case study report
Q64899507Application of enhanced recovery after surgery in patients undergoing radical cystectomy.
Q67953748Application of smooth Teflon clip to inferior vena cava during radical cystectomy to prevent postoperative pulmonary embolism
Q36619292Are bladder cancer patients with pT0 disease following radical cystectomy cured of cancer?
Q69621957Are frozen-section examinations of ureteral margins required for all patients undergoing radical cystectomy for bladder cancer?
Q82933347Assessing the minimum number of lymph nodes needed at radical cystectomy in patients with bladder cancer
Q38963972Assessing the relative influence of hospital and surgeon volume on short-term mortality after radical cystectomy.
Q93347303Assessing trends in urinary diversion after radical cystectomy for bladder cancer in the United States
Q44509337Assessment of QOL and survival for patients undergoing radical cystectomy or bladder preservation for invasive bladder cancer
Q77182067Assessment of morbidity and functional results in bladder replacement with Hautmann ileal neobladder after radical cystectomy: a clinical experience in 55 highly selected patients
Q80994999Assessment of perioperative psychological distress in patients undergoing radical cystectomy for bladder cancer
Q91590487Assessment of transurethral resection of the bladder specimens with pT1 high-grade urothelial carcinoma for the predictor features of muscularis propria invasion on radical cystectomy specimens
Q38770148Association Between Preoperative Albumin Levels and Length of Stay after Radical Cystectomy
Q64075488Association Between Preoperative Hydronephrosis and Prognosis After Radical Cystectomy Among Patients With Bladder Cancer: A Systemic Review and Meta-Analysis
Q89914536Association Between Smoking Exposure, Neoadjuvant Chemotherapy Response and Survival Outcomes Following Radical Cystectomy: Systematic Review and Meta-Analysis
Q61443903Association between De Ritis ratio (aspartate aminotransferase/alanine aminotransferase) and oncological outcomes in bladder cancer patients after radical cystectomy
Q38972582Association between diabetes mellitus and oncological outcomes in bladder cancer patients undergoing radical cystectomy
Q97527303Association between perioperative glucocorticoids and cancer metastasis and survival in patients undergoing radical cystectomy for urothelial carcinoma of the bladder: A single-center retrospective study
Q92487407Association between perioperative morbidity and mortality after radical cystectomy: an opportunity to understand the complication snowball effect
Q43742712Association between the number of dissected lymph nodes during pelvic lymphadenectomy and cancer-specific survival in patients with lymph node-negative urothelial carcinoma of the bladder undergoing radical cystectomy
Q48293504Association between urinary diversion and quality of life after radical cystectomy
Q46071112Association of Distance to Treatment Facility With Survival and Quality Outcomes After Radical Cystectomy: A Multi-Institutional Study
Q53086009Association of T-cell co-regulatory protein expression with clinical outcomes following radical cystectomy for urothelial carcinoma of the bladder.
Q41148310Association of distance to treatment facility on quality and survival outcomes after radical cystectomy for bladder cancer
Q104288840Association of intraoperative hypothermia with oncologic outcomes following radical cystectomy
Q73366498Association of plasma urokinase-type plasminogen activator and its receptor with clinical outcome in patients undergoing radical cystectomy for transitional cell carcinoma of the bladder
Q54345476Association of procedure volume with radical cystectomy outcomes in a nationwide database.
Q90043400Association of super-extended lymphadenectomy at radical cystectomy with perioperative complications and re-hospitalization
Q37165890Associations among age, comorbidity and clinical outcomes after radical cystectomy: results from the Alberta Urology Institute radical cystectomy database.
Q50160319Associations between Travel Distance, Hospital Volume, and Outcomes Following Radical Cystectomy in Patients with Muscle-Invasive Bladder Cancer
Q37485158Associations between comorbidity, and overall survival and bladder cancer specific survival after radical cystectomy: results from the Alberta Urology Institute Radical Cystectomy database.
Q47880228Associations of specific postoperative complications with costs after radical cystectomy.
Q93050757Atypical Early Recurrence after Robot-Assisted Radical Cystectomy: Port-Site Metastasis
Q92042223Atypical oncologic failure after laparoscopic and robot-assisted radical cystectomy at a single institution
Q100750717Author Reply Re: Bansal D, Nayak B, Singh P, Nayyar R, Ramachandran R, Kumar R, Seth A. Randomized controlled trial to compare outcomes with and without the enhanced recovery after surgery protocol in patients undergoing radical cystectomy. Indian J
Q40214112Avoiding complications with radical cystectomy
Q90929714BCG instillation versus radical cystectomy for high-risk NMIBC with squamous/glandular histologic variants
Q44129192BCG septicemia after radical cystectomy: a rare postoperative complication following BCG therapy
Q59341100BLADDER PRESERVATION MULTIMODALITY THERAPY AS AN ALTERNATIVE TO RADICAL CYSTECTOMY FOR TREATMENT OF MUSCLE INVASIVE BLADDER CANCER
Q57111098Bacillus Calmette-Guérin treatment of urothelial carcinoma arising in the ileal neobladder after radical cystectomy
Q46519956Balancing disease and risk in octogenarians undergoing radical cystectomy
Q41085821Balancing risk and benefit of extended pelvic lymph node dissection in patients undergoing radical cystectomy
Q84739590Baseline renal function status limits patient eligibility to receive perioperative chemotherapy for invasive bladder cancer and is minimally affected by radical cystectomy
Q104556347Bayesian network analysis of open, laparoscopic, and robot-assisted radical cystectomy for bladder cancer
Q78250824Behavior of the rectosigmoid bladder after radical cystectomy and sigmoid colostomy
Q78284128Behavior of the rectosigmoid bladder after radical cystectomy and sigmoid colostomy
Q72842622Behaviour and urodynamic properties of orthotopic ileal bladder substitute after radical cystectomy
Q37710569Behavioural profile and human adaptation of survivors after radical cystectomy and ileal conduit.
Q93157213Beneficial effect of fluid warming in elderly patients with bladder cancer undergoing Da Vinci robotic-assisted laparoscopic radical cystectomy
Q44803113Benefit in regionalisation of care for patients treated with radical cystectomy: a nationwide inpatient sample analysis
Q37053991Benefit of Adjuvant Chemotherapy and Pelvic Lymph Node Dissection in pT3 and Node Positive Bladder Cancer Patients Treated with Radical Cystectomy
Q80374514Benefit of radical cystectomy in the elderly patient with significant co-morbidities
Q93125729Benefits and Complications during the Stay at an Early Rehabilitation Facility after Radical Cystectomy and Orthotopic Ileum Neobladder Reconstruction
Q36352060Benefits of laparoscopic prostate-sparing radical cystectomy
Q38316142Best practices in robot-assisted radical cystectomy and urinary reconstruction: recommendations of the Pasadena Consensus Panel.
Q57130426Better compliance contributes to better nocturnal continence with orthotopic ileal neobladder than ileocolonic neobladder after radical cystectomy for bladder cancer
Q46690466Bilateral vocal cord paralysis after radical cystectomy in a patient with a history of bulbar polio
Q69984128Biochemical and morphologic studies of the prostate gland in men subjected to radical cystectomy
Q48298615Biphasic decline in renal function after radical cystectomy with urinary diversion
Q73675357Bladder Replacement and Urinary Diversion After Radical Cystectomy
Q81588108Bladder cancer after radiotherapy for prostate cancer: detailed analysis of pathological features and outcome after radical cystectomy
Q98287639Bladder cancer following renal transplantation: experiences with radical cystectomy and adjuvant radiotherapy
Q38644602Bladder cancer in 2015: Improving indication, technique and outcome of radical cystectomy
Q38141129Bladder cancer in geriatric patients. Alternatives to radical cystectomy.
Q53742526Bladder cancer in men and women treated by radiation therapy and/or radical cystectomy.
Q44989926Bladder cancer: Conditional survival after radical cystectomy
Q86641725Bladder cancer: biomarker panel predicts recurrence after radical cystectomy
Q87458555Bladder cancer: faster recovery after radical cystectomy with alvimopan
Q84039276Bladder cancer: nomogram aids clinical decision making after radical cystectomy
Q71833944Bladder cancer: results of radical cystectomy for invasive and recurrent superficial tumors
Q84911432Bladder cancer: robot-assisted laparoscopic radical cystectomy: a single-center experience
Q44357692Bladder carcinoma 1: Radical cystectomy, neoadjuvant and adjuvant therapy modalities
Q71525424Bladder carcinoma: results with preoperative radiation therapy and radical cystectomy
Q57050821Bladder preservation approach versus radical cystectomy for high-grade non-muscle-invasive bladder cancer: a meta-analysis of cohort studies
Q81817884Bladder preservation in selected patients with muscle-invasive bladder cancer by complete transurethral resection of the bladder plus systemic chemotherapy: long-term follow-up of a phase 2 nonrandomized comparative trial with radical cystectomy
Q84999374Bladder preservation multimodality therapy as an alternative to radical cystectomy for treatment of muscle invasive bladder cancer
Q42514626Bladder replacement after radical cystectomy using detubularized right colonic segment
Q45891355Bladder replacement by detubed ileo-caecal graft after radical cystectomy
Q68067245Bladder replacement by entero-cystoplasty after radical cystectomy for bladder cancer--the urethral Kock pouch
Q68974871Bladder replacement by ileocystoplasty following radical cystectomy
Q39143350Blood Transfusion Requirement and Not Preoperative Anemia Are Associated with Perioperative Complications Following Intracorporeal Robot-Assisted Radical Cystectomy
Q39890311Blood Transfusion is Associated with Increased Perioperative Morbidity and Adverse Oncologic Outcomes in Bladder Cancer Patients Receiving Neoadjuvant Chemotherapy and Radical Cystectomy
Q35748056Blood loss associated with radical cystectomy: a prospective, randomized study comparing Impact LigaSure vs. stapling device
Q41255396Blood transfusion and hemostatic agents used during radical cystectomy
Q37642096Body image following radical cystectomy and ileal neobladder or conduit in korean patients
Q42604246Bowel preparation and peri-operative management for radical cystectomy in Turkey: Turkish Urooncology Association multicenter survey
Q89122590Building the Case for Adjuvant Chemotherapy After Radical Cystectomy: Commentary on: Effectiveness of Adjuvant Chemotherapy for Locally Advanced Bladder Cancer
Q104280541Bupivacaine local anesthetic to decrease opioid requirements after radical cystectomy: Does formulation matter?
Q44546663Burden and timing of venothrombolic events in patients younger than 65 years undergoing radical cystectomy for bladder cancer
Q102067204C-reactive Protein/Albumin Ratio and Acute Kidney Injury after Radical Cystectomy among Elderly Patients: A Propensity Score-Matched Analysis
Q37407271C5a receptor expression is associated with poor prognosis in urothelial cell carcinoma patients treated with radical cystectomy or nephroureterectomy
Q43143687CORRIGENDUM: A Comparative Study of Fast-Track Versus Conventional Surgery in Patients Undergoing Laparoscopic Radical Cystectomy and Ileal Conduit Diversion: Chinese Experience
Q39677557COUNTERPOINT: Is Immediate Radical Cystectomy Justified When Non-Muscle-Invasive Bladder Cancer First Presents as High-Grade T1 Urothelial Carcinoma on Re-Resection?
Q37424615CT findings in urinary diversion after radical cystectomy: postsurgical anatomy and complications
Q99578183Can anesthetics affect bladder cancer recurrence? Total intravenous versus volatile anesthesia in patients undergoing robot-assisted radical cystectomy: A single institution retrospective analysis
Q81270822Can excretory urography detect upper urinary tract tumors after radical cystectomy for urothelial cancer?
Q100492539Can frozen-section analysis of ureteric margins at the time of radical cystectomy predict upper tract recurrence?
Q53110548Can neutrophil-lymphocyte ratio and lymph node density be used as prognostic factors in patients undergoing radical cystectomy?
Q90416201Can robotic-assisted radical cystectomy provide patients with a smaller trauma and faster recovery period? A systematic review and meta-analysis of comparative trials
Q50910865Can the Preoperative Neutrophil-to-Lymphocyte Ratio Significantly Predict the Conditional Survival Probability in Muscle-invasive Bladder Cancer Patients Undergoing Radical Cystectomy?
Q38605252Cancer and All-Cause Mortality in Bladder Cancer Patients Undergoing Radical Cystectomy: Development and Validation of a Nomogram for Treatment Decision-Making
Q83116462Cancer specific outcomes in patients with pT0 disease following radical cystectomy
Q60622169Cancer-specific mortality following radical cystectomy for bladder cancer with lymph node involvement: impact of pathologic disease features and adjuvant chemotherapy
Q45387855Cancer-specific survival after radical cystectomy and standardized extended lymphadenectomy for node-positive bladder cancer: prediction by lymph node positivity and density
Q77493702Carcinoma in situ and tumor multifocality predict the risk of prostatic urethral involvement at radical cystectomy in men with transitional cell carcinoma of the bladder
Q44028972Carcinoma of the bladder: Treatment by radical cystectomy
Q47831641Cardiopulmonary reserve as determined by cardiopulmonary exercise testing correlates with length of stay and predicts complications after radical cystectomy.
Q30440468Care of the patient undergoing radical cystectomy with a robotic approach.
Q77351993Causes of increased hospital stay after radical cystectomy in a clinical pathway setting
Q78516965Causes of increased length of stay following radical cystectomy
Q54967645Causes, Timing, Hospital Costs and Perioperative Outcomes of Index vs Nonindex Hospital Readmissions after Radical Cystectomy: Implications for Regionalization of Care.
Q38876688Caveolin-1 as prognostic factor of disease recurrence and survival in patients treated with radical cystectomy for bladder cancer
Q44381729Cavernous nerve graft reconstruction during radical prostatectomy or radical cystectomy: safe and technically feasible
Q54960847Challenges facing regionalization of radical cystectomy.
Q34192945Challenging boundaries: an enhanced recovery programme for radical cystectomy
Q37610511Change in Psoas Muscle Volume as a Predictor of Outcomes in Patients Treated with Chemotherapy and Radical Cystectomy for Muscle-Invasive Bladder Cancer
Q58818806Changes in body composition, muscle function and energy expenditure after radical cystectomy
Q44771172Changes in patient characteristics and outcomes for radical cystectomy in England
Q82237310Changes in the upper urinary tract after radical cystectomy and urinary diversion: a comparison of antirefluxing and refluxing orthotopic bladder substitutes and the ileal conduit
Q91949440Characterising 'bounce-back' readmissions after radical cystectomy
Q88010554Characteristics and Associated Factors of Postoperative Pulmonary Complications in Patients Undergoing Radical Cystectomy for Bladder Cancer: A National Surgical Quality Improvement Program Study
Q80274704Characteristics and outcomes of patients with carcinoma in situ only at radical cystectomy
Q43870448Characteristics and outcomes of patients with clinical T1 grade 3 urothelial carcinoma treated with radical cystectomy: results from an international cohort
Q51576729Characteristics and outcomes of patients with clinical carcinoma in situ only treated with radical cystectomy: an international study of 243 patients.
Q51601159Characteristics and outcomes of patients with pT4 urothelial carcinoma at radical cystectomy: a retrospective international study of 583 patients.
Q47233707Characteristics of lymph node metastases defining the outcome after radical cystectomy of urothelial bladder carcinoma
Q50645475Characterization of Late Recurrence After Radical Cystectomy in a Large Multicenter Cohort of Bladder Cancer Patients.
Q104744465Characterization of perioperative androgen profiles in men with bladder cancer undergoing radical cystectomy
Q38833117Characterization of perioperative infection risk among patients undergoing radical cystectomy: Results from the national surgical quality improvement program.
Q92191703Charlson comorbidity score is associated with readmission to the index operative hospital after radical cystectomy and correlates with 90-day mortality risk
Q92544846Chemoradiation Vs Radical Cystectomy for Muscle-invasive Bladder Cancer: A Propensity Score-weighted Comparative Analysis Using the National Cancer Database
Q33448166Chewing gum has a stimulatory effect on bowel motility in patients after open or robotic radical cystectomy for bladder cancer: a prospective randomized comparative study
Q38272281Choroidal and cutaneous metastasis from urothelial carcinoma of the bladder after radical cystectomy: a case report and literature review.
Q50495236Chronic urinary retention after radical cystectomy and orthotopic neobladder in women: Risk factors and relation to time.
Q90955652Cigarette smoking is associated with adverse pathological response and increased disease recurrence amongst patients with muscle-invasive bladder cancer treated with cisplatin-based neoadjuvant chemotherapy and radical cystectomy: a single-centre ex
Q71697406Clearance of serum PSA after open surgery for benign prostatic hypertrophy, radical cystectomy, and radical prostatectomy
Q38655076Clinical Lymphadenopathy in Urothelial Cancer: A Transatlantic Collaboration on Performance of Cross-sectional Imaging and Oncologic Outcomes in Patients Treated with Radical Cystectomy Without Neoadjuvant Chemotherapy
Q38594015Clinical Outcomes After Neoadjuvant Chemotherapy and Radical Cystectomy in the Presence of Urothelial Carcinoma of the Bladder With Squamous or Glandular Differentiation.
Q89056133Clinical Significance of Incidental Prostatic Carcinoma on Radical Cystectomy Histology Specimens: a Clinicopathological and Survival Analysis
Q45022059Clinical analysis of bladder cancer patients treated by radical cystectomy
Q46858107Clinical analysis of bladder cancer patients undergoing radical cystectomy
Q43756593Clinical and patient-reported outcomes of SPARE - a randomised feasibility study of selective bladder preservation versus radical cystectomy
Q41471527Clinical and therapeutic factors associated with adverse pathological outcomes in clinically node-negative patients treated with neoadjuvant cisplatin-based chemotherapy and radical cystectomy
Q99566106Clinical efficacy and safety of enhanced recovery after surgery for patients treated with radical cystectomy and ileal urinary diversion: a systematic review and meta-analysis of randomized controlled trials
Q35618646Clinical evaluation of patients treated with a detubularised isolated ureterosigmoidostomy diversion after radical cystectomy.
Q36090092Clinical experience of laparoscopic-assisted radical cystectomy with continent ileal reservoir
Q36328773Clinical impact of postoperative loss in psoas major muscle and nutrition index after radical cystectomy for patients with urothelial carcinoma of the bladder
Q96223110Clinical markers of morbidity, mortality and survival in bladder cancer patients treated with radical cystectomy. A systematic review
Q37053896Clinical outcome of radical cystectomy for patients with pT4 bladder cancer
Q83335128Clinical outcomes following radical cystectomy for primary nontransitional cell carcinoma of the bladder compared to transitional cell carcinoma of the bladder
Q101061348Clinical outcomes of a cohort of patients with bulky, clinically node-positive bladder cancer undergoing radical cystectomy in the contemporary era
Q51756460Clinical outcomes of patients with pT0 bladder cancer after radical cystectomy: a single-institute experience.
Q93122518Clinical outcomes of robot-assisted radical cystectomy and continent urinary diversion
Q85726345Clinical outcomes of urothelial carcinoma of the prostate detected in radical cystectomy specimens
Q84378687Clinical predictive factors of poor outcome in patients with stage pT0 disease at radical cystectomy
Q91916718Clinical predictors and survival outcome of patients receiving suboptimal neoadjuvant chemotherapy and radical cystectomy for muscle-invasive bladder cancer: a single-center experience
Q37447069Clinical prognostic factors for radical cystectomy in bladder cancer
Q38140068Clinical significance of ureteric 'skip lesions' at the time of radical cystectomy: the M.D. Anderson experience and literature review.
Q74216421Clinical under staging of high risk nonmuscle invasive urothelial carcinoma treated with radical cystectomy
Q34786617Clinical use of serum CA-125 levels in patients undergoing radical cystectomy for transitional cell carcinoma of the bladder
Q40739560Clinical variables which serve as predictors of cancer-specific survival among patients treated with radical cystectomy for transitional cell carcinoma of the bladder and prostate
Q30784290Clinical-pathologic stage discrepancy in bladder cancer patients treated with radical cystectomy: results from the national cancer data base
Q90571307Clinically node-positive (cN+) urothelial carcinoma of the bladder treated with chemotherapy and radical cystectomy: Clinical outcomes and development of a postoperative risk stratification model
Q36864718Clinicopathologic features of prostate adenocarcinoma incidentally discovered at the time of radical cystectomy: an evidence-based analysis
Q92029546Clinicopathological factors in bladder cancer for cancer-specific survival outcomes following radical cystectomy: a systematic review and meta-analysis
Q82664109Clinicopathological features of recurrence after radical cystectomy for patients with transitional cell carcinoma of the bladder
Q84437364Clinicopathological outcomes after radical cystectomy for clinical T2 urothelial carcinoma: further evidence to support the use of neoadjuvant chemotherapy
Q57071535Colony-stimulating factors detected in tumor cells and voided urine are potential prognostic markers for patients with muscle-invasive bladder cancer undergoing radical cystectomy
Q46385900Combination chemotherapy of ifosfamide, 5-fluorouracil, etoposide and cisplatin as perioperative treatment in lymph node positive bladder carcinoma patients treated by radical cystectomy
Q46506619Combined general and epidural anaesthesia versus general anaesthesia for radical cystectomy
Q90750294Combined reporting of surgical quality, cancer control and functional outcomes of robot-assisted radical cystectomy with intracorporeal orthotopic neobladder into a novel trifecta
Q86033904Comment re: Sternberg CN, Skoneczna I, Kerst JM, et al. Immediate Versus Deferred Chemotherapy After Radical Cystectomy in Patients with pT3-pT4 or N+ M0 Urothelial Carcinoma of the Bladder (EORTC 30994): An Intergroup, Open-label, Randomised Phase
Q89029849Commentary on "Detection and oncological effect of circulating tumor cells in patients with variant urothelial carcinoma histology treated with radical cystectomy."
Q86365585Commentary on "Impact of statin use on oncologic outcomes in patients with urothelial carcinoma ofthe bladder treated with radical cystectomy." da Silva RD, Xylinas E, Kluth L, Crivelli JJ, Chrystal J, Chade D, Guglielmetti GB, Pycha A, Lotan Y, Kar
Q44199136Commentary on "Predictive capacity of four comorbidity indices estimating perioperative mortality after radical cystectomy for urothelial carcinoma of the bladder." Mayr R, May M, Martini T, Lodde M, Pycha A, Comploj E, Wieland WF, Denzinger S, Otto
Q41713681Commentary on "Robot-assisted laparoscopic vs open radical cystectomy: Comparison of complications and perioperative oncological outcomes in 200 patients." Kader AK, Richards KA, Krane LS, Pettus JA, Smith JJ, Hemal AK, Division of Urology, UC San D
Q38116604Commentary on "Surveillance guidelines based on recurrence patterns after radical cystectomy for bladder cancer: the Canadian Bladder Cancer Network experience." Yafi FA, Aprikian AG, Fradet Y, Chin JL, Izawa J, Rendon R, Estey E, Fairey A, Cagianno
Q57020510Comments on Brimo F, Downes MR, Jamaspishvili T, Berman D, Barkan G, Athanazio D, Abro S, Visram K, Yilmaz A, Solanki S, Hahn E, Siemens R, Kassouf W, Trpkov K. Prognostic pathological factors in radical cystectomy after neoadjuvant chemotherapy. His
Q44084230Comorbidity and performance indices as predictors of cancer-independent mortality but not of cancer-specific mortality after radical cystectomy for urothelial carcinoma of the bladder
Q50942157Comorbidity relationship to outcome of radical cystectomy in Chinese: a single institution study with the ACE-27 comorbidity index.
Q93220405Comparative Effectiveness in Perioperative Outcomes of Robotic versus Open Radical Cystectomy: Results from a Multicenter Contemporary Retrospective Cohort Study
Q93348927Comparative Effectiveness of Bladder-preserving Tri-modality Therapy Versus Radical Cystectomy for Muscle-invasive Bladder Cancer
Q38835752Comparative Effectiveness of Trimodal Therapy Versus Radical Cystectomy for Localized Muscle-invasive Urothelial Carcinoma of the Bladder
Q40069486Comparative Perioperative Outcomes in Septuagenarians and Octogenarians Undergoing Radical Cystectomy for Bladder Cancer-Do Outcomes Differ?
Q34467381Comparative analysis of early perioperative outcomes following radical cystectomy by either the robotic or open method.
Q51897069Comparative analysis of laparoscopic and robot-assisted radical cystectomy with ileal conduit urinary diversion.
Q51386151Comparative analysis of outcomes and costs following open radical cystectomy versus robot-assisted laparoscopic radical cystectomy: results from the US Nationwide Inpatient Sample.
Q40381359Comparative analysis of the effect of prostatic invasion patterns on cancer-specific mortality after radical cystectomy in pT4a urothelial carcinoma of the bladder
Q89826168Comparative effectiveness of open, laparoscopic and robot-assisted radical cystectomy for bladder cancer: a systematic review and network meta-analysis
Q92233819Comparative effectiveness of palliative chemotherapy versus neoadjuvant chemotherapy followed by radical cystectomy versus cystectomy followed by adjuvant chemotherapy versus cystectomy for regional node-positive bladder cancer: A retrospective anal
Q92896579Comparative effectiveness of radical cystectomy and radiotherapy without chemotherapy in frail patients with bladder cancer
Q47249826Comparative effectiveness of robot-assisted vs. open radical cystectomy
Q50930128Comparative impact of continent and incontinent urinary diversion on long-term renal function after radical cystectomy in patients with preoperative chronic kidney disease 2 and chronic kidney disease 3a.
Q36953757Comparative outcomes of pure squamous cell carcinoma and urothelial carcinoma with squamous differentiation in patients treated with radical cystectomy.
Q44237046Comparative performance of comorbidity indices for estimating perioperative and 5-year all cause mortality following radical cystectomy for bladder cancer
Q91014519Comparative sensitivity and specificity of imaging modalities in staging bladder cancer prior to radical cystectomy: a systematic review and meta-analysis
Q45336033Comparative study of morbidity and mortality between ileal conduit and ureterosigmoidostomy after radical cystectomy for bladder neoplasm.
Q34747411Comparative study of various forms of urinary diversion after radical cystectomy in muscle invasive carcinoma urinary bladder
Q35582575Comparing Open Radical Cystectomy and Robot-assisted Laparoscopic Radical Cystectomy: A Randomized Clinical Trial
Q90326600Comparing Provider-Led Sexual Health Counseling of Male and Female Patients Undergoing Radical Cystectomy
Q89337029Comparing Survival Outcomes and Costs Associated With Radical Cystectomy and Trimodal Therapy for Older Adults With Muscle-Invasive Bladder Cancer
Q87071909Comparing long-term outcomes of primary and progressive carcinoma invading bladder muscle after radical cystectomy
Q90807508Comparing open-radical cystectomy and robot-assisted radical cystectomy: current status and analysis of the evidence
Q96767851Comparing peri-operative complications between laparoscopic and robotic radical cystectomy for bladder cancer
Q41581386Comparing the Effects of Combined General/Epidural Anaesthesia and General Anaesthesia on Serum Cytokine Levels in Radical Cystectomy.
Q71956921Comparison between results of ileal conduit and continent ileal bladder (VIP), after radical cystectomy
Q68355713Comparison between short-course high-dose preoperative irradiation with immediate radical cystectomy and salvage cystectomy after full-dose irradiation
Q90468770Comparison of 2-Year Oncological Outcome and Early Recurrence Patterns in Patients with Urothelial Bladder Carcinoma Treated with Open or Robot-Assisted Radical Cystectomy with an Extracorporeal Urinary Diversion
Q53504464Comparison of 2002 TNM nodal status with lymph node density in node-positive patients after radical cystectomy for bladder cancer: analysis by the number of lymph nodes removed.
Q42238126Comparison of 90-day complications between ileal conduit and neobladder reconstruction after radical cystectomy: a retrospective multi-institutional study in Japan
Q92538945Comparison of Costs of Radical Cystectomy vs Trimodal Therapy for Patients With Localized Muscle-Invasive Bladder Cancer
Q102055473Comparison of Laparoendoscopic Single-Site and Laparoscopic Radical Cystectomy for Male Patients with Bladder Cancer: Perioperative and Oncologic Outcomes
Q91863552Comparison of Laparoscopic and Robot-assisted Radical Cystectomy for Bladder Cancer: Perioperative and Oncologic Outcomes
Q98954116Comparison of Major Complications at 30 and 90 days Following Radical Cystectomy
Q100395997Comparison of Outcomes Between Radical Radiotherapy and Radical Cystectomy in Muscle Invasive Bladder Cancer in a Cancer Specialized Unit of a Developing Country
Q89136920Comparison of Outcomes in Patients With Muscle-invasive Bladder Cancer Treated With Radical Cystectomy Versus Bladder Preservation
Q53354088Comparison of Perioperative Morbidity of Radical Cystectomy With Neobladder Versus Ileal Conduit: A Matched Pair Analysis of 170 Patients.
Q88914640Comparison of Perioperative Outcomes Between Open and Robotic Radical Cystectomy: A Population-Based Analysis
Q90993391Comparison of Preoperative Neutrophil-Lymphocyte and Platelet-Lymphocyte Ratios in Bladder Cancer Patients Undergoing Radical Cystectomy
Q97566135Comparison of a Significant Decline in the Glomerular Filtration Rate between Ileal Conduit and Ileal Neobladder Urinary Diversions after Radical Cystectomy: A Propensity Score-Matched Analysis
Q38783985Comparison of anesthetic management and outcomes of robot-assisted versus open radical cystectomy
Q44227310Comparison of complications from radical cystectomy between old-old versus oldest-old patients
Q42619234Comparison of early postoperative morbidity after robot-assisted and open radical cystectomy: results of a prospective observational study.
Q43294016Comparison of epidural and intravenous patient controlled analgesia in patients undergoing radical cystectomy.
Q82984571Comparison of hand-assisted laparoscopic and open radical cystectomy for bladder cancer
Q39153843Comparison of initial experiences of robot-assisted radical cystectomy with those of laparoscopic for bladder cancer
Q90081438Comparison of intracorporeal and extracorporeal urinary diversions after laparoscopic radical cystectomy in females with bladder cancer
Q51584341Comparison of modified Taguchi and Bricker ureteral reimplantation techniques after radical cystectomy.
Q41998977Comparison of outcomes between trimodal therapy and radical cystectomy in muscle-invasive bladder cancer: a propensity score matching analysis
Q51053993Comparison of pathological staging and grading of urothelial bladder carcinoma in post-transurethral resection and post-radical cystectomy specimens.
Q89800313Comparison of perioperative and oncologic outcomes between robot-assisted and laparoscopic radical cystectomy for bladder cancer: a systematic review and updated meta-analysis
Q64884209Comparison of perioperative complications and health-related quality of life between robot-assisted and open radical cystectomy: A systematic review and meta-analysis.
Q91620708Comparison of perioperative outcomes and complications of robot assisted radical cystectomy with extracorporeal vs intracorporeal urinary diversion
Q37028090Comparison of perioperative outcomes for epidural versus intravenous patient-controlled analgesia after radical cystectomy
Q92546431Comparison of perioperative outcomes in robot-assisted radical cystectomy and laparoscopic radical cystectomy
Q37257074Comparison of postoperative acute kidney injury between ileal conduit and neobladder urinary diversions after radical cystectomy: A propensity score matching analysis
Q48066795Comparison of radical cystectomy and chemoradiotherapy in patients with locally advanced bladder cancer
Q54549413Comparison of radical cystectomy with conservative treatment in geriatric (≥80) patients with muscle-invasive bladder cancer.
Q47326201Comparison of readmission and short-term mortality rates between different types of urinary diversion in patients undergoing radical cystectomy
Q100511765Comparison of renal function after open radical cystectomy, extracorporeal robot assisted radical cystectomy, and intracorporeal robot assisted radical cystectomy
Q38784370Comparison of robotic-assisted and open radical cystectomy in a community-based, non-tertiary health care setting
Q84372934Comparison of surgical stress response to laparoscopic and open radical cystectomy
Q79866954Comparison of the clinical and pathologic staging in patients undergoing radical cystectomy for bladder cancer
Q39921660Comparison of the clinical effectiveness of 3D and 2D imaging systems for laparoscopic radical cystectomy with pelvic lymph node dissection
Q52678462Comparison of the prognosis of primary and progressive muscle-invasive bladder cancer after radical cystectomy: A systematic review and meta-analysis.
Q102209786Comparison of the prognosis of primary vs. progressive muscle invasive bladder cancer after radical cystectomy: Results from a large multicenter study
Q36183644Comparison of two kinds of cutaneous ureterostomy using in radical cystectomy
Q38889141Complete Tissue Submission to Increase Lymph Node Detection in Pelvic Lymph Node Packets Submitted for Patients Undergoing Radical Prostatectomy and Radical Cystectomy
Q52965436Complete laparoscopic approach for radical cystectomy and continent urinary diversion (sigma rectum pouch).
Q31024148Complete long-term survival data from a trial of adjuvant chemotherapy vs control after radical cystectomy for locally advanced bladder cancer
Q83314613Complete long-term survival data from a trial of adjuvant chemotherapy vs control after radical cystectomy for locally advanced bladder cancer
Q41305192Complications after ileal conduit: Urinary diversion-associated complications after radical cystectomy
Q31047164Complications after radical cystectomy: analysis of population-based data
Q42276444Complications after robot-assisted radical cystectomy: results from the International Robotic Cystectomy Consortium.
Q38646225Complications and health-related quality of life after robot-assisted versus open radical cystectomy: a systematic review and meta-analysis of four RCTs.
Q51625691Complications and mortality after radical cystectomy for bladder transitional cell cancer.
Q37105651Complications and oncologic outcomes following robot-assisted radical cystectomy: What is the real benefit?
Q47809069Complications and quality of life in elderly patients with several comorbidities undergoing cutaneous ureterostomy with single stoma or ileal conduit after radical cystectomy.
Q91313538Complications and reoperations after laparoscopic radical cystectomy in a Japanese multicenter cohort
Q37501415Complications following radical cystectomy for bladder cancer in the elderly
Q73430784Complications for radical cystectomy. Impact of the American Society of Anesthesiologists score
Q38443264Complications from robot-assisted radical cystectomy: Where do we stand?
Q79822974Complications in laparoscopic radical cystectomy. The South American experience with 59 cases
Q81479579Complications in radical cystectomy performed at a teaching hospital
Q49356663Complications instead of improved survival and local freedom from recurrence after early radical cystectomy in muscle-invasive bladder cancer compared to multimodal maintenance therapy
Q104285701Complications of Ileal Conduits after Radical Cystectomy: Interventional Radiologic Management
Q26772314Complications of Radical Cystectomy and Orthotopic Reconstruction
Q40829428Complications of a single stage radical cystectomy and ileal conduit diversion: review of 214 cases
Q35830345Complications of laparoscopic radical cystectomy during the initial experience.
Q39853533Complications of radical cystectomy and correlation with nutritional assessment
Q35525667Complications of radical cystectomy and urinary diversion: a retrospective review of 675 cases in 2 decades
Q71334948Complications of radical cystectomy for carcinoma of the bladder
Q78645458Complications of radical cystectomy for nonmuscle invasive disease: comparison with muscle invasive disease
Q36790510Complications of radical cystectomy.
Q71180121Complications of radical cystectomy: impact of the timing of perioperative chemotherapy
Q71494477Complications of single-stage radical cystectomy and ileal conduit
Q40365823Complications of ureteroileal conduit with radical cystectomy: review of 336 cases
Q50016406Complications within 90 days after radical cystectomy for bladder cancer: results of a multicenter prospective study in Japan
Q91208921Comprehensive characterization of perioperative reoperation following radical cystectomy
Q53923251Computed Tomography Loopogram: A Novel Technique for Upper Tract Evaluation After Radical Cystectomy.
Q69755482Computerized tomography: an unreliable method for accurate staging of bladder tumors in patients who are candidates for radical cystectomy
Q89036843Concomitant CIS on TURBT does not impact oncological outcomes in patients treated with neoadjuvant or induction chemotherapy followed by radical cystectomy
Q79163021Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ-confined TCC at radical cystectomy
Q92663523Concomitant carcinoma in situ may not be a prognostic factor for patients with bladder cancer following radical cystectomy: a PRISMA-compliant systematic review and meta-analysis
Q88013005Concomitant seminal vesicle invasion in pT4a urothelial carcinoma of the bladder with contiguous prostatic infiltration is an adverse prognosticator for cancer-specific survival after radical cystectomy
Q57582151Concordance and Clinical Significance of Uncommon Variants of Bladder Urothelial Carcinoma in Transurethral Resection and Radical Cystectomy Specimens
Q37053926Concordance in Biomarker Status Between Bladder Tumors at Time of Transurethral Resection and Subsequent Radical Cystectomy: Results of a 5-year Prospective Study
Q71536563Concurrent cisplatin and radiotherapy for patients with muscle invasive bladder cancer who are not candidates for radical cystectomy
Q53101324Conditional survival after radical cystectomy for bladder cancer: evidence for a patient changing risk profile over time.
Q59649528Conditional survival of patients with urothelial carcinoma of the urinary bladder treated with radical cystectomy
Q51768028Contemporary 90-day mortality rates after radical cystectomy in the elderly.
Q88344201Contemporary Preoperative and Intraoperative Management of the Radical Cystectomy Patient
Q78645471Contemporary concepts of radical cystectomy and the treatment of bladder cancer
Q38833271Contemporary evidence for robot-assisted radical cystectomy for treating bladder cancer
Q38206405Contemporary gender-specific outcomes in Germany after radical cystectomy for bladder cancer
Q36111236Contemporary management of the urethra in patients after radical cystectomy for bladder cancer
Q40121742Contemporary open radical cystectomy: analysis of perioperative outcomes
Q44829874Contemporary outcomes of 2287 patients with bladder cancer who were treated with radical cystectomy: a Canadian multicentre experience
Q41428274Contemporary radical cystectomy outcomes in patients with invasive bladder cancer: a population-based study
Q88498839Contemporary rates of adherence to international guidelines for pelvic lymph node dissection in radical cystectomy: a population-based study
Q98509221Contemporary treatment patterns for Non-Muscle Invasive Bladder Cancer: Has the Use of Radical Cystectomy changed in the BCG Shortage Era?
Q46026027Contemporary trends of in-hospital complications and mortality for radical cystectomy.
Q91643806Contemporary trends of pelvic lymph node dissection at radical cystectomy for urothelial carcinoma of urinary bladder and associated cancer specific mortality and complications: comparison between octogenarian versus younger patients
Q91517907Contemporary use and survival after perioperative systemic chemotherapy in patients with locally advanced non-metastatic urothelial carcinoma of the bladder treated with radical cystectomy
Q38661971Contemporary use trends and survival outcomes in patients undergoing radical cystectomy or bladder-preservation therapy for muscle-invasive bladder cancer
Q40553448Continent and orthotopic urinary diversion following radical cystectomy. Should these reconstructive procedures now be considered standard of care?
Q53630444Continent urinary diversion after radical cystectomy: 3 years' experience.
Q91447931Continuous Erector Spinae Plane and Intrathecal Opioid Analgesia: Novel Regimen Avoiding Thoracic Epidural Analgesia and Systemic Morphine in Open Radical Cystectomy: A Case Series
Q51853959Controlled hypotensive anesthesia to reduce blood loss in radical cystectomy for bladder cancer.
Q38559138Controversies in Robotics: Open Versus Robotic Radical Cystectomy
Q41346526Copy number variations of circulating, cell-free DNA in urothelial carcinoma of the bladder patients treated with radical cystectomy: a prospective study
Q96953057Coronavirus (COVID-19) Pandemic and Radical Cystectomy
Q91406203Correction to: Prognostic Role of the Immunoscore for Patients with Urothelial Carcinoma of the Bladder Who Underwent Radical Cystectomy
Q60556407Correction: Multifactorial, Site-Specific Recurrence Models after Radical Cystectomy for Urothelial Carcinoma: External Validation in a Cohort of Korean Patients
Q92667812Correction: Robot-assisted radical cystectomy with intracorporeal urinary diversion versus open radical cystectomy (iROC): protocol for a randomised controlled trial with internal feasibility study
Q53325245Correlation between biopsy and radical cystectomy in assessing grade and depth of invasion in bladder urothelial carcinoma.
Q61952795Correlation between malnutrition, body mass index and complications in patients with urinary bladder cancer who underwent radical cystectomy
Q90958451Correlation between organ-specific co-morbidities and complications in bladder cancer patients undergoing radical cystectomy
Q38460001Correlation of immunohistochemical molecular staging of bladder biopsies and radical cystectomy specimens
Q49099007Corrigendum re: "Early Recurrence Patterns Following Totally Intracorporeal Robot-assisted Radical Cystectomy: Results from the EAU Robotic Urology Section (ERUS) Scientific Working Group" [Eur Urol 2017;71:723-6].
Q46847991Corrigendum to "Characteristics and Outcomes of Patients with Clinical T1 Grade 3 Urothelial Carcinoma Treated with Radical Cystectomy: Results from an International Cohort" [Eur Urol 2010;57:300-9].
Q96637842Corrigendum to Xanthogranulomatous Ureteritis Mimicking Ureteral Involvement by Cancer in a Radical Cystectomy Specimen
Q38672150Cost Analysis of the Enhanced Recovery After Surgery Protocol in Patients Undergoing Radical Cystectomy for Bladder Cancer
Q38062887Cost analysis of open radical cystectomy versus robot-assisted radical cystectomy
Q42695341Cost analysis of open radical cystectomy versus robot-assisted radical cystectomy.
Q51767288Cost analysis of robotic versus open radical cystectomy for bladder cancer.
Q34123987Cost benefits of intraoperative cell salvage in radical cystectomy
Q91191968Cost comparison between open radical cystectomy, laparoscopic radical cystectomy, and robot-assisted radical cystectomy for patients with bladder cancer: a systematic review of segmental costs
Q96748475Cost comparison of laparoscopic versus robot-assisted radical cystectomy
Q90392164Cost-Effectiveness of Robot-assisted Radical Cystectomy Using a Propensity-matched Cohort
Q27021586Cost-analysis comparison of robot-assisted laparoscopic radical cystectomy (RC) vs open RC
Q84415859Cost-effectiveness analysis of immediate radical cystectomy versus intravesical Bacillus Calmette-Guerin therapy for high-risk, high-grade (T1G3) bladder cancer
Q38226736Cost-effectiveness of neoadjuvant chemotherapy before radical cystectomy for muscle-invasive bladder cancer
Q81515542Costs of radical cystectomy
Q87132740Critical Analysis of Early Recurrence after Laparoscopic Radical Cystectomy in a Large Cohort by the ESUT
Q40502548Critical Analysis of Hospital Readmission and Cost Burden After Robot-Assisted Radical Cystectomy
Q39445151Critical Review of Outcomes from Radical Cystectomy: Can Complications from Radical Cystectomy Be Reduced by Surgical Volume and Robotic Surgery?
Q42632953Critical analysis of complications after robotic-assisted radical cystectomy with identification of preoperative and operative risk factors
Q84106224Critical evaluation of the American Joint Committee on Cancer TNM nodal staging system in patients with lymph node-positive disease after radical cystectomy
Q40805887Critical review of radical cystectomy and indicators of prognosis.
Q38791867Current Status of Robot-Assisted Radical Cystectomy and Intracorporeal Urinary Diversion
Q26779973Current Status of Robot-Assisted Radical Cystectomy: What is the Real Benefit?
Q35898119Current Strategies to Enhance Recovery following Radical Cystectomy: Single Centre Initial Experience
Q90227024Current Zero clamping technique during radical cystectomy
Q99718829Current evidence for robotic surgery in radical cystectomy
Q36982116Current perioperative management of radical cystectomy with intestinal urinary reconstruction for muscle-invasive bladder cancer and reduction of the incidence of postoperative ileus
Q92303630Current status and future perspective of robot-assisted radical cystectomy for invasive bladder cancer
Q37826124Current status and outcomes of robot-assisted laparoscopic radical cystectomy and urinary diversion.
Q70794125Current status of adjuvant chemotherapy after radical cystectomy for deeply invasive bladder cancer
Q89701039Current status of laparoscopic and robot-assisted nerve-sparing radical cystectomy in male patients
Q38114947Current status of minimally invasive radical cystectomy: an outcome-based comparison
Q37624387Current status of robot-assisted radical cystectomy
Q38030860Current status of robot-assisted radical cystectomy for bladder cancer
Q38203741Current status of robotic and laparoscopic techniques in radical cystectomy and diversion procedures for bladder cancer: review
Q38564954Current status of robotic assisted radical cystectomy with intracorporeal ileal neobladder for bladder cancer
Q92679701Current treatment of pediatric bladder and prostate rhabdomyosarcoma (bladder preserving vs. radical cystectomy)
Q39469634Cutaneous ureterostomy with definitive ureteral stent as urinary diversion option in unfit patients after radical cystectomy.
Q95654609Cytotoxic T-cell-related gene expression signature predicts improved survival in muscle-invasive urothelial bladder cancer patients after radical cystectomy and adjuvant chemotherapy
Q96639067D2-40/podoplanin expression in cancer stroma by immunohistochemical staining is associated with poor prognosis in bladder cancer patients after radical cystectomy
Q90169903De Ritis Ratio (Aspartate Transaminase/Alanine Transaminase) as a Significant Prognostic Factor in Patients Undergoing Radical Cystectomy with Bladder Urothelial Carcinoma: A Propensity Score-Matched Study
Q51783821Decrease in incidence of surgical site infections in contemporary series of patients with radical cystectomy.
Q92552533Decrease in skeletal muscle index 1 year after radical cystectomy as a prognostic indicator in patients with urothelial bladder cancer
Q38982801Decreased Overall and Bladder Cancer-Specific Mortality with Adjuvant Chemotherapy After Radical Cystectomy: Multivariable Competing Risk Analysis
Q78953922Decreasing blood loss in patients treated with radical cystectomy: a prospective randomizes trial using a new stapling device
Q61454788Decreasing incidence of venous thromboembolic events after radical cystectomy: are we finally improving?
Q46452421Decreasing operative time and incontinence rates in patients treated with radical cystectomy and urethral diversion: a prospective randomized trial using a new suturing device (CAPIO).
Q59798082Decreasing rates of venous thromboembolism after radical cystectomy: an encouraging trend and more work is still needed
Q40542218Deep Surgical Site Infections after Open Radical Cystectomy and Urinary Diversion Significantly Increase Hospitalisation Time and Total Treatment Costs
Q51337185Deep venous thrombosis in patients undergoing salvage radical cystectomy.
Q45217289Defining Morbidity of Robot-Assisted Radical Cystectomy Using a Standardized Reporting Methodology
Q91648791Defining a "High Volume" Radical Cystectomy Hospital: Where Do We Draw the Line?
Q81733374Defining early morbidity of radical cystectomy for patients with bladder cancer using a standardized reporting methodology
Q98193361Defining postoperative ileus and associated risk factors in patients undergoing radical cystectomy with an Enhanced Recovery After Surgery (ERAS) program
Q50769053Defining the minimum hospital case-load to achieve optimum outcomes in radical cystectomy.
Q104749697Definition of a Structured Training Curriculum for Robot-assisted Radical Cystectomy with Intracorporeal Ileal Conduit in Male Patients: A Delphi Consensus Study Led by the ERUS Educational Board
Q38067928Definition, incidence, risk factors, and prevention of paralytic ileus following radical cystectomy: a systematic review
Q93143623Definitive BCG immunotherapy versus radical cystectomy in intermediate or high-risk nonmuscle invasive bladder cancer patients: A retrospective study
Q70508209Definitive and adjunctive external irradiation in bladder cancer without radical cystectomy
Q96349426Delayed blood transfusion is associated with mortality following radical cystectomy
Q42630735Delayed massive hemorrhage due to external iliac artery pseudo-aneurysm and uretero-iliac artery fistula following robotic radical cystectomy and intracorporeal Studer pouch reconstruction: Endovascular management of an unusual complication.
Q91661214Delaying Radical Cystectomy After Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer is Associated with Adverse Survival Outcomes
Q79075055Delaying Radical Cystectomy for Muscle Invasive Bladder Cancer Results in Worse Pathological Stage
Q92165244Delays in radical cystectomy for muscle-invasive bladder cancer
Q97566419Detailed Analysis of Urinary Tract Infections after Robot-Assisted Radical Cystectomy
Q51375032Detailed histological investigation of the female urethra: application to radical cystectomy.
Q38843266Detecting asymptomatic recurrence after radical cystectomy contributes to better prognosis in patients with muscle-invasive bladder cancer
Q39063627Detection and Clinical Significance of Circulating Tumor Cells in Patients Undergoing Radical Cystectomy for Urothelial Bladder Cancer
Q38969871Detection and oncological effect of circulating tumour cells in patients with variant urothelial carcinoma histology treated with radical cystectomy
Q88152991Detection and oncological effect of circulating tumour cells in patients with variant urothelial carcinoma histology treated with radical cystectomy
Q48881544Detection of asymptomatic recurrence during routine oncological followup after radical cystectomy is associated with improved patient survival
Q46493694Detection of micrometastases in pelvic lymph nodes in patients undergoing radical cystectomy for locally invasive bladder cancer by real-time reverse transcriptase-PCR for cytokeratin 19 and uroplakin II.
Q82362861Detection of nuclear matrix protein 22 and survivin baseline level in patients after radical cystectomy
Q39636706Determinants of radical cystectomy operative time
Q45771451Determining factors for hospital discharge status after radical cystectomy in a large contemporary cohort
Q88144236Determining the optimal time for radical cystectomy after neoadjuvant chemotherapy
Q72733771Detubularized sigmoid colon for bladder replacement after radical cystectomy
Q44681885Detubularized sigmoid neobladder versus detubularized W-shaped ileal neobladder as a bladder substitute after radical cystectomy for carcinoma of the urinary bladder: a study of 60 patients.
Q92110322Development and Acceptability Testing of a Patient Decision Aid for Urinary Diversion with Radical Cystectomy
Q97417439Development and Cross-Validation of a Nomogram for Chronic Kidney Disease Following Robot-Assisted Radical Cystectomy
Q37551255Development and Validation of Consensus Contouring Guidelines for Adjuvant Radiation Therapy for Bladder Cancer After Radical Cystectomy
Q99403825Development and Validation of a Model for Predicting Urethral Recurrence in Male Patients with Muscular Invasive Bladder Cancer After Radical Cystectomy Combined with Urinary Diversion
Q47401845Development and Validation of a Quality Assurance Score for Robot-assisted Radical Cystectomy: A 10-year Analysis.
Q44042378Development and external validation of lymph node density cut-off points in prospective series of radical cystectomy and pelvic lymph node dissection
Q41647263Development and external validation of nomograms predicting disease-free and cancer-specific survival after radical cystectomy
Q30470690Development and implementation of a clinical pathway for radical cystectomy and urinary system reconstruction
Q100667174Development and validation of a prognostic nomogram for predicting cancer-specific survival after radical cystectomy in patients with bladder cancer:A population-based study
Q44276267Development and validation of a reference table for prediction of postoperative mortality rate in patients treated with radical cystectomy: a population-based study
Q52321739Development and validation of surgical training tool: cystectomy assessment and surgical evaluation (CASE) for robot-assisted radical cystectomy for men.
Q92664281Development of a New Comorbidity Assessment Tool for Specific Prediction of Perioperative Mortality in Contemporary Patients Treated with Radical Cystectomy
Q57192145Development of a Prediction Tool for Exclusive Locoregional Recurrence After Radical Cystectomy in Patients With Muscle-Invasive Bladder Cancer
Q50225627Development of a Preoperative Nomogram Incorporating Biomarkers of Systemic Inflammatory Response to Predict Nonorgan-confined Urothelial Carcinoma of the Bladder at Radical Cystectomy.
Q84919645Development of a nomogram to predict non-organ-confined bladder urothelial cancer before radical cystectomy
Q38722878Development of a patient and institutional-based model for estimation of operative times for robot-assisted radical cystectomy: results from the International Robotic Cystectomy Consortium.
Q46468318Development, validation and clinical application of Pelvic Lymphadenectomy Assessment and Completion Evaluation: intraoperative assessment of lymph node dissection after robot-assisted radical cystectomy for bladder cancer.
Q38865764Diabetes and elevated urea level predict for uretero-ileal stricture after radical cystectomy and ileal conduit formation
Q80608260Diagnosis, risk factors, and outcome of urethral recurrences following radical cystectomy for bladder cancer in 729 male patients
Q40356169Diagnostic Accuracy of Hexaminolevulinate in a Cohort of Patients Undergoing Radical Cystectomy.
Q60606984Diagnostic Efficacy of [11C]Choline Positron Emission Tomography/Computed Tomography Compared With Conventional Computed Tomography in Lymph Node Staging of Patients With Bladder Cancer Prior to Radical Cystectomy
Q41176058Diagnostic accuracy of intraoperative frozen sections during radical cystectomy does not affect disease-free or overall survival: a study of 364 patients with urothelial carcinoma of the urinary bladder
Q67906837Diagnostic and therapeutic aspects of impotence secondary to radical cystectomy and prostatectomy
Q50207486Diarrhea and flatulence are major bowel disorders after radical cystectomy: Results from a cross-sectional study in bladder cancer patients
Q90708863Differences in short-term outcomes between open versus robot-assisted radical cystectomy in frail malnourished patients
Q91766029Differences in trends in the use of robot-assisted and open radical cystectomy and changes over time in peri-operative outcomes among selected centres in North America and Europe: an international multicentre collaboration
Q90354874Different models for prediction of radical cystectomy postoperative complications and care pathways
Q82293052Differential complication rates following radical cystectomy in the irradiated and nonirradiated pelvis
Q52995953Differential effect on survival of pelvic lymph node dissection at radical cystectomy for muscle invasive bladder cancer.
Q61917185Diffusion-weighted magnetic resonance imaging in patients selected for radical cystectomy: detection rate of pelvic lymph node metastases
Q46474298Discharge patterns after radical cystectomy: contemporary trends in the United States
Q79772772Discrepancy between clinical and pathologic stage: impact on prognosis after radical cystectomy
Q82479264Discrepancy between clinical and pathological stage: external validation of the impact on prognosis in an international radical cystectomy cohort
Q83229154Discrepancy between clinical and pathological stage: external validation of the impact on prognosis in an international radical cystectomy cohort
Q52650771Discriminative Ability of Commonly Used Indexes to Predict Adverse Outcomes After Radical Cystectomy: Comparison of Demographic Data, American Society of Anesthesiologists, Modified Charlson Comorbidity Index, and Modified Frailty Index.
Q74327063Disease specific survival as endpoint of outcome for bladder cancer patients following radical cystectomy
Q36221402Disease-Free Survival at 2 and 3 Years is a Significant Early Surrogate Marker Predicting the 5-Year Overall Survival in Patients Treated with Radical Cystectomy for Urothelial Carcinoma of the Bladder: External Evaluation and Validation in a Cohort
Q43814020Disease-free survival at 2 or 3 years correlates with 5-year overall survival of patients undergoing radical cystectomy for muscle invasive bladder cancer
Q49763935Disparities in the Use of Continent Urinary Diversions after Radical Cystectomy for Bladder Cancer
Q69729875Dissection of the prostatic apex for radical cystectomy and detubed ileocystoplasty
Q43346730Distressful symptoms after radical cystectomy with urinary diversion for urinary bladder cancer: a Swedish population-based study
Q51045913Distressful symptoms and well-being after radical cystectomy and orthotopic bladder substitution compared with a matched control population.
Q37053768Do African American Patients Treated with Radical Cystectomy for Bladder Cancer have Worse Overall Survival? Accounting for Pathologic Staging and Patient Demographics Beyond Race Makes a Difference
Q51150690Do blood groups have effect on prognosis of patients undergoing radical cystectomy?
Q38508249Do circulating tumor cells have a role in deciding on adjuvant chemotherapy after radical cystectomy?
Q57124420Do patients benefit from routine follow-up to detect recurrences after radical cystectomy and ileal orthotopic bladder substitution?
Q92671226Do patients benefit from total intracorporeal robotic radical cystectomy?: A comparative analysis with extracorporeal robotic radical cystectomy from a Korean multicenter study
Q44617181Do pure squamous cell carcinomas and urothelial carcinomas have similar prognosis after radical cystectomy?
Q36099770Do vascular, lymphatic, and perineural invasion have prognostic implications for bladder cancer after radical cystectomy?
Q87670762Does Implementing an Enhanced Recovery After Surgery Protocol Increase Hospital Charges? Comparisons From a Radical Cystectomy Program at a Specialty Cancer Center
Q92347120Does Postoperative Rehabilitation for Radical Cystectomy Call for Enhanced Recovery after Surgery? A Systematic Review and Meta-analysis
Q84570608Does extended lymph node dissection affect the lymph node density and survival after radical cystectomy?
Q79369809Does extended lymphadenectomy increase the morbidity of radical cystectomy?
Q37530304Does extended lymphadenectomy preclude laparoscopic or robot-assisted radical cystectomy in advanced bladder cancer?
Q43582440Does increasing the nodal yield improve outcomes in patients without nodal metastasis at radical cystectomy?
Q37915525Does initial learning curve compromise outcomes for robot-assisted radical cystectomy? A critical evaluation of the first 60 cases while establishing a robotics program
Q48907275Does intubated uretero-ureterocutaneostomy provide better health-related quality of life than orthotopic neobladder in patients after radical cystectomy for invasive bladder cancer?
Q38123653Does minimally invasive surgery for radical cystectomy provide similar long-term cancer control as open radical surgery?
Q84819296Does partial cystectomy compromise oncologic outcomes for patients with bladder cancer compared to radical cystectomy? A matched case-control analysis
Q38007021Does patient age affect survival after radical cystectomy?
Q87999862Does preoperative neutrophil/lymphocyte rate have an effect on survival of the bladder cancer patients who received radical cystectomy?
Q49763383Does previous abdominal surgery adversely affect perioperative and oncologic outcomes of laparoscopic radical cystectomy?
Q51671138Does previous robot-assisted radical prostatectomy experience affect outcomes at robot-assisted radical cystectomy? Results from the International Robotic Cystectomy Consortium.
Q35151984Does radical cystectomy improve overall survival in octogenarians with muscle-invasive bladder cancer?
Q41669681Does radical cystectomy outperform other bladder preservative treatments in elderly patients with advanced bladder cancer?
Q61454750Does robotic radical cystectomy impede oncological outcome in bladder cancer patients?
Q35590489Does skip metastasis or other lymph node parameters have additional effects on survival of patients undergoing radical cystectomy for bladder cancer?
Q92508902Does the Use of a Robot Decrease the Complication Rate Adherent to Radical Cystectomy? A Systematic Review and Meta-Analysis of Studies Comparing Open with Robotic Counterparts
Q38857368Does the extent of lymphadenectomy in radical cystectomy for bladder cancer influence disease-free survival? A prospective single-center study.
Q41737126Does the extent of variant histology affect oncological outcomes in patients with urothelial carcinoma of the bladder treated with radical cystectomy?
Q83219199Does the greater number of lymph nodes removed during standard lymph node dissection predict better patient survival following radical cystectomy?
Q51817927Does the presence of significant risk factors affect perioperative outcomes after robot-assisted radical cystectomy?
Q56978842Does the robot have a role in Radical Cystectomy ?
Q38720755Dose dense MVAC prior to radical cystectomy: a real-world experience
Q35393098Downstaging of TURBT-Based Muscle-Invasive Bladder Cancer by Radical Cystectomy Predicts Better Survival
Q28262766Downstaging to non-invasive urothelial carcinoma is associated with improved outcome following radical cystectomy for patients with cT2 disease
Q38884339Dramatic impact of blood transfusion on cancer-specific survival after radical cystectomy irrespective of tumor stage
Q92737329Dynamic readmission prediction using routine postoperative laboratory results after radical cystectomy
Q40157239EORTC progression score identifies patients at high risk of cancer-specific mortality after radical cystectomy for secondary muscle-invasive bladder cancer
Q27853185ERCC1 as a Prognostic and Predictive Biomarker for Urothelial Carcinoma of the Bladder following Radical Cystectomy
Q76647643EXPERIENCE WITH PREOPERATIVE IRRADIATION FOLLOWED BY RADICAL CYSTECTOMY FOR THE TREATMENT OF BLADDER CANCER
Q58705132Early Complications and Mortality following Radical Cystectomy: Associations with Malnutrition and Obesity
Q46501148Early Oncologic Failure after Robot-Assisted Radical Cystectomy: Results from the International Robotic Cystectomy Consortium.
Q90446893Early Oncological and Functional Outcomes of Prostate Capsule Sparing Cystectomy Compared with Standard Radical Cystectomy
Q92817960Early Postoperative Morbidity of Robotic Versus Open Radical Cystectomy in Obese Patients
Q39212852Early Recurrence Patterns Following Totally Intracorporeal Robot-assisted Radical Cystectomy: Results from the EAU Robotic Urology Section (ERUS) Scientific Working Group
Q84773055Early and Late Perioperative Outcomes Following Radical Cystectomy: 90-Day Readmissions, Morbidity and Mortality in a Contemporary Series
Q42245322Early and late complications of robot-assisted radical cystectomy: a standardized analysis by urinary diversion type
Q80215567Early and late treatment-related morbidity following radical cystectomy
Q51474671Early and late treatment-related morbidity following radical cystectomy.
Q47880272Early discharge and post-discharge outcomes in patients undergoing radical cystectomy for bladder cancer
Q41992357Early metastasis to anterior abdominal wall following radical cystectomy: A rare presentation
Q61952798Early mortality after radical cystectomy in Poland
Q44656811Early nasogastric tube removal combined with metoclopramide after radical cystectomy and urinary diversion
Q33874673Early oncologic outcomes of robotic vs. open radical cystectomy for urothelial cancer
Q42677000Early oncological outcomes for bladder urothelial carcinoma patients treated with robotic-assisted radical cystectomy
Q89986167Early recovery after surgery for radical cystectomy: comprehensive assessment and meta-analysis of existing protocols
Q83563523Early removal of nasogastric tube is beneficial for patients undergoing radical cystectomy with urinary diversion
Q83229181Early vs delayed radical cystectomy for 'high-risk' carcinoma not invading bladder muscle: delay of cystectomy reduces cancer-specific survival
Q85068603Early vs delayed radical cystectomy for 'high-risk' carcinoma not invading bladder muscle: delay of cystectomy reduces cancer-specific survival
Q87129996Editorial Comment from Dr Abe to Comparative impact of continent and incontinent urinary diversion on long-term renal function after radical cystectomy in patients with preoperative chronic kidney disease 2 and chronic kidney disease 3a
Q89542726Editorial Comment from Dr Abe to Oncological outcomes and recurrence patterns after laparoscopic radical cystectomy for bladder cancer: A Japanese multicenter cohort
Q48197068Editorial Comment from Dr Schmid to Comparative impact of continent and incontinent urinary diversion on long-term renal function after radical cystectomy in patients with preoperative chronic kidney disease 2 and chronic kidney disease 3a.
Q89542412Editorial Comment from Dr Tanaka and Dr Fujii to Oncological outcomes and recurrence patterns after laparoscopic radical cystectomy for bladder cancer: A Japanese multicenter cohort
Q90209747Editorial Comment on: Does the Use of the Robot Decrease the Complication Rate Adherent to Radical Cystectomy? A Systematic Review and Meta-Analysis of Studies Comparing Open to Robotic Counterparts by Tzelves et al. (From: Tzelves L, Skolarikos A,
Q88630835Editorial Comment on: Rates and Predictors of Conversion to Open Surgery During Minimally Invasive Radical Cystectomy by Ko et al
Q91895856Editorial Comment to Complications and reoperations after laparoscopic radical cystectomy in a Japanese multicenter cohort
Q92303526Editorial Comment to Current status and future perspective of robot-assisted radical cystectomy for invasive bladder cancer
Q48073701Editorial Comment to Health-related quality of life after radical cystectomy and neobladder reconstruction in women: impact of voiding and continence status
Q53794403Editorial Comment to Improved technique for intracorporeal neobladder-urethral anastomosis in laparoscopic radical cystectomy.
Q92139323Editorial Comment to Perioperative and oncological outcomes of laparoscopic radical cystectomy with intracorporeal versus extracorporeal ileal conduit: A matched-pair comparison in a multicenter cohort in Japan
Q54216248Editorial Comment to Perioperative blood transfusion in radical cystectomy: Analysis of the National Surgical Quality Improvement Program database.
Q88032421Editorial Comment to Role of routine computed tomography scan in the oncological follow up of patients treated by radical cystectomy for bladder cancer
Q91253468Editorial Comment to Utility of robot-assisted radical cystectomy with intracorporeal urinary diversion for muscle-invasive bladder cancer
Q94567160Editorial Comment: Does the Use of a Robot Decrease the Complication Rate Adherent to Radical Cystectomy? A Systematic Review and Meta-Analysis of Studies Comparing Open with Robotic Counterparts
Q42342910Editorial Concerning "Impact of the Level of Urothelial Carcinoma Involvement of the Prostate on Survival after Radical Cystectomy".
Q56975518Editorial comment from Dr Schiavina et al. to Standardized assessment of complications in a contemporary series of European patients undergoing radical cystectomy
Q44741716Editorial comment from Dr Smith to Standardized assessment of complications in a contemporary series of European patients undergoing radical cystectomy
Q95433772Editorial comment on "Urinary bladder cancer treated with radical cystectomy: perioperative parameters and early complications prospectively registered in a national population-based database"
Q43622722Editorial comment on "Urinary bladder cancer treated with radical cystectomy: perioperative parameters and early complications prospectively registered in a national population-based database".
Q81733379Editorial comment on: Defining early morbidity of radical cystectomy for patients with bladder cancer using a standardized reporting methodology
Q94705631Editorial comment on: Defining early morbidity of radical cystectomy for patients with bladder cancer using a standardized reporting methodology
Q80158626Editorial comment on: P0 stage at radical cystectomy for bladder cancer is associated with improved outcome independent of traditional clinical risk factors
Q94523393Editorial comment on: P0 stage at radical cystectomy for bladder cancer is associated with improved outcome independent of traditional clinical risk factors
Q81669753Editorial comment on: Potential impact of postoperative early complications on the timing of adjuvant chemotherapy in patients undergoing radical cystectomy: a high-volume tertiary cancer center experience
Q81585164Editorial comment on: Recoverability of erectile function in post-radical cystectomy patients: subjective and objective evaluations
Q53187173Editorial comment on: characteristics and outcomes of patients with clinical T1 grade 3 urothelial carcinoma treated with radical cystectomy: results from an international cohort.
Q81056965Editorial comment on: laparoscopic and robotic assisted radical cystectomy for bladder cancer: a critical analysis
Q51888692Editorial comment on: laparoscopic and robotic assisted radical cystectomy for bladder cancer: a critical analysis.
Q81117620Editorial comment on: robotic-assisted laparoscopic radical cystectomy with extracorporeal urinary diversion: initial experience
Q51888167Editorial comment on: robotic-assisted laparoscopic radical cystectomy with extracorporeal urinary diversion: initial experience.
Q54066342Editorial comment on: robotic-assisted laparoscopic radical cystectomy with extracorporeal urinary diversion: initial experience.
Q85919318Editorial comment to (18) F-fluorodeoxyglucose positron emission tomography-computed tomography for preoperative lymph node staging in patients undergoing radical cystectomy for bladder cancer: a prospective study
Q84251965Editorial comment to The clinical significance of urine cytology after a radical cystectomy for urothelial cancer
Q84701249Editorial comment to development and external validation of lymph node density cut-off points in prospective series of radical cystectomy and pelvic lymph node dissection
Q82329569Editorial comment to extended versus limited lymph node dissection in radical cystectomy: impact on recurrence pattern and survival
Q86595250Editorial comment to radical cystectomy and orthotopic urinary diversion in male patients with pT4a urothelial bladder carcinoma: oncological outcomes
Q85003082Editorial comment to stage-specific impact of extended versus standard pelvic lymph node dissection in radical cystectomy
Q57103719Editorial comment to: Ileal versus sigmoid neobladder as bladder substitute after radical cystectomy for bladder cancer: A meta-analysis
Q83537284Editorial comment. Perioperative mortality is significantly greater in septuagenarian and octogenarian patients treated with radical cystectomy for urothelial carcinoma of the bladder
Q64928207Editorial comment. Perioperative mortality is significantly greater in septuagenarian and octogenarian patients treated with radical cystectomy for urothelial carcinoma of the bladder.
Q89639755Editorial comment: understanding the cost of bladder preservation in muscle invasive bladder cancer-an evaluation of radical cystectomy versus trimodal therapy costs
Q87230245Effect of ABO blood type on mortality in patients with urothelial carcinoma of the bladder treated with radical cystectomy
Q41079735Effect of African-American Race on Tumor Recurrence After Radical Cystectomy for Urothelial Carcinoma of the Bladder
Q41720279Effect of Allogeneic Intraoperative Blood Transfusion on Survival in Patients Treated With Radical Cystectomy for Nonmetastatic Bladder Cancer: Results From a Single High-Volume Institution
Q47827570Effect of Hospital and Surgeon Case Volume on Perioperative Quality of Care and Short-term Outcomes After Radical Cystectomy for Muscle-invasive Bladder Cancer: Results From a European Tertiary Care Center Cohort
Q41112633Effect of Intraoperative Red Blood Cell Transfusion on Postoperative Complications After Open Radical Cystectomy: Old Versus Fresh Stored Blood.
Q37530344Effect of Neoadjuvant Chemotherapy on Renal Function following Radical Cystectomy: Is there a Meaningful Impact?
Q98897301Effect of Neurovascular Bundle Sparing Radical Cystectomy on Postoperative Continence and Sexual Function: A Systematic Review and Meta-Analysis
Q50128548Effect of Nonurothelial Histologic Variants on the Outcomes of Radical Cystectomy for Nonmetastatic Muscle-invasive Urinary Bladder Cancer.
Q92099836Effect of Preperitoneal Versus Epidural Analgesia on Postoperative Inflammatory Response and Pain Following Radical Cystectomy: A Prospective, Randomized Trial
Q51826006Effect of Stage Migration on Bladder Cancer: A Slow but Steady Improvement in Long-Term Survival Rates After Radical Cystectomy in Previous 25 Years.
Q54255211Effect of a Radical Cystectomy Care Pathway on Postoperative Length of Stay and Outcomes.
Q46517220Effect of a minimum lymph node policy in radical cystectomy and pelvic lymphadenectomy on lymph node yields, lymph node positivity rates, lymph node density, and survivorship in patients with bladder cancer
Q35848937Effect of alvimopan on accelerates gastrointestinal recovery after radical cystectomy: A systematic review and meta-analysis
Q85235285Effect of alvimopan on return of bowel function after robot-assisted radical cystectomy
Q91186407Effect of centralization on complex surgical care: A population-based case study of radical cystectomy
Q50552337Effect of delayed radical cystectomy for invasive bladder tumors on lymph node positivity, cancer-specific survival and total survival.
Q53085995Effect of diabetes mellitus and metformin use on oncologic outcomes of patients treated with radical cystectomy for urothelial carcinoma.
Q38163229Effect of gender on outcomes following radical cystectomy for urothelial carcinoma of the bladder: a critical analysis of 1,994 patients.
Q81212424Effect of healthcare provider characteristics on nodal yield at radical cystectomy
Q91857355Effect of hospital volume on 90-day mortality after radical cystectomy for bladder cancer in Spain
Q68180797Effect of ileal conduit on patients' activities following radical cystectomy
Q90711548Effect of neoadjuvant chemotherapy in patients undergoing radical cystectomy for muscle-invasive bladder cancer: a retrospective, multi-institutional study
Q34626603Effect of preoperative nutritional deficiency on mortality after radical cystectomy for bladder cancer
Q58603667Effect of variant histology presence and squamous differentiation on oncological results and patient's survival after radical cystectomy
Q41202141Effect on postoperative survival of the status of distal ureteral margin: The necessity to achieve negative margins at the time of radical cystectomy
Q68252987Effective outpatient use of polyethylene glycol-electrolyte bowel preparation for radical cystectomy and ileal conduit urinary diversion
Q54301231Effectiveness of Adjuvant Chemotherapy After Radical Cystectomy for Locally Advanced and/or Pelvic Lymph Node-Positive Muscle-invasive Urothelial Carcinoma of the Bladder: A Propensity Score-Weighted Competing Risks Analysis.
Q101212265Effectiveness of ESPITO analgesia in enhancing recovery in patients undergoing open radical cystectomy when compared to a contemporaneous cohort receiving standard analgesia: an observational study
Q44426851Effectiveness of adjuvant chemotherapy in transitional cell carcinoma of the urinary bladder with lymph node involvement and/or lymphovascular invasion treated by radical cystectomy
Q91856558Effectiveness of hyaluronic acid/carboxymethylcellulose in preventing adhesive bowel obstruction after laparoscopic radical cystectomy
Q92234906Effectiveness of postoperative radiotherapy after radical cystectomy for locally advanced bladder cancer
Q51739567Effects of Nonsteroidal Anti-Inflammatory Drugs as Patient Controlled Analgesia on Early Bowel Function Recovery after Radical Cystectomy.
Q36046681Effects of dexmedetomidine on anesthesia recovery period and postoperative cognitive function of patients after robot-assisted laparoscopic radical cystectomy
Q42681854Efficacy and Safety of Intraoperative Tranexamic Acid Infusion for Reducing Blood Transfusion During Open Radical Cystectomy.
Q36993621Efficacy and Safety of Stroke Volume Variation-Guided Fluid Therapy for Reducing Blood Loss and Transfusion Requirements During Radical Cystectomy: A Randomized Clinical Trial
Q89025205Efficacy and Safety of Stroke Volume Variation-Guided Fluid Therapy for Reducing Blood Loss and Transfusion Requirements During Radical Cystectomy: A Randomized Clinical Trial: Erratum
Q35048726Efficacy of (18)F-fluorodeoxyglucose-positron emission tomography/computed tomography in restaging muscle-invasive bladder cancer following radical cystectomy.
Q91726837Efficacy of Prophylactic Antimicrobial Administration of Tazobactam/Piperacillin for Radical Cystectomy with Urinary Diversion: A Multicenter Study
Q44433553Efficacy of a multiprofessional rehabilitation programme in radical cystectomy pathways: a prospective randomized controlled trial
Q50667620Efficacy of preoperative uro-stoma education on self-efficacy after Radical Cystectomy; secondary outcome of a prospective randomized controlled trial.
Q46974499Efficacy of radical cystectomy plus adjuvant intraarterial chemotherapy with gemcitabine and cisplatin on locally advanced bladder cancer
Q34337059Efficacy of robot-assisted radical cystectomy (RARC) in advanced bladder cancer: results from the International Radical Cystectomy Consortium (IRCC)
Q84153499Efficient delivery of radical cystectomy after neoadjuvant chemotherapy for muscle-invasive bladder cancer: a multidisciplinary approach
Q100460956Electroacupuncture for ileus following laparoscopic radical cystectomy and Bricker urinary diversion: a case report
Q99211308Electronic Rapid Fitness Assessment Identifies Factors Associated with Adverse Early Postoperative Outcomes Following Radical Cystectomy
Q81564856Elevated plasma D-dimer as a predictor of postoperative complications after radical cystectomy
Q51167345Eligibility for neoadjuvant/adjuvant cisplatin-based chemotherapy among radical cystectomy patients.
Q44662104En bloc transpubic urethrectomy in conjunction with radical cystectomy for bladder carcinoma in males
Q36212247Endoscopic management of ureterointestinal strictures after radical cystectomy
Q38846587Enhanced Recovery After Robot-assisted Radical Cystectomy: EAU Robotic Urology Section Scientific Working Group Consensus View.
Q91244736Enhanced Recovery After Surgery for Radical Cystectomy
Q38381401Enhanced Recovery After Surgery protocols for radical cystectomy surgery: review of current evidence and local protocols
Q92873434Enhanced Recovery after Radical Cystectomy
Q49894984Enhanced Recovery after Surgery Pathway in Patients Undergoing Open Radical Cystectomy is Safe and Accelerates Bowel Function Recovery
Q99365971Enhanced recovery after surgery (ERAS) following radical cystectomy: is it worth implementing for all patients?
Q92522739Enhanced recovery after surgery (ERAS) in radical cystectomy patients: from consensus to evidences
Q97095254Enhanced recovery after surgery (ERAS) protocols in patients undergoing radical cystectomy with ileal urinary diversions: A randomized controlled trial
Q48108896Enhanced recovery after surgery for radical cystectomy with ileal urinary diversion: a multi-institutional, randomized, controlled trial from the Chinese bladder cancer consortium
Q47954563Enhanced recovery after surgery: are we ready, and can we afford not to implement these pathways for patients undergoing radical cystectomy?
Q38174824Enhanced recovery pathway following radical cystectomy
Q38229447Enhanced recovery programmes for patients undergoing radical cystectomy
Q42642652Enhanced recovery protocol after radical cystectomy for bladder cancer
Q91002520Entero-neovesical fistula after radical cystectomy and orthotopic ileal neobladder: A report of two cases requiring surgical management
Q38842793Enumerating pelvic recurrence following radical cystectomy for bladder cancer: A Canadian multi-institutional study.
Q92137478Epidural anesthesia may be associated with increased postoperative complications in the elderly population undergoing radical cystectomy: an analysis from the National Surgical Quality Improvement Project (NSQIP) database
Q44092825Erectile dysfunction after radical cystectomy
Q90071595Erectile function after radical cystectomy: Comparing surgical stapler with LigaSure in division of vascular pedicles
Q69927075Erection deficit in patients subjected to a radical cystectomy. Diagnostic evaluation by Doppler and sacral evoked reflexes
Q90813872Erratum to 'Predictive value of lymphangiogenesis and proliferation markers on mRNA level in urothelial carcinoma of the bladder after radical cystectomy' [Urologic Oncology: Seminars and Original Investigations 36/12 (2018) 505-534]
Q42580342Erratum to: 'Perioperative use of crystalloids in patients undergoing open radical cystectomy: balanced Ringer's maleate versus a glucose 5%/potassium-based balanced solution: study protocol for a randomized controlled trial'.
Q88809494Erratum to: Baumann BC, Bosch WR, Bahl A, et al. Development and validation of consensus contouring guidelines for adjuvant radiation therapy for bladder cancer after radical cystectomy. Int J Radiat Oncol Biol Phys 2016;96:78-86
Q42348365Erratum to: Clinical impact of postoperative loss in psoas major muscle and nutrition index after radical cystectomy for patients with urothelial carcinoma of the bladder
Q86940553Erratum to: Reduced length of stay in radical cystectomy patients with oral versus parenteral post-operative nutrition protocol
Q87825458Erratum to: Robotic radical cystectomy: technical tips and tricks
Q104575624Erratum: Surgical Outcomes of Transvaginal Neobladder-Vaginal Fistula Repair After Radical Cystectomy with Ileal Orthotopic Neobladder: A Case-Control Study [Erratum]
Q77130802Estimated blood loss and transfusion requirements of radical cystectomy
Q51783490Estimating postoperative mortality and morbidity risk of radical cystectomy with continent diversion using predictor equations.
Q36276801Estimation of mortality and morbidity risk of radical cystectomy using POSSUM and the Portsmouth predictor equation
Q83817576Estimation of the true number of lymph nodes in lymphadenectomy specimens from radical cystectomy
Q51015062Evaluating sexual function in women after radical cystectomy as treatment for bladder cancer.
Q51861410Evaluating the learning curve for robot-assisted laparoscopic radical cystectomy.
Q35354332Evaluating the utility of a preoperative nomogram for predicting 90-day mortality following radical cystectomy for bladder cancer.
Q92234846Evaluation of Cause of Death After Radical Cystectomy for Patients With Bladder Cancer: The Impact of Age at the Time of Surgery
Q40379924Evaluation of Computed Tomography for Lymph Node Staging in Bladder Cancer Prior to Radical Cystectomy
Q91195134Evaluation of Incisional Negative Pressure Wound Therapy in the Prevention of Surgical Site Occurrences After Radical Cystectomy: A New Addition to Enhanced Recovery After Surgery Protocol
Q103052568Evaluation of Uretero-Enteric Anastomotic Strictures after the Introduction of Robot-Assisted Radical Cystectomy with Intracorporeal Urinary Diversion-Results from a Large Tertiary Referral Center
Q36467861Evaluation of a model to predict recurrence after radical cystectomy in bilharzial bladder cancer patients
Q59796760Evaluation of an enhanced recovery protocol on patients having radical cystectomy for bladder cancer
Q39337493Evaluation of conservative approach in the management of ureteroenteric strictures following radical cystectomy with Bricker ileal conduit: a single-center experience
Q50905895Evaluation of current surveillance guidelines following radical cystectomy and proposal of a novel risk-based approach.
Q51424832Evaluation of different lymph node (LN) variables as prognostic markers in patients undergoing radical cystectomy and extended LN dissection to the level of the inferior mesenteric artery.
Q51095626Evaluation of findings during re-exploration for obstructive ileus after radical cystectomy and ileal-loop urinary diversion: insight into potential technical improvements.
Q99571476Evaluation of health care-associated infections following radical cystectomy
Q91413318Evaluation of laparoscopic approach in radical cystectomy from implementation to consolidation: Internal validation
Q79926745Evaluation of laparoscopic radical cystectomy for loco-regionally advanced bladder cancer
Q86962363Evaluation of risk of muscle invasion, perivesical and/or lymph node affectation by diffusion-weighted magnetic nuclear resonance in the patient who is a candidate for radical cystectomy
Q39985082Evaluation of the improved tubeless cutaneous ureterostomy technique following radical cystectomy in cases of invasive bladder cancer complicated by peritoneal metastasis
Q88971116Evaluation of the prognostic value of LMR, PLR, NLR, and dNLR in urothelial bladder cancer patients treated with radical cystectomy
Q83925415Evaluation of the relevance of lymph node density in a contemporary series of patients undergoing radical cystectomy
Q43900072Evidence from the 'PROspective MulticEnTer RadIcal Cystectomy Series 2011 (PROMETRICS 2011)' study: how are preoperative patient characteristics associated with urinary diversion type after radical cystectomy for bladder cancer?
Q44659554Evidence of Atypical Recurrences After Robot-Assisted Radical Cystectomy: A Comprehensive Review of the Literature
Q33460633Evolution of the Southampton Enhanced Recovery Programme for radical cystectomy and the aggregation of marginal gains
Q93384262Examining the relationship between complications and perioperative mortality following radical cystectomy: a population-based analysis
Q48187525Examining the role of centralisation of radical cystectomy for bladder cancer
Q70091998Excessive antidiuretic hormone secretion after radical cystectomy
Q38897266Exercise-based pre-habilitation is feasible and effective in radical cystectomy pathways-secondary results from a randomized controlled trial
Q89615823Expeditious Radical Cystectomy in Patients with High-risk Bladder Cancer Remains an Important Part of Patient Care
Q92487429Experience of surgeon, hospital, and comprehensive cancer team critical to the outcomes of radical cystectomy and urinary diversion
Q44487249Experience with ureteroenteric strictures after radical cystectomy and diversion: open surgical revision
Q33668036Experiences on 25 cases of radical cystectomy.
Q53062429Expression and prognostic significance of cancer stem cell markers CD24 and CD44 in urothelial bladder cancer xenografts and patients undergoing radical cystectomy.
Q39894250Expression of angiogenesis inhibitors in human bladder cancer may explain rapid metastatic progression after radical cystectomy.
Q53287064Expression of cell cycle–related molecular markers in patients treated with radical cystectomy for squamous cell carcinoma of the bladder☆
Q39445806Extended Duration Enoxaparin Decreases the Rate of Venous Thromboembolic Events after Radical Cystectomy Compared to Inpatient Only Subcutaneous Heparin.
Q50117644Extended Venous Thromboembolism Prophylaxis after Radical Cystectomy: A Call for Adherence to Current Guidelines
Q58562395Extended Versus Limited Lymph Node Dissection in Bladder Cancer Patients Undergoing Radical Cystectomy: Survival Results from a Prospective, Randomized Trial
Q91852357Extended hospital stay after radical cystectomy with enhanced recovery protocol
Q45270402Extended lymphadenectomy to the lower paraaortic nodes during radical cystectomy
Q51790521Extended outpatient chemoprophylaxis reduces venous thromboembolism after radical cystectomy.
Q38907285Extended partial cystectomy with augmentation cystoplasty in urachal adenocarcinoma: An oncologically favorable but underutilized alternative to radical cystectomy
Q88477452Extended pelvic lymph node dissection at radical cystectomy for bladder cancer improves survival: Results of a nationwide population-based study
Q36120392Extended pelvic lymph node dissection: before or after radical cystectomy? A multicenter study of the Turkish society of urooncology
Q82327868Extended versus limited lymph node dissection in radical cystectomy: impact on recurrence pattern and survival
Q92172964Extended versus non-extended lymphadenectomy during radical cystectomy for patients with bladder cancer: a meta-analysis of the effect on long-term and short-term outcomes
Q92184454Extended versus standard lymph node dissection for urothelial carcinoma of the bladder in patients undergoing radical cystectomy
Q53128804Extended versus superextended lymph-node dissection in radical cystectomy: subgroup analysis of possible recurrence-free survival benefit.
Q26864095Extended vs non-extended pelvic lymph node dissection and their influence on recurrence-free survival in patients undergoing radical cystectomy for bladder cancer: a systematic review and meta-analysis of comparative studies
Q46897455Extent of lymph node dissection and recurrence-free survival after radical cystectomy: a meta-analysis
Q38996290Extent of lymphadenectomy in patients with bladder cancer undergoing radical cystectomy - a multi-institutional analysis.
Q24814634Extent of lymphadenectomy in radical cystectomy for bladder cancer
Q38303587Extent of pelvic lymph node dissection during radical cystectomy: is bigger better?
Q84863400Extent of pelvic lymph node dissection during radical cystectomy: where and why!
Q78860560Extent of surgery and pathology evaluation has an impact on bladder cancer outcomes after radical cystectomy
Q41402220External Validation of Bladder Cancer Predictive Nomograms for Recurrence, Cancer-Free Survival and Overall Survival following Radical Cystectomy.
Q92952865External iliac artery pseudoaneurysm following radical cystectomy: A report of two cases
Q41626549External iliac vein injury and its repair during laparoscopic radical cystectomy
Q40568645External stent versus double J drainage in patients with radical cystectomy and orthotopic urinary diversion: A randomized controlled trial.
Q37679546External stoma and peristomal complications following radical cystectomy and ileal conduit diversion: a systematic review.
Q87416628External validation of a model to predict locoregional failure after radical cystectomy
Q39652224External validation of a risk model to predict recurrence-free survival after radical cystectomy in patients with pathological tumor stage T3N0 urothelial carcinoma of the bladder
Q83768314External validation of disease-free survival at 2 or 3 years as a surrogate and new primary endpoint for patients undergoing radical cystectomy for urothelial carcinoma of the bladder
Q44097656External validation of extranodal extension and lymph node density as predictors of survival in node-positive bladder cancer after radical cystectomy
Q51152269External validation of preoperative and postoperative nomograms for prediction of cancer-specific survival, overall survival and recurrence after robot-assisted radical cystectomy for urothelial carcinoma of the bladder.
Q98624882Extra-Peritoneal versus Trans-Peritoneal Open Radical Cystectomy - Comparison of Two Techniques in Early Post-Operative Complications
Q98191262Extramammary Paget's disease of the glans penis secondary to urethral recurrence of bladder carcinoma after radical cystectomy: A case report
Q48309155Extraperitoneal radical cystectomy and ureterocutaneostomy in octogenarians.
Q52908264Extraperitoneal radical cystectomy with extraperitonealization of the ileal neobladder: a comparison to the transperitoneal technique.
Q37221765Extraperitoneal versus transperitoneal laparoscopic radical cystectomy for selected elderly bladder cancer patients: a single center experience
Q97589478FGFR3 Mutation Status and FGFR3 Expression in a Large Bladder Cancer Cohort Treated by Radical Cystectomy: Implications for Anti-FGFR3 Treatment?†
Q91602775FOXA1 Gene Expression for Defining Molecular Subtypes of Muscle-Invasive Bladder Cancer after Radical Cystectomy
Q88843761Facing the Fate of the Remnant Urothelium After Radical Cystectomy: There Is Room for Improvement
Q49645203Factors Affecting the Cost of Radical Cystectomy in the USA: Some Centres Are More Equal than Others.
Q36040453Factors Impacting the Occurrence of Local, Distant and Atypical Recurrences after Robot-Assisted Radical Cystectomy: A Detailed Analysis of 310 Patients
Q63966630Factors affecting choice between ureterostomy, ileal conduit and continent reservoir after radical cystectomy: Japanese series
Q46181356Factors affecting one-year survival after radical cystectomy: A prospective study.
Q46324327Factors affecting outcomes after radical cystectomy in African Americans
Q51354932Factors associated with non-orthotopic urinary diversion after radical cystectomy.
Q92046414Factors influencing ICU admission and associated outcome in patients undergoing radical cystectomy with enhanced recovery pathway
Q90293694Factors influencing intraoperative conversion from planned orthotopic to non-orthotopic urinary diversion during radical cystectomy
Q46642513Factors influencing post-recurrence survival in bladder cancer following radical cystectomy.
Q82530354Factors influencing the choice of urinary diversion in patients undergoing radical cystectomy
Q82584720Factors influencing the choice of urinary diversion in patients undergoing radical cystectomy
Q35210280Factors influencing the length of stay after radical cystectomy: implications for cancer care and perioperative management
Q96617760Factors predicting early mortality after radical cystectomy for urothelial carcinoma in a contemporary cohort of patients
Q46543034Factors predicting incisional surgical site infection in patients undergoing open radical cystectomy for bladder cancer.
Q37702347Failure of bacille Calmette-Guérin in patients with high risk non-muscle-invasive bladder cancer unsuitable for radical cystectomy: an update of available treatment options
Q80339394Fast and safe closing of urethra during laparoscopic radical cystectomy
Q43123638Fast recovery after radical cystectomy. A multidisciplinary challenge
Q43177876Fast track program in patients undergoing radical cystectomy: results in 362 consecutive patients
Q38132503Fast track surgery to reduce short-term complications following radical cystectomy and intestinal urinary diversion with Vescica Ileale Padovana neobladder: proposal for a tailored enhanced recovery protocol and preliminary report from a pilot study
Q48178668Fast-track surgery and technical nuances to reduce complications after radical cystectomy and intestinal urinary diversion with the modified Indiana pouch
Q43630602Favourable outcomes of patients with clinical stage T3N0M0 bladder cancer treated with induction low-dose chemo-radiotherapy plus partial or radical cystectomy vs immediate radical cystectomy: a single-institutional retrospective comparative study
Q51601748Feasibility and outcomes of robotic-assisted laparoscopic radical cystectomy for bladder cancer in older patients.
Q35887917Feasibility and safety of radical cystectomy under combined spinal and epidural anesthesia in octogenarian patients with ASA score ≥3: A case series.
Q40536860Feasibility and safety study for the use of wound protectors during robotic radical cystectomy and ileal conduit
Q90929960Feasibility of Laparoscopic Radical Cystectomy in Elderly Patients: A Comparative Analysis of Clinical Outcomes in a Single Institution
Q49573673Feasibility of expert and crowd-sourced review of intraoperative video for quality improvement of intracorporeal urinary diversion during robotic radical cystectomy
Q43069424Feasibility of lymphadenectomy in laparoscopic radical cystectomy
Q48143698Feasibility of radical cystectomy in exclusive spinal and/or epidural anaesthesia
Q36989813Febrile Urinary Tract Infection after Radical Cystectomy and Ileal Neobladder in Patients with Bladder Cancer.
Q45363607Female gender is associated with a worse survival after radical cystectomy for urothelial carcinoma of the bladder: a competing risk analysis
Q90670438Female radical cystectomy patients have a higher risk of surgical site infections
Q38315456Female reproductive organ-sparing radical cystectomy: contemporary indications, techniques and outcomes
Q48787779Female robotic radical cystectomy
Q80172853Female sexual dysfunction after radical cystectomy: a new outcome measure
Q30245195Female sexual dysfunction post radical cystectomy and urinary diversion
Q44937326Fertility preserving radical cystectomy in a young female with malignant mesenchymal tumour of urinary bladder
Q35887892Few modifiable factors predict readmission following radical cystectomy.
Q91416818Fewer tumour draining sentinel nodes in patients with progressing muscle invasive bladder cancer, after neoadjuvant chemotherapy and radical cystectomy
Q45884122Fibrinogen substitution improves whole blood clot firmness after dilution with hydroxyethyl starch in bleeding patients undergoing radical cystectomy: a randomized, placebo-controlled clinical trial
Q41161677Final Pathological Stage after Neoadjuvant Chemotherapy and Radical Cystectomy for Bladder Cancer-Does pT0 Predict Better Survival than pTa/Tis/T1?
Q62626260Final robotic frontier: the evolution and current state of robot-assisted radical cystectomy
Q41837967Finding treatment success in patients unfit for radical cystectomy
Q80828401Fine needle aspiration of urethral recurrence of urothelial carcinoma after radical cystectomy presenting as a perineal mass: a case report
Q89574312First experience with a new form of orthotopic ileal neobladder (Leuven N-Pouch) following radical cystectomy
Q51130110Fistula between external iliac artery and ileal conduit after radical cystectomy: a life-threatening complication.
Q50242005Fistulous Complications following Radical Cystectomy for Bladder Cancer: Analysis of a Large Modern Cohort
Q71050273Five-year followup of a prospective trial of radical cystectomy and neoadjuvant chemotherapy: Nordic Cystectomy Trial I. The Nordic Cooperative Bladder Cancer Study Group
Q70807145Five-year results of neoadjuvant cisplatin, methotrexate and vinblastine chemotherapy plus radical cystectomy in locally advanced bladder cancer
Q46836360Flow cytometric analysis of the DNA content in the urinary bladder cancers treated by radical cystectomy and pre-operative irradiation
Q50458622Fluorescence-enhanced robotic radical cystectomy using unconjugated indocyanine green for pelvic lymphangiography, tumor marking, and mesenteric angiography: the initial clinical experience.
Q53636094Fluorescence-guided bladder tumour resection: impact on survival after radical cystectomy.
Q38101102Follow-up after radical cystectomy based on patterns of tumour recurrence and its risk factors
Q82539543For Wider Acceptance of Radical Cystectomy and Extended Pelvic Lymphadenectomy
Q92264551Frailty and preoperative risk assessment before radical cystectomy
Q61454781Frailty and sarcopenia impact surgical and oncologic outcomes after radical cystectomy in patients with bladder cancer
Q36923856Frailty as a marker of adverse outcomes in patients with bladder cancer undergoing radical cystectomy
Q93193393Frailty as a predictor of complications after radical cystectomy: A prospective study of various preoperative assessments
Q92597866Frailty as a prognostic indicator in the radical cystectomy population: a review
Q48588271Frequency and prognostic significance of incidental prostate cancer at radical cystectomy: Results from an international retrospective study
Q54658640Frozen section analysis of ureteral margins in patients undergoing radical cystectomy for bladder cancer: differential impact of carcinoma in situ in the bladder on reliability and impact on tumour recurrence in the upper urinary tract.
Q39442486Functional Outcomes Following Radical Cystectomy in Women with Bladder Cancer: A Systematic Review
Q90751272Functional Status in Patients Requiring Nursing Home Stay After Radical Cystectomy
Q46044993Functional bladder replacement after radical cystectomy in the female: experimental investigation of a new concept.
Q42638642Functional outcomes and complications in patients with bladder cancer undergoing robotic-assisted radical cystectomy with extracorporeal Indiana pouch continent cutaneous urinary diversion
Q90570382Functional outcomes obtained with intracorporeal neobladder after robotic radical cystectomy for cancer: a narrative review
Q34195084Gasless minimum incision access used for extracorporeal orthotopic bladder substitution after laparoscopic radical cystectomy
Q35089783Gastric pouch after simple or radical cystectomy for benign and malignant bladder disease
Q46208344Gastrointestinal Complications Following Radical Cystectomy Using Enhanced Recovery Protocol.
Q38820188Gastrointestinal Complications in Patients Who Undergo Radical Cystectomy with Enhanced Recovery Protocol
Q80134884Gemcitabine and cisplatin after radical cystectomy for bladder cancer in an adjuvant setting: feasibility study from the Genito-Urinary Group of the French Federation of Cancer Centers
Q52686816Gender Specific Differences in Disease-Free, Cancer Specific and Overall Survival after Radical Cystectomy for Bladder Cancer: A Systematic Review and Meta-Analysis.
Q91261038Gender and Mortality after Radical Cystectomy: Competing Risk Analysis
Q51712140Gender and age differences in blood utilization and length of stay in radical cystectomy: a population-based study.
Q91951491Gender differences in oncologic and functional outcomes in patients with bladder cancer undergoing radical cystectomy with urinary diversion
Q35796511Gender differences in radical cystectomy: complications and blood loss
Q47259653Gender-dependent cancer-specific survival following radical cystectomy
Q47151888Gender-related Outcome in Bladder Cancer Patients undergoing Radical Cystectomy.
Q44793009Gender-specific differences in cancer-specific survival after radical cystectomy for patients with urothelial carcinoma of the urinary bladder in pathologic tumor stage T4a.
Q51177253Gender-specific differences in clinicopathologic outcomes following radical cystectomy: an international multi-institutional study of more than 8000 patients.
Q45904406Gender-specific outcomes of bladder cancer patients: a stage-specific analysis in a contemporary, homogenous radical cystectomy cohort.
Q45362887Gender-specific survival following radical cystectomy for pT4 bladder cancer.
Q51236645General anesthesia versus epidural and general anesthesia in radical cystectomy.
Q42620903Getting under the hood of the volume-outcome relationship for radical cystectomy
Q50066547Giant Abdominal Wall Pseudocyst After Open Radical Cystectomy
Q96025555Goal-directed versus Standard Fluid Therapy to Decrease Ileus after Open Radical Cystectomy: A Prospective Randomized Controlled Trial
Q47433575Grading complication following radical cystectomy and ileal conduit for bladder cancer using Clavien grading system
Q80827069Gross hematuria 10 years after radical cystectomy: adenomatous polyp
Q38159876Guidelines for perioperative care after radical cystectomy for bladder cancer: Enhanced Recovery After Surgery (ERAS(®)) society recommendations
Q33438922Gum chewing stimulates bowel motility in patients undergoing radical cystectomy with urinary diversion
Q93335394Gynecologic Organ Involvement During Radical Cystectomy for Bladder Cancer: Is It Time to Routinely Spare the Ovaries?
Q51703318Gynecologic-tract sparing extra peritoneal retrograde radical cystectomy with neobladder.
Q88771704Gynecological organ involvement at robot-assisted radical cystectomy in females: Is anterior exenteration necessary?
Q91748676HRQOL related to urinary diversion in Radical Cystectomy: a systematic review of recent literature
Q45059818Hand assisted laparoscopic radical cystectomy for cancer bladder
Q83141074Hand-assisted laparoscopic radical cystectomy and extracorporeal urinary diversion: experience with 31 cases
Q83395777Hand-assisted versus pure laparoscopic radical cystectomy: a clinical outcome comparison
Q47627477Health Related Quality of Life Following Radical Cystectomy: Comparative Analysis from the Medicare Health Outcomes Survey
Q47579037Health Related Quality of Life in Patients Treated With Radical Cystectomy and Urinary Diversion for Urothelial Carcinoma of the Bladder: Development and Validation of a New Disease Specific Questionnaire
Q38799838Health care services utilization during the last 6 months of life among patients with bladder cancer who underwent radical cystectomy in Quebec, Canada
Q36066874Health related quality of life after radical cystectomy and urinary diversion for bladder cancer: a systematic review and critical analysis of the literature
Q39342758Health related quality of life after radical cystectomy in women: orthotopic neobladder versus ileal loop conduit and impact of incontinence
Q48407728Health related quality of life after radical cystectomy: comparative study between orthotopic sigmoid versus ileal neobladders
Q53129263Health related quality of life after radical cystectomy: comparison of ileal conduit to continent orthotopic neobladder.
Q74246116Health related quality of life assessment after radical cystectomy: comparison of ileal conduit with continent orthotopic neobladder
Q87991201Health-Related Quality of Life after Radical Cystectomy for Bladder Cancer in Elderly Patients with Ileal Orthotopic Neobladder or Ileal Conduit: Results from a Multicentre Cross-Sectional Study Using Validated Questionnaires
Q33470789Health-Related Quality of Life after Radical Cystectomy: A Cross Sectional Study with Matched Pair Analysis on Ileal Conduit Versus Ileal Orthotopic Neobladder Diversion
Q91761633Health-Related Quality of Life of Patients with Bladder Cancer in the RAZOR Trial - A Multi-Institutional Randomized Trial Comparing Robot versus Open Radical Cystectomy
Q35736201Health-care services utilization and costs associated with radical cystectomy for bladder cancer: a descriptive population-based study in the province of Quebec, Canada
Q91285074Health-related quality of life after radical cystectomy and ileal orthotopic neobladder: effect of detailed continence outcomes
Q46774738Health-related quality of life after radical cystectomy and neobladder reconstruction in women: impact of voiding and continence status
Q81247096Health-related quality of life after radical cystectomy for bladder cancer in elderly patients with an ileal conduit, ureterocutaneostomy, or orthotopic urinary reservoir: a comparative questionnaire survey
Q95785032Health-related quality of life after radical cystectomy for bladder cancer: a comparison of ileal conduit and orthotopic bladder replacement
Q51959681Health-related quality of life after radical cystectomy for bladder cancer: a comparison of ileal conduit and orthotopic bladder replacement.
Q48074927Health-related quality of life from a prospective randomised clinical trial of robot-assisted laparoscopic vs open radical cystectomy
Q55338384Health-related quality of life in bladder cancer patients undergoing radical cystectomy and urinary stoma: still many gaps.
Q92042684Health-related quality of life in patients undergoing radical cystectomy with modified single stoma cutaneous ureterostomy, bilateral cutaneous ureterostomy and ileal conduit
Q98161481Health-related quality of life is not related to laparoscopic or robotic technique in radical cystectomy
Q42655571Health-related quality of life outcomes after robot-assisted and open radical cystectomy using a validated bladder-specific instrument: a multi-institutional study.
Q93336796Health-related quality-of-life after radical cystectomy among Norwegian men and women compared to the general population
Q48134768Hemiparesis after robotic laparoscopic radical cystectomy and ileal conduit formation in steep Trendelenburg position
Q51603318Hemodynamic and oxygenation variables during radical cystectomy. Does the anesthetic technique really matter?
Q101451384High HNRNPA3 expression is associated with lymph node metastasis and poor prognosis in patients treated with radical cystectomy
Q70315138High dose, short course preoperative radiation therapy and immediate single stage radical cystectomy with pelvic node dissection in the management of bladder cancer
Q37182805High expression of H3K27me3 is an independent predictor of worse outcome in patients with urothelial carcinoma of bladder treated with radical cystectomy
Q37560686High expression of heat shock protein 105 predicts a favorable prognosis for patients with urinary bladder cancer treated with radical cystectomy
Q39590213High expression of karyopherin-α2 defines poor prognosis in non-muscle-invasive bladder cancer and in patients with invasive bladder cancer undergoing radical cystectomy
Q52921872High grade neuroendocrine carcinoma of the urinary bladder treated by radical cystectomy: a series of small cell, mixed neuroendocrine and large cell neuroendocrine carcinoma.
Q41730736High hospital and surgeon volume and its impact on overall survival after radical cystectomy among patients with bladder cancer in Quebec
Q40428531High incidence of clinically significant concomitant prostate cancer in patients undergoing radical cystectomy for bladder cancer: A 10-year single-center experience
Q95802419High mortality rates after radical cystectomy: we must have acceptable protocols and consider the rationale of cutaneous ureterostomy for high-risk patients
Q38801504High-Risk of Adverse Pathologic Features in Patients With Clinical T1 High-Grade Bladder Cancer Undergoing Radical Cystectomy
Q33680113High-grade hydronephrosis predicts poor outcomes after radical cystectomy in patients with bladder cancer
Q44261352Higher surgeon and hospital volume improves long-term survival after radical cystectomy
Q35898629Highest risk of symptomatic venous thromboembolic events after radical cystectomy occurs in patients with obesity or nonurothelial cancers
Q91502009Histologic variants associated with biological aggressiveness and poor prognosis in patients treated with radical cystectomy
Q104289649Histological investigation of the female vesicourethral junction and adjacent tissues for nerve-sparing radical cystectomy
Q100421252Histology at transurethral resection of bladder tumor and radical cystectomy for bladder cancer: Insights from population-based data
Q92483703Histopathological and perioperative factors influencing the length of hospital stay and patients' outcome after radical cystectomy for urothelial carcinoma
Q90837502Histopathological predictive factors for the overall survival rate in patients with urothelial carcinoma of the bladder treated by radical cystectomy: a Romanian cohort study
Q88736302History of Non-Muscle-Invasive Bladder Cancer May Have a Worse Prognostic Impact in cT2-4aN0M0 Bladder Cancer Patients Treated With Radical Cystectomy
Q47743959Hospital Charges and Length of Stay Following Radical Cystectomy in the Enhanced Recovery After Surgery Era.
Q90147978Hospital Quality Metrics for Radical Cystectomy: Disease Specific and Correlated to Mortality Outcomes
Q93182743Hospital length of stay following radical cystectomy for muscle-invasive bladder cancer: Development and validation of a population-based prediction model
Q80214045Hospital lymph node counts and survival after radical cystectomy
Q46325754Hospital volume and 90-day mortality risk after radical cystectomy: a population-based cohort study
Q38764012Hospital volume and perioperative outcomes for radical cystectomy: a population study
Q104751874Hospital volume is associated with postoperative mortality following radical cystectomy for treatment of bladder cancer
Q89087278Hospitalisation and readmission costs after radical cystectomy in a nationally representative sample: does urinary reconstruction matter?
Q38653692Hospitalization before surgery and subsequent risk of infective complications after radical cystectomy: A population-based analysis
Q91806163How cancer-specific mortality changes over time after radical cystectomy: Conditional survival of patients with nonmetastatic urothelial carcinoma of the urinary bladder
Q89955467How the Beneficial Effects of Alvimopan Differ With Surgical Approach for Radical Cystectomy
Q92970919How to improve patient selection for neoadjuvant chemotherapy in bladder cancer patients candidate for radical cystectomy and pelvic lymph node dissection
Q37602822How to lower postoperative complications after radical cystectomy - a review
Q41979875How to predict the risk of complication or death after radical cystectomy?
Q33339210Hydronephrosis is an independent predictor of poor clinical outcome in patients treated for muscle-invasive transitional cell carcinoma with radical cystectomy
Q68733920Hyperbilirubinemia after single-stage radical cystectomy and ileal loop diversion
Q98191179Hypercalcemia associated with lymph node metastasis following radical cystectomy for bladder cancer
Q42488078Hypoxia Marker GLUT-1 (Glucose Transporter 1) is an Independent Prognostic Factor for Survival in Bladder Cancer Patients Treated with Radical Cystectomy
Q38037276ICUD-EAU International Consultation on Bladder Cancer 2012: Radical cystectomy and bladder preservation for muscle-invasive urothelial carcinoma of the bladder
Q96026810IMPLEMENTATION OF A DEDICATED ENHANCED RECOVERY AFTER SURGERY (ERAS) PROGRAM FOR RADICAL CYSTECTOMY PATIENTS IS ASSOCIATED WITH DECREASED POSTOPERATIVE INPATIENT OPIOID USAGE AND PAIN SCORES
Q84466347Identification and management of emptying failure in male patients with orthotopic neobladders after radical cystectomy for bladder cancer
Q36750736Identification of the best complete blood count-based predictors for bladder cancer outcomes in patients undergoing radical cystectomy
Q84933155Identifying additional lymph nodes in radical cystectomy lymphadenectomy specimens
Q92898839Identifying and Codifying Complications after Radical Cystectomy: Comparison of Administrative Diagnostic and Procedure Codes, and Clinical Chart Review
Q46689693Identifying risk factors for potentially avoidable complications following radical cystectomy
Q38937090Idiographic quality of life assessment before radical cystectomy
Q73328598Ileal conduit diversion after radical cystectomy: pro
Q36755098Ileal conduit post radical cystectomy: modifications of the technique
Q53276502Ileal conduit vs orthotopic neobladder: Which one offers the best health-related quality of life in patients undergoing radical cystectomy? A systematic review of literature and meta-analysis.
Q38609460Ileal conduit: standard urinary diversion for elderly patients undergoing radical cystectomy
Q42456549Ileal neobladder for bladder substitution after radical cystectomy
Q35902579Ileal versus sigmoid neobladder as bladder substitute after radical cystectomy for bladder cancer: A meta-analysis
Q42492047Ileocaecal vs ileal neobladder after radical cystectomy in patients with bladder cancer: a comparative study
Q91453996Ileus and small bowel obstruction after radical cystectomy for bladder cancer: Analysis from the Nationwide Inpatient Sample
Q36446891Immediate Radical Cystectomy for Massive Bleeding of Bladder Cancer
Q53175159Immediate radical cystectomy vs conservative management for high grade cT1 bladder cancer: is there a survival difference?
Q38202970Immediate total parenteral nutrition after radical cystectomy and urinary diversion
Q33419283Immediate versus deferred chemotherapy after radical cystectomy in patients with pT3-pT4 or N+ M0 urothelial carcinoma of the bladder (EORTC 30994): an intergroup, open-label, randomised phase 3 trial
Q42237188Immunological tumor status may predict response to neoadjuvant chemotherapy and outcome after radical cystectomy in bladder cancer
Q36624367Immunomodulatory effects of total intravenous and balanced inhalation anesthesia in patients with bladder cancer undergoing elective radical cystectomy: preliminary results
Q61454753Immunonutrition in radical cystectomy: a novel approach to reduce postoperative complications?
Q63984729Impact of Anaesthetist Volume on Radical Cystectomy Outcomes
Q92850840Impact of Body Mass Index and Pretreatment Hemoglobin Level on Prognosis Following Radical Cystectomy for Bladder Cancer in Males and Females
Q98731887Impact of Clinical Response to Neoadjuvant Chemotherapy in the Era of Robot Assisted Radical Cystectomy: Results of a Single-Center Experience
Q92338808Impact of Gender on Chemotherapeutic Response and Oncologic Outcomes in Patients Treated With Radical Cystectomy and Perioperative Chemotherapy for Bladder Cancer: A Systematic Review and Meta-Analysis
Q49815092Impact of Packed Red Blood Cells and Fresh Frozen Plasma Given During Radical Cystectomy and Urinary Diversion on Cancer-related Outcome and Survival: An Observational Cohort Study
Q99201835Impact of Perioperative Multidisciplinary Rehabilitation Pathway on Early Outcomes after Robot-Assisted Radical Cystectomy: A Matched Analysis
Q102060646Impact of Preoperative Serum Albumin-Globulin Ratio on Disease Outcome After Radical Cystectomy for Urothelial Carcinoma of the Bladder
Q98293791Impact of Prognostic Nutritional Index on Postoperative Pulmonary Complications in Radical Cystectomy: A Propensity Score-Matched Analysis
Q89957719Impact of Routine Laboratory Parameters in Patients Undergoing Radical Cystectomy for Urothelial Carcinoma of the Bladder: A Long-Term Follow-Up
Q101451695Impact of Smoking Habit on Perioperative Morbidity in Patients Treated with Radical Cystectomy for Urothelial Bladder Cancer: A Systematic Review and Meta-analysis
Q71963796Impact of a Collaborative Care Approach to Radical Cystectomy and Urinary Reconstruction
Q64319523Impact of a change in duration of prophylactic antibiotics on infectious complications after radical cystectomy with a neobladder
Q49617221Impact of a goal directed therapy in the implementation of an ERAS (Enhanced recovery after surgery) protocol in laparoscopic radical cystectomy
Q36207699Impact of academic affiliation on radical cystectomy outcomes in North America: A population-based study
Q47422484Impact of adequate pelvic lymph node dissection on overall survival after radical cystectomy: A stratified analysis by clinical stage and receipt of neoadjuvant chemotherapy
Q90941487Impact of adjuvant chemotherapy in patients with adverse features and variant histology at radical cystectomy for muscle-invasive carcinoma of the bladder: Does histologic subtype matter?
Q42775246Impact of adjuvant chemotherapy on patients with lymph node metastasis at the time of radical cystectomy.
Q85502780Impact of adjuvant chemotherapy on patients with pathological Stage T3b and/or lymph node metastatic bladder cancer after radical cystectomy
Q47328870Impact of an enhanced recovery after surgery programme in radical cystectomy. A cohort-comparative study
Q92801209Impact of an enhanced recovery pathway on length of stay and complications in elective radical cystectomy: a before and after cohort study
Q92318762Impact of an oral nutrition protocol in patients treated with elective radical cystectomy: a long term follow-up
Q96813657Impact of anemia on the survival of patients undergoing radical cystectomy for bladder cancer
Q48448129Impact of body mass index on clinical and cost outcomes after radical cystectomy
Q51614697Impact of body mass index on radical cystectomy.
Q34466110Impact of body mass index on robot-assisted radical cystectomy
Q46036751Impact of body mass index on robot-assisted radical cystectomy with intracorporeal urinary diversion.
Q40714046Impact of body mass index on the oncological outcomes of patients treated with radical cystectomy for muscle-invasive bladder cancer.
Q46448073Impact of complications and hospital-free days on health related quality of life 1 year after radical cystectomy
Q86698424Impact of concomitant carcinoma in situ on upstaging and outcome following radical cystectomy for bladder cancer
Q93038948Impact of enhanced recovery after surgery protocols versus standard of care on perioperative outcomes of radical cystectomy: a systematic review and meta-analysis of comparative studies
Q45905367Impact of histological variants on oncological outcomes of patients with urothelial carcinoma of the bladder treated with radical cystectomy.
Q40906007Impact of histopathological variant on the outcome of patients treated by radical cystectomy
Q33213908Impact of hospital and surgeon volume on in-hospital mortality from radical cystectomy: data from the health care utilization project
Q98176445Impact of hospital and surgeon volumes on short-term and long-term outcomes of radical cystectomy
Q86603999Impact of hospital volume on local recurrence and distant metastasis in bladder cancer patients treated with radical cystectomy in Sweden
Q38188120Impact of hospital volume on perioperative outcomes and costs of radical cystectomy: analysis of the Maryland Health Services Cost Review Commission database
Q61454786Impact of immunonutrition on radical cystectomy immunoresponse and outcomes; opportunity for peri-operative optimization
Q89999032Impact of lymph node dissection in radical cystectomy for bladder cancer: How many vs how far?
Q30989295Impact of malpractice caps on use and outcomes of radical cystectomy for bladder cancer: data from the surveillance, epidemiology, and end results program
Q46121062Impact of marital status in patients undergoing radical cystectomy for bladder cancer
Q38090151Impact of micropapillary urothelial carcinoma variant histology on survival after radical cystectomy
Q40427194Impact of neoadjuvant chemotherapy on complications of minimally invasive radical cystectomy
Q90293717Impact of neoadjuvant chemotherapy on short-term complications and survival following radical cystectomy
Q102060647Impact of neuraxial analgesia on outcomes following radical cystectomy: A systematic review
Q43569010Impact of peri-operative blood transfusion on the outcomes of patients undergoing radical cystectomy for urothelial carcinoma of the bladder
Q40701908Impact of photodynamic diagnosis-assisted transurethral resection of bladder tumors on the prognostic outcome after radical cystectomy: results from PROMETRICS 2011.
Q46543785Impact of pre-operative MRI-measured membranous urethral length on urinary continence after radical cystectomy and orthotopic substitution: clinical and urodynamic evaluation
Q41351075Impact of preoperative hemoglobin and CRP levels on cancer-specific survival in patients undergoing radical cystectomy for transitional cell carcinoma of the bladder: results of a single-center study
Q95407126Impact of preoperative thrombocytosis on pathological outcomes and survival in patients treated with radical cystectomy for bladder carcinoma
Q34466543Impact of previous abdominal surgery on robot-assisted radical cystectomy
Q79297916Impact of primary tumour characteristics on the survival of patients with lymph node metastases in bladder cancer following radical cystectomy
Q41965520Impact of provider volume on operative mortality after radical cystectomy in a publicly funded healthcare system
Q85598854Impact of smoking and smoking cessation on outcomes in bladder cancer patients treated with radical cystectomy
Q36276796Impact of stage and comorbidities on five-year survival after radical cystectomy in Poland: single centre experience
Q47880226Impact of stapling devices on radical cystectomy: comparative study between low- and high-volume surgeons
Q45951908Impact of statin use on oncologic outcomes in patients with urothelial carcinoma of the bladder treated with radical cystectomy.
Q40541109Impact of suboptimal neoadjuvant chemotherapy on peri-operative outcomes and survival after robot-assisted radical cystectomy: a multicentre multinational study
Q42689150Impact of surgeon and volume on extended lymphadenectomy at the time of robot-assisted radical cystectomy: results from the International Robotic Cystectomy Consortium (IRCC).
Q45014323Impact of surgeon volume on the morbidity and costs of radical cystectomy in the USA: a contemporary population-based analysis
Q36176989Impact of surgical margin status on the outcome of bladder cancer treated by radical cystectomy: a meta-analysis
Q41273357Impact of the Level of Urothelial Carcinoma Involvement of the Prostate on Survival after Radical Cystectomy
Q97524376Impact of timing of adjuvant chemotherapy following radical cystectomy for bladder cancer on patient survival
Q51878931Impact of tumour volume on surgical and pathological outcomes after robot-assisted radical cystectomy.
Q43567433Impaired cardiopulmonary reserve in an elderly population is related to postoperative morbidity and length of hospital stay after radical cystectomy
Q97892964Impairment and Longitudinal Recovery of Older Adults Treated with Radical Cystectomy for Muscle-Invasive Bladder Cancer
Q97690807Implementation of ERAS (Enhanced Recovery After Surgery) protocols for radical cystectomy patients: The pathway to standardization. A systematic review
Q92952852Implementation of ERAS protocol in robot-assisted radical cystectomy with intracorporeal ileal conduit urinary diversion: An outcome analysis beyond the learning curve
Q91516733Implementation of a Perioperative Venous Thromboembolism Prophylaxis Program for Patients Undergoing Radical Cystectomy on an Enhanced Recovery After Surgery Protocol
Q47293877Implementation of an Enhanced Recovery After Surgery (ERAS) protocol can improve outcomes for patients undergoing radical cystectomy
Q92792503Implementation of enhanced recovery after surgery in patients undergoing radical cystectomy: A retrospective cohort study
Q38203011Implementation of the Exeter enhanced recovery programme for patients undergoing radical cystectomy
Q41685242Implications of Definitive Prostate Cancer Therapy on Soft Tissue Margins and Survival in Patients Undergoing Radical Cystectomy for Bladder Urothelial Cancer
Q93182670Implications of micropapillary urothelial carcinoma variant on prognosis following radical cystectomy: A multi-institutional investigation
Q88639444Improved Outcomes of Enhanced Recovery After Surgery (ERAS) Protocol for Radical Cystectomy with Addition of a Multidisciplinary Care Process in a US Comprehensive Cancer Care Center
Q53935751Improved perioperative outcome with norepinephrine and a restrictive fluid administration during open radical cystectomy and urinary diversion.
Q88301433Improved surgical outcomes following radical cystectomy at high-volume centers influence overall survival
Q89224661Improved technique for intracorporeal neobladder-urethral anastomosis in laparoscopic radical cystectomy
Q93034387Improving Estimates of Perioperative Morbidity After Radical Cystectomy Using the European Association of Urology Quality Criteria for Standardized Reporting and Introducing the Comprehensive Complication Index
Q81292338Improving outcomes after radical cystectomy
Q91617673Improving outcomes of radical cystectomy: A call for passive over active regionalization
Q36606956Improving outcomes with radical cystectomy for high-grade invasive bladder cancer
Q37894684Improving selection of appropriate urinary diversion following radical cystectomy for bladder cancer.
Q36990721Improving the prognosis of patients after radical cystectomy. Part I: the role of lymph node dissection
Q36990725Improving the prognosis of patients after radical cystectomy. Part II: the role of perioperative chemotherapy
Q91279636In-Hospital Outcomes after Radical Cystectomy for Bladder Cancer: Comparing National Trends in the United States and Germany from 2006 to 2014
Q38655158In-depth Critical Analysis of Complications Following Robot-assisted Radical Cystectomy with Intracorporeal Urinary Diversion
Q86997025In-hospital mortality and failure-to-rescue rates after radical cystectomy
Q41891611In-vitro cytocidal effect of water on bladder cancer cells: The potential role for intraperitoneal lavage during radical cystectomy
Q53909910Incarcerated femoral hernia after radical cystectomy.
Q101563320Incidence and Clinical Impact of Inflammatory Fluorodeoxyglucose Positron Emission Tomography Uptake After Neoadjuvant Pembrolizumab in Patients with Organ-confined Bladder Cancer Undergoing Radical Cystectomy
Q40060285Incidence and Effect of Thromboembolic Events in Radical Cystectomy Patients Undergoing Preoperative Chemotherapy for Muscle-invasive Bladder Cancer
Q40075778Incidence and Predictors of 30-Day Readmission in Patients Treated With Radical Cystectomy: A Single Center European Experience
Q35942093Incidence and Risk Factors of Acute Kidney Injury after Radical Cystectomy: Importance of Preoperative Serum Uric Acid Level
Q39021486Incidence and effect of variant histology on oncological outcomes in patients with bladder cancer treated with radical cystectomy
Q39470187Incidence and location of lymph node metastases in patients undergoing radical cystectomy for clinical non-muscle invasive bladder cancer: results from a prospective lymph node mapping study.
Q64078912Incidence and microbiology of post-operative infections after radical cystectomy and ureteral stent removal; a retrospective cohort study
Q88087589Incidence and perioperative risk factors for early acute kidney injury after radical cystectomy and urinary diversion
Q37416794Incidence and predictors of understaging in patients with clinical T1 urothelial carcinoma undergoing radical cystectomy
Q91162478Incidence and prognosis of clinically significant incidental prostate cancer after radical cystectomy for bladder cancer
Q47800647Incidence and risk factors for acute kidney injury after radical cystectomy
Q92706945Incidence and risk factors for peritoneal carcinomatosis following open radical cystectomy
Q44229777Incidence and risk factors of 30-day early and 90-day late morbidity and mortality of radical cystectomy during a 13-year follow-up: a comparative propensity-score matched analysis of complications between neobladder and ileal conduit
Q43479662Incidence and risk factors of early postoperative paralytic ileus after radical cystectomy and cutaneous ureterostomy with a unilateral and parallel stoma
Q46015451Incidence and risk factors of parastomal hernia in patients undergoing radical cystectomy and ileal conduit diversion.
Q46679577Incidence of and risk factors for surgical site infection in patients with radical cystectomy with urinary diversion
Q84569181Incidence of occult lymph-node metastasis missed by standard pathological examination in patients with bladder cancer undergoing radical cystectomy
Q45008049Incidence, extent and location of unsuspected pelvic lymph node metastasis in patients undergoing radical cystectomy for bladder cancer
Q89568576Incidence, predictive factors and survival outcomes of incidental prostate cancer in patients who underwent radical cystectomy for bladder cancer
Q50735900Incidence, risk factors, and complications of postoperative delirium in elderly patients undergoing radical cystectomy.
Q34626197Incidental appendectomy during radical cystectomy--is it necessary?
Q33990041Incidental appendectomy during radical cystectomy: an interdepartmental survey and review of the literature
Q38798073Incisional and Parastomal Hernia following Radical Cystectomy and Urinary Diversion: The University of Southern California Experience
Q58705124Increased Surgical Complications in Smokers Undergoing Radical Cystectomy
Q75435923Increased body mass index predicts increased blood loss during radical cystectomy
Q89567682Increasing use of positron emission tomography among medicare beneficiaries undergoing radical cystectomy
Q45065686Indication of radical cystectomy in patients with carcinoma of the bladder
Q74130933Indications for admission to the surgical intensive care unit after radical cystectomy and urinary diversion
Q40239210Indications for urethrectomy in men undergoing single stage radical cystectomy for bladder cancer.
Q91322087Induction Chemotherapy Followed by Surgery Versus Upfront Radical Cystectomy in Patients With Clinically Node-positive Muscle-invasive Bladder Cancer
Q39470406Infectious complications in transfused patients after radical cystectomy
Q90252974Inferior epigastric artery pseudoaneurysm secondary to port placement during a robot-assisted laparoscopic radical cystectomy
Q50539369Influence and Impact of Cognitive Trajectories on Outcome in Patients Undergoing Radical Cystectomy: An Observational Study.
Q52803559Influence of Body Mass Index on Clinical Outcome Parameters, Complication Rate and Survival after Radical Cystectomy: Evidence from a Prospective European Multicentre Study.
Q41667481Influence of Comorbidity on Mortality and Morbidity in the Radical Cystectomy for Bladder Cancer
Q91566799Influence of Simple and Radical Cystectomy on Sexual Function and Pelvic Organ Prolapse in Female Patients: A Scoping Review of the Literature
Q84023302Influence of body mass index on operability, morbidity and disease outcome following radical cystectomy
Q93055230Influence of preoperative hydronephrosis and ureteral orifice involvement in the survival of patients undergoing radical cystectomy: A retrospective comparative study
Q38477324Influence of stage discrepancy on outcome in patients treated with radical cystectomy.
Q100382341Inguinal lymph node metastasis of bladder carcinoma after radical cystectomy: A case report and review of literature
Q102140554Initial Experience with Intracorporeal Laparoscopic Radical Cystectomy and Detaenial Sigmoid Neobladder Reconstruction
Q83774606Initial experience of robot-assisted radical cystectomy with total intracorporeal urinary diversion: comparison with extracorporeal method
Q35777579Initial experience with ketamine-based analgesia in patients undergoing robotic radical cystectomy and diversion
Q33792772Initial experiences with robot-assisted laparoscopic radical cystectomy
Q41467236Initial experiences with the enhanced recovery after surgery (ERAS) protocol in open radical cystectomy
Q38049697Innovations in radical cystectomy and pelvic lymph node dissection
Q45077187Insulin-like growth factor-1 receptor overexpression is associated with outcome in invasive urothelial carcinoma of urinary bladder: a retrospective study of patients treated using radical cystectomy
Q98176101Integrated Treatment by an Ostomy Care Team of a Complicated Mucocutaneous Separation After Radical Cystectomy With Ileal Conduit Urinary Diversion: A Case Report
Q71301660Integrated preoperative irradiation and radical cystectomy
Q51839920Integrative Assessment of Pretreatment Inflammation-, Nutrition-, and Muscle-Based Prognostic Markers in Patients with Muscle-Invasive Bladder Cancer Undergoing Radical Cystectomy.
Q46044976Intermediate-term oncologic outcomes of robot-assisted radical cystectomy for urothelial carcinoma
Q89949508Internal audit of an enhanced recovery after surgery protocol for radical cystectomy
Q91091256Internal double-J stent was associated with a lower incidence of ureteroileal anastomosis stricture than external ureteral catheter for patients undergoing radical cystectomy and orthotopic neobladder: A systematic review and meta-analysis
Q90587233Internal hernia from the interureteric space after robot-assisted radical cystectomy and urinary diversion: Two case reports
Q46514410Internal urinary diversion following radical cystectomy for bladder cancer
Q37131247Internal versus external ureteric stents for uretero-ileal anastomosis after laparoscopic radical cystectomy with orthotopic neobladder: A prospective comparative study
Q39148271International Robotic Radical Cystectomy Consortium: A way forward
Q46165799International validation of the prognostic value of lymphovascular invasion in patients treated with radical cystectomy
Q46506621Interventional radiology methods of treating ureteral strictures developed on anastomoses after the radical cystectomy in Mainz pouch II and ileal conduit derivation
Q91219276Intestinal malrotation in a patient who underwent radical cystectomy and ileal conduit construction: A case report
Q40319613Intestinal neobladder fistula after radical cystectomy and orthotopic ileal neobladder
Q86639048Intestinal perforation after radical cystectomy due to drain: case report
Q69520094Intestinal strictures complicating preoperative radiation therapy followed by radical cystectomy
Q85305371Intra-arterial chemotherapy for pelvic recurrence after radical cystectomy for bladder urothelial cancer
Q73354092Intra-operative autotransfusion in radical cystectomy
Q42042323Intra-operative cell salvage in radical cystectomy
Q92912184Intra-operative norepinephrine administration and cancer-related outcomes following radical cystectomy for bladder cancer: A cohort study
Q91300208Intracorporeal Studer Pouch Formation with Balbay's Technique Following Robotic Radical Cystectomy for Bladder Cancer: Experience with 22 Cases with Oncologic and Functional Outcomes
Q102219068Intracorporeal Urinary Diversion in Robotic Radical Cystectomy
Q47232375Intracorporeal robot-assisted radical cystectomy, together with an enhanced recovery programme, improves postoperative outcomes by aggregating marginal gains.
Q100530122Intracorporeal urinary diversion during robot-assisted radical cystectomy using indocyanine green
Q96577524Intracorporeal versus extracorporeal urinary diversion after robotic-assisted radical cystectomy: evidence from a systematic review and pooled analysis of observational studies
Q102320771Intracorporeal versus extracorporeal urinary diversion following robot-assisted radical cystectomy: a meta-analysis, cumulative analysis, and systematic review
Q98567961Intraoperative Only versus Extended Duration Use of Antimicrobial Prophylaxis for Infectious Complications in Radical Cystectomy with Intestinal Urinary Diversion
Q102387027Intraoperative Ureteral Stent Use at Radical Cystectomy is Associated with Higher 30-Day Complication Rates
Q69971680Intraoperative autotransfusion in radical cystectomy for carcinoma of the bladder
Q80273322Intraoperative cell salvage during radical cystectomy does not affect long-term survival
Q42617099Intraoperative continuous norepinephrine infusion combined with restrictive deferred hydration significantly reduces the need for blood transfusion in patients undergoing open radical cystectomy: results of a prospective randomised trial
Q61449312Intraoperative hypothermia is a significant prognostic predictor of radical cystectomy especially for stage II muscle-invasive bladder cancer
Q78213560Intravesical therapy with pertussis toxin before radical cystectomy in patients with bladder cancer: a Phase I study
Q85222296Intravesical tumor involvement of the trigone is associated with nodal metastasis in patients undergoing radical cystectomy
Q40600708Introducing an enhanced recovery programme to an established totally intracorporeal robot-assisted radical cystectomy service
Q80482485Introduction of an enhanced recovery protocol for radical cystectomy
Q46746626Introduction of an enhanced recovery protocol to reduce short-term complications following radical cystectomy and intestinal urinary diversion with vescica ileale Padovana neobladder
Q39174669Introduction of robot-assisted radical cystectomy within an established enhanced recovery programme
Q72346596Invasion depth is the most important prognostic factor for transitional-cell carcinoma in a prospective trial of radical cystectomy and adjuvant chemotherapy
Q37169732Invasive T1 bladder cancer: indications and rationale for radical cystectomy
Q84538821Invasive bladder cancer and the role of follow-up: should we consider the match over at radical cystectomy or should we play for extra time?
Q45981130Invasive bladder carcinoma treated by radical cystectomy: survival of patients
Q36662333Invasive urothelial carcinoma, lymphoma-like/plasmacytoid variant, successfully treated by radical cystectomy with adjuvant chemotherapy: a case report
Q37988362Investigation of anal sphincter function following Mainz pouch type II urinary diversion after radical cystectomy.
Q73591411Involvement of internal genitalia in female patients undergoing radical cystectomy for bladder cancer: a clinicopathologic study of 37 cases
Q74073433Involvement of the anterior urethra in male patients with transitional cell-carcinoma of the bladder undergoing radical cystectomy with simultaneous urethrectomy
Q91921152Is Bcl-2 a predictive marker of neoadjuvant chemotherapy response in patients with urothelial bladder cancer undergoing radical cystectomy?
Q92638623Is Fast Track protocol a safe tool to reduce hospitalization time after radical cystectomy with ileal urinary diversion? Initial results from a single high-volume centre
Q38635958Is Health-Related Quality of Life after Radical Cystectomy Using Validated Questionnaires Really Better in Patients with Ileal Orthotopic Neobladder Compared to Ileal Conduit: A Meta-Analysis of Retrospective Comparative Studies
Q38449423Is Immediate Radical Cystectomy Necessary for All Patients with Non-Muscle-Invasive Micropapillary Bladder Cancer?
Q98882653Is It Safe to Offer Radical Cystectomy to Patients above 85 Years of Age? A Long-Term Follow-Up in a Single-Center Institution
Q91855585Is Routine Removal of the Ovaries Advisable during Radical Cystectomy?
Q43635639Is TURBT able to cure high risk recurrent superficial or muscle invasive bladder cancer: factors resulting in pT0 radical cystectomy specimens
Q52968595Is eligibility for a chemotherapy protocol a good prognostic factor for invasive bladder cancer after radical cystectomy?
Q95820547Is eligibility for a chemotherapy protocol a good prognostic factor for invasive bladder cancer after radical cystectomy?
Q61454764Is experience with extracorporeal urinary diversion following robotic assisted radical cystectomy necessary before transitioning to intracorporeal urinary diversion?
Q44220342Is extended pharmacologic venous thromboembolism prophylaxis uniformly safe after radical cystectomy?
Q36227512Is frozen section analysis of the urethra at the time of radical cystectomy and orthotopic neobladder urinary diversion mandatory?
Q38458428Is frozen section analysis of ureteral margins at time of radical cystectomy useful?
Q91617410Is hysterectomy beneficial in radical cystectomy for female patient with urothelial carcinoma of bladder? A retrospective analysis of consecutive 112 cases from a single institution
Q43633132Is incidental appendectomy necessary during radical cystectomy?
Q35558116Is it necessary to insert nasogastric tube routinely after radical cystectomy with urinary diversion? A meta-analysis
Q61454749Is it oncologically and clinically safe to adopt a bladder sparing approach in complete responders following neoadjuvant chemotherapy alone without proceeding to a radical cystectomy?
Q81504156Is less radical cystectomy better, and how can we be sure?
Q42683443Is patient outcome compromised during the initial experience with robot-assisted radical cystectomy? Results of 164 consecutive cases
Q84056546Is pure laparoscopic radical cystectomy still an attractive solution for the treatment of muscle-invasive bladder cancer?
Q68280600Is radical cystectomy indicated in patients with regional lymphatic metastases?
Q35093233Is radical cystectomy mandatory in every patient with variant histology of bladder cancer
Q51368850Is robot-assisted radical cystectomy justified in the elderly? A comparison of robotic versus open radical cystectomy for bladder cancer in elderly ≥75 years old.
Q52684398Is robot-assisted radical cystectomy superior to standard open radical cystectomy? An Indian perspective.
Q45798358Is robot-assisted radical cystectomy the right way to reduce complications in patients undergoing radical cystectomy?
Q51874164Is robotic radical cystectomy an appropriate treatment for bladder cancer? Short-term oncologic and clinical follow-up in 50 consecutive patients.
Q57052071Is robotic radical cystectomy ready for prime time?
Q38647825Is robotic-assisted radical cystectomy (RARC) with intracorporeal diversion becoming the new gold standard of care?
Q42151861Is sparing the prostate still considered radical cystectomy? The case against prostate-sparing cystectomy for bladder cancer
Q38675168Is survival after radical cystectomy for bladder cancer in Saudi patients different from that of Western patients?
Q45958003Is the complication rate of radical cystectomy predictive of the complication rate of other urological procedures?
Q45074979Is the incidence of uretero-intestinal anastomotic stricture increased in patients undergoing radical cystectomy with previous pelvic radiation?
Q86101245Is there a relationship between leapfrog volume thresholds and perioperative outcomes after radical cystectomy?
Q39146600Is there evidence for a close connection between side of intravesical tumor location and ipsilateral lymphatic spread in lymph node-positive bladder cancer patients at radical cystectomy? Results of the PROMETRICS 2011 database
Q46033293Karnofsky performance status predicts overall survival, cancer-specific survival, and progression-free survival following radical cystectomy for urothelial carcinoma.
Q79451533Ki-67 is an independent predictor of bladder cancer outcome in patients treated with radical cystectomy for organ-confined disease
Q41515177LAPAROSCOPIC AND OPEN RADICAL CYSTECTOMY FOR BLADDER CANCER
Q40795695Laparo-endoscopic single-site radical cystectomy with orthotopic urinary diversion: Technique, feasibility, and the 3-year follow-up.
Q47887500Laparoendoscopic Single-Site Radical Cystectomy vs Conventional Laparoscopic Radical Cystectomy for Patient with Bladder Urothelial Carcinoma: Matched Case-Control Analysis
Q84582215Laparoendoscopic single-site radical cystectomy and pelvic lymph node dissection: initial experience and 2-year follow-up
Q50523333Laparoendoscopic single-site radical cystectomy and urinary diversion: initial experience in China using a homemade single-port device.
Q41287583Laparoscopic Radical Cystectomy Versus Extraperitoneal Radical Cystectomy: Is the Extraperitoneal Technique Rewarding?
Q93369434Laparoscopic Radical Cystectomy With Extracorporeal Neobladder: Our Initial Experience
Q37201133Laparoscopic Radical Cystectomy and Ileal Neobladder for Muscle Invasive Bladder Cancer in Combination with One Stage Prophylactic Laparoscopic Sacrospinal Fixation to Avoid Future Pelvic Organ Prolapse
Q37426968Laparoscopic Radical Cystectomy in the Elderly - Results of a Single Center LRC only Series.
Q40962834Laparoscopic Radical Cystectomy in the Elderly Patients
Q40967148Laparoscopic Versus Open Radical Cystectomy for Patients Older than 75 Years: a Single-Center Comparative Analysis
Q33327621Laparoscopic and robotic assisted radical cystectomy for bladder cancer: a critical analysis
Q52001791Laparoscopic and robotic radical cystectomy.
Q46094778Laparoscopic assisted radical cystectomy with ileal neobladder: a comparison with the open approach
Q81798344Laparoscopic assisted radical cystectomy: the montsouris experience after 84 cases
Q85202175Laparoscopic extended pelvic lymph node dissection during radical cystectomy: technique and clinical outcomes
Q78412953Laparoscopic hand assisted radical cystectomy with ileal conduit urinary diversion
Q91148112Laparoscopic intracorporeal ileal conduit after laparoscopic radical cystectomy: A modified technique to facilitate ureteroenteric anastomosis
Q98191223Laparoscopic pelvic organ prolapse repair by mesh interposition following radical cystectomy
Q51483624Laparoscopic prostate-sparing radical cystectomy: the Montsouris technique and preliminary results.
Q35643013Laparoscopic radical cystectomy
Q44850440Laparoscopic radical cystectomy
Q48918269Laparoscopic radical cystectomy
Q80580920Laparoscopic radical cystectomy
Q80042286Laparoscopic radical cystectomy and bilateral ureteric ligation for muscle-invasive bladder cancer in a patient on hemodialysis
Q74246032Laparoscopic radical cystectomy and continent orthotopic ileal neobladder performed completely intracorporeally: the initial experience
Q80612671Laparoscopic radical cystectomy and extracorporeal urinary diversion: a single center experience of 48 cases with three years of follow-up
Q42618212Laparoscopic radical cystectomy and ileal conduit reconstruction: preliminary experience
Q102328082Laparoscopic radical cystectomy and nephroureterectomy en bloc resection with lomboaortic and pelvic lymph node dissection
Q36046107Laparoscopic radical cystectomy and urinary diversion
Q35871198Laparoscopic radical cystectomy and urinary diversion: fad or future?
Q81174299Laparoscopic radical cystectomy and urinary diversion: fad or future?
Q51749022Laparoscopic radical cystectomy combined with bilateral nephroureterectomy and specimen extraction through the vagina.
Q83254501Laparoscopic radical cystectomy for bladder cancer with prostatic and neurovascular sparing: initial experience
Q42623016Laparoscopic radical cystectomy for cancer: oncological outcomes at up to 5 years
Q42604402Laparoscopic radical cystectomy for muscle-invasive bladder cancer: pathological and oncological outcomes
Q93016462Laparoscopic radical cystectomy in octogenarians: analysis of a Japanese multicenter cohort
Q42655882Laparoscopic radical cystectomy in the female
Q83929384Laparoscopic radical cystectomy with and without orthotopic bladder replacement
Q36046098Laparoscopic radical cystectomy with continent urinary diversion
Q73924448Laparoscopic radical cystectomy with continent urinary diversion (rectal sigmoid pouch) performed completely intracorporeally: the initial 5 cases
Q42640118Laparoscopic radical cystectomy with continent urinary diversion (rectosigmoid pouch) performed completely intracorporeally: an intermediate functional and oncologic analysis
Q80352565Laparoscopic radical cystectomy with continent urinary diversion (rectosigmoid pouch) performed completely intracorporeally: an intermediate functional and oncologic analysis
Q43726012Laparoscopic radical cystectomy with extended pelvic lymph node dissection for bladder urothelial carcinoma: complications and oncologic outcomes in 210 cases
Q81448907Laparoscopic radical cystectomy with extracorporeal ileal conduit urinary diversion for treatment of Chinese bladder cancer patients
Q57110953Laparoscopic radical cystectomy with extracorporeal ileal neobladder for muscle-invasive urothelial carcinoma of the bladder: technique and short-term outcomes
Q96577526Laparoscopic radical cystectomy with extracorporeal urinary diversion: an Italian single center experience with 10-year outcomes
Q42674591Laparoscopic radical cystectomy with extracorporeal urinary diversion: preliminary experience
Q36046078Laparoscopic radical cystectomy with ileal conduit diversion
Q39354064Laparoscopic radical cystectomy with ileal conduit diversion: the first case report in Thailand.
Q28256192Laparoscopic radical cystectomy with ileal conduit urinary diversion
Q51056203Laparoscopic radical cystectomy with ileal neobladder and rectum pouch: the initial experience of 28 cases in China.
Q50109472Laparoscopic radical cystectomy with intracorporeal ileal conduit diversion: five cases with a 2-year follow-up
Q92552573Laparoscopic radical cystectomy with intracorporeal ileal conduit: one center experience and clinical outcomes
Q53328706Laparoscopic radical cystectomy with intracorporeal orthotopic ileal neobladder: technique and clinical outcomes.
Q51360876Laparoscopic radical cystectomy with intracorporeally constructed Y-shaped orthotopic ileal neobladder using nonabsorbable titanium staples exclusively.
Q37626497Laparoscopic radical cystectomy with novel orthotopic neobladder with bilateral isoperistaltic afferent limbs: initial experience
Q42596407Laparoscopic radical cystectomy with orthotopic gastric neobladder: technique and initial outcomes
Q42664282Laparoscopic radical cystectomy with orthotopic ileal neobladder for bladder cancer: oncologic results of 171 cases with a median 3-year follow-up
Q47397626Laparoscopic radical cystectomy with orthotopic ileal neobladder in the female: report of 14 cases.
Q47766839Laparoscopic radical cystectomy with orthotopic ileal neobladder: a report of 85 cases
Q51555964Laparoscopic radical cystectomy with orthotopic ileal neobladder: report of 33 cases.
Q74780088Laparoscopic radical cystectomy with orthotopic neobladder
Q60045402Laparoscopic radical cystectomy with pelvic re-peritonealization: the technique and initial clinical outcomes
Q40678031Laparoscopic radical cystectomy with prostate capsule sparing. Initial experience
Q39417429Laparoscopic radical cystectomy with total intracorporeal ileal neobladder: first case report in Thailand
Q35742700Laparoscopic radical cystectomy with urinary diversion
Q74780064Laparoscopic radical cystectomy with urinary diversion: completely intracorporeal technique
Q95784991Laparoscopic radical cystectomy with urinary diversion: completely intracorporeal technique
Q36730075Laparoscopic radical cystectomy with urinary diversion: what is the optimal technique?
Q81036369Laparoscopic radical cystectomy-where are we really?
Q53209479Laparoscopic radical cystectomy.
Q37793760Laparoscopic radical cystectomy. Where do we stand?
Q27000412Laparoscopic radical cystectomy: a 5-year review of a single institute's operative data and complications and a systematic review of the literature
Q42611488Laparoscopic radical cystectomy: an Italian survey.
Q37442714Laparoscopic radical cystectomy: current status, outcomes, and patient selection
Q82041375Laparoscopic radical cystectomy: formidable challenge to the gold standard
Q42660056Laparoscopic radical cystectomy: initial experience using the single-incision triangulated umbilical surgery (SITUS) technique
Q50033992Laparoscopic radical cystectomy: innovations and classics
Q37095976Laparoscopic radical cystectomy: long-term outcomes
Q33819916Laparoscopic radical cystectomy: neobladder or ileal conduit, debate still goes on
Q57107336Laparoscopic right hemicolectomy for metachronous ascending colon cancer with preservation of an ileal conduit constructed after previous radical cystectomy for bladder cancer
Q33717058Laparoscopic versus open radical cystectomy for elderly patients over 75-year-old: a single center comparative analysis.
Q46510192Laparoscopic versus open radical cystectomy for muscle-invasive bladder cancer: a single institute comparative analysis
Q33688743Laparoscopic versus open radical cystectomy for patients with bladder cancer over 75-year-old: a prospective randomized controlled trial
Q42640381Laparoscopic versus open radical cystectomy for the management of bladder cancer: mid-term oncological outcome
Q33623496Laparoscopic versus open radical cystectomy in bladder cancer: a systematic review and meta-analysis of comparative studies
Q89693336Laparoscopic versus open radical cystectomy in the treatment of locally advanced T3 and T4 bladder cancer: Perioperative and Mid-term oncological outcomes
Q79483564Laparoscopic-assisted nephroureterectomy after radical cystectomy for transitional cell carcinoma
Q51171513Laparoscopic-assisted radical cystectomy with U-shaped orthotopic ileal neobladder constructed using nonabsorbable titanium staples.
Q40521952Laparoscopically assisted transvaginal radical cystectomy
Q90452799Large Single Institution Comparison of Perioperative Outcomes and Complications of Open Radical Cystectomy, Intracorporeal Robot-Assisted Radical Cystectomy and Robotic Extracorporeal Approach
Q50718028Late Oncological Occurrences Following Radical Cystectomy in Patients with Bladder Cancer
Q92958756Late Recurrence of Bladder Cancer following Radical Cystectomy: Characteristics and Outcomes
Q91617467Late Recurrences Following Radical Cystectomy Have Distinct Prognostic and Management Considerations
Q98197076Late complications of robot-assisted radical cystectomy with totally intracorporeal urinary diversion
Q38944943Late intestinal obstruction after radical cystectomy and urinary diversion: urological and oncological perspectives.
Q46197567Late recurrence after radical cystectomy: patterns, risk factors and outcomes
Q39618396Learning from our patients: complications and the future of radical cystectomy for bladder cancer.
Q41446293Lee mortality index as comorbidity measure in patients undergoing radical cystectomy
Q64910618Left ureteral tumor five years after radical cystectomy associated with duplication of inferior vena cava: a case report
Q91916172Letter to the Editor RE: Venkatramani and Parekh, Editorial Comment on: Does the Use of a Robot Decrease the Complication Rate Adherent to Radical Cystectomy? A Systematic Review and Meta-Analysis of Studies Comparing Open with Robotic Counterparts
Q35178498Life-threatening rupture of an external iliac artery pseudoaneurysm caused by necrotizing fasciitis following laparoscopic radical cystectomy: a case report
Q51704610Ligasure versus sutures in bladder replacement with Montie ileal neobladder after radical cystectomy.
Q73753930Limitations of computerized tomography in staging invasive bladder cancer before radical cystectomy
Q82688604Limited, extended, superextended, megaextended pelvic lymph node dissection at the time of radical cystectomy: what should we perform?
Q104075723Liposomal bupivacaine decreases post-operative length of stay and opioid use in patients undergoing radical cystectomy
Q86089221Local and systemic recurrence patterns of urothelial cancer after radical cystectomy
Q35921613Local recurrence after radical cystectomy for invasive bladder cancer: an analysis of predictive factors
Q51691515Local recurrence in patients after radical cystectomy and orthotopic ileal neobladder: impact on function.
Q53352606Local recurrence of bladder cancer occurring eight years after radical cystectomy.
Q44246782Local urethral recurrence after radical cystectomy and orthotopic bladder substitution in women: a prospective study.
Q92114345Location of Metastatic Bladder Cancer as a Determinant of In-hospital Mortality After Radical Cystectomy
Q49700228Long Non-Coding RNA Cancer Susceptibility Candidate 2a (CASC2a) Is a Marker of Early Recurrence After Radical Cystectomy in Patients with Urothelial Carcinoma of the Bladder
Q51038905Long term complications following ileal conduit urinary diversion after radical cystectomy.
Q91299966Long term oncologic outcome in patients with bladder cancer after radical cystectomy: Impact of carcinoma in situ in the era of neoadjuvant chemotherapy
Q91692221Long-Term Follow-Up and Oncological Outcome of Patients Undergoing Radical Cystectomy for Bladder Cancer following an Enhanced Recovery after Surgery (ERAS) Protocol: Results of a Large Randomized, Prospective, Single-Center Study
Q92899631Long-term Changes in Renal Function, Blood Electrolyte Levels, and Nutritional Indices after Radical Cystectomy and Ileal Conduit in Patients with Bladder Cancer
Q47902259Long-term Health-related Quality of Life Outcomes Following Radical Cystectomy
Q91327411Long-term Oncological Outcomes from an Early Phase Randomised Controlled Three-arm Trial of Open, Robotic, and Laparoscopic Radical Cystectomy (CORAL)
Q42687016Long-term analysis of oncological outcomes after laparoscopic radical cystectomy in Europe: results from a multicentre study by the European Association of Urology (EAU) section of Uro-technology
Q48093762Long-term changes in renal function outcomes following radical cystectomy and urinary diversion
Q42640085Long-term evaluation of oncologic and functional outcomes after laparoscopic open-assisted radical cystectomy: a matched-pair analysis.
Q84794273Long-term follow-up after radical cystectomy with emphasis on complications and reoperations: a Swedish population-based survey
Q38796570Long-term functional outcomes after radical cystectomy with ileal bladder substitute: does the definition of continence matter?
Q33627559Long-term oncologic outcomes after radical cystectomy for bladder cancer at a single institution.
Q38488664Long-term oncologic outcomes following robot-assisted radical cystectomy: results from the International Robotic Cystectomy Consortium.
Q92692214Long-term oncologic outcomes of robot-assisted radical cystectomy (RARC) with totally intracorporeal urinary diversion (ICUD): a multi-center study
Q46259441Long-term oncological outcomes in women undergoing radical cystectomy and orthotopic diversion for bladder cancer
Q45913209Long-term outcome of radical cystectomy in ESDR patients with bladder urothelial carcinoma.
Q97093351Long-term outcomes of incidental prostate cancer at radical cystectomy
Q53322873Long-term outcomes of radical cystectomy with preservation of prostatic capsule.
Q42686709Long-term outcomes of robot-assisted radical cystectomy for bladder cancer
Q46168241Long-term outcomes of salvage radical cystectomy for recurrent urothelial carcinoma of the bladder following partial cystectomy
Q85772422Long-term renal function outcomes after radical cystectomy
Q45438263Long-term renal function outcomes in bladder cancer after radical cystectomy.
Q94570699Long-term results of a single-center prospective randomized trial assessing efficacy of a shortened course of adjuvant chemotherapy after radical cystectomy in patients with locally advanced bladder cancer
Q42595663Long-term results of orthotopic neobladder reconstruction after radical cystectomy
Q38374204Long-term results of radical cystectomy and role of adjuvant chemotherapy for small cell carcinoma of the bladder.
Q60304906Long-term urinary tract effect of ileal conduit after radical cystectomy compared with bladder preservation: a nationwide, population-based cohort study with propensity score-matching analysis
Q50858205Long-term urodynamic and functional analysis of orthotopic "W" ileal neobladder following radical cystectomy.
Q33967578Long-term urodynamic evaluation of laparoscopic radical cystectomy with orthotopic ileal neobladder for bladder cancer
Q48104965Long-term women-reported quality of life after radical cystectomy and orthotopic ileal neobladder reconstruction
Q38988320Longer average blood storage duration is associated with increased risk of infection and overall morbidity following radical cystectomy
Q85109899Longitudinal evaluation of the concordance and prognostic value of lymphovascular invasion in transurethral resection and radical cystectomy specimens
Q36998797Longitudinal risk of upper tract recurrence following radical cystectomy for urothelial cancer and the potential implications for long-term surveillance
Q45202138Loss of SPINK1 expression is associated with unfavorable outcomes in urothelial carcinoma of the bladder after radical cystectomy
Q39640899Low Pretreatment Neutrophil-to-Lymphocyte Ratio Predicts for Good Outcomes in Patients Receiving Neoadjuvant Chemotherapy Before Radical Cystectomy for Muscle Invasive Bladder Cancer
Q37282825Low grade papillary transitional cell carcinoma pelvic recurrence masquerading as high grade invasive carcinoma, ten years after radical cystectomy
Q64885857Low-dose chemoradiotherapy followed by partial or radical cystectomy against muscle-invasive bladder cancer: an intent-to-treat survival analysis.
Q48121488Low-dose oral desmopressin for treatment of nocturia and nocturnal enuresis in patients after radical cystectomy and orthotopic urinary diversion.
Q37802932Lower extremity neuropathy after robot assisted laparoscopic radical prostatectomy and radical cystectomy
Q37502768Lower skeletal muscle index and early complications in patients undergoing radical cystectomy for bladder cancer
Q77775673Lower urinary tract substitution after radical cystectomy with urethral mucosa and submucosa removal in females with trigonal and/or bladder neck involvement
Q36749513Lunar phases and zodiac signs do not influence quality of radical cystectomy--a statistical analysis of 452 patients with invasive bladder cancer
Q41432861Lymph node count at radical cystectomy does not influence long-term survival if surgeons adhere to a standardized template
Q53080227Lymph node density affects cancer-specific survival in patients with lymph node-positive urothelial bladder cancer following radical cystectomy.
Q45348244Lymph node density for patient counselling about prognosis and for designing clinical trials of adjuvant therapies after radical cystectomy
Q31141557Lymph node density is superior to TNM nodal status in predicting disease-specific survival after radical cystectomy for bladder cancer: analysis of pooled data from MDACC and MSKCC.
Q36452450Lymph node dissection during laparoscopic (LRC) and open (ORC) radical cystectomy due to muscle invasive bladder urothelial cancer (pT2-3, TCC).
Q47252660Lymph node dissection during radical cystectomy following prior radiation therapy: results from the SEER database.
Q38124003Lymph node dissection during radical cystectomy for bladder cancer treatment: considerations on relevance and extent
Q46587989Lymph node dissection technique is more important than lymph node count in identifying nodal metastases in radical cystectomy patients: a comparative mapping study
Q46220955Lymph node involvement in patients with bladder cancer treated with radical cystectomy: a patho-anatomical study--a single center experience
Q28588025Lymph node mapping in patients with bladder cancer undergoing radical cystectomy and lymph node dissection to the level of the inferior mesenteric artery
Q81338036Lymph node metastases in non-muscle invasive bladder cancer are correlated with the number of transurethral resections and tumour upstaging at radical cystectomy
Q53157159Lymph node yield at radical cystectomy predicts mortality in node-negative and not node-positive patients.
Q45819570Lymph node yield in node-negative patients predicts cancer specific survival following radical cystectomy for transitional cell carcinoma
Q33669763Lymph node-positive bladder cancer treated with radical cystectomy and lymphadenectomy: effect of the level of node positivity.
Q42665316Lymphadenectomy at the time of robot-assisted radical cystectomy: results from the International Robotic Cystectomy Consortium
Q68335528Lymphadenectomy during radical cystectomy for bladder cancer
Q38104493Lymphadenectomy for bladder cancer at the time of radical cystectomy
Q62778138Lymphadenectomy with radical cystectomy at an Australian tertiary referral institution: time trends and impact on oncological outcomes
Q80179110Lymphatic invasion is a prognostic factor for bladder cancer treated with radical cystectomy
Q39010863Lymphocyte-to-monocyte ratio and neutrophil-to-lymphocyte ratio as biomarkers for predicting lymph node metastasis and survival in patients treated with radical cystectomy.
Q58107187Lymphovascular invasion have a similar prognostic value as lymph node involvement in patients undergoing radical cystectomy with urothelial carcinoma
Q84218618Lymphovascular invasion in radical cystectomy specimen: is it an independent prognostic factor in patients without lymph node metastases?
Q43196454Lymphovascular invasion is an independent predictor of oncological outcomes in patients with lymph node-negative urothelial bladder cancer treated by radical cystectomy: a multicentre validation trial
Q46226093Lymphovascular invasion is associated with oncologic outcomes following radical cystectomy for squamous cell carcinoma of the urinary bladder
Q46906313Lymphovascular invasion is independently associated with bladder cancer recurrence and survival in patients with final stage T1 disease and negative lymph nodes after radical cystectomy
Q43622475Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy
Q81992819Lymphovascular invasion of urothelial cancer in matched transurethral bladder tumor resection and radical cystectomy specimens
Q42699174MID-TERM ONCOLOGICAL OUTCOME AND TECHNICAL MODIFICATIONS FOR LAPAROSCOPIC RADICAL CYSTECTOMY AT OUR INSTITUTION: 60 CASES ANALYSIS.
Q53682198MP61-02 BALANCING ONCOLOGIC BENEFIT WITH RISK OF COMPLICATIONS: THE EXTENT PELVIC LYMPH NODE DISSECTION DURING RADICAL CYSTECTOMY
Q81238546Macroscopic, but not microscopic, perivesical fat invasion at radical cystectomy is an adverse predictor of recurrence and survival
Q90938405Major Oncological Surgery (Radical Cystectomy) in Octogenarians- is it Safe?
Q78110643Major surgery (radical cystectomy with urethrectomy) in a patient with von Willebrand's disease type I. Reliability and limits of hemocoagulative tests
Q53060401Malignant ureteroenteric anastomotic stricture following radical cystectomy with urinary diversion: Patterns, risk factors, and outcomes.
Q38606356Management of Challenging Urethro-ileal Anastomosis During Robotic Assisted Radical Cystectomy with Intracorporeal Neobladder Formation
Q50443131Management of Node-Positive Bladder Cancer After Neoadjuvant Chemotherapy and Radical Cystectomy: A Survey of Current UK Practice.
Q90707523Management of Pelvic Organ Prolapse After Radical Cystectomy
Q92585813Management of anticoagulation and antiplatelet agents in the radical cystectomy patient
Q50979459Management of benign ureteral strictures following radical cystectomy and urinary diversion for bladder cancer.
Q64041381Management of cavernous abdominal wall defects post radical cystectomy in adult exstrophy complex
Q80395918Management of clinical T1 bladder transitional cell carcinoma by radical cystectomy
Q83984300Management of concomitant ureteral carcinoma in situ at radical cystectomy
Q36256764Management of neobladder-vaginal fistula and stress incontinence following radical cystectomy in women: a review
Q39095748Management of rectal injuries during radical cystectomy
Q71278137Management of the urethra in men undergoing radical cystectomy for bladder cancer
Q67369490Management of the urethra in patients undergoing radical cystectomy for bladder carcinoma
Q69696860Management of the urethra in patients undergoing radical cystectomy for bladder carcinoma
Q93534600Management of the urethra in patients undergoing radical cystectomy for bladder carcinoma
Q71667873Management of urethral recurrence after radical cystectomy and neobladder creation by urethroscopic resection and fulguration
Q43498380Marital status: a gender-independent risk factor for poorer survival after radical cystectomy
Q99567062Massive intra-abdominal recurrence after robotic-assisted radical cystectomy: A case report and critical appraisal of literature
Q38003772Matched comparison of robotic-assisted and open radical cystectomy
Q69729845May radical cystectomy be able to cure advanced bladders' transitional cell carcinoma (T.C.C.) with lymph node spread?
Q100395217Measured glomerular filtration rate (GFR) significantly and rapidly decreases after radical cystectomy for bladder cancer
Q78645604Meckel's diverticulum as the site of implanting ureter to the Bricker segment after radical cystectomy
Q43086764Mesenteric Fibromatosis Mimicking Tumor Recurrence Following Radical Cystectomy and Bladder Replacement.
Q100548157Meta-analysis of neoadjuvant chemotherapy compared to radical cystectomy alone in improving overall survival of muscle-invasive bladder cancer patients
Q40814194Metabolic changes associated with radical cystectomy
Q53091821Metabolic syndrome, obesity, and radical cystectomy complications: a clavien classification system-based analysis.
Q93355662Metastatic Small Cell Carcinoma of the Urinary Bladder That Recurred in the Vagina 6 Years after Radical Cystectomy: A Case Report
Q40674227Methods of urinary diversion following radical cystectomy
Q83409506Mid-term oncological control after laparoscopic radical cystectomy in men: a single-centre experience
Q92253656Midterm Health-related Quality of Life After Radical Cystectomy: A Propensity Score-matched Analysis
Q83167983Mini-laparotomy approach to radical cystectomy
Q51889659Minimally invasive radical cystectomy for bladder cancer?
Q51931298Minimally invasive radical cystectomy.
Q90869907Minimally invasive versus open radical cystectomy for bladder cancer: A systematic review and meta-analysis
Q97529048Minimally invasive versus open radical cystectomy: long term oncologic outcomes compared
Q90195881Minimally invasive vs open radical cystectomy in patients with bladder cancer: A systematic review and meta-analysis of randomized controlled trials
Q50922313Minimum incision endoscopic radical cystectomy in patients with malignant tumors of the urinary bladder: clinical and oncological outcomes at a single institution.
Q92758028Modeling 1-year Relapse-free Survival After Neoadjuvant Chemotherapy and Radical Cystectomy in Patients with Clinical T2-4N0M0 Urothelial Bladder Carcinoma: Endpoints for Phase 2 Trials
Q73266952Modification of the surgical technique in radical cystectomy
Q36207083Modified Glasgow Prognostic Score is Associated With Risk of Recurrence in Bladder Cancer Patients After Radical Cystectomy: A Multicenter Experience
Q46557919Modified N-shaped ileal neobladder after radical cystectomy
Q92548670Modified U-Shaped ileal neobladder designed for facilitating neobladder-urethral anastomosis in extracorporeal reconstruction after robotic-assisted radical cystectomy
Q92735253Modified colpocleisis for repair of pelvic organ prolapse post-radical cystectomy
Q42486949Modified le bag pouch after radical cystectomy: continence, urodynamic results and morbidity.
Q92047927Molecular Subtyping of Clinically Localized Urothelial Carcinoma Reveals Lower Rates of Pathological Upstaging at Radical Cystectomy Among Luminal Tumors
Q44881898Molecular determination of perivesical and lymph node metastasis after radical cystectomy for urothelial carcinoma of the bladder.
Q90132125Molecular lymph node staging for bladder cancer patients undergoing radical cystectomy with pelvic lymph node dissection
Q100566922Morbidity and mortality after robot-assisted radical cystectomy with intracorporeal urinary diversion in octogenarians - results from the EAU Robotic Urology Section (ERUS) Scientific Working Group
Q42613073Morbidity and mortality of octogenarians following open radical cystectomy using a standardized reporting system
Q69595656Morbidity and mortality of radical cystectomy (1971-78 and 1978-85)
Q47828680Morbidity and quality of life in elderly patients receiving ileal conduit or orthotopic neobladder after radical cystectomy for invasive bladder cancer.
Q96341602Morbidity, mortality, and quality assessment following open radical cystectomy in elderly patients with bladder cancer
Q90348403More Extensive Lymph Node Dissection Improves Survival Benefit of Radical Cystectomy in Metastatic Urothelial Carcinoma of the Bladder
Q51021321More on robot-assisted laparoscopic radical cystectomy.
Q104137748Mortality after radical cystectomy is strongly related to the institution's volume of surgeries
Q36015796Mortality after radical cystectomy: impact of obesity versus adiposity after adjusting for skeletal muscle wasting
Q45075575Mortality associated with feeding catheter jejunostomy after radical cystectomy
Q86604375Mortality following radical cystectomy: a good start, but how low can we go?
Q37125906Mortality increases when radical cystectomy is delayed more than 12 weeks: results from a Surveillance, Epidemiology, and End Results-Medicare analysis.
Q89609782Mortality prediction model for patients with bladder urothelial tumor after radical cystectomy
Q68279088Motion picture: rectal bladder with Gersuny procedure after radical cystectomy
Q87767417Moving Towards Widespread Implementation of Enhanced Recovery Protocols for Radical Cystectomy
Q82808484Multi-institutional analysis of robotic radical cystectomy for bladder cancer: perioperative outcomes and complications in 227 patients
Q92552014Multicenter Analysis of Postoperative Complications in Octogenarians After Radical Cystectomy and Ureterocutaneostomy: The Role of the Frailty Index
Q46391819Multicenter evaluation of the prognostic value of pT0 stage after radical cystectomy due to urothelial carcinoma of the bladder
Q82082555Multicenter validation of the prognostic value of patient age in patients treated with radical cystectomy
Q33462438Multidisciplinary rehabilitation can impact on health-related quality of life outcome in radical cystectomy: secondary reported outcome of a randomized controlled trial
Q63984763Multidomain Quantitative Recovery Following Radical Cystectomy for Patients Within the Robot-assisted Radical Cystectomy with Intracorporeal Urinary Diversion Versus Open Radical Cystectomy Randomised Controlled Trial: The First 30 Patients
Q51687818Multifactorial, site-specific recurrence model after radical cystectomy for urothelial carcinoma.
Q33769119Multifactorial, site-specific recurrence models after radical cystectomy for urothelial carcinoma: external validation in a cohort of Korean patients
Q91661194Multilevel Analysis of Readmissions After Radical Cystectomy for Bladder Cancer in the USA: Does the Hospital Make a Difference?
Q92665279Multimodal Prehabilitation to Enhance Functional Capacity Following Radical Cystectomy: A Randomized Controlled Trial
Q80485523Multimodal perioperative plan for radical cystectomy and intestinal urinary diversion. I. Effect on recovery of intestinal function and occurrence of complications
Q82952674Multimodality treatment versus radical cystectomy: bladder sparing at cost of life?
Q53790877Multiple factor analysis of metachronous upper urinary tract transitional cell carcinoma after radical cystectomy.
Q52543514Multivariate evaluation of determinants affecting regional lymph node metastasis and survival in bladder cancer patients who underwent radical cystectomy.
Q45140061Multivariate evaluation of survival factors and postoperative adjuvant chemotherapy in patients with bladder cancer treated by radical cystectomy
Q57488165Muscle Invasive Bladder Cancer (MIBC) - The Gold Standard Radical Cystectomy or Bladder Preserving Approach, YES or NO?
Q43913506Muscle invasive bladder cancer after radical cystectomy. Prognostic factors of adjuvant chemotherapy
Q38195977NLR is predictive of upstaging at the time of radical cystectomy for patients with urothelial carcinoma of the bladder
Q57283036National Cancer Database Comparison of Radical Cystectomy vs Chemoradiotherapy for Muscle-Invasive Bladder Cancer: Implications of Using Clinical vs Pathologic Staging
Q91981786National Practice Patterns and Overall Survival After Adjuvant Radiotherapy Following Radical Cystectomy for Urothelial Bladder Cancer in the USA, 2004-2013
Q50071456National Surgical Quality Improvement Program surgical risk calculator poorly predicts complications in patients undergoing radical cystectomy with urinary diversion
Q97528815National Trends and Impact of Regionalization of Radical Cystectomy on Survival Outcomes in Patients with Muscle Invasive Bladder Cancer
Q39708611National comparison of oncologic quality indicators between open and robotic-assisted radical cystectomy
Q55332437National database of patients treated with radical cystectomy provides a current standard and comparison for future technologies.
Q42662417National trends in the utilization of robotic-assisted radical cystectomy: an analysis using the Nationwide Inpatient Sample
Q50174879Natural History and Predictors of Parastomal Hernia after Robot-Assisted Radical Cystectomy and Ileal Conduit Urinary Diversion
Q38930776Natural History, Predictors and Management of Ureteroenteric Strictures after Robot Assisted Radical Cystectomy
Q36487162Natural history of pT3-4 or node positive bladder cancer treated with radical cystectomy and no neoadjuvant chemotherapy in a contemporary North-American multi-institutional cohort
Q36636971Natural history of positive urinary cytology after radical cystectomy
Q96961248Near-infrared fluorescence imaging of ureters with intravenous indocyanine green during radical cystectomy to prevent ureteroenteric anastomotic strictures
Q73138805Neoadjuvant CMV chemotherapy plus radical cystectomy in locally advanced bladder cancer: the impact of pathologic response on long-term results
Q92487425Neoadjuvant Chemotherapy Does Not Increase the Morbidity of Radical Cystectomy: A 10-year Retrospective Nationwide Study
Q90628430Neoadjuvant Chemotherapy is Not Associated with Adverse Perioperative Outcomes after Robot-Assisted Radical Cystectomy: A Case for Increased Use from the IRCC
Q91784901Neoadjuvant Gemcitabine-Cisplatin Plus Radical Cystectomy-Pelvic Lymph Node Dissection for Muscle-invasive Bladder Cancer: A 12-year Experience
Q41601417Neoadjuvant Platinum-Based Chemotherapy is an Independent Predictor for Preoperative Thromboembolic Events in Bladder Cancer Patients Undergoing Radical Cystectomy
Q98186253Neoadjuvant chemotherapy before radical cystectomy: why we must adhere?
Q101352138Neoadjuvant chemotherapy plus radical cystectomy versus radical cystectomy alone in clinical T2 bladder cancer without hydronephrosis
Q38661975Neoadjuvant chemotherapy prior to radical cystectomy for muscle-invasive bladder cancer with variant histology
Q45066764Neoadjuvant chemotherapy with gemcitabine plus carboplatin followed by immediate radical cystectomy for muscle-invasive bladder cancer
Q52863343Neoadjuvant chemotherapy-related histologic changes in radical cystectomy: assessment accuracy and prediction of response.
Q72539459Neoadjuvant cisplatin chemotherapy before radical cystectomy in invasive transitional cell carcinoma of the bladder: a prospective randomized phase III study
Q50060639Neoadjuvant dose dense MVAC versus GC in patients with cT3-4aN0M0 bladder cancer treated with radical cystectomy
Q45792869Neobladder-rectal fistula as early postoperative complication of radical cystectomy and orthotopic neobaldder construction
Q68269454Nephroureterectomy after radical cystectomy
Q39595233Nerve Sparing, Robot-Assisted Radical Cystectomy with Intracorporeal Bladder Substitution in the Male
Q53504677Nerve and seminal sparing radical cystectomy with orthotopic urinary diversion for select patients with superficial bladder cancer: an innovative surgical approach.
Q51778651Nerve-sparing laparoscopic radical cystectomy: technique and initial outcomes.
Q51761721Nerve-sparing radical cystectomy and orthotopic bladder replacement in female patients.
Q48271152Nerve-sparing radical cystectomy has a beneficial impact on urinary continence after orthotopic bladder substitution, which becomes even more apparent over time.
Q33559656Nestin is an independent predictor of cancer-specific survival after radical cystectomy in patients with urothelial carcinoma of the bladder
Q46456410Neurofuzzy modeling to determine recurrence risk following radical cystectomy for nonmetastatic urothelial carcinoma of the bladder
Q51823993Neurovascular preservation in female orthotopic radical cystectomy significantly improves sexual function.
Q61852812Neutral Third Party versus Treating Institution for Evaluating Quality of Life after Radical Cystectomy
Q87990514Neutrophil-lymphocyte ratio evaluation in patients undergoing radical cystectomy
Q39869134Neutrophil-to-lymphocyte ratio as a detection marker of tumor recurrence in patients with muscle-invasive bladder cancer after radical cystectomy
Q36654421Neutrophil-to-lymphocyte ratio is a prognostic marker in bladder cancer patients after radical cystectomy
Q45832723New retractor facilitates exposure of the vascular pedicles in Chinese men with complex pelvis during radical cystectomy
Q38924850No Differences in Population-based Readmissions After Open and Robotic-assisted Radical Cystectomy: Implications for Post-discharge Care
Q57123782No advantage is gained by preoperative bowel preparation in radical cystectomy and ileal conduit: a randomized controlled trial of 86 patients
Q90291492No increased risk of short-term complications after radical cystectomy for muscle-invasive bladder cancer among patients treated with preoperative chemotherapy: a nation-wide register-based study
Q64246715No survival difference between super extended and standard lymph node dissection at radical cystectomy: what can we learn from the first prospective randomized phase III trial?
Q46630430Nodal involvement in bladder cancer cases treated with radical cystectomy: incidence and prognosis
Q98282778Nomogram Predicting Bladder Cancer-specific Mortality After Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-invasive Bladder Cancer: Results of an International Consortium
Q80212552Nomogram for predicting disease recurrence after radical cystectomy for transitional cell carcinoma of the bladder
Q53013621Nomograms provide improved accuracy for predicting survival after radical cystectomy.
Q54729569Non-O blood type is associated with an increased risk of venous thromboembolism after radical cystectomy.
Q53123583Non-muscle invasive high grade urothelial carcinoma of the bladder. Which factors can influence understaging at the time of radical cystectomy?
Q36312300Non-muscle-invasive bladder cancer: the role of radical cystectomy
Q74618402Nordic prospective trials of radical cystectomy and neoadjuvant chemotherapy. The Nordic Cooperative Bladder Cancer Study Group
Q97542709Novel "double-pulling" technique for neobladder-urethral anastomosis in laparoscopic radical cystectomy
Q37661376Novel closing method using subcutaneous continuous drain for preventing surgical site infections in radical cystectomy.
Q104756045Nursing Implication of People Treated by Radical Cystectomy Postsurgery and Rehabilitation
Q90466677Nutrition risk and assessment process in patients with bladder cancer undergoing radical cystectomy
Q37240903Nutritional predictors of complications following radical cystectomy
Q48609390ORTHOTOPIC URINE DERIVATION AFTER RADICAL CYSTECTOMY (REVIEW)
Q97592249Obesity is associated with adverse short-term perioperative outcomes in patients treated with open and robot-assisted radical cystectomy for bladder cancer
Q44519064Obesity is associated with worse oncological outcomes in patients treated with radical cystectomy
Q45250550Obesity is associated with worse oncological outcomes in patients treated with radical cystectomy
Q95497413Obstruction of ileal loop in bricker type bladder after laparoscopic radical cystectomy
Q72330862Obstruction of the rectosigmoid and sigmoid flexure after radical cystectomy for cancer of the bladder
Q43475595Older patients suffer from adverse histopathological features after radical cystectomy
Q87495189Oncologic Equivalence between Laparoscopic/Robotic and Open Radical Cystectomy
Q41648995Oncologic Outcomes and Predictive Factors for Recurrence Following Robot-Assisted Radical Cystectomy for Urothelial Carcinoma: Multicenter Study from Korea
Q40507279Oncologic Outcomes of Robot-Assisted Radical Cystectomy: Results of a High-Volume Robotic Center
Q85994910Oncologic outcome after laparoscopic radical cystectomy without neoadjuvant or adjuvant therapy with a median follow-up of 32 months
Q39280988Oncologic outcome and urinary function after radical cystectomy for rhabdomyosarcoma in children: role of the orthotopic ileal neobladder based on 15-year experience at a single center.
Q43552944Oncologic outcomes achieved by radical cystectomy
Q93047468Oncologic outcomes after robot-assisted versus open radical cystectomy: a systematic review and meta-analysis
Q45325031Oncologic outcomes and survival in pT0 tumors after radical cystectomy in patients without neoadjuvant chemotherapy: results from a large multicentre collaborative study
Q42640080Oncologic outcomes between open and robotic-assisted radical cystectomy: a propensity score matched analysis
Q38207349Oncologic outcomes following robot-assisted radical cystectomy with minimum 5-year follow-up: the Roswell Park cancer institute experience
Q43573519Oncologic outcomes for lymph node-positive urothelial carcinoma patients treated with robot assisted radical cystectomy: with mean follow-up of 3.5 years
Q48729142Oncologic surveillance following radical cystectomy: an individualized risk-based approach
Q35922856Oncologic surveillance in bladder cancer following radical cystectomy: A systematic review and meta-analysis
Q58093745Oncologic, Perioperative Outcomes of Female Radical Cystectomy: Results from a Multicenter Study in Korea
Q42603628Oncologic, functional, and complications outcomes of robot-assisted radical cystectomy with totally intracorporeal neobladder diversion
Q40812479Oncological Outcomes in Patients Treated with Radical Cystectomy for Bladder Cancer: Comparison Between Open, Laparoscopic, and Robot-Assisted Approaches
Q95583410Oncological Outcomes of Radical Cystectomy for Transitional Cell Carcinoma of Bladder
Q51907972Oncological and functional outcome of radical cystectomy in patients with bladder cancer and obstructive uropathy.
Q37926212Oncological and functional outcomes after robot-assisted radical cystectomy: critical review of current status
Q47655843Oncological and functional outcomes of postoperative total parenteral nutrition after radical cystectomy in bladder cancer patients: A single-center randomized trial
Q36714745Oncological and functional outcomes of radical cystectomy and orthotopic bladder replacement in women
Q91141659Oncological and functional outcomes of robot-assisted radical cystectomy in bladder cancer patients in a single tertiary center: Can these be preserved throughout the learning curve?
Q38791133Oncological and functional outcomes of sexual function-preserving cystectomy compared with standard radical cystectomy in men: A systematic review.
Q83387450Oncological followup after radical cystectomy for bladder cancer-is there any benefit?
Q97589130Oncological outcome according to attainment of pentafecta after robot assisted radical cystectomy among bladder cancer patients using KORARC database (730 multicenter robot radical cystectomy database)
Q98879971Oncological outcome according to attainment of pentafecta after robot assisted radical cystectomy among bladder cancer patients using KORARC database (730 multicenter robot radical cystectomy database) BJU Int 2020 Jul 8. doi: 10.1111/ bju.15178
Q46521700Oncological outcome after radical cystectomy and orthotopic bladder substitution in women
Q86926187Oncological outcome of primary versus secondary muscle-invasive bladder cancer is comparable after radical cystectomy
Q37677307Oncological outcomes after radical cystectomy for bladder cancer: open versus minimally invasive approaches
Q92684853Oncological outcomes and recurrence patterns after laparoscopic radical cystectomy for bladder cancer: A Japanese multicenter cohort
Q38245360Oncological outcomes of advanced muscle-invasive bladder cancer with a micropapillary variant after radical cystectomy and adjuvant platinum-based chemotherapy
Q51506783Oncological outcomes of robot-assisted radical cystectomy.
Q41239316One-Stage Radical Cystectomy for Bladder Carcinoma: Operative Mortality, Cost/Benefit Analysis
Q67535551One-stage radical cystectomy for bladder carcinoma: operative mortality, cost/benefit analysis
Q54969979Ongoing efforts to reduce perioperative morbidity of radical cystectomy: towards widespread adoption of extended-duration thromboprophylaxis.
Q47717680Open radical cystectomy in England: the current standard of care - an analysis of the BAUS cystectomy audit and HES data
Q90765571Open radical cystectomy is a reliable surgery with acceptable complication rates in elderly male patients: a retrospective, tertiary hospital-based study
Q36925426Open radical cystectomy with lymphadenectomy remains the treatment of choice for invasive bladder cancer
Q58804612Open radical cystectomy: lessons from the British Association of Urological Surgeons (BAUS) registry
Q38639574Open radical cystectomy: still the gold standard for muscle invasive bladder cancer
Q37090683Open surgical repair of ureteral strictures and fistulas following radical cystectomy and urinary diversion.
Q81482242Open to debate. The motion: seminal-nerve sparing radical cystectomy is an efficacious and safe treatment for selected bladder cancer patients
Q42617656Open versus laparoscopy-assisted radical cystectomy: results of a prospective study.
Q89287585Open versus robot-assisted radical cystectomy: 30-day perioperative comparison and predictors for cost-to-patient, complication, and readmission
Q35223315Open versus robotic radical cystectomy with intracorporeal Studer diversion
Q100750709Open versus robotic radical cystectomy: Results from the 3-year follow-up of the RAZOR trial
Q42602543Open-assisted laparoscopic radical cystectomy using an ileal neobladder with intracorporeal urethra-neobladder anastomosis: technique and early experiences
Q101053860Optimal Delivery of Follow-Up Care After Radical Cystectomy for Bladder Cancer
Q80058785Optimal nutrition should improve the outcome and costs of radical cystectomy
Q37469467Optimal timing of radical cystectomy for patients with T1 bladder cancer.
Q54132494Optimal timing of radical cystectomy for patients with invasive transitional cell carcinoma of the bladder.
Q39813009Optimal timing of radical cystectomy in T1 high-grade bladder cancer
Q58594892Optimizing Nutrition Prior to Radical Cystectomy
Q98721089Optimizing Women's Sexual Function and Sexual Experience After Radical Cystectomy
Q43047312Optimizing a frail elderly patient for radical cystectomy with a prehabilitation program.
Q39279633Optimizing bladder cancer locoregional failure risk stratification after radical cystectomy using SWOG 8710.
Q53515170Optimizing outcome reporting after radical cystectomy for organ-confined urothelial carcinoma of the bladder using oncological trifecta and pentafecta.
Q84170751Optimizing the approach for lymph node dissection during laparoscopic radical cystectomy
Q40505991Options in replacement cystoplasty following radical cystectomy: high hopes or successful reality
Q33859644Organ-conserving approaches to muscle-invasive bladder cancer: future alternatives to radical cystectomy
Q53889052Orthotopic bladder substitution after radical cystectomy: 5 years of experience with a novel personal modification of the ileal s pouch.
Q48914165Orthotopic bladder substitution following radical cystectomy in women: comparative study between sigmoid and ileal neobladders
Q55439119Orthotopic bladder substitution for bladder cancer patients undergoing radical cystectomy: A call to action.
Q51273969Orthotopic continent urinary diversion after radical cystectomy in pediatric patients with genitourinary rhabdomyosarcoma.
Q86503594Orthotopic detaenial sigmoid neobladder after radical cystectomy: technical considerations, complications and functional outcomes
Q36588194Orthotopic genital sparing radical cystectomy in pre-menopausal women with muscle-invasive bladder carcinoma: A prospective study
Q72703108Orthotopic ileal bladder substitute after radical cystectomy: urodynamic features
Q46146643Orthotopic ileal bladder substitution following radical cystectomy using the linear-cutter stapling device.
Q72539450Orthotopic ileal neobladder in female patients after radical cystectomy: 2-year experience
Q74622695Orthotopic ileocolic neobladder reconstruction following radical cystectomy: history, technique and results of the Johns Hopkins experience, 1986-1998
Q35004341Orthotopic neobladder following radical cystectomy in patients with high perioperative risk and co-morbid medical conditions
Q73266895Orthotopic neobladder reconstruction after radical cystectomy
Q48418997Orthotopic neobladder reconstruction after radical cystectomy in patients with a solitary functioning kidney: clinical outcome and evaluation
Q37627282Orthotopic sigmoid neobladder after radical cystectomy: assessment of complications, functional outcomes and quality of life in 82 Japanese patients
Q48108963Orthotopic urinary diversion after radical cystectomy in treatment of muscle invasive bladder cancer
Q41665800Orthotopic urinary diversion with preservation of erectile and ejaculatory function in men requiring radical cystectomy for nonurothelial malignancy: a new technique
Q36413302Our experiences with robot-assisted laparoscopic radical cystectomy: orthotopic neobladder by the suprapubic incision method
Q83900992Outcome after radical cystectomy in patients with clinical T2 bladder cancer in whom neoadjuvant chemotherapy has failed
Q80553123Outcome after radical cystectomy with limited or extended pelvic lymph node dissection
Q47278323Outcome and quality of life in patients operated on with radical cystectomy and three different urinary diversion techniques
Q37197518Outcome following radical cystectomy and bladder-preservation therapy in patients with invasive carcinoma of urinary bladder
Q44800643Outcome in patients with exclusive carcinoma in situ (CIS) after radical cystectomy
Q73107007Outcome in patients with seminal vesicle invasion after radical cystectomy
Q52719951Outcome of Mainz II Pouch Urinary Diversion after Radical Cystectomy in Patients with Muscle-invasive Bladder Cancer: Our Experience.
Q41368214Outcome of Muscle-Invasive Urothelial Bladder Cancer After Radical Cystectomy
Q46722034Outcome of anterior vaginal wall sparing during female radical cystectomy with orthotopic urinary diversion
Q34528663Outcome of patients undergoing radical cystectomy for invasive bladder cancer
Q37171971Outcome of patients with bladder cancer with pN+ disease after preoperative chemotherapy and radical cystectomy.
Q73316409Outcome of patients with grossly node positive bladder cancer after pelvic lymph node dissection and radical cystectomy
Q54399364Outcome of patients with micropapillary urothelial carcinoma following radical cystectomy: ERBB2 (HER2) amplification identifies patients with poor outcome.
Q85264951Outcome of patients with pathological tumor stage T3 urothelial carcinoma of the bladder following radical cystectomy in a single-center series with 116 patients
Q77711389Outcome of radical cystectomy for bladder cancer according to the disease type at presentation
Q34045519Outcome of radical cystectomy for invasive bladder cancer
Q50881510Outcome predictors of radical cystectomy in patients with cT4 prostate cancer: a multi-institutional study of 62 patients.
Q47897350Outcomes Following Clinical Complete Response to Neoadjuvant Chemotherapy for Muscle-invasive Urothelial Carcinoma of the Bladder in Patients Refusing Radical Cystectomy
Q43469590Outcomes Following Radical Cystectomy for Plasmacytoid Urothelial Carcinoma: Defining the Need for Improved Local Cancer Control
Q43600412Outcomes after urothelial recurrence in bladder cancer patients undergoing radical cystectomy
Q104747800Outcomes and complications of radical cystectomy with ileal conduit urinary diversion: A comparison between open, semi-robotic and totally robotic surgery
Q93067516Outcomes and learning curve for robotic-assisted radical cystectomy: an Australian experience
Q50493416Outcomes and prognostic factors in patients with a single lymph node metastasis at time of radical cystectomy.
Q85377312Outcomes following radical cystectomy for micropapillary bladder cancer versus pure urothelial carcinoma: a matched cohort analysis
Q85409274Outcomes following radical cystectomy for nested variant of urothelial carcinoma: a matched cohort analysis
Q92012277Outcomes following radical cystectomy: a population-based study from Queensland, Australia
Q80450576Outcomes in patients with pathological carcinoma in situ only disease at radical cystectomy
Q47562152Outcomes of Intracorporeal Urinary Diversion after Robot-Assisted Radical Cystectomy: Results from the International Robotic Cystectomy Consortium.
Q90096046Outcomes of an enhanced recovery after radical cystectomy program in a prospective multicenter study: compliance and key components for success
Q37997128Outcomes of artificial urinary sphincter placement in men after radical cystectomy and orthotopic urinary diversions for the treatment of stress urinary incontinence: the University of Southern California experience
Q37990173Outcomes of laparoscopic and robotic radical cystectomy in the elderly patients
Q36040572Outcomes of pT0N0 at radical cystectomy: The Canadian Bladder Cancer Network experience
Q44034661Outcomes of patients after aborted radical cystectomy for intraoperative findings of metastatic disease
Q46120103Outcomes of patients with clinical CIS-only disease treated with radical cystectomy
Q79621497Outcomes of patients with clinical T1 grade 3 urothelial cell bladder carcinoma treated with radical cystectomy
Q80792635Outcomes of patients with clinical T1 grade 3 urothelial cell bladder carcinoma treated with radical cystectomy
Q82737109Outcomes of radical cystectomy
Q35122661Outcomes of radical cystectomy and bladder preservation treatment for muscle-invasive urothelial carcinoma of the bladder
Q79329951Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium
Q53165616Outcomes of radical cystectomy in potential candidates for bladder preservation therapy.
Q46009354Outcomes of radical cystectomy with extended lymphadenectomy alone in patients with lymph node-positive bladder cancer who are unfit for or who decline adjuvant chemotherapy.
Q51900001Outcomes of robot-assisted radical cystectomy: learning curves, margins and lymph node yield
Q83877588Outcomes of single lymph node positive urothelial carcinoma after radical cystectomy
Q79907953Overall clinical outcomes after nerve and seminal sparing radical cystectomy for the treatment of organ confined bladder cancer
Q88646235Overall survival in patients with residual disease after radical cystectomy and neoadjuvant chemotherapy
Q34925757Overexpression of EIF-5A2 is an independent predictor of outcome in patients of urothelial carcinoma of the bladder treated with radical cystectomy
Q36574137Overexpression of RNF2 Is an Independent Predictor of Outcome in Patients with Urothelial Carcinoma of the Bladder Undergoing Radical Cystectomy
Q37214749P0 stage at radical cystectomy for bladder cancer is associated with improved outcome independent of traditional clinical risk factors
Q100725158PD-L1 expression in tumor-infiltrating lymphocytes (TILs) as an independent predictor of prognosis in patients with pN0 bladder cancer undergoing radical cystectomy
Q39677562POINT: Is Immediate Radical Cystectomy Justified When Non-Muscle-Invasive Bladder Cancer First Presents as High-Grade T1 Urothelial Carcinoma on Re-Resection?
Q72770745Panniculectomy in conjunction with radical cystectomy in the obese patient
Q92295217Parastomal Hernia Repair With 3-D Mesh Implants After Radical Cystectomy and Ileal Conduit Urinary Diversion - A Single-center Experience Using a Purpose Made Alloplastic Mesh Implant
Q26738774Parastomal hernias after radical cystectomy and ileal conduit diversion
Q45015430Parenteral nutrition does not improve postoperative recovery from radical cystectomy: results of a prospective randomised trial
Q68001298Partial cystectomy: and alternative to radical cystectomy? Apropos of a series of 75 patients
Q28255916Pathologic downstaging is a surrogate marker for efficacy and increased survival following neoadjuvant chemotherapy and radical cystectomy for muscle-invasive urothelial bladder cancer
Q74716114Pathologic evaluation of radical cystectomy specimens
Q80126913Pathologic evaluation of radical cystectomy specimens: a cooperative group report
Q90473137Pathologic measures of quality compare favorably in patients undergoing robot-assisted radical cystectomy to open cystectomy cohorts: a National Cancer Database analysis
Q44648038Pathologic nodal staging score for bladder cancer: a decision tool for adjuvant therapy after radical cystectomy
Q58552455Pathological Profile, Early Complications, Functional and Oncological Outcome after Radical Cystectomy - Ileal Conduit for Bladder Cancer Patients in Sanglah General Hospital between January 2013 and December 2016
Q38168391Pathological T0 following radical cystectomy with or without neoadjuvant chemotherapy: a useful surrogate.
Q88673185Pathological characteristics and prognostic indicators of different histopathological types of urinary bladder cancer following radical cystectomy in a large single-center Egyptian cohort
Q40489195Pathological downstaging and survival after induction chemotherapy and radical cystectomy for clinically node-positive bladder cancer-Results of a nationwide population-based study.
Q92756445Pathological downstaging following radical cystectomy for muscle-invasive bladder cancer: Survival outcomes in the setting of neoadjuvant chemotherapy versus transurethral resection only
Q53081353Pathological evaluation and quality of surgery in radical cystectomy in New South Wales, Australia.
Q74246103Pathological findings of gynecologic organs obtained at female radical cystectomy
Q83571379Pathological upstaging detected in radical cystectomy procedures is associated with a significantly worse tumour-specific survival rate for patients with clinical T1 urothelial carcinoma of the urinary bladder
Q45340458Pathological upstaging during radical cystectomy is associated with worse recurrence-free survival in patients with bacillus Calmette-Guerin-refractory bladder cancer
Q37607679Pathology of bladder cancer among diabetic patients undergoing radical cystectomy with a history of pioglitazone (Actos) use
Q37257437Pathology of the prostate in radical cystectomy specimens: a critical review
Q38990152Patient Frailty and Discharge Disposition Following Radical Cystectomy
Q38592301Patient Psoas Muscle Mass as a Predictor of Complications and Survival After Radical Cystectomy
Q69386093Patient adjustment to an ileal conduit after radical cystectomy
Q89639811Patient decision aids for urinary diversion after radical cystectomy: their potential and pitfalls
Q91091943Patient frailty predicts worse perioperative outcomes and higher cost after radical cystectomy
Q92615875Patient perspectives of vigorous intensity aerobic interval exercise prehabilitation prior to radical cystectomy: a qualitative focus group study
Q90375910Patient reported and physician recorded bowel dysfunction following colorectal resection and radical cystectomy: a prospective, comparative study
Q57781881Patient's outcome of bladder cancer managed by radical cystectomy with lymphadenectomy at a university hospital
Q38880286Patient-Reported Convalescence and Quality of Life Recovery: A Comparison of Open and Robotic-Assisted Radical Cystectomy
Q88106451Patient-Reported Outcomes Are Associated With Enhanced Recovery Status in Patients With Bladder Cancer Undergoing Radical Cystectomy
Q39286841Patient-assessed outcomes in Swedish and Egyptian men undergoing radical cystectomy and orthotopic bladder substitution--a prospective comparative study
Q38691499Patient-centered risk stratification of disposition outcomes following radical cystectomy
Q87817634Patient-reported outcome after radical cystectomy: translation and psychometric validation of the Swedish version of the Functional Assessment of Cancer Therapy Scale Vanderbilt Cystectomy Index
Q39351878Patient-reported outcomes for patients undergoing radical cystectomy: a prospective case-control study
Q33879717Pattern of failure in bladder cancer patients treated with radical cystectomy: rationale for adjuvant radiotherapy.
Q88228534Pattern of node metastases in patients treated with radical cystectomy and extended or superextended pelvic lymph node dissection due to bladder cancer
Q49380161Patterns and predictors of recurrence after open radical cystectomy for bladder cancer: a comprehensive review of the literature.
Q39959318Patterns and prognostic significance of clinical recurrences after radical cystectomy for bladder cancer: A 20-year single center experience.
Q40828065Patterns of Failure After Radical Cystectomy for pT3-4 Bladder Cancer: Implications for Adjuvant Radiation Therapy.
Q40750653Patterns of care for readmission after radical cystectomy in New York State and the effect of care fragmentation
Q84916976Patterns of local recurrence after radical cystectomy in a contemporary series of patients with muscle-invasive bladder cancer
Q46523499Patterns of recurrence of bladder carcinoma following radical cystectomy.
Q53671266Patterns, risks and outcomes of urethral recurrence after radical cystectomy for urothelial cancer; over 20 year single center experience.
Q92250409Pelvic Floor Organ Prolapse After Radical Cystectomy in Patients With Uroepithelial Carcinoma
Q39416398Pelvic Lymph Node Staging by Combined 18F-FDG-PET/CT Imaging in Bladder Cancer Prior to Radical Cystectomy.
Q81312575Pelvic floor reconstruction before orthotopic bladder replacement after radical cystectomy for bladder cancer
Q34585907Pelvic lymph node dissection and outcome of robot-assisted radical cystectomy for bladder carcinoma
Q90928632Pelvic lymph node dissection during radical cystectomy for muscle-invasive bladder cancer
Q42127319Pelvic lymph node dissection in the context of radical cystectomy: a thorough insight into the connection between patient, surgeon, pathologist and treating institution
Q74130836Pelvic lymph node metastases from bladder cancer: outcome in 83 patients after radical cystectomy and pelvic lymphadenectomy
Q70084404Pelvic lymphadenectomy and radical cystectomy for transitional cell carcinoma of the bladder with pelvic nodal disease
Q37509611Pelvic lymphadenectomy during radical cystectomy: a review of the literature
Q44633799Pelvic recurrence after radical cystectomy without preoperative radiation
Q53824235Pelvic recurrence after radical cystectomy: a call to arms.
Q57808395Pembrolizumab as Neoadjuvant Therapy Before Radical Cystectomy in Patients With Muscle-Invasive Urothelial Bladder Carcinoma (PURE-01): An Open-Label, Single-Arm, Phase II Study
Q82914481Penile haemodynamic changes in post-radical cystectomy patients
Q72592233Penile self-injection for impotence in patients after radical cystectomy
Q69098146Penile self-injection for impotence in patients after radical cystectomy-ileal loop
Q41729156Performance status as a significant prognostic predictor in patients with urothelial carcinoma of the bladder who underwent radical cystectomy.
Q48000121Performing radical cystectomy and urinary diversion in regional anesthesia: potential risk reduction in the treatment of bladder cancer
Q37932064Peri- and postoperative outcomes of robot-assisted radical cystectomy (RARC).
Q64113922Peri-Operative Outcomes after Open and Robot-Assisted Radical Cystectomy by Using an Advanced Bipolar Seal and Cut Technology (Caiman®): A Prospective, Comparative, and Multi-Institutional Study
Q38954368Peri-operative allogeneic blood transfusion and outcomes after radical cystectomy: a population-based study
Q47640057Peri-operative allogeneic blood transfusion does not adversely affect oncological outcomes after radical cystectomy for urinary bladder cancer: a propensity score-weighted European multicentre study.
Q92260104Peri-operative efficacy and long-term survival benefit of robotic-assisted radical cystectomy in septuagenarian patients compared with younger patients: a nationwide multi-institutional study in Japan
Q42288559Peri-operative morbidity and mortality related to radical cystectomy: a multi-institutional retrospective study in Japan
Q34434982Peri-operative morbidity associated with radical cystectomy in a multicenter database of community and academic hospitals.
Q37579695Perineal herniation of an ileal neobladder following radical cystectomy and consecutive rectal resection for recurrent bladder carcinoma
Q53554545Perineural invasion by transitional cell carcinoma of the bladder in patients submitted to radical cystectomy: what is the prognostic value?
Q41502091Perineural invasion in transitional cell carcinoma and the effect on prognosis following radical cystectomy
Q92871305Period-specific mean annual hospital volume of radical cystectomy is associated with outcome and perioperative quality of care: a nationwide population-based study
Q28088588Perioperative Blood Transfusion Promotes Worse Outcomes of Bladder Cancer after Radical Cystectomy: A Systematic Review and Meta-Analysis
Q51742815Perioperative Immunonutrition Modulates Inflammatory Response after Radical Cystectomy: Results of a Pilot Randomized Controlled Clinical Trial.
Q91775116Perioperative Mortality and Long-Term Survival after Radical Cystectomy: A Population-Based Study in a Southern European Country on 4,389 Patients
Q57804258Perioperative Oral Nutrition Supplementation Reduces Prevalence of Sarcopenia following Radical Cystectomy: Results of a Prospective Randomized Controlled Trial
Q91305601Perioperative Outcomes and Complications after Robotic Radical Cystectomy With Intracorporeal or Extracorporeal Ileal Conduit Urinary Diversion: Head-to-head Comparison From a Single-Institutional Prospective Study
Q50048566Perioperative Outcomes and Early Survival in Octogenarians Who Underwent Radical Cystectomy for Bladder Cancer
Q39806172Perioperative Outcomes, Health Care Costs, and Survival After Robotic-assisted Versus Open Radical Cystectomy: A National Comparative Effectiveness Study.
Q39067951Perioperative Transfusion of Leukocyte-depleted Blood Products in Contemporary Radical Cystectomy Cohort Does Not Adversely Impact Short-term Survival
Q50207474Perioperative and long-term outcomes after radical cystectomy in hemodialysis patients.
Q53828681Perioperative and mid-term oncologic outcomes of robotic assisted radical cystectomy with totally intracorporeal neobladder: Results of a propensity score matched comparison with open cohort from a single-centre series.
Q39874551Perioperative and oncologic outcomes of robot-assisted vs. open radical cystectomy in bladder cancer patients: A comparison of two high-volume referral centers
Q92108155Perioperative and oncological outcomes of laparoscopic radical cystectomy with intracorporeal versus extracorporeal ileal conduit: A matched-pair comparison in a multicenter cohort in Japan
Q92223309Perioperative and oncological outcomes of robot-assisted radical cystectomy in octogenarians
Q39921800Perioperative and survival outcomes of laparoscopic radical cystectomy for bladder cancer in patients over 70 years
Q46636584Perioperative antibiotics in radical cystectomy with ileal conduit urinary diversion: efficacy and risk of antimicrobial prophylaxis on the operation day alone
Q85261974Perioperative blood transfusion and radical cystectomy: does timing of transfusion affect bladder cancer mortality?
Q38843337Perioperative blood transfusion in radical cystectomy: Analysis of the National Surgical Quality Improvement Program database
Q40596744Perioperative change in neutrophil-lymphocyte ratio predicts the overall survival of patients with bladder cancer undergoing radical cystectomy
Q43996369Perioperative complications after neoadjuvant chemotherapy and radical cystectomy for bladder cancer
Q87466849Perioperative complications and 90-day mortality of radical cystectomy in the elderly (75+): a retrospective, multicentre study
Q56978273Perioperative complications and mortality after radical cystectomy when using a standardized reporting methodology
Q95305713Perioperative complications and oncological outcomes following radical cystectomy among different racial groups: A long-term, single-center study
Q42671865Perioperative complications and oncological safety of robot-assisted (RARC) vs. open radical cystectomy (ORC).
Q50753978Perioperative complications and surgical oncology outcomes in an initial study from 84 patients submitted to laparoscopic radical cystectomy.
Q85085320Perioperative complications of radical cystectomy after induction chemoradiotherapy in bladder-sparing protocol against muscle-invasive bladder cancer: a single institutional retrospective comparative study with primary radical cystectomy
Q48671881Perioperative complications of radical cystectomy in a contemporary series
Q40927020Perioperative management and oncological outcomes following radical cystectomy for bladder cancer: a matched retrospective cohort study
Q92968888Perioperative management of cold agglutinin autoimmune hemolytic anemia in an older adult undergoing radical cystectomy for bladder cancer
Q92522000Perioperative management of radical cystectomy in the Nordic countries
Q50692343Perioperative morbidity and mortality of octogenarians treated by radical cystectomy-a multi-institutional retrospective study in Japan.
Q35125738Perioperative morbidity of radical cystectomy: A review
Q47647584Perioperative morbidity, bowel function and oncologic outcome after radical cystectomy and ileal orthotopic neobladder reconstruction: Studer-pouch versus I-pouch
Q92487470Perioperative mortality following radical cystectomy: the slippery slope of complications
Q56777841Perioperative mortality is significantly greater in septuagenarian and octogenarian patients treated with radical cystectomy for urothelial carcinoma of the bladder
Q24197694Perioperative nutrition for the treatment of bladder cancer by radical cystectomy
Q92157594Perioperative nutrition for the treatment of bladder cancer by radical cystectomy
Q92584997Perioperative nutrition for the treatment of bladder cancer by radical cystectomy: A Cochrane review summary
Q85210763Perioperative outcome of laparoscopic radical cystectomy: comparison to open radical cystectomy
Q35777567Perioperative outcomes after radical cystectomy at NCI-designated centres: Are they any better?
Q43754468Perioperative outcomes and Oncologic Efficacy from a Pilot Prospective Randomized Clinical Trial of Open Versus Robotic Assisted Radical Cystectomy
Q88621745Perioperative outcomes and complications of intracorporeal vs extracorporeal urinary diversion after robot-assisted radical cystectomy for bladder cancer: a real-life, multi-institutional french study
Q42669950Perioperative outcomes and oncologic efficacy from a pilot prospective randomized clinical trial of open versus robotic assisted radical cystectomy
Q38125925Perioperative outcomes in radical cystectomy: how to reduce morbidity?
Q55283881Perioperative outcomes of minimally invasive versus open radical cystectomy: A single-center experience.
Q39212180Perioperative outcomes with laparoscopic radical cystectomy: "pure laparoscopic" and "open-assisted laparoscopic" approaches
Q92587835Perioperative recovery in different urinary reconstruction approaches of radical cystectomy: Are the advantages of laparoscopy consistent?
Q35960332Perioperative search for circulating tumor cells in patients undergoing radical cystectomy for bladder cancer
Q38379148Perioperative strategies to reduce postoperative complications after radical cystectomy
Q40168355Perioperative treatment and radical cystectomy for bladder cancer--a population based trend analysis of 10,338 patients in the Netherlands.
Q33462188Perioperative use of crystalloids in patients undergoing open radical cystectomy: balanced Ringer's maleate versus a glucose 5%/potassium-based balanced solution: study protocol for a randomized controlled trial
Q46187716Phase I-II RTOG study (99-06) of patients with muscle-invasive bladder cancer undergoing transurethral surgery, paclitaxel, cisplatin, and twice-daily radiotherapy followed by selective bladder preservation or radical cystectomy and adjuvant chemoth
Q36724794Photodynamic therapy of superficial bladder cancer. An alternative to radical cystectomy?
Q49788369Physician Perceptions of Patient Health: A Comparative Analysis between Urologist and Hospitalist Perceptions of Need for Inpatient Hospitalist Comanagement Following Radical Cystectomy
Q100645790Plasma Fibrinogen Predicts the Prognosis of Bladder Cancer Patients After Radical Cystectomy
Q74830108Point and counterpoint. Radical cystectomy or multimodality therapy for TCC of the bladder?
Q33820181Population-based analyses of radical cystectomy and urinary diversion for bladder cancer in northern Italy
Q40212938Population-based assessment of racial/ethnic differences in utilization of radical cystectomy for patients diagnosed with bladder cancer
Q51269681Population-based trends in urinary diversion among patients undergoing radical cystectomy for bladder cancer.
Q46509021Port site metastases after robot-assisted laparoscopic radical cystectomy.
Q39139626Port-Site Metastases After Robotic Radical Cystectomy: A Systematic Review and Management Options
Q49335592Port-site Metastases After Robot-assisted Radical Cystectomy: Is There a Publication Bias?
Q98191373Port-site incisional hernia from an 8-mm robotic trocar following robot-assisted radical cystectomy: Report of a rare case
Q90173492Port-site metastasis and atypical recurrences after robotic-assisted radical cystectomy (RARC): an updated comprehensive and systematic review of current evidences
Q85918736Positive surgical margins and their locations in specimens are adverse prognosis features after radical cystectomy in non-metastatic carcinoma invading bladder muscle: results from a nationwide case-control study
Q51732754Positive surgical margins in soft tissue following radical cystectomy for bladder cancer and cancer specific survival.
Q90387196Positive ureteric margins at radical cystectomy: Can it be predicted at initial transurethral resection of bladder tumour?
Q56243455Post-Operative Infections among Patients Undergoing Radical Cystectomy at a Tertiary Center
Q45740660Post-operative infection and prophylactic antibiotic administration after radical cystectomy with orthotopic neobladder urinary diversion.
Q92741332Posterior muscle-fascial reconstruction and knotless urethro-neo bladder anastomosis during robot-assisted radical cystectomy: Description of the technique and its impact on urinary continence
Q96820247Posterior reconstruction during robotic-assisted radical cystectomy with intracorporeal orthotopic ileal neobladder: description and outcomes of a simple step
Q39021197Postoperative Atrial Fibrillation Predicts Long-Term Cardiovascular Events after Radical Cystectomy
Q49795841Postoperative C-reactive protein is a reliable marker to detect complications after radical cystectomy
Q88072085Postoperative Outcomes After Radical Cystectomy in Patients With Prior Pelvic Radiation
Q38506375Postoperative Pain Management after Radical Cystectomy: Comparing Traditional versus Enhanced Recovery Protocol Pathway
Q38379133Postoperative changes in serum CO2 as an indicator of postoperative complications after radical cystectomy
Q91149088Postoperative cognitive dysfunction after robot-assisted radical cystectomy (RARC) with cerebral oxygen monitoring an observational prospective cohort pilot study
Q90996731Postoperative complications and 90-day mortality in radical cystectomy in high-risk patients: A monocentric retrospective observational study
Q51010000Postoperative complications and short-term oncological outcomes of patients aged ≥80 years undergoing robot-assisted radical cystectomy.
Q87711582Postoperative ileus after radical cystectomy: looking for answers to an age-old problem
Q72557138Postoperative management of patients undergoing radical cystectomy and urinary diversion
Q39354964Postoperative management of radical cystectomy. Review of the evidence on the prevention and treatment of urological complications
Q41838264Postoperative mortality and complications after radical cystectomy for bladder cancer in Quebec: A population-based analysis during the years 2000-2009.
Q79976034Postoperative nomogram predicting risk of recurrence after radical cystectomy for bladder cancer
Q102131339Postoperative outcomes of Fast Track enhanced recovery protocol in open radical cystectomy: comparison with standard management in a high-volume center and Trifecta proposal
Q33373072Postoperative thrombotic microangiopathy following radical cystectomy for bladder cancer.
Q93383681Postoperative weight loss followed by radical cystectomy predicts poor prognosis in patients with muscle-invasive bladder cancer
Q89228564Potential Implications of Shortening Length of Stay Following Radical Cystectomy in a Pre-ERAS Population
Q51051743Potential impact of 18F-FDG PET/CT on patients selection for neoadjuvant chemotherapy before radical cystectomy.
Q37221832Potential impact of postoperative early complications on the timing of adjuvant chemotherapy in patients undergoing radical cystectomy: a high-volume tertiary cancer center experience.
Q46965510Potential risk factors and outcomes of artificial urinary sphincter placement after radical cystectomy and orthotopic neobladder urinary diversion
Q96949361Practice patterns for extended venous thromboembolism chemoprophylaxis among urologic oncologists after radical cystectomy
Q33994334Pre-treatment neutrophil-to-lymphocyte ratio as predictor of adverse outcomes in patients undergoing radical cystectomy for urothelial carcinoma of the bladder.
Q70452256Predeposit autologous blood transfusions in patients undergoing irradiation and radical cystectomy
Q57801526Predicting 90-day and long-term mortality in octogenarians undergoing radical cystectomy
Q91889163Predicting Short-term Outcomes After Radical Cystectomy Based on Frailty
Q92915490Predicting complications following radical cystectomy with the ACS NSQIP universal surgical risk calculator
Q44249777Predicting individual outcomes after radical cystectomy: an external validation of current nomograms
Q50195455Predicting local failure after radical cystectomy in patients with bladder cancer: Implications for the selection of candidates at adjuvant radiation therapy
Q102323409Predicting morbidity and mortality after radical cystectomy using risk calculators: A comprehensive review of the literature
Q38755792Predicting occult lymph node-positive disease at the time of radical cystectomy: a systematic review
Q89622365Predicting perioperative mortality after radical cystectomy: comorbidity assessment tools are only part of the puzzle
Q37103989Predicting survival after radical cystectomy for bladder cancer
Q44419779Predicting the probability of 90-day survival of elderly patients with bladder cancer treated with radical cystectomy.
Q53336343Predicting the survival of bladder carcinoma patients treated with radical cystectomy.
Q43903670Prediction of 90-day mortality after radical cystectomy for bladder cancer in a prospective European multicenter cohort
Q40772011Prediction of Locally Advanced Urothelial Carcinoma of the Bladder Using Clinical Parameters before Radical Cystectomy--A Prospective Multicenter Study
Q57064398Prediction of acute kidney injury after radical cystectomy and urinary diversion
Q40233664Prediction of cancer-specific survival after radical cystectomy in pT4a urothelial carcinoma of the bladder: development of a tool for clinical decision-making
Q90271602Prediction of complication related death after radical cystectomy for bladder cancer with machine learning methodology
Q91289268Prediction of early (30-day) and late (30-90-day) mortality after radical cystectomy in a comprehensive cancer centre over two decades
Q40288397Prediction of mortality after radical cystectomy for bladder cancer by machine learning techniques.
Q45151298Prediction of outcome in patients with urothelial carcinoma of the bladder following radical cystectomy using artificial neural networks
Q84230099Prediction of prognosis after radical cystectomy for pathologic node-negative bladder cancer
Q51820528Prediction of survival after radical cystectomy for invasive bladder carcinoma: risk group stratification, nomograms or artificial neural networks?
Q100453382Prediction of the Need for an Extended Lymphadenectomy at the Time of Radical Cystectomy in Patients with Bladder Cancer
Q83399508Predictive capacity of four comorbidity indices estimating perioperative mortality after radical cystectomy for urothelial carcinoma of the bladder
Q38675035Predictive factors for final pathologic ureteral sections on 700 radical cystectomy specimens: Implications for intraoperative frozen section decision-making
Q86016277Predictive factors of evolution of patients after pT0 radical cystectomy due to bladder cancer
Q47785950Predictive value of combined immunohistochemical markers in patients with pT1 urothelial carcinoma at radical cystectomy
Q93182617Predictive value of lymphangiogenesis and proliferation markers on mRNA level in urothelial carcinoma of the bladder after radical cystectomy
Q104736330Predictive value of preoperative lymphocyte-to-monocyte ratio on survival outcomes in bladder cancer patients after radical cystectomy
Q89379880Predictors of Benign Uretero-enteric Anastomotic Strictures After Radical Cystectomy and Urinary Diversion
Q104516307Predictors of Need for Catheterization and Urinary Retention after Radical Cystectomy and Orthotopic Neobladder in Male Patients
Q90252734Predictors of Recurrence, and Progression-Free and Overall Survival following Open versus Robotic Radical Cystectomy: Analysis from the RAZOR Trial with a 3-Year Followup
Q95645642Predictors of adequate lymph node dissection in patients with non-muscle invasive bladder cancer undergoing radical cystectomy and effect on survival
Q46489162Predictors of cancer-specific mortality after disease recurrence following radical cystectomy
Q41027602Predictors of costs associated with radical cystectomy for bladder cancer: A population-based retrospective cohort study in the province of Quebec, Canada
Q47624161Predictors of female genital organ involvement in radical cystectomy for urothelial carcinoma of the bladder: A single-center retrospective analysis of 112 female patients
Q37598208Predictors of lymph node involvement in bladder cancer treated with radical cystectomy
Q91255288Predictors of oncological outcomes in T1G3 patients treated with BCG who undergo radical cystectomy
Q36164729Predictors of outcome after radical cystectomy for bladder cancer in saudi patients; single institution experience.
Q64969535Predictors of postoperative complications after robot-assisted radical cystectomy with extracorporeal urinary diversion.
Q57089334Predictors of preoperative delays before radical cystectomy for bladder cancer in Quebec, Canada: a population-based study
Q35956231Predictors of referral for neoadjuvant chemotherapy prior to radical cystectomy for muscle-invasive bladder cancer and changes in practice over time
Q91469066Predictors of surgical site infection after radical cystectomy: should we enhance surgical antibiotic prophylaxis?
Q45184861Predictors of survival in patients with soft tissue surgical margin involvement at radical cystectomy
Q30587187Predictors of the use of orthotopic bladder reconstruction after radical cystectomy for bladder cancer: data from a pilot study of 1756 cases 2004-2011.
Q40491159Preliminary Comparative Effectiveness of Robotic Versus Open Radical Cystectomy in Elderly Patients
Q34220341Preliminary experience with radical cystectomy and w-ileal pouch for muscle invasive transitional cell bladder carcinoma.
Q73286125Preliminary ligation of vascular pedicles in male radical cystectomy
Q38963720Preoperative Anemia and Low Hemoglobin Level Are Associated With Worse Clinical Outcomes in Patients With Bladder Cancer Undergoing Radical Cystectomy: A Meta-Analysis
Q58698642Preoperative C-reactive protein/albumin ratio is a significant predictor of survival in bladder cancer patients after radical cystectomy: a retrospective study
Q40194329Preoperative Favorable Characteristics in Bladder Cancer Patients Cannot Substitute the Necessity of Extended Lymphadenectomy During Radical Cystectomy: A Sensitivity Curve Analysis
Q63966593Preoperative Hydronephrosis Predicts Advanced Bladder Cancer but Is Not an Independent Factor for Cancer-Specific Survival after Radical Cystectomy
Q38901788Preoperative Imaging for Clinical Staging Prior to Radical Cystectomy
Q88091385Preoperative Incidence of Deep Venous Thrombosis in Patients With Bladder Cancer Undergoing Radical Cystectomy
Q39512178Preoperative Nutritional Status and The Impact on Radical Cystectomy Recovery: An International Comparative Study
Q37046205Preoperative Patient Reported Mental Health is Associated with High Grade Complications after Radical Cystectomy.
Q33755824Preoperative Prognostic Nutritional Index is a Significant Predictor of Survival with Bladder Cancer after Radical Cystectomy: a retrospective study
Q93047866Preoperative Thrombocytosis in Patients Undergoing Radical Cystectomy for Urothelial Cancer of the Bladder: An Independent Prognostic Parameter for an Impaired Oncological Outcome
Q38359518Preoperative and modifiable factors to lower postoperative complications after radical cystectomy
Q57300536Preoperative anemia and extensive transfusion during stay-in-hospital are critical for patient`s mortality: A retrospective multicenter cohort study of oncological patients undergoing radical cystectomy
Q41127920Preoperative anemia is associated with adverse outcome in patients with urothelial carcinoma of the bladder following radical cystectomy
Q91968935Preoperative chemotherapy for prostatic stromal invasive urothelial bladder cancer: comparison of oncological outcomes of male patients with cT4a disease undergoing radical cystectomy with or without preoperative chemotherapy
Q50126305Preoperative chronic kidney disease before radical cystectomy as predictor of oncological outcomes: a pick of the iceberg?
Q47594245Preoperative chronic kidney disease is predictive of oncological outcome of radical cystectomy for bladder cancer.
Q42365275Preoperative chronic kidney disease predicts poor oncological outcomes after radical cystectomy in patients with muscle-invasive bladder cancer
Q39165708Preoperative determinant of early postoperative renal function following radical cystectomy and intestinal urinary diversion
Q40168486Preoperative findings, pathological stage PSA recurrence in men with prostate cancer incidentally detected at radical cystectomy: our experience in 242 cases
Q96226584Preoperative frailty and outcome in patients undergoing radical cystectomy
Q37227652Preoperative hydronephrosis as an indicator of survival after radical cystectomy
Q40083209Preoperative immunonutrition prior to radical cystectomy: a pilot study
Q69688330Preoperative irradiation and radical cystectomy for bladder cancer
Q68690615Preoperative irradiation and radical cystectomy for stages T2 and T3 squamous cell carcinoma of the bladder
Q71502499Preoperative irradiation and radical cystectomy in carcinoma of the bladder
Q69938194Preoperative irradiation with and without chemotherapy as adjunct to radical cystectomy
Q53484321Preoperative lymphocyte-monocyte and platelet-lymphocyte ratios as predictors of overall survival in patients with bladder cancer undergoing radical cystectomy.
Q34226276Preoperative lymphocyte-to-monocyte ratio predicts clinical outcome in patients undergoing radical cystectomy for transitional cell carcinoma of the bladder: a retrospective analysis
Q46920358Preoperative neutrophil/lymphocyte ratio predicts overall survival and extravesical disease in patients undergoing radical cystectomy
Q50141388Preoperative nutritional factors and outcomes after radical cystectomy: A narrative review
Q79317747Preoperative plasma soluble E-cadherin predicts metastases to lymph nodes and prognosis in patients undergoing radical cystectomy
Q39529506Preoperative prediction of malignant involvement of resected ureters in patients undergoing radical cystectomy for bladder cancer
Q92037583Preoperative predictors of early death risk in bladder cancer patients treated with robot-assisted radical cystectomy
Q34373728Preoperative serum albumin is associated with mortality and complications after radical cystectomy
Q84989776Preoperative staging of locally advanced bladder cancer before radical cystectomy using 3 tesla magnetic resonance imaging with a standardized protocol
Q88131534Preoperatively Dilated Ureters are a Specific Risk Factor for the Development of Ureteroenteric Strictures after Open Radical Cystectomy and Ileal Neobladder
Q57281756Presence of lymphocytic infiltrate cytotoxic T lymphocyte CD3+, CD8+, and immunoscore as prognostic marker in patients after radical cystectomy
Q44470687Presentation and outcome following radical cystectomy in Hispanics with bladder cancer
Q46898743Presentation, location and overall survival of pelvic recurrence after radical cystectomy for transitional cell carcinoma of the bladder
Q39460899Presentation, methods of diagnosis and therapy for pelvic recurrence following radical cystectomy for transitional cell carcinoma of the bladder
Q79355866Preservation of ejaculatory and erectile function after radical cystectomy for urothelial malignancy
Q39713639Preservation of prostate during radical cystectomy: evaluation of prevalence of prostate cancer associated with bladder cancer
Q78292863Preservation of the anterior vaginal wall during female radical cystectomy with orthotopic urinary diversion: technique and results
Q51272592Preservation of the internal genital organs during radical cystectomy in selected women with bladder cancer: a report on 15 cases with long term follow-up.
Q46549839Preservation of urosexual functions after radical cystectomy
Q59798041Pretreatment assessment and perioperative nutritional interventions for patients with bladder cancer undergoing radical cystectomy
Q53062494Pretreatment neutrophil-to-lymphocyte ratio is associated with advanced pathologic tumor stage and increased cancer-specific mortality among patients with urothelial carcinoma of the bladder undergoing radical cystectomy.
Q52701379Pretreatment neutrophil-to-lymphocyte ratio predicts worse survival outcomes and advanced tumor staging in patients undergoing radical cystectomy for bladder cancer.
Q102319733Prevalence and Predictors of Venous Thromboembolism after Robot-Assisted Radical Cystectomy
Q45410645Prevalence of Clostridium Difficile Infection in Patients After Radical Cystectomy and Neoadjuvant Chemotherapy
Q62778279Prevention and management of complications following radical cystectomy for bladder cancer
Q37708678Prevention and management of complications following radical cystectomy for bladder cancer.
Q38069959Prevention and management of complications following robot-assisted radical cystectomy: lessons learned after >250 consecutive cases
Q42197292Primary Signet-Ring Cell Carcinoma of the Urinary Bladder Successfully Managed with Radical Cystectomy in a Young Patient.
Q38025151Primary and secondary malignant involvement of gynaecological organs at radical cystectomy for bladder cancer: review of literature and retrospective analysis of 360 cases
Q98191178Primary diffuse large B-cell lymphoma of the ileal conduit created after radical cystectomy
Q68012721Prognosis of bladder cancer. III. The value of radical cystectomy in the management of invasive bladder cancer
Q88091274Prognostic Features for Objectively Defined Urinary Continence after Radical Cystectomy and Ileal Orthotopic Neobladder in a Contemporary Cohort
Q53011547Prognostic Impact of Renin-Angiotensin Inhibitors in Patients with Bladder Cancer Undergoing Radical Cystectomy.
Q38672188Prognostic Model for Predicting Survival in Patients with Disease Recurrence Following Radical Cystectomy
Q92379448Prognostic Role of the Immunoscore for Patients with Urothelial Carcinoma of the Bladder Who Underwent Radical Cystectomy
Q64075778Prognostic Significance of the Lymphocyte-to-Monocyte Ratio in Bladder Cancer Undergoing Radical Cystectomy: A Meta-Analysis of 5638 Individuals
Q90754536Prognostic Value of Concomitant Carcinoma In Situ in the Radical Cystectomy Specimen: A Systematic Review and Meta-Analysis
Q57934684Prognostic Value of Perinodal Lymphovascular Invasion Following Radical Cystectomy for Lymph Node–positive Urothelial Carcinoma
Q104750286Prognostic Value of Preoperative Albumin-to-Alkaline Phosphatase Ratio in Patients with Muscle-Invasive Bladder Cancer After Radical Cystectomy
Q89365105Prognostic Value of Testing PD-L1 Expression After Radical Cystectomy in High-risk Patients
Q53241403Prognostic Value of the Preoperative Platelet-to-leukocyte Ratio for Oncologic Outcomes in Patients Undergoing Radical Cystectomy for Bladder Cancer.
Q51917175Prognostic accuracy of an artificial neural network in patients undergoing radical cystectomy for bladder cancer: a comparison with logistic regression analysis.
Q35891117Prognostic factors for conditional survival in patients with muscle-invasive urothelial carcinoma of the bladder treated with radical cystectomy
Q80412444Prognostic factors in a recent series of patients treated with radical cystectomy for bladder cancer
Q44118200Prognostic factors in patients with stage pT0/pT1/pTa in the radical cystectomy specimen
Q36286292Prognostic factors in radical cystectomy affecting survival
Q77346920Prognostic factors of outcome after radical cystectomy for bladder cancer: a retrospective study of a homogeneous patient cohort
Q50574271Prognostic factors, pattern of recurrence and survival in a Danish bladder cancer cohort treated with radical cystectomy.
Q37426972Prognostic features for quality of life after radical cystectomy and orthotopic neobladder.
Q40946240Prognostic impact of perioperative lymphocyte-monocyte ratio in patients with bladder cancer undergoing radical cystectomy
Q46569857Prognostic impact of preoperative hematological disorders and a risk stratification model in bladder cancer patients treated with radical cystectomy
Q97549437Prognostic impact of preoperative renal function in patients treated with radical cystectomy: a multi-institutional retrospective study
Q90181678Prognostic impact of tumor-associated immune cell infiltrates at radical cystectomy for bladder cancer
Q50060622Prognostic of older age for patients with invasive-muscle-bladder cancer and treated by radical cystectomy
Q88728657Prognostic pathological factors in radical cystectomy after neoadjuvant chemotherapy
Q48960264Prognostic risk stratification of pathological stage T2N0 bladder cancer after radical cystectomy
Q44207378Prognostic risk stratification of pathological stage T3N0 bladder cancer after radical cystectomy
Q53135982Prognostic risk stratification of patients with urothelial carcinoma of the bladder with recurrence after radical cystectomy.
Q39660094Prognostic role and HER2 expression of circulating tumor cells in peripheral blood of patients prior to radical cystectomy: a prospective study
Q52623391Prognostic role of delay before radical cystectomy: retrospective analysis of a single-centre cohort with 376 patients.
Q48239450Prognostic significance of HALP (hemoglobin, albumin, lymphocyte and platelet) in patients with bladder cancer after radical cystectomy
Q40170042Prognostic significance of Her2/neu overexpression in patients with muscle invasive urinary bladder cancer treated with radical cystectomy
Q38476001Prognostic significance of Ki-67 expression in transitional cell bladder carcinoma after radical cystectomy
Q80993514Prognostic significance of adjuvant cisplatin-based combination chemotherapy following radical cystectomy in patients with invasive bladder cancer
Q44588949Prognostic significance of hydronephrosis in bladder cancer treated by radical cystectomy
Q54668939Prognostic significance of insulin-like growth factor (IGF) binding protein-2 to IGF-binding protein-3 ratio in patients undergoing radical cystectomy for invasive transitional cell carcinoma of the bladder.
Q38929626Prognostic significance of lymphatic, vascular and perineural invasion for bladder cancer patients treated by radical cystectomy
Q35106939Prognostic significance of lymphovascular invasion in radical cystectomy on patients with bladder cancer: a systematic review and meta-analysis
Q45994760Prognostic significance of lymphovascular invasion of bladder cancer treated with radical cystectomy.
Q96160763Prognostic significance of previous tonsillectomy after radical cystectomy for bladder cancer
Q97093355Prognostic significance of serum lactate dehydrogenase in patients undergoing radical cystectomy for bladder cancer
Q104288846Prognostic significance of the Ki67 index and programmed death-ligand 1 expression after radical cystectomy in patients with muscle-invasive bladder cancer
Q35063376Prognostic significance of vascular and perineural invasion in urothelial bladder cancer treated with radical cystectomy
Q81647471Prognostic significance of vascular invasion in patients with bladder cancer who underwent radical cystectomy
Q43866787Prognostic value of 11C-choline PET/CT and CT for predicting survival of bladder cancer patients treated with radical cystectomy
Q73263717Prognostic value of Ki-67 antigen and p53 protein in urinary bladder cancer: immunohistochemical analysis of radical cystectomy specimens
Q50943065Prognostic value of Ki67 and p63 expressions in bladder cancer patients who underwent radical cystectomy.
Q41496553Prognostic value of computed tomography before radical cystectomy in patients with invasive bladder cancer: imaging predicts survival
Q84794267Prognostic value of lymph-node dissection in patients undergoing radical cystectomy following previous oncological treatment for bladder cancer
Q56988216Prognostic value of lymphovascular invasion in bladder cancer in patients treated with radical cystectomy
Q83739138Prognostic value of neutrophil-to-lymphocyte ratio and establishment of novel preoperative risk stratification model in bladder cancer patients treated with radical cystectomy
Q95834619Prognostic value of preoperative hematologic biomarkers in urothelial carcinoma of the bladder treated with radical cystectomy: a systematic review and meta-analysis
Q90076698Prognostic value of preoperative hydronephrosis in patients with bladder cancer undergoing radical cystectomy: A meta-analysis
Q100756381Prognostic value of pretreatment inflammatory markers in variant histologies of the bladder: is inflammation linked to survival after radical cystectomy?
Q90593425Prognostic value of the combined expression of tumor-associated trypsin inhibitor (TATI) and p53 in patients with bladder cancer undergoing radical cystectomy
Q37689089Prognostic value of vascular mimicry in patients with urothelial carcinoma of the bladder after radical cystectomy
Q74562269Prognostic variables in patients who have undergone radical cystectomy for transitional cell carcinoma of the bladder
Q55263257Prognostication in Patients Treated with Radical Cystectomy for Urothelial Bladder Carcinoma: A New Simplified Model Incorporating Histological Variants.
Q39204644Progressive ureteral dilations and retrograde placement of single-j stent guided by flexible cystoscope for management of ureteroenteral anastomotic stricture in patients after radical cystectomy and bricker urinary diversion
Q38836916Propensity Score Analysis of Radical Cystectomy Versus Bladder-Sparing Trimodal Therapy in the Setting of a Multidisciplinary Bladder Cancer Clinic
Q48341672Propensity matched comparative analysis of survival following chemoradiation or radical cystectomy for muscle-invasive bladder cancer
Q91860572Propensity-matched analysis of patient-reported outcomes for neoadjuvant chemotherapy prior to radical cystectomy
Q93182623Propensity-score-matched comparison of soft tissue surgical margins status between open and robotic-assisted radical cystectomy
Q40305305Prophylactic Antibiotics and Postoperative Complications of Radical Cystectomy: A Population Based Analysis in the United States.
Q50023179Prophylactic antibiotics following radical cystectomy reduces urinary tract infections and readmission for sepsis from a urinary source
Q90881098Prophylactic mesh used in ileal conduit formation following radical cystectomy: a retrospective cohort
Q36076583Prophylactic radical cystectomy for the management of keratinizing squamous metaplasia of the bladder in a man with tetraplegia
Q46063382Prophylaxis against radiation injury. The use of elemental diet prior to and during radiotherapy for invasive bladder cancer and in early postoperative feeding following radical cystectomy and ileal conduit
Q37197530Pros and cons of radical cystectomy in the treatment of T1G3 bladder cancer
Q38852083Prospective Evaluation of Continence Following Radical Cystectomy and Orthotopic Urinary Diversion Using a Validated Questionnaire
Q48501255Prospective Evaluation of Nutritional Factors to Predict the Risk of Complications for Patients Undergoing Radical Cystectomy: A Cohort Study
Q47264224Prospective Implementation of Enhanced Recovery After Surgery Protocols to Radical Cystectomy.
Q45931175Prospective comparison of quality-of-life outcomes between ileal conduit urinary diversion and orthotopic neobladder reconstruction after radical cystectomy: a statistical model.
Q44004970Prospective evaluation of a molecular marker panel for prediction of recurrence and cancer-specific survival after radical cystectomy
Q44293813Prospective evaluation of a preoperative biomarker panel for prediction of upstaging at radical cystectomy
Q48120334Prospective evaluation of health-related quality of life after radical cystectomy: focus on peri- and postoperative complications
Q48068728Prospective health-related quality of life analysis for patients undergoing radical cystectomy and urinary diversion.
Q91685396Prospective implementation of a nonopioid protocol for patients undergoing robot-assisted radical cystectomy with extracorporeal urinary diversion
Q40798997Prospective mapping of lymph node metastasis in Japanese patients undergoing radical cystectomy for bladder cancer: characteristics of micrometastasis
Q43255674Prospective randomized controlled trial of robotic versus open radical cystectomy for bladder cancer: perioperative and pathologic results
Q40168747Prospective study comparing laparoscopic and open radical cystectomy: Surgical and oncological results
Q64996627Prospective, randomized clinical trial comparing use of intraoperative transesophageal echocardiography to standard care during radical cystectomy.
Q80572345Prospectively packaged lymph node dissections with radical cystectomy: evaluation of node count variability and node mapping
Q40678159Prostate capsule sparing radical cystectomy - a safe procedure for few
Q37905553Prostate capsule sparing radical cystectomy: oncologic safety and clinical outcome
Q35201624Prostate capsule sparing versus nerve sparing radical cystectomy for bladder cancer: results of a randomized, controlled trial
Q36417260Prostate sparing radical cystectomy--not for all, but an option for some.
Q38111872Prostate-sparing radical cystectomy for selected patients with bladder cancer.
Q36929046Prostatic involvement by urothelial carcinoma of the bladder: clinicopathological features and outcome after radical cystectomy
Q92741420Pubis bone osteomyelitys after robotic radical cystectomy with continent intracorporeal urinary diversion: Multidisciplinary approach to a complex situation
Q44142775Pubovaginal slings for stress urinary incontinence following radical cystectomy and orthotopic neobladder reconstruction in women.
Q39046515Pure but Not Mixed Histologic Variants Are Associated With Poor Survival at Radical Cystectomy in Bladder Cancer Patients
Q35430308Pure intracorporeal laparoscopic radical cystectomy with orthotopic "U" shaped ileal neobladder.
Q36872870Pure laparoscopic radical cystectomy with ileal conduit: a single surgeon's mid-term outcomes
Q50228976Quality Improvement Efforts in Radical Cystectomy: From Prehab to Rehab
Q37398251Quality assurance and benchmarking for radical cystectomy: monitoring early complications and mortality using cumulative summation charts
Q52591362Quality of Life After Radical Cystectomy.
Q41467522Quality of Life Assessment With Orthotopic Ileal Neobladder Reconstruction After Radical Cystectomy: Results From a Prospective Italian Multicenter Observational Study.
Q37261045Quality of care in bladder cancer: trends in urinary diversion following radical cystectomy
Q40784057Quality of life after radical cystectomy and orthotopic bladder substitution: a comparison between Italian and Swedish men.
Q37151228Quality of life after radical cystectomy for bladder cancer in men with an ileal conduit or continent urinary diversion: A comparative study
Q41674534Quality of life after radical cystectomy for bladder cancer in patients with an ileal conduit, cutaneous or urethral kock pouch
Q37601666Quality of life and body image for bladder cancer patients undergoing radical cystectomy and urinary diversion--a prospective cohort study with a systematic review of literature
Q100694851Quality of life and functional outcomes after radical cystectomy with ileal orthotopic neobladder replacement for bladder cancer: a multicentre observational study
Q44947181Quality of life and overall survival in high risk patients after radical cystectomy with a simple urinary derivation
Q100389356Quality of life in patients after radical cystectomy with modified ureterocutaneostomy and Bricker urinary diversion
Q41602376Quality of life outcomes after radical cystectomy: long-term standardized assessment of Studer Pouch versus I-Pouch.
Q35853658Quality-of-life outcomes and unmet needs between ileal conduit and orthotopic ileal neobladder after radical cystectomy in a Chinese population: a 2-to-1 matched-pair analysis
Q93228493Quantifying the Overall Survival Benefit With Early Radical Cystectomy for Patients With Histologically Confirmed T1 Non-muscle-invasive Bladder Cancer
Q76748740RADICAL CYSTECTOMY AFTER SUPERVOLTAGE RADIOTHERAPY
Q45085092RETRACTED: Modified U-shaped ileal neobladder after radical cystectomy: assessment of functional outcomes and complications in Chinese patients
Q91112369Racial disparity in quality of care and overall survival among black vs. white patients with muscle-invasive bladder cancer treated with radical cystectomy: A national cancer database analysis
Q92404631Radiation therapy before radical cystectomy combined with immunotherapy in locally advanced bladder cancer - study protocol of a prospective, single arm, multicenter phase II trial (RACE IT)
Q34528679Radiation, chemotherapy and transurethral surgery: an organ-sparing alternative to the radical cystectomy
Q104491416Radical Cystectomy Against Intravesical BCG for High-Risk High-Grade Nonmuscle Invasive Bladder Cancer: Results From the Randomized Controlled BRAVO-Feasibility Study
Q39195419Radical Cystectomy Compared to Combined Modality Treatment for Muscle-Invasive Bladder Cancer: A Systematic Review and Meta-Analysis
Q38588919Radical Cystectomy Perioperative Care Redesign.
Q46628912Radical Cystectomy Versus Chemoradiation for Muscle-invasive Bladder Cancer: Impact of Treatment Facility and Sociodemographics
Q38129878Radical Cystectomy after BCG Immunotherapy for High-Risk Nonmuscle-Invasive Bladder Cancer in Patients with Previous Prostate Radiotherapy.
Q38788023Radical Cystectomy and Cutaneous Ureterostomy in 4 Dogs with Trigonal Transitional Cell Carcinoma: Description of Technique and Case Series
Q96138552Radical Cystectomy and Ileal Conduit Diversion for Bladder Urothelial Carcinoma With Sarcomatoid and Squamous Variants After Renal Transplantation
Q97881648Radical Cystectomy and Perioperative Sexual Function: A Cross-Sectional Analysis
Q53107639Radical Cystectomy and the Multidisciplinary Management of Muscle-Invasive Bladder Cancer.
Q42010264Radical Cystectomy for Bladder Cancer
Q41613018Radical Cystectomy for Bladder Cancer in Patients With and Without a History of Pelvic Irradiation: Survival Outcomes and Diversion-related Complications.
Q51148960Radical Cystectomy for Bladder Cancer in the 70+ Population: A Nation-Wide Registry Analysis of 845 Patients
Q66910292Radical Cystectomy for Carcinoma of the Bladder: 16 Years of Experience
Q82497905Radical Cystectomy for Transitional Cell Carcinoma with Orthotopic Neobladder in Renal Transplant Recipients: Surgical Procedure, Functional and Therapeutic Evaluation
Q91537078Radical Cystectomy in Female Patients - Improving Outcomes
Q91268702Radical Cystectomy in Pathological T4a and T4b Bladder Cancer Patients: Is There Any Space for Sub Stratification?
Q42350219Radical Cystectomy is the best choice for most patients with muscle-invasive bladder cancer? | Opinion: No.
Q42350221Radical Cystectomy is the best choice for most patients with muscle-invasive bladder cancer? | Opinion: Yes.
Q41988453Radical Cystectomy with Ileal Conduit Urinary Diversion in a Patient with a Left Ventricular Assist Device
Q100993068Radical Cystectomy with Ileal Neobladder in a patient with Hemophilia! A case report
Q40170914Radical Cystectomy without Radiation Therapy for Carcinoma of the Bladder
Q87148076Radical Cystectomy-The Waiting is the Hardest Part…or is it?
Q42787228Radical cystectomy
Q88212949Radical cystectomy
Q68055718Radical cystectomy (anterior exenteration) in the female patient
Q47144768Radical cystectomy (bladder removal) against intravesical BCG immunotherapy for high-risk non-muscle invasive bladder cancer (BRAVO): a protocol for a randomised controlled feasibility study
Q43636096Radical cystectomy - open or robot-assisted?
Q45872273Radical cystectomy - robot assisted ileal conduits: 100 cases
Q83161547Radical cystectomy after bacillus Calmette-Guérin for high-risk Ta, T1, and carcinoma in situ: defining the risk of initial bladder preservation
Q72090784Radical cystectomy after coronary artery bypass graft
Q64093375Radical cystectomy and W-shaped ileal orthotopic neobladder reconstruction with serosa-lined tunneled ureteroileal anastomoses: A critical analysis of the short-term voiding patterns and urodynamic and functional outcomes
Q44656851Radical cystectomy and adjuvant chemotherapy
Q41464467Radical cystectomy and adjuvant chemotherapy for bladder cancer in the elderly: a population-based study
Q34011444Radical cystectomy and bladder substitution.
Q50935694Radical cystectomy and extended pelvic lymphadenectomy: survival of patients with lymph node metastasis above the bifurcation of the common iliac vessels treated with surgery only.
Q43629085Radical cystectomy and ileal conduit for invasive bladder tumour
Q73306192Radical cystectomy and ileal conduit for invasive bladder tumour
Q44280979Radical cystectomy and ileal neobladder reconstruction in elderly female patients over 70 years old: morbidity, functional and oncological long-term results
Q87381548Radical cystectomy and ileal orthotopic bladder substitution after radical retropubic prostatectomy: functional and oncological results
Q69203114Radical cystectomy and ileocaecal bladder reconstruction for carcinoma of the urinary bladder. A study of 130 patients
Q45981738Radical cystectomy and lower urinary tract reconstruction after cardiac allograft transplantation.
Q80029281Radical cystectomy and lymphadenectomy for invasive bladder cancer: towards the evolution of an optimal surgical standard
Q41862983Radical cystectomy and lymphadenectomy to two patients with pelvic kidney: surgical pitfalls and considerations
Q51171441Radical cystectomy and orthotopic bladder replacement in females.
Q34900101Radical cystectomy and orthotopic bladder substitution using ileum
Q38148941Radical cystectomy and orthotopic bladder substitution: surgical tricks and management of complications
Q37988532Radical cystectomy and orthotopic ileal bladder substitution with serous lined extramural ureteral reimplantation--report of 8 cases
Q46438603Radical cystectomy and orthotopic urinary diversion in male patients with pT4a urothelial bladder carcinoma: oncological outcomes.
Q34202585Radical cystectomy and orthotopic urinary reconstruction in patients with bladder cancer after renal transplantation: clinical outcomes and description of technique
Q41962984Radical cystectomy and pelvic lymphadenectomy with ileal conduit urinary diversion and abdominal wall reconstruction: an interesting case of multidisciplinary management
Q91864696Radical cystectomy and subsequent ureterohysterostomy in a bitch
Q37610934Radical cystectomy and surgical quality of care
Q38176436Radical cystectomy and the implications of comorbidity
Q51448218Radical cystectomy and urinary diversion in women: impact on sexual function.
Q88577191Radical cystectomy and venous thromboembolism: are we doing enough?
Q53835137Radical cystectomy at Roswell Park Memorial Institute. Preoperative and post operative observations.
Q104284619Radical cystectomy compared to intravesical BCG immunotherapy for high-risk non-muscle invasive bladder cancer - is there a long-term survival difference? A Swedish nationwide analysis
Q92807586Radical cystectomy complications and perioperative mortality
Q46216660Radical cystectomy for BCG failure: has the timing improved in recent years?
Q84478166Radical cystectomy for BCG failure: has the timing improved in recent years?
Q73499966Radical cystectomy for advanced carcinoma of the bladder
Q74625251Radical cystectomy for advanced carcinoma of the bladder
Q74661052Radical cystectomy for advanced carcinoma of the bladder
Q35070782Radical cystectomy for bladder cancer after definitive prostate cancer treatment
Q43564933Radical cystectomy for bladder cancer today--a homogeneous series without neoadjuvant therapy
Q44240471Radical cystectomy for bladder cancer: 10-year survival
Q37197485Radical cystectomy for bladder cancer: A single center experience.
Q48723492Radical cystectomy for bladder cancer: a qualitative study of patient experiences and implications for practice
Q82978248Radical cystectomy for bladder cancer: morbidity of laparoscopic versus open surgery
Q37663875Radical cystectomy for bladder cancer: oncologic outcome in 271 Chinese patients
Q36111220Radical cystectomy for bladder cancer: the case for early intervention
Q67872452Radical cystectomy for carcinoma of bilharzial bladder. Technique and results
Q70474334Radical cystectomy for carcinoma of the bilharzial bladder
Q67455041Radical cystectomy for carcinoma of the bladder
Q69068991Radical cystectomy for carcinoma of the bladder in the elderly patient
Q46599382Radical cystectomy for carcinoma of the bladder: 2,720 consecutive cases 5 years later
Q73512849Radical cystectomy for carcinoma of the bladder: critical evaluation of the results in 1,026 cases
Q44209236Radical cystectomy for clinically muscle invasive bladder cancer: does prior non-invasive disease affect clinical outcomes?
Q46255975Radical cystectomy for elderly patients with bladder carcinoma: an updated experience with 404 patients
Q71067351Radical cystectomy for high risk patients with superficial bladder cancer in the era of orthotopic urinary reconstruction
Q45163433Radical cystectomy for historical and pathologic T1, N0, M0 (stage A) transitional cell cancer. Need for adjuvant systemic chemotherapy?
Q74034991Radical cystectomy for invasive bladder cancer in the octogenarian
Q77536720Radical cystectomy for invasive bladder cancer--a local experience
Q33968539Radical cystectomy for invasive bladder cancer: contemporary results and remaining controversies
Q46470892Radical cystectomy for invasive bladder cancer: long-term results of a standard procedure
Q50153553Radical cystectomy for invasive bladder cancer: results of multi-institutional pooled analysis
Q72629059Radical cystectomy for invasive squamous cell bladder cancer in a renal transplant patient
Q68746191Radical cystectomy for invasive tumors of the bladder in patients over 70 years of age
Q102058471Radical cystectomy for locally advanced urothelial carcinoma of the urinary bladder: Health-related quality of life, oncological outcomes and predictors for survival
Q92968881Radical cystectomy for management of inflammatory myofibroblastic tumor of the urinary bladder: A rare case report
Q92055481Radical cystectomy for pT1 urothelial carcinoma of bladder not amenable to TURBT: Long-term results
Q59649551Radical cystectomy for patients with pT4 urothelial carcinoma in a large population-based study
Q36771798Radical cystectomy for primary bladder malignancy: a 10 year review.
Q46737967Radical cystectomy for primary neuroendocrine tumors of the bladder: the university of southern california experience
Q50075582Radical cystectomy for recurrent urothelial carcinoma after prior partial cystectomy: perioperative and oncologic outcomes
Q68267087Radical cystectomy for residual of recurrent tumour after definitive radiotherapy (salvage cystectomy)
Q41058919Radical cystectomy for stage T3b bladder cancer
Q54218047Radical cystectomy for stages Ta, Tis and T1 transitional cell carcinoma of the bladder.
Q35014729Radical cystectomy for the treatment of T1 bladder cancer: the Canadian Bladder Cancer Network experience
Q44726875Radical cystectomy for the treatment of infiltrating bladder carcinoma. Analysis of 15 years
Q51777769Radical cystectomy for transitional cell carcinoma of the bladder. Long-term survival in high risk patients.
Q36790519Radical cystectomy for urothelial cancer of the bladder: contemporary advances.
Q51356161Radical cystectomy for urothelial carcinoma of the bladder without neoadjuvant or adjuvant therapy: long-term results in 1100 patients.
Q37516493Radical cystectomy for urothelial carcinoma of the bladder: an analysis of perioperative and survival outcome
Q95837487Radical cystectomy improves survival in patients with stage T1 squamous cell carcinoma and neuroendocrine carcinoma of the urinary bladder
Q86855345Radical cystectomy in Australia
Q38170798Radical cystectomy in a Dutch University hospital: long-term outcomes and prognostic factors in a homogeneous surgery-only series
Q100297918Radical cystectomy in a cohort of octogenarians managed in the ERAS era
Q68054559Radical cystectomy in bladder cancer: mortality and morbidity. A series of 123 cases
Q53558529Radical cystectomy in eldery.
Q57822536Radical cystectomy in frail octogenarians in thoracic continuous spinal anesthesia and analgesia: a pilot study
Q41486474Radical cystectomy in octogenarian patients: a difficult decision to take.
Q36181060Radical cystectomy in octogenarians
Q37732786Radical cystectomy in octogenarians--does morbidity outweigh the potential survival benefits?
Q36126900Radical cystectomy in patients aged > or = 75 years: an updated review of patients treated with curative and palliative intent.
Q74237266Radical cystectomy in patients older than 75 years: assessment of morbidity and mortality
Q69729847Radical cystectomy in patients over 70 years
Q82296466Radical cystectomy in patients over 70 years of age: impact of comorbidity on perioperative morbidity and mortality
Q56767943Radical cystectomy in patients over 80 years old in Quebec: A population-based study of outcomes
Q37728241Radical cystectomy in patients previously treated for localized prostate cancer.
Q38629461Radical cystectomy in patients with disseminated disease: An assessment of perioperative outcomes using the National Surgical Quality Improvement Program database
Q38054199Radical cystectomy in patients with preexisting three-piece inflatable penile prosthesis
Q44455639Radical cystectomy in presence of fused "cake" kidney
Q35150659Radical cystectomy in regionally advanced bladder cancer
Q81556604Radical cystectomy in septuagenarian patients with bladder cancer
Q47109760Radical cystectomy in the elderly - Is this a safe treatment option?
Q54046642Radical cystectomy in the elderly patient.
Q42637271Radical cystectomy in the elderly patient: a contemporary comparison of perioperative complications in a single institution series
Q44596927Radical cystectomy in the elderly: Comparison of survival between younger and older patients
Q34420950Radical cystectomy in the elderly: comparison of clincal outcomes between younger and older patients
Q81170521Radical cystectomy in the elderly: comparison of survival between younger and older patients
Q43445003Radical cystectomy in the elderly: national trends and disparities in perioperative outcomes and quality of care
Q41640834Radical cystectomy in the octogenarian
Q69787511Radical cystectomy in the treatment of advanced bladder cancer
Q40519150Radical cystectomy in the treatment of bladder cancer in Iceland: A population-based study
Q45620809Radical cystectomy in the treatment of bladder cancer: oncological outcome and survival predictors
Q45967681Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients.
Q92737313Radical cystectomy in women: Impact of the robot-assisted versus open approach on surgical outcomes
Q74322449Radical cystectomy is safe in elderly patients at high risk
Q37378993Radical cystectomy is the treatment of choice for invasive bladder cancer
Q47570039Radical cystectomy or bladder preservation with radiochemotherapy in elderly patients with muscle-invasive bladder cancer: Retrospective International Study of Cancers of the Urothelial Tract (RISC) Investigators
Q34251619Radical cystectomy over the age of 75 is safe and increases survival.
Q91510218Radical cystectomy pentafecta: a proposal for standardisation of outcomes reporting following robot-assisted radical cystectomy
Q95332008Radical cystectomy plus chemotherapy in patients with pure squamous cell bladder carcinoma: a population-based study
Q92084645Radical cystectomy under continuous antiplatelet therapy with acetylsalicylic acid
Q71927099Radical cystectomy using endoscopic stapling devices: preliminary experience with a simple and reliable technique
Q74393999Radical cystectomy versus alternative treatments for muscle-confined bladder cancer
Q36959541Radical cystectomy versus bladder-preserving therapy for muscle-invasive urothelial carcinoma: examining confounding and misclassification biasin cancer observational comparative effectiveness research.
Q38454497Radical cystectomy versus organ-sparing trimodality treatment in muscle-invasive bladder cancer: A systematic review of clinical trials
Q86101575Radical cystectomy vs. chemoradiation in T2-4aN0M0 bladder cancer: a case-control study
Q57113693Radical cystectomy with W-shaped orthotopic ileal neobladder constructed with non-absorbable titanium staples-long term follow-up
Q36750597Radical cystectomy with an extended pelvic lymphadenectomy: rationale and results
Q80274621Radical cystectomy with extended lymphadenectomy in the presence of a pelvic kidney
Q40242869Radical cystectomy with extended lymphadenectomy: evaluating separate package versus en bloc submission for node positive bladder cancer
Q30440856Radical cystectomy with ileal conduit diversion: early prospective evaluation of the impact of robotic assistance
Q67953333Radical cystectomy with ileocystoplasty: 30 year experience
Q71917567Radical cystectomy with or without adjuvant polychemotherapy for non-organ-confined transitional cell carcinoma of the urinary bladder: prognostic impact of lymph node involvement
Q43567449Radical cystectomy with or without planned preoperative irradiation in the treatment of bladder cancer
Q67239428Radical cystectomy with or without prior irradiation in the treatment of bladder cancer
Q67587967Radical cystectomy with or without prior irradiation in the treatment of bladder cancer
Q35192404Radical cystectomy with or without urethrectomy?
Q27693214Radical cystectomy with orthotopic neobladder for invasive bladder cancer: a critical analysis of long term oncological, functional and quality of life results
Q37836461Radical cystectomy with orthotopic neobladder for invasive bladder cancer: a critical analysis of long-term oncological, functional, and quality of life results
Q37997967Radical cystectomy with orthotopic neobladder reconstruction following prior radical prostatectomy
Q37037025Radical cystectomy with pelvic lymphadenectomy: pathologic, operative and morbidity outcomes in a Brazilian cohort
Q70038526Radical cystectomy with preservation of sexual and urinary function. Use of the ileocolonic pouch ("Le Bag")
Q80241026Radical cystectomy with preservation of sexual function and fertility in patients with transitional cell carcinoma of the bladder: new technique
Q81473852Radical cystectomy with preservation of sexual function and urinary continence: description of a new technique
Q79165179Radical cystectomy with sparing partial prostate for invasive bladder cancer
Q46344162Radical cystectomy with super-extended lymphadenectomy: impact of separate vs en bloc lymph node submission on analysis and outcomes.
Q80274675Radical cystectomy with ultrasound-guided partial prostatectomy for bladder cancer: a complication-preventing concept
Q70599603Radical cystectomy without preoperative radiotherapy for invasive bladder carcinoma--a justified approach?
Q87616049Radical cystectomy, hysterectomy with double adnexectomy and bilateral nephroureterectomy with transvaginal extraction
Q70892443Radical cystectomy--cornerstone or millstone?
Q68535354Radical cystectomy--often too late?
Q79446071Radical cystectomy--often too late? 1987
Q80204448Radical cystectomy--often too late? Yes, but ...
Q102155587Radical cystectomy-what is the optimal surgical approach?
Q85038291Radical cystectomy: Analysis of postoperative course
Q37008763Radical cystectomy: defining the threshold for a surgeon to achieve optimum outcomes.
Q30240141Radical cystectomy: do we need standardization?
Q77562187Radical cystectomy: extending the limits of pelvic lymph node dissection improves survival for patients with bladder cancer confined to the bladder wall
Q87294225Radical cystectomy: how do blood transfusions affect oncological outcomes?
Q47897931Radical cystectomy: minimizing operative blood loss with a "stapling technique".
Q46141349Radical cystectomy: open vs robotic approach
Q73103957Radical cystectomy: posterior dissection following prior therapy
Q53759383Radical cystectomy: the minimally invasive approach.
Q46157917Radical cystectomy: the potential for cure and reconstruction.
Q64922439Radiotherapy with radical cystectomy for bladder cancer: A systematic review and meta-analysis.
Q87519975Randomised phase III study of neoadjuvant chemotherapy with methotrexate, doxorubicin, vinblastine and cisplatin followed by radical cystectomy compared with radical cystectomy alone for muscle-invasive bladder cancer: Japan Clinical Oncology Group
Q57138336Randomized Trial Comparing Open Radical Cystectomy and Robot-assisted Laparoscopic Radical Cystectomy: Oncologic Outcomes
Q96439271Randomized controlled trial to compare outcomes with and without the enhanced recovery after surgery protocol in patients undergoing radical cystectomy
Q71697223Rapid preoperative bowel preparation for patients undergoing radical cystectomy
Q99567681Rates and Patterns of Recurrences, and Survival Outcomes after Robot-Assisted Radical Cystectomy: Results from the International Robotic Cystectomy Consortium
Q88279439Rates and Predictors of Conversion to Open Surgery During Minimally Invasive Radical Cystectomy
Q91561683Rates of other-cause mortality after radical cystectomy are decreasing over time-A population-based analysis over two decades
Q71588366Rationale and technique of nerve sparing radical cystectomy before an orthotopic neobladder procedure in women
Q98183599Re-establishing the Role of Robot-assisted Radical Cystectomy After the 2020 EAU Muscle-invasive and Metastatic Bladder Cancer Guideline Panel Recommendations
Q97677159Re-operation within 30 days of radical cystectomy: Identifying high-risk patients and complications using ACS-NSQIP database
Q84390153Re: Alvimopan provides rapid gastrointestinal recovery without nasogastric tube decompression after radical cystectomy and urinary diversion
Q91511889Re: 90-Day Complication Rate in Patients Undergoing Radical Cystectomy with Enhanced Recovery Protocol: A Prospective Cohort Study
Q91368773Re: A Prospective Randomized Pilot Study Evaluating an ERAS Protocol versus a Standard Protocol for Patients Treated with Radical Cystectomy and Urinary Diversion for Bladder Cancer
Q88423933Re: A Prospective Randomized Trial of the Effects of Early Enteral Feeding after Radical Cystectomy
Q83904005Re: A double-blind randomized controlled clinical trial to assess the effect of Doppler optimized intraoperative fluid management on outcome following radical cystectomy: P. Pillai, I. McEleavy, M. Gaughan, C. Snowden, I. Nesbitt, G. Durkan, M. John
Q85015158Re: A double-blind randomized controlled clinical trial to assess the effect of Doppler optimized intraoperative fluid management on outcome following radical cystectomy: P. Pillai, I. McEleavy, M. Gaughan, C. Snowden, I. Nesbitt, G. Durkan, M. John
Q92497699Re: Accurate Quantification of Residual Cancer Cells in Pelvic Washing Reveals Association with Cancer Recurrence following Robot-Assisted Radical Cystectomy
Q99254544Re: Acute Kidney Injury Following Enhanced Recovery After Surgery in Patients Undergoing Radical Cystectomy
Q53051702Re: Adjuvant Chemotherapy vs Observation for Patients with Adverse Pathologic Features at Radical Cystectomy Previously Treated With Neoadjuvant Chemotherapy.
Q91766108Re: Adjuvant Chemotherapy vs Observation for Patients with Adverse Pathologic Features at Radical Cystectomy Previously Treated with Neoadjuvant Chemotherapy
Q48871104Re: Adjuvant Cisplatin-Based Combined Chemotherapy for Lymph Node (LN)-Positive Urothelial Carcinoma of the Bladder (UCB) after Radical Cystectomy (RC): A Retrospective International Study of >1500 Patients
Q88344554Re: Adjuvant Sandwich Chemotherapy Plus Radiotherapy vs Adjuvant Chemotherapy Alone for Locally Advanced Bladder Cancer After Radical Cystectomy: A Randomized Phase 2 Trial
Q90705579Re: Adjuvant Sandwich Chemotherapy plus Radiotherapy vs Adjuvant Chemotherapy Alone for Locally Advanced Bladder Cancer after Radical Cystectomy: A Randomized Phase 2 Trial
Q88331423Re: Alvimopan for Recovery of Bowel Function after Radical Cystectomy
Q87410440Re: Atiqullah Aziz, Matthias May, Maximilian Burger, et al. PROMETRICS 2011 research group. Prediction of 90-day mortality after radical cystectomy for bladder cancer in a prospective European multicenter cohort. Eur Urol 2014;66:156-163
Q100750716Re: Bansal D, Nayak B, Singh P, Nayyar R, Ramachandran R, Kumar R, et al. Randomized controlled trial to compare outcomes with and without the enhanced recovery after surgery protocol in patients undergoing radical cystectomy. Indian J Urol 2020;36:
Q84593339Re: Beat Roth, Frédéric D. Birkhäuser, Pascal Zehnder, et al. Parenteral nutrition does not improve postoperative recovery from radical cystectomy: results of a prospective randomised trial. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.201
Q91360409Re: Bernard H. Bochner, Guido Dalbagni, Karim H. Marzouk, et al. Randomized Trial Comparing Open Radical Cystectomy and Robot-assisted Laparoscopic Radical Cystectomy: Oncologic Outcomes. Eur Urol 2018;74:465-71: Can the Pattern of Cancer Recurrence
Q86955472Re: Brian J. Linder, Igor Frank, John C. Cheville, et al. The impact of perioperative blood transfusion on cancer recurrence and survival following radical cystectomy. Eur Urol 2013;63:839-45
Q82736998Re: Changes in body composition: muscle function and energy expenditure after radical cystectomy
Q91852493Re: Characterization of Late Recurrence after Radical Cystectomy in a Large Multicenter Cohort of Bladder Cancer Patients
Q85694309Re: Cheryl T. Lee, Sam S. Chang, Ashish M. Kamat, et al. Alvimopan accelerates gastrointestinal recovery after radical cystectomy: a multicenter randomized placebo-controlled trial. Eur urol 2014;66:265-72
Q98612621Re: Cigarette Smoking is Associated with Adverse Pathological Response and Increased Disease Recurrence amongst Patients with Muscle-Invasive Bladder Cancer Treated with Cisplatin-Based Neoadjuvant Chemotherapy and Radical Cystectomy: A Single-Centr
Q50069819Re: Clinical and Therapeutic Factors Associated with Adverse Pathological Outcomes in Clinically Node-Negative Patients Treated with Neoadjuvant Cisplatin-Based Chemotherapy and Radical Cystectomy
Q86729886Re: Comparing Open Radical Cystectomy and Robot-Assisted Laparoscopic Radical Cystectomy: A Randomized Clinical Trial
Q50627178Re: Comparing Open Radical Cystectomy and Robot-assisted Laparoscopic Radical Cystectomy: A Randomized Clinical Trial.
Q91479642Re: Comparing Survival Outcomes and Costs Associated with Radical Cystectomy and Trimodal Therapy for Older Adults with Muscle-Invasive Bladder Cancer
Q87408715Re: Comparison of radical cystectomy with conservative treatment in geriatric (≥80) patients with muscle-invasive bladder cancer
Q49689188Re: Complications and Quality of Life in Elderly Patients with Several Comorbidities Undergoing Cutaneous Ureterostomy with Single Stoma or Ileal Conduit after Radical Cystectomy
Q88056831Re: Complications and Quality of Life in Elderly Patients with Several Comorbidities Undergoing Cutaneous Ureterostomy with Single Stoma or Ileal Conduit after Radical Cystectomy
Q40904142Re: Conditional Survival after Radical Cystectomy for Bladder Cancer: Evidence for a Patient Changing Risk Profile over Time
Q58560094Re: Contemporary Use Trends and Survival Outcomes in Patients Undergoing Radical Cystectomy or Bladder-Preservation Therapy for Muscle-Invasive Bladder Cancer
Q89221507Re: Cost-Effectiveness of Neoadjuvant Chemotherapy before Radical Cystectomy for Muscle-Invasive Bladder Cancer
Q88762890Re: Critical Analysis of Early Recurrence After Laparoscopic Radical Cystectomy in a Large Cohort by the ESUT
Q52850079Re: Critical Analysis of Early Recurrence after Laparoscopic Radical Cystectomy in a Large Cohort by the ESUT: S. Albisinni, L. Fossion, M. Oderda, O. M. Aboumarzouk, F. Aoun, T. Tokas, V. Varca, R. Sanchez-Salas, X. Cathelineau, P. Chlosta, F. Gabo
Q53682182Re: Daniel P. Nguyen, Bashir Al Hussein Al Awamlh, Xian Wu, et al. Recurrence Patterns After Open and Robot-assisted Radical Cystectomy for Bladder Cancer. Eur Urol 2015;68:399–405
Q89357145Re: Decreased Overall and Bladder Cancer-specific Mortality with Adjuvant Chemotherapy After Radical Cystectomy: Multivariable Competing Risk Analysis
Q91882311Re: Dipen J. Parekh, Isidinha M. Reis, Erik P. Castle, et al. Robot-assisted Radical Cystectomy Versus Open Radical Cystectomy in Patients with Bladder Cancer (RAZOR): An Open-label, Randomised, Phase 3, Non-inferiority Trial. Lancet 2018;391:2525-3
Q87669371Re: Does Radical Cystectomy Outperform Other Bladder Preservative Treatments in Elderly Patients with Advanced Bladder Cancer?
Q91225810Re: Effectiveness of Adjuvant Chemotherapy after Radical Cystectomy for Locally Advanced and/or Pelvic Lymph Node-Positive Muscle-Invasive Urothelial Carcinoma of the Bladder: A Propensity Score-Weighted Competing Risks Analysis
Q88765572Re: Efficacy and Safety of Intraoperative Tranexamic Acid Infusion for Reducing Blood Transfusion during Open Radical Cystectomy
Q85312691Re: Enhanced Recovery Protocol after Radical Cystectomy for Bladder Cancer: S. Daneshmand, H. Ahmadi, A. K. Schuckman, A. P. Mitra, J. Cai, G. Miranda and H. Djaladat J Urol 2014;192:50-56
Q99603380Re: Epidural Anesthesia May be Associated with Increased Postoperative Complications in the Elderly Population Undergoing Radical Cystectomy: An Analysis from the National Surgical Quality Improvement Project (NSQIP) Database
Q90158815Re: Evaluation of Cause of Death after Radical Cystectomy for Patients with Bladder Cancer: The Impact of Age at the Time of Surgery
Q88228298Re: Extended Duration Enoxaparin Decreases the Rate of Venous Thromboembolic Events after Radical Cystectomy Compared to Inpatient Only Subcutaneous Heparin: J. J. Pariser, S. M. Pearce, B. B. Anderson, V. T. Packiam, V. N. Prachand, N. D. Smith and
Q92410480Re: Extended Versus Limited Lymph Node Dissection in Bladder Cancer Patients Undergoing Radical Cystectomy: Survival Results from a Prospective, Randomized Trial
Q93108476Re: Extended Versus Limited Lymph Node Dissection in Bladder Cancer Patients Undergoing Radical Cystectomy: Survival Results from a Prospective, Randomized Trial
Q91852488Re: Extended versus Limited Lymph Node Dissection in Bladder Cancer Patients Undergoing Radical Cystectomy: Survival Results from a Prospective, Randomized Trial
Q97891300Re: Extended versus Standard Lymph Node Dissection for Urothelial Carcinoma of the Bladder in Patients Undergoing Radical Cystectomy
Q40904135Re: Factors Influencing the Length of Stay after Radical Cystectomy: Implications for Cancer Care and Perioperative Management
Q90765443Re: Frailty as a Predictor of Complications after Radical Cystectomy: A Prospective Study of Various Preoperative Assessments
Q54223816Re: Gender-Specific Differences in Clinicopathologic Outcomes following Radical Cystectomy: An International Multi-Institutional Study of More than 8000 Patients.
Q57814255Re: Georg Jancke, Firas Aljabery, Sigurdur Gudjonsson, et al. Port-site Metastases After Robot-assisted Radical Cystectomy: Is There a Publication Bias? Eur Urol 2018;73:641-2
Q51871235Re: Georges-Pascal Haber, Sebastien Crouzet, Inderbir S. Gill. Laparoscopic and robotic-assisted radical cystectomy for bladder cancer: a critical analysis. Eur Urol 2008;54:54-64.
Q81581687Re: Gynecologic-tract sparing extra peritoneal retrograde radical cystectomy with neobladder
Q53182468Re: Hans-Martin Fritsche, Maximilian Burger, Robert S. Svatek et al. Characteristics and outcomes of patients with clinical T1 grade 3 urothelial carcinoma treated with radical cystectomy: results from an international cohort. Eur Urol 2010;57:300-9
Q83934161Re: Hans-Martin Fritsche, Maximilian Burger, Robert S. Svatek, et al. Characteristics and outcomes of patients with clinical T1 grade 3 urothelial carcinoma treated with radical cystectomy: results from an international cohort. Eur Urol 2010;57:300-
Q84635736Re: Hassan Abol-Enein, Derya Tilki, Ahmed Mosbah, et al. Does the extent of lymphadenectomy in radical cystectomy for bladder cancer influence disease-free survival? A prospective single-center study. Eur Urol 2011;60:572-7
Q104561756Re: Health Related Quality of Life of Patients with Bladder Cancer in the RAZOR Trial: A Multi-institutional Randomized Trial Comparing Robot Versus Open Radical Cystectomy
Q47907317Re: Health-Related Quality of Life after Radical Cystectomy and Neobladder Reconstruction in Women: Impact of Voiding and Continence Status
Q90227583Re: Hospitalisation and Readmission Costs after Radical Cystectomy in a Nationally Representative Sample: Does Urinary Reconstruction Matter?
Q89004525Re: Hussein et al.: Development and Validation of a Quality Assurance Score for Robot-assisted Radical Cystectomy: A 10-Year Analysis (Urology 2016;97:124-129)
Q44444077Re: Identifying additional lymph nodes in radical cystectomy lymphadenectomy specimens
Q47617093Re: Immediate Versus Deferred Chemotherapy After Radical Cystectomy in Patients with pT3-pT4 or N+ M0 Urothelial Carcinoma of the Bladder (EORTC 30994): An Intergroup, Open-label, Randomised Phase 3 Trial
Q53238196Re: Immediate versus Deferred Chemotherapy after Radical Cystectomy in Patients with pT3-pT4 or N+ M0 Urothelial Carcinoma of the Bladder (EORTC 30994): An Intergroup, Open-Label, Randomised Phase 3 Trial.
Q99588938Re: Impact of Adjuvant Chemotherapy in Patients with Adverse Features and Variant Histology at Radical Cystectomy for Muscle-Invasive Carcinoma of the Bladder: Does Histologic Subtype Matter?
Q93108500Re: Impact of Adjuvant Chemotherapy in Patients with Adverse Features and Variant Histology at Radical Cystectomy for Muscle-invasive Carcinoma of the Bladder: Does Histologic Subtype Matter?
Q58560494Re: Impact of Body Mass Index on Robot-Assisted Radical Cystectomy with Intracorporeal Urinary Diversion
Q88759865Re: Impact of Suboptimal Neoadjuvant Chemotherapy on Peri-Operative Outcomes and Survival after Robot-Assisted Radical Cystectomy: A Multicentre Multinational Study
Q40305609Re: Impact of Surgeon Volume on the Morbidity and Costs of Radical Cystectomy in the USA: A Contemporary Population-Based Analysis
Q82237472Re: Impact of malpractice caps on use and outcomes of radical cystectomy for bladder cancer: data from the surveillance, epidemiology, and end results program
Q88011756Re: Impact of preoperative hemoglobin and CRP levels on cancer-specific survival in patients undergoing radical cystectomy for transitional cell carcinoma of the bladder: results of a single-center study
Q87804515Re: Impact of statin use on oncologic outcomes in patients with urothelial carcinoma of the bladder treated with radical cystectomy: R. D. da Silva, E. Xylinas, L. Kluth, J. J. Crivelli, J. Chrystal, D. Chade, G. B. Guglielmetti, A. Pycha, Y. Lotan,
Q92583490Re: Implementation of a Perioperative Venous Thromboembolism Prophylaxis Program for Patients Undergoing Radical Cystectomy on an Enhanced Recovery after Surgery Protocol
Q90093997Re: Incidence and Microbiology of Post-Operative Infections after Radical Cystectomy and Ureteral Stent Removal; A Retrospective Cohort Study
Q88032755Re: Incidence and risk factors for acute kidney injury after radical cystectomy
Q80450838Re: Increased body mass index predicts increased blood loss during radical cystectomy
Q89936614Re: Influence and Impact of Cognitive Trajectories on Outcome in Patients Undergoing Radical Cystectomy: An Observational Study
Q85404628Re: Intermediate-Term Oncologic Outcomes of Robot-Assisted Radical Cystectomy for Urothelial Carcinoma
Q100996364Re: Intra-operative Ureteral Stent Use at Radical Cystectomy is Associated with Higher 30-Day Complications Rates
Q90744093Re: Intracorporeal Robot-Assisted Radical Cystectomy, Together with an Enhanced Recovery Programme, Improves Postoperative Outcomes by Aggregating Marginal Gains
Q86965746Re: Intraoperative Continuous Norepinephrine Infusion Combined with Restrictive Deferred Hydration Significantly Reduces the Need for Blood Transfusion in Patients Undergoing Open Radical Cystectomy: Results of a Prospective Randomised Trial
Q87669364Re: Intraoperative Continuous Norepinephrine Infusion Combined with Restrictive Deferred Hydration Significantly Reduces the Need for Blood Transfusion in Patients Undergoing Open Radical Cystectomy: Results of a Prospective Randomised Trial
Q87647104Re: Jim C. Hu, Bilal Chughtai, Padraic O'Malley, et al. Perioperative Outcomes, Health Care Costs, and Survival After Robotic-assisted Versus Open Radical Cystectomy: A National Comparative Effectiveness Study. Eur Urol 2016;70:195-202: Comparative
Q91758828Re: Jürgen E. Gschwend, Matthias M. Heck, Jan Lehmann, et al. Extended Versus Limited Lymph Node Dissection in Bladder Cancer Patients Undergoing Radical Cystectomy: Survival Results from a Prospective, Randomized Trial. Eur Urol 2019;75:604-11
Q88983397Re: Karl H. Pang, Ruth Groves, Suresh Venugopal, Aidan P. Noon, James W.F. Catto. Prospective Implementation of Enhanced Recovery After Surgery Protocols to Radical Cystectomy. Eur Urol 2018;73:363-71
Q83815829Re: Khan et al.: analysis of early complications of robotic-assisted radical cystectomy using a standardized reporting system (Urology 2011;77:357-362)
Q51580661Re: Khan et al.: analysis of early complications of robotic-assisted radical cystectomy using a standardized reporting system (Urology 2011;77:357-362).
Q50946507Re: Lambert et al.: Using preoperative albumin levels as a surrogate marker for outcomes after radical cystectomy for bladder cancer (Urology 2013;81:587-592).
Q79866991Re: Laparoscopic-assisted nephroureterectomy after radical cystectomy for transitional cell carcinoma
Q84704407Re: Liberman et al.: Perioperative mortality is significantly greater in septuagenarian and octogenarian patients treated with radical cystectomy for urothelial carcinoma of the bladder (Urology 2011;77:660-663)
Q54197217Re: Long-Term Changes in Renal Function Outcomes following Radical Cystectomy and Urinary Diversion.
Q96582351Re: Long-Term Oncological Outcomes from an Early Phase Randomised Controlled Three-Arm Trial of Open, Robotic, and Laparoscopic Radical Cystectomy (CORAL)
Q86189377Re: Long-term renal function outcomes after radical cystectomy
Q89118644Re: Low Pretreatment Neutrophil-to-Lymphocyte Ratio Predicts for Good Outcomes in Patients Receiving Neoadjuvant Chemotherapy Before Radical Cystectomy for Muscle Invasive Bladder Cancer
Q90677167Re: Malte W. Vetterlein, Jakob Klemm, Philipp Gild, et al. Improving Estimates of Perioperative Morbidity After Radical Cystectomy Using the European Association of Urology Quality Criteria for Standardized Reporting and Introducing the Comprehensiv
Q94500894Re: Malte W. Vetterlein, Jakob Klemm, Philipp Gild, et al. Improving Estimates of Perioperative Morbidity After Radical Cystectomy Using the European Association of Urology Quality Criteria for Standardized Reporting and Introducing the Comprehensiv
Q89205880Re: Marc A. Furrer, Adrian Fellmann, Marc P. Schneider, George N. Thalmann, Fiona C. Burkhard, Patrick Y. Wuethrich. Impact of Packed Red Blood Cells and Fresh Frozen Plasma Given During Radical Cystectomy and Urinary Diversion on Cancer-related Out
Q57989414Re: Marital Status: A Gender-independent Risk Factor for Poorer Survival After Radical Cystectomy
Q62660609Re: Matthew E. Nielsen, Shahrokh F. Shariat, Pierre I. Karakiewicz et al. Advanced Age Is Associated with Poorer Bladder Cancer-Specific Survival in Patients Treated with Radical Cystectomy. Eur Urol 2007;51:699–708
Q96826669Re: National Cancer Database Comparison of Radical Cystectomy vs Chemoradiotherapy for Muscle-Invasive Bladder Cancer: Implications of Using Clinical vs Pathologic Staging
Q74486140Re: Nerve and seminal sparing radical cystectomy with orthotopic urinary diversion for select patients with superficial bladder cancer: an innovative surgical approach
Q80115090Re: Nomograms provide improved accuracy for predicting survival after radical cystectomy
Q47795522Re: Oncologic Outcomes following Robot-Assisted Radical Cystectomy with Minimum 5-Year Follow-up: The Roswell Park Cancer Institute Experience
Q43490250Re: Oncologic outcomes and survival in pT0 tumors after radical cystectomy in patients without neoadjuvant chemotherapy: results from a large multicentre collaborative study
Q74216627Re: Outcome of patients with grossly node positive bladder cancer after pelvic lymph node dissection and radical cystectomy
Q53327879Re: Pak et al.: Utilization Trends and Short-term Outcomes of Robotic Versus Open Radical Cystectomy for Bladder Cancer (Urology 2017;103:117-123) and Borza et al.: No Differences in Population-based Readmissions After Open and Robotic-assisted Cyst
Q90987691Re: Pembrolizumab as Neoadjuvant Therapy Before Radical Cystectomy in Patients with Muscle-invasive Urothelial Bladder Carcinoma (PURE-01): An Open-label, Single-arm, Phase II Study
Q80601685Re: Perineural invasion by transitional cell carcinoma of the bladder in patients submitted to radical cystectomy: what is the prognostic value?
Q86965744Re: Perioperative Complications and 90-Day Mortality of Radical Cystectomy in the Elderly (75+): A Retrospective, Multicentre Study
Q92540471Re: Perioperative Oral Nutrition Supplementation Reduces Prevalence of Sarcopenia following Radical Cystectomy: Results of a Prospective Randomized Controlled Trial
Q95500015Re: Perioperative Oral Nutrition Supplementation Reduces Prevalence of Sarcopenia following Radical Cystectomy: Results of a Prospective Randomized Controlled Trial
Q91632539Re: Perioperative Outcomes and Complications after Robotic Radical Cystectomy with Intracorporeal or Extracorporeal Ileal Conduit Urinary Diversion: Head-to-Head Comparison from a Single-Institutional Prospective Study
Q91738735Re: Population-Based Assessment of Racial/Ethnic Differences in Utilization of Radical Cystectomy for Patients Diagnosed with Bladder Cancer
Q52990863Re: Potential Impact of 18F-FDG PET/CT on Patients Selection for Neoadjuvant Chemotherapy before Radical Cystectomy.
Q91479564Re: Predicting Local Failure after Radical Cystectomy in Patients with Bladder Cancer: Implications for the Selection of Candidates at Adjuvant Radiation Therapy
Q53836483Re: Preoperatively Dilated Ureters are a Specific Risk Factor for the Development of Ureteroenteric Strictures after Open Radical Cystectomy and Ileal Neobladder: R. E. Hautmann, R. de Petriconi, A. Kahlmeyer, M. Enders and B. Volkmer J Urol 2017;19
Q90158841Re: Prognostic Significance of Lymphatic, Vascular and Perineural Invasion for Bladder Cancer Patients Treated by Radical Cystectomy
Q49899429Re: Propensity Score Analysis of Radical Cystectomy Versus Bladder-sparing Trimodal Therapy in the Setting of a Multidisciplinary Bladder Cancer Clinic
Q49963356Re: Propensity Score Analysis of Radical Cystectomy versus Bladder-Sparing Trimodal Therapy in the Setting of a Multidisciplinary Bladder Cancer Clinic
Q54301217Re: Prospective evaluation of a preoperative biomarker panel for prediction of upstaging at radical cystectomy.
Q49609002Re: Radical Cystectomy (Bladder Removal) Against Intravesical BCG Immunotherapy for High-risk Non-muscle Invasive Bladder Cancer (BRAVO): A Protocol for a Randomised Controlled Feasibility Study.
Q44681312Re: Radical cystectomy in patients with preexisting three-piece inflatable penile prosthesis
Q91991749Re: Rates and Predictors of Conversion to Open Surgery During Minimally Invasive Radical Cystectomy
Q50644656Re: Recurrence Patterns after Open and Robot-Assisted Radical Cystectomy for Bladder Cancer.
Q90585308Re: Retrosigmoid versus Traditional Ileal Conduit for Urinary Diversion after Radical Cystectomy
Q84460141Re: Richard E. Hautmann, Oliver Hautmann, Börn G. Volkmer, Stefan Hautmann. Nerve-sparing radical cystectomy: a new technique. Eur Urol Suppl 2010;9:428-432
Q87156089Re: Risk of fracture after radical cystectomy and urinary diversion for bladder cancer
Q91112266Re: Robot-assisted Radical Cystectomy Versus Open Radical Cystectomy in Patients with Bladder Cancer (RAZOR): An Open-label, Randomised, Phase 3, Non-inferiority Trial
Q91140162Re: Robot-assisted Radical Cystectomy Versus Open Radical Cystectomy in Patients with Bladder Cancer (RAZOR): An Open-label, Randomised, Phase 3, Non-inferiority Trial
Q88885385Re: Role of routine computed tomography scan in the oncological follow up of patients treated by radical cystectomy for bladder cancer
Q45839944Re: Roman Mayr, Matthias May, Thomas Martini, et al. Comorbidity and performance indices as predictors of cancer-independent mortality but not of cancer-specific mortality after radical cystectomy for urothelial carcinoma of the bladder. Eur Urol 20
Q60622175Re: Sarcopenia as a Predictor of Complications and Survival Following Radical Cystectomy
Q54157886Re: Short-Form Charlson Comorbidity Index for Assessment of Perioperative Mortality after Radical Cystectomy.
Q84590651Re: Significance of distal ureteral margin at radical cystectomy for urothelial carcinoma. M. K. Tollefson, M. L. Blute, S. A. Farmer and I. Frank J Urol 2010; 183: 81-86
Q97891448Re: Spillover Effects of the Hospital Readmissions Reduction Program on Radical Cystectomy Readmissions
Q45799889Re: Standardized analysis of frequency and severity of complications after robot-assisted radical cystectomy
Q98498258Re: Stephen B. Williams, Marcus G.K. Cumberbatch, Ashish M. Kamat, et al. Reporting Radical Cystectomy Outcomes Following Implementation of Enhanced Recovery After Surgery Protocols: A Systematic Review and Individual Patient Data Meta-analysis. Eur
Q98612623Re: Surgical Safety of Radical Cystectomy and Pelvic Lymph Node Dissection following Neoadjuvant Pembrolizumab in Patients with Bladder Cancer: Prospective Assessment of Perioperative Outcomes from the PURE-01 Trial
Q49012358Re: Syed Johar Raza, Timothy Wilson, James O. Peabody, et al. Long-term Oncologic Outcomes Following Robot-assisted Radical Cystectomy: Results from the International Robotic Cystectomy Consortium. Eur Urol 2015;68:721-8.
Q91088757Re: Ten-Year Oncologic Outcomes following Robot-Assisted Radical Cystectomy: Results from the International Robotic Cystectomy Consortium
Q54296398Re: The Association of ABO Blood Type with Disease Recurrence and Mortality among Patients with Urothelial Carcinoma of the Bladder Undergoing Radical Cystectomy.
Q58563675Re: The Cancer of the Bladder Risk Assessment (COBRA) Score: Estimating Mortality after Radical Cystectomy
Q88036397Re: The Correlation of Media Ranking's "Best" Hospitals and Surgical Outcomes following Radical Cystectomy for Urothelial Cancer
Q40408296Re: The Effect of Broader, Directed Antimicrobial Prophylaxis Including Fungal Coverage on Perioperative Infectious Complications after Radical Cystectomy
Q42102119Re: The Effect of Broader, Directed Antimicrobial Prophylaxis Including Fungal Coverage on Perioperative Infectious Complications after Radical Cystectomy
Q90158858Re: The Feasibility and Safety of Reproductive Organ Preserving Radical Cystectomy for Elderly Female Patients with Muscle-Invasive Bladder Cancer: A Retrospective Propensity Score-Matched Study
Q90390056Re: The Impact of Non-Urothelial Variant Histology on Oncological Outcomes following Radical Cystectomy
Q53804106Re: The Prognostic Significance of the Early Postoperative Neutrophil-to-Lymphocyte Ratio in Patients with Urothelial Carcinoma of the Bladder Undergoing Radical Cystectomy.
Q88036718Re: The Timing of Radical Cystectomy for bacillus Calmette-Guérin Failure: Comparison of Outcomes and Risk Factors for Prognosis: C. R. Haas, L. J. Barlow, G. M. Badalato, G. J. DeCastro, M. C. Benson and J. M. McKiernan J Urol 2016;195:1704-1709
Q70386084Re: The effect of nutritional status and support on morbidity and mortality of bladder cancer patients treated by radical cystectomy
Q35993984Re: The feasibility of radical cystectomy in elderly patients
Q68080591Re: The role of radical cystectomy in the management of high grade superficial bladder cancer (PA, P1, PIS and P2)
Q68045487Re: The role of radical cystectomy in the management of high grade superficial bladder cancer (Pa, P1, PIS and P2)
Q80983644Re: The role of squamous differentiation in patients with transitional cell carcinoma of the bladder treated with radical cystectomy
Q94551280Re: The role of squamous differentiation in patients with transitional cell carcinoma of the bladder treated with radical cystectomy
Q84114684Re: The z-shaped ileal neobladder after radical cystectomy: an 18 years experience with 329 patients
Q51112258Re: Udo Nagele, Markus Kuczyk, Aristotelis G. Anastasiadis, Karl-Dietrich Sievert, Jörg Seibold and Arnulf Stenzl. Radical cystectomy and orthotopic bladder replacement in females, Eur Urol 2006;50:249-257.
Q44407622Re: Upper urinary tract recurrence following radical cystectomy for bladder cancer: a meta-analysis on 13,185 patients: S. Picozzi, C. Ricci, M. Gaeta, D. Ratti, A. Macchi, S. Casellato, G. Bozzini and L. Carmignani. J Urol 2012; 188: 2046-2054.
Q46410356Re: Ureteroenteric anastomotic strictures after radical cystectomy--does operative approach matter?: C. B. Anderson, T. M. Morgan, S. Kappa, D. Moore, P. E. Clark, R. Davis, D. F. Penson, D. A. Barocas, J. A. Smith, Jr., M. S. Cookson and S. S. Chan
Q91086942Re: Urinary Tract Infections following Radical Cystectomy and Urinary Diversion: A Review of 1133 Patients
Q88331425Re: Use of Adjuvant Chemotherapy in Radical Cystectomy Patients Aged >65 Years: A Population-Based Study from the Surveillance Epidemiology and End Results (SEER)-Medicare Database
Q89777397Re: Use of Indocyanine Green to Minimise Uretero-Enteric Strictures after Robotic Radical Cystectomy
Q89944686Re: Utility and Significance of Ureteric Frozen Section Analysis during Radical Cystectomy
Q101057842Re: Utility of Routine Preoperative 18F-Fluorodeoxyglucose Positron Emission Tomography/Computerized Tomography in Identifying Pathological Lymph Node Metastases at Radical Cystectomy
Q83213309Re: bladder preservation multimodality therapy as an alternative to radical cystectomy for treatment of muscle invasive bladder cancer
Q46440068Re: does partial cystectomy compromise oncologic outcomes for patients with bladder cancer compared to radical cystectomy? A matched case-control analysis
Q45148808Re: effect of a minimum lymph node policy in radical cystectomy and pelvic lymphadenectomy on lymph node yields, lymph node positivity rates, lymph node density, and survivorship in patients with bladder cancer
Q86554623Re: impact of statin use on oncologic outcomes in patients with urothelial carcinoma of the bladder treated with radical cystectomy: R. D. Da silva, e. Xylinas, L. Kluth, j. J. Crivelli, j. Chrystal, d. Chade, g. B. Guglielmetti, a. Pycha, y. Lotan,
Q54356244Re: incidence, risk factors, and complications of postoperative delirium in elderly patients undergoing radical cystectomy.
Q81634484Re: laparoscopic assisted radical cystectomy with ileal neobladder: a comparison with the open approach
Q33369466Re: lymph node density is superior to TNM nodal status in predicting disease-specific survival after radical cystectomy for bladder cancer: analysis of pooled data from MDACC and MSKCC.
Q46598773Re: orthotopic detaenial sigmoid neobladder after radical cystectomy: technical considerations, complications and functional outcomes: K. Xu, C-X Liu, S-B. Zheng, H-L. Li, Y-W. Xu, A-B. Xu, B-S. Chen and H-Y. Shen J Urol 2013; 190: 928–934.
Q73477354Re: orthotopic urinary diversion with preservation of erectile and ejaculatory function in men requiring radical cystectomy for nonurothelial malignancy: a new technique
Q93929960Re: orthotopic urinary diversion with preservation of erectile and ejaculatory function in men requiring radical cystectomy for nonurothelial malignancy: a new technique
Q50880699Re: outcomes of artificial urinary sphincter placement in men after radical cystectomy and orthotopic urinary diversions for the treatment of stress urinary incontinence: the University of Southern California experience.
Q86548598Re: outcomes of laparoscopic and robotic radical cystectomy in the elderly patients
Q77493823Re: pelvic lymph node metastases from bladder cancer: outcome in 83 patients after radical cystectomy and pelvic lymphadenectomy
Q45025917Re: perioperative outcomes and oncologic efficacy from a pilot prospective randomized clinical trial of open versus robotic assisted radical cystectomy: D. J. Parekh, J. Messer, J. Fitzgerald. B. Ercole and R. Svatek J Urol 2013; 189: 474-479.
Q80548339Re: radical cystectomy after bacillus Calmette-Guérin for high-risk Ta, T1 and carcinoma in situ: defining the risk of initial bladder preservation
Q85891200Re: radical cystectomy over the age of 75 is safe and increases survival
Q80874731Re: results from three municipal hospitals regarding radical cystectomy on elderly patients
Q85674193Re: robotic-assisted radical cystectomy with extracorporeal urinary diversion for urothelial carcinoma of the bladder: analysis of complications and oncologic outcomes in 175 patients with a median follow-up of 3 years
Q80066490Re: superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy
Q83213314Re: surgery-related complications of robot-assisted radical cystectomy with intracorporeal urinary diversion
Q46043466Readmission Following Radical Cystectomy: A Ray of Light in the "Black Box"?
Q40070821Readmission Rate and Causes at 90-Day after Radical Cystectomy in Patients on Early Recovery after Surgery Protocol
Q35606282Readmission after robot-assisted radical cystectomy: outcomes and predictors at 90-day follow-up
Q64078508Real-time indocyanine green angiography with the SPY fluorescence imaging platform decreases benign ureteroenteric strictures in urinary diversions performed during radical cystectomy
Q58577856Real-world Impact of Minimally Invasive Versus Open Radical Cystectomy on Perioperative Outcomes and Spending
Q92590307Reasons why not all Danish patients with muscle invasive bladder cancer receive neoadjuvant chemotherapy before radical cystectomy
Q90596570Receipt of 5-Alpha Reductase Inhibitors Before Radical Cystectomy: Do They Render High-Grade Bladder Tumors Less Aggressive?
Q37822392Recent advances in robot-assisted radical cystectomy
Q51093644Reconstructed urinary bladder following radical cystectomy for bladder cancer. Multidetector CT evaluation of normal findings and complications.
Q73328602Reconstruction of the urinary tract after radical cystectomy: the case for continent urinary diversion
Q46357687Recoverability of erectile function in post-radical cystectomy patients: subjective and objective evaluations
Q90946686Recovery from Anesthesia after Robotic-Assisted Radical Cystectomy: Two Different Reversals of Neuromuscular Blockade
Q41837132Recurrence of inflammatory myofibroblastic tumor in bladder secondary to prostate treated with laparoscopic radical cystectomy
Q36505102Recurrence patterns after open and robot-assisted radical cystectomy for bladder cancer.
Q84797637Recurrence patterns of bladder transitional cell carcinoma after radical cystectomy
Q80404934Recurrence-free survival after radical cystectomy of patients downstaged by transurethral resection
Q91646335Recurrent Anterior Vaginal Wall Hernia after a Radical Cystectomy
Q38913953Redefining the implications of nasogastric tube placement following radical cystectomy in the alvimopan era.
Q41457027Reduced length of stay in radical cystectomy patients with oral versus parenteral post-operative nutrition protocol
Q47567960Reducing Overutilization of Preoperative Medical Referrals among Patients Undergoing Radical Cystectomy Using an Evidence-Based Algorithm
Q91766578Reducing Readmissions following Radical Cystectomy: Moving Beyond Enhanced Recovery
Q86821420Reducing readmissions and mortality after radical cystectomy
Q35556030Reducing time to oral diet and hospital discharge in patients undergoing radical cystectomy using a perioperative care plan
Q30408866Refining patient selection for neoadjuvant chemotherapy before radical cystectomy
Q94940583Reframing financial incentives around reducing readmission after radical cystectomy
Q37342899Regional differences in practice patterns and outcomes in patients treated with radical cystectomy in a universal healthcare system
Q35056471Regional lymph node status in patients with bladder cancer found to be pathological stage T0 at radical cystectomy following systemic chemotherapy
Q84220476Regional lymph node status in patients with bladder cancer found to be pathological stage T0 at radical cystectomy following systemic chemotherapy
Q40241451Regionalization of radical cystectomy in the United States
Q53152401Relationship of the number of removed lymph nodes to bladder cancer and competing mortality after radical cystectomy.
Q99233208Relentlessly make yourself obsolete: Robot-assisted radical cystectomy, the emerging standard of care
Q79707639Reliability of frozen section examination of external iliac, hypogastric, and obturator lymph nodes during radical cystectomy: a multicenter study
Q84570708Reliability of frozen section examination of obturator lymph nodes and impact on lymph node dissection borders during radical cystectomy: results of a prospective multicentre study by the Turkish Society of Urooncology
Q100504452Renal function outcomes in the early and intermediate phases after radical cystectomy by ileal conduit
Q40146286Renal outcome after radical cystectomy and urinary diversion performed with restrictive hydration and vasopressor administration in the frame of an enhanced recovery program: A follow-up study of a randomized clinical trial
Q40341466Reoperations following Robot-Assisted Radical Cystectomy: A Decade of Experience
Q62626323Reply from Authors re: Bernard H. Bochner. Oncologic Outcomes Achieved by Radical Cystectomy. Eur Urol 2013;64:225–6
Q88215052Reply from Authors re: Girish S. Kulkarni, Zachary Klaassen. Trimodal Therapy is Inferior to Radical Cystectomy for Muscle-invasive Bladder Cancer using Population-level Data: Is There Evidence in the (Lack of) Details? Eur Urol 2017;72:488-9: Using
Q51241301Reply from authors re: Manfred P. Wirth, Johannes Huber. What really matters is rarely measured: outcome of routine care and patient-reported outcomes. Eur Urol 2013;64:58-9: robot-assisted versus open radical cystectomy: beating a dead horse.
Q85622314Reply to Farshad Pourmalek, Hamidreza Abdi, and Peter C. Black's Letter to the Editor re: Daniel P. Nguyen, Bashir Al Hussein Al Awamlh, Xian Wu, et al. Recurrence Patterns After Open and Robot-assisted Radical Cystectomy for Bladder Cancer. Eur Uro
Q57296883Reply to Francesco Montorsi and Giorgio Gandaglia's Letter to the Editor re: Georg Jancke, Firas Aljabery, Sigurdur Gudjonsson, et al. Port-site Metastases After Robot-assisted Radical Cystectomy: Is There a Publication Bias? Eur Urol 2018;73:641-2
Q97642060Reply to Francesco Montorsi, Marco Bandini, Alberto Briganti, et al. Re-establishing the Role of Robot-assisted Radical Cystectomy After the 2020 EAU Muscle-invasive and Metastatic Bladder Cancer Guideline Panel Recommendations. Eur Urol. In press:
Q94587653Reply to Francesco Montorsi, Marco Bandini, and Andrea Necchi's Letter to the Editor re: Malte W. Vetterlein, Jakob Klemm, Philipp Gild, et al. Improving Estimates of Perioperative Morbidity After Radical Cystectomy Using the European Association of
Q98664340Reply to Gianluca Giannarini, Vincenzo Ficarra, and Claudio Valotto's Letter to the Editor re: Stephen B. Williams, Marcus G.K. Cumberbatch, Ashish M. Kamat, et al. Reporting Radical Cystectomy Outcomes Following Implementation of Enhanced Recovery
Q90677173Reply to Liang Sun and Yi Feng's Letter to the Editor re: Malte W. Vetterlein, Jakob Klemm, Philipp Gild, et al. Improving Estimates of Perioperative Morbidity After Radical Cystectomy Using the European Association of Urology Quality Criteria for S
Q88983390Reply to Mark C. Kendall's Letter to the Editor re: Karl H. Pang, Ruth Groves, Suresh Venugopal, Aidan P. Noon, James W.F. Catto. Prospective Implementation of Enhanced Recovery After Surgery Protocols to Radical Cystectomy. Eur Urol 2018;73:363-71
Q86120921Reply to Michael A. Gorin, Arthur I. Sagalowsky and Mark S. Soloway's Letter to the Editor re: S. Picozzi, C. Ricci, M. Gaeta et al. Upper urinary tract recurrence following radical cystectomy for bladder cancer: a meta-analysis on 13,185 patients.
Q45839588Reply to Samuel Bishara and Jim Adshead's letter to the editor re: Brian J. Linder, Igor Frank, John C. Cheville, et al. The impact of perioperative blood transfusion on cancer recurrence and survival following radical cystectomy. Eur Urol 2013;63:8
Q85751063Reply to Santosh Kumar and Aditya Prakash Sharma's letter to the editor re: Cheryl T. Lee, Sam S. Chang, Ashish M. Kamat, et al. Alvimopan accelerates gastrointestinal recovery after radical cystectomy: a multicenter randomized placebo-controlled tr
Q91768801Reply to Satoru Taguchi, Tohru Nakagawa, and Hiroshi Fukuhara's Letter to the Editor re: Jürgen E. Gschwend, Matthias M. Heck, Jan Lehmann, et al. Extended Versus Limited Lymph Node Dissection in Bladder Cancer Patients Undergoing Radical Cystectomy
Q91321972Reply to Siebren Dijkstra and Carl J. Wijburg's Letter to the Editor re: Bernard H. Bochner, Guido Dalbagni, Karim H. Marzouk, et al. Randomized Trial Comparing Open Radical Cystectomy and Robot-assisted Laparoscopic Radical Cystectomy: Oncologic Ou
Q87405119Reply to Vladimir Novotny, Manfred P. Wirth, Michael Froehner's letter to the editor re: Atiqullah Aziz, Matthias May, Maximilian Burger, et al. PROMETRICS 2011 research group. Prediction of 90-day mortality after radical cystectomy for bladder canc
Q87416749Reply to external validation of a model to predict local failure after radical cystectomy
Q99254540Reply to the Letter to the Editor: Acute Kidney Injury Following Enhanced Recovery After Surgery in Patients Undergoing Radical Cystectomy
Q91516887Reported rates of clostridium difficile following radical cystectomy in national datasets compared to individual institutions
Q36080543Reporting Bias Leading to Discordant Venous Thromboembolism Rates in the United States Versus Non-US Countries Following Radical Cystectomy: A Systematic Review and Meta-analysis
Q97093026Reporting Radical Cystectomy Outcomes Following Implementation of Enhanced Recovery After Surgery Protocols: A Systematic Review and Individual Patient Data Meta-analysis
Q46214248Reproductive organ involvement in female patients undergoing radical cystectomy for urothelial bladder cancer
Q90264598Requiem for Open Radical Cystectomy in Bladder Cancer Patients
Q84067812Residual pathological stage at radical cystectomy significantly impacts outcomes for initial T2N0 bladder cancer
Q42117852Resolution of hypercalcemia of malignancy following radical cystectomy in a patient with paraneoplastic syndrome associated with urothelial carcinoma of the bladder
Q85939914Response letter to "What can be more prognostic than the pTNM category assessed in radical cystectomy samples?" by Sükösd F, Ivanyi B and Pajor L
Q46468853Response to Editorial Comment to Health-related quality of life after radical cystectomy and neobladder reconstruction in women: impact of voiding and continence status.
Q88180013Response to Re: Incidence and risk factors for acute kidney injury after radical cystectomy
Q89930581Response to Re: Role of routine computed tomography scan in the oncological follow up of patients treated by radical cystectomy for bladder cancer
Q43283539Response to adjuvant chemotherapy after radical cystectomy in patients with infiltrative bladder: Analysis of 397 cases
Q87222107Response to article - Mohanty NK, Kumar A, Vasudeva P, Jain M, Prakash S, Arora RP. Analysis of the perioperative and five-year oncological outcome of two hundred cases of open radical cystectomy: A single center experience. Indian J Cancer 2012;49
Q47987489Restrictive deferred hydration combined with preemptive norepinephrine infusion during radical cystectomy reduces postoperative complications and hospitalization time: a randomized clinical trial
Q39286593Restrictive transfusion in radical cystectomy is safe
Q52920923Results from three municipal hospitals regarding radical cystectomy on elderly patients.
Q68175047Results of contemporary radical cystectomy for invasive bladder cancer: a clinicopathological study with an emphasis on the inadequacy of the tumor, nodes and metastases classification
Q71613004Results of radical cystectomy and pelvic lymphadenectomy for bladder cancer with pelvic node metastases
Q43468531Results of radical cystectomy for primary bladder cancer. Retrospective study of more than 200 cases
Q72313742Results of radical cystectomy for transitional cell carcinoma of the bladder and the effect of chemotherapy
Q95812238Results with radical cystectomy for treating bladder cancer: a 'reference standard' for high-grade, invasive bladder cancer
Q54301197Rethinking Radical Cystectomy as the Best Choice for Most Patients With Muscle-Invasive Bladder Cancer.
Q97093358Rethinking the one-size-fits-most approach to venous thromboembolism prophylaxis after radical cystectomy
Q92683183Retraction notice to "Modified U-shaped ileal neobladder after radical cystectomy: assessment of functional outcomes and complications in Chinese patients"
Q83437853Retraction to: "Outcome of anterior vaginal wall sparing during female radical cystectomy with orthotopic urinary diversion." [ European Journal of Surgical Oncology 34 (2008) 115-121]
Q41302704Retro-ureteral Small Bowel Herniation After Radical Cystectomy
Q43213489Retrograde radical cystectomy and consequent peritoneal cavity reconstruction benefits localized male bladder cancer: results from a cohort study
Q57113884Retroperitoneal hernia following radical cystectomy: case report
Q90849438Retrosigmoid Versus Traditional Ileal Conduit for Urinary Diversion After Radical Cystectomy
Q43988678Retrospective analysis of 246 patients after radical cystectomy for treatment of bladder cancer without preoperative radiotherapy
Q38833958Retrospective analysis of a surgical innovation using the IDEAL framework: radical cystectomy with epidural anaesthesia
Q53101669Retrospective analysis of the efficacy of two cycles of M-VAC neoadjuvant chemotherapy followed by radical cystectomy for muscle-invasive bladder cancer.
Q34551328Retrospective review and long-term follow-up of radical cystectomy in a developing country
Q39812629Risk Factors and Microbial Distribution of Urinary Tract Infections Following Radical Cystectomy
Q36069231Risk Factors for Developing Metabolic Acidosis after Radical Cystectomy and Ileal Neobladder
Q98733933Risk Factors for Urethral Recurrence in Men After Radical Cystectomy with Orthotopic Urinary Diversion for Urothelial Carcinoma: A Retrospective Cohort Study
Q39739690Risk assessment for occult malignancy in the prostate before radical cystectomy
Q92137751Risk factors and oncological outcomes of urethral recurrence in male patients with muscle invasive bladder cancer after radical cystectomy combined with urinary diversion: a propensity score-matched case control study
Q101117279Risk factors and outcomes of myocardial injury after non-cardiac surgery in high-risk patients who underwent radical cystectomy
Q84838427Risk factors and outcomes of urethral recurrence following radical cystectomy
Q91421670Risk factors and reasons for reoperation after radical cystectomy
Q40537604Risk factors and timing of venous thromboembolism after radical cystectomy in routine clinical practice: a population-based study
Q82536968Risk factors for disconcordance between pre and post radical cystectomy stages
Q36914875Risk factors for infectious readmissions following radical cystectomy: results from a prospective multicenter dataset
Q57175147Risk factors for loco-regional recurrence after radical cystectomy of muscle-invasive bladder cancer: A systematic-review and framework for adjuvant radiotherapy
Q43693664Risk factors for mortality and morbidity related to radical cystectomy
Q40582570Risk factors for patients with pelvic lymph node metastases following radical cystectomy with en bloc pelvic lymphadenectomy: concept of lymph node density
Q37770477Risk factors for recurrence following radical cystectomy for pathologic node negative bladder cancer.
Q43485665Risk factors for surgical site infection in radical cystectomy: efficacy of buried suture by absorbable thread for skin closure
Q34143388Risk factors for the development of parastomal hernia after radical cystectomy.
Q41473578Risk factors for the development of postoperative paralytic ileus after radical cystectomy: a report of 740 cases
Q92262374Risk factors of calculi in upper urinary tract after radical cystectomy with urinary diversion
Q53840977Risk factors of hospital readmission after radical cystectomy and urinary diversion: analysis of a large contemporary series.
Q36600514Risk factors of postoperative complications after radical cystectomy with continent or conduit urinary diversion in Armenia.
Q90425946Risk factors of postoperative major adverse cardiac events after radical cystectomy: implication of diastolic dysfunction
Q74511712Risk factors of urethral involvement of bladder cancer after radical cystectomy with orthotopic neobladder in females
Q49200956Risk factors, follow-up, and treatment of urethral recurrence following radical cystectomy and urinary diversion for bladder cancer: a meta-analysis of 9498 patients
Q41049731Risk for Clostridium difficile infection after radical cystectomy for bladder cancer: Analysis of a contemporary series
Q36575727Risk groups in bladder cancer patients treated with radical cystectomy
Q81170454Risk groups in patients with bladder cancer treated with radical cystectomy: statistical and clinical model improving homogeneity
Q57806040Risk of Ovarian Malignancy in Patients Undergoing Radical Cystectomy for Bladder Cancer
Q52373193Risk of Readmission After Uncomplicated Hospitalization After Radical Cystectomy.
Q53379340Risk of end stage kidney disease after radical cystectomy according to urinary diversion type.
Q34260524Risk of fracture after radical cystectomy and urinary diversion for bladder cancer
Q37604328Risk of in-hospital complications after radical cystectomy for urinary bladder carcinoma: population-based follow-up study of 7608 patients
Q71278134Risk of local urethral recurrence after radical cystectomy for bladder cancer
Q41467216Risk of urethral, vaginal and cervical involvement in patients undergoing radical cystectomy for bladder cancer: results of a contemporary cystectomy series from M. D. Anderson Cancer Center
Q87409228Risk prediction models of locoregional failure after radical cystectomy for urothelial carcinoma: external validation in a cohort of korean patients
Q41462223Risk stratification for locoregional recurrence after radical cystectomy for urothelial carcinoma of the bladder
Q83001143Risk stratification of organ confined bladder cancer after radical cystectomy using cell cycle related biomarkers
Q36419132Risk stratification of pT1-3N0 patients after radical cystectomy for adjuvant chemotherapy counselling
Q84904080Risk stratification of survival by lymphovascular invasion, pathological stage, and surgical margin in patients with bladder cancer treated with radical cystectomy
Q42371550Risk-stratified surveillance and cost effectiveness of follow-up after radical cystectomy in patients with muscle-invasive bladder cancer
Q47993535Risks and benefits of pelvic lymphadenectomy in octogenarians undergoing radical cystectomy due to urothelial carcinoma of the bladder.
Q42681722Robot Assisted Extended Pelvic Lymphadenectomy at Radical Cystectomy: Lymph Node Yield Compared With Second Look Open Dissection
Q102381356Robot Assisted Radical Cystectomy Outcomes in Micropapillary and Plasmacytoid Variants
Q90129682Robot Assisted Radical Cystectomy vs Open Radical Cystectomy: Over 10 years of the Mayo Clinic Experience
Q37720922Robot assisted laparoscopic pelvic lymphadenectomy at the time of radical cystectomy rivals that of open surgery: single institution report.
Q56515977Robot assisted radical cystectomy versus open radical cystectomy in bladder cancer (RACE): study protocol of a non-randomized comparative effectiveness study
Q47434693Robot assisted radical cystectomy with totally intracorporeal urinary diversion: initial, single-surgeon's experience after a modified modular training
Q89836209Robot-Assisted Radical Cystectomy With Orthotopic Neobladder as a Urinary Diversion for a Kidney Transplant Recipient: A Case Report
Q39969196Robot-Assisted Radical Cystectomy for Bladder Cancer in Octogenarians
Q88724797Robot-Assisted Radical Cystectomy in Men: Technique of Spaces
Q56200815Robot-Assisted Radical Cystectomy in the Management of Bladder Cancer
Q100994583Robot-Assisted Radical Cystectomy with Intracorporeal Ileal Conduit in a Patient with Situs Inversus Totalis
Q91629955Robot-Assisted Radical Cystectomy with Intracorporeal Orthotopic Ileal Neobladder: A Safe Strategy in Elderly Patients? Results of Propensity Score Matching in a Single High-Volume Center
Q53169212Robot-Assisted Radical Cystectomy with Total Intracorporeal Urinary Diversion: Comparative Analysis with Extracorporeal Urinary Diversion.
Q92322043Robot-assisted Laparoscopic Radical Cystectomy and Sigmoid Orthotopic Neobladder Reconstruction for a Bladder Rhabdomyosarcoma Child: Case Report and Literature Review
Q91661391Robot-assisted Radical Cystectomy Versus Open Radical Cystectomy: A Meta-analysis of Oncologic, Perioperative, and Complication-related outcomes
Q38654974Robot-assisted Versus Open Radical Cystectomy in Patients Receiving Perioperative Chemotherapy for Muscle-invasive Bladder Cancer: The Oncologist's Perspective from a Multicentre Study.
Q94664641Robot-assisted intracorporeal orthotopic bladder substitution after radical cystectomy: perioperative morbidity and oncological outcomes - a single institution experience
Q47219662Robot-assisted laparoscopic radical cystectomy is a safe and effective procedure for patients with bladder cancer compared to laparoscopic and open surgery: Perioperative outcomes of a single-center experience
Q53021942Robot-assisted laparoscopic radical cystectomy with complete intracorporeal urinary diversion.
Q52564790Robot-assisted laparoscopic radical cystectomy with extracorporeal urinary diversion: Initial experience and outcomes.
Q34585914Robot-assisted laparoscopic radical cystectomy: initial experience on 27 consecutive patients.
Q42606731Robot-assisted laparoscopic vs open radical cystectomy: comparison of complications and perioperative oncological outcomes in 200 patients
Q43849212Robot-assisted nerve-sparing radical cystectomy with bilateral extended pelvic lymph node dissection (PLND) and intracorporeal urinary diversion for bladder cancer: initial experience in 27 cases
Q38574487Robot-assisted radical cystectomy
Q47332507Robot-assisted radical cystectomy
Q42619214Robot-assisted radical cystectomy (RARC) with intracorporeal neobladder - what is the effect of the learning curve on outcomes?
Q55019389Robot-assisted radical cystectomy - first Polish clinical outcomes.
Q35078670Robot-assisted radical cystectomy and intracorporeal neobladder formation: on the way to a standardized procedure
Q92587654Robot-assisted radical cystectomy and intracorporeal orthotopic neobladder: 1-year functional outcomes
Q35533840Robot-assisted radical cystectomy and intracorporeal urinary diversion - safe and reproducible?
Q42675199Robot-assisted radical cystectomy and pelvic lymph node dissection: a multi-institutional study from Korea.
Q42615500Robot-assisted radical cystectomy and pelvic lymph node dissection: initial experience at Roswell Park Cancer Institute
Q36046114Robot-assisted radical cystectomy and urinary diversion
Q40528398Robot-assisted radical cystectomy and urinary diversion in female patients: technique with preservation of the uterus and vagina
Q38321027Robot-assisted radical cystectomy and urinary diversion: technical recommendations from the Pasadena Consensus Panel.
Q99726192Robot-assisted radical cystectomy for non-metastatic urothelial carcinoma of urinary bladder: a comparison between intracorporeal versus extracorporeal orthotopic ileal neobladder
Q98191278Robot-assisted radical cystectomy in a patient with muscle-invasive bladder cancer following radiotherapy for prostate cancer
Q38145512Robot-assisted radical cystectomy in octogenarians
Q51910797Robot-assisted radical cystectomy in the management of bladder cancer.
Q37140925Robot-assisted radical cystectomy in women: technique and initial experience
Q40081077Robot-assisted radical cystectomy is a promising alternative to open surgery in the Japanese population with a high rate of octogenarians
Q53620801Robot-assisted radical cystectomy using a side-docking technique.
Q56355790Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trial
Q37814637Robot-assisted radical cystectomy versus open radical cystectomy: a complete cost analysis
Q42641091Robot-assisted radical cystectomy versus open radical cystectomy: assessment of postoperative pain.
Q33995446Robot-assisted radical cystectomy with intracorporeal neobladder diversion: The Karolinska experience
Q100441375Robot-assisted radical cystectomy with intracorporeal neobladder: impact of learning curve and long-term assessment of functional outcomes
Q91117162Robot-assisted radical cystectomy with intracorporeal urinary diversion - The new 'gold standard'? Evidence from a systematic review
Q94957457Robot-assisted radical cystectomy with intracorporeal urinary diversion decreases postoperative complications only in highly comorbid patients: findings that rely on a standardized methodology recommended by the European Association of Urology Guide
Q51424718Robot-assisted radical cystectomy with intracorporeal urinary diversion in patients with transitional cell carcinoma of the bladder.
Q56516396Robot-assisted radical cystectomy with intracorporeal urinary diversion versus open radical cystectomy (iROC): protocol for a randomised controlled trial with internal feasibility study
Q40974706Robot-assisted radical cystectomy with intracorporeal urinary diversion: impact on an established enhanced recovery protocol
Q92261010Robot-assisted radical cystectomy with totally intracorporeal urinary diversion: surgical and early functional outcomes through the learning curve in a single high-volume center
Q92936653Robot-assisted radical cystectomy: Review of surgical technique, and perioperative, oncological and functional outcomes
Q37703837Robot-assisted radical cystectomy: an expert panel review of the current status and future direction
Q45360321Robot-assisted radical cystectomy: description of an evolved approach to radical cystectomy.
Q46986868Robot-assisted radical cystectomy: extracorporeal vs intracorporeal urinary diversion
Q42639213Robot-assisted radical cystectomy: intermediate survival results at a mean follow-up of 25 months
Q91273768Robot-assisted radical cystectomy: patient selection and special considerations
Q37675823Robot-assisted radical cystectomy: recent advances and review of the literature
Q36184429Robotic Assisted Radical Cystectomy with Extracorporeal Urinary Diversion Does Not Show a Benefit over Open Radical Cystectomy: A Systematic Review and Meta-Analysis of Randomised Controlled Trials
Q103834156Robotic Radical Cystectomy Outcomes after Intervention for Prostate Cancer
Q102219066Robotic Radical Cystectomy in the Contemporary Management of Bladder Cancer
Q92155449Robotic Radical Cystectomy with Intracorporeal Studer Pouch Formation for Bladder Cancer: Experience in Ninety-Eight Cases
Q48059548Robotic and conventional open radical cystectomy lead to similar postoperative health-related quality of life
Q42622597Robotic and laparoscopic high extended pelvic lymph node dissection during radical cystectomy: technique and outcomes
Q51165953Robotic and laparoscopic radical cystectomy for bladder cancer: long-term oncologic outcomes.
Q33396587Robotic and laparoscopic radical cystectomy in the management of bladder cancer
Q50960510Robotic assisted laparoscopic radical cystectomy with stentless intracorporeal modified Ves.Pa neobladder: early experience.
Q51354888Robotic assisted radical cystectomy and urinary diversion.
Q89639824Robotic assisted radical cystectomy: insights on long term oncological outcomes from the International Robotic Cystectomy Consortium
Q38029495Robotic assisted radical cystectomy: oncological safety.
Q51856416Robotic assisted radical cystectomy: short to medium-term oncologic and functional outcomes.
Q42671810Robotic intracorporeal orthotopic neobladder during radical cystectomy in 132 patients
Q45937288Robotic laparoscopic radical cystectomy inhalational versus total intravenous anesthesia: a pilot study.
Q38226919Robotic or open radical cystectomy, which is safer? A systematic review and meta-analysis of comparative studies.
Q33290630Robotic radical cystectomy
Q92840598Robotic radical cystectomy
Q53756053Robotic radical cystectomy - revision and resection: An evolution in operative technique and platforms.
Q50684312Robotic radical cystectomy and enhanced recovery: a new pathway.
Q33995439Robotic radical cystectomy and intracorporeal urinary diversion: The USC technique
Q34357563Robotic radical cystectomy and urinary diversion in the management of bladder cancer.
Q51786277Robotic radical cystectomy for bladder cancer.
Q51598049Robotic radical cystectomy for bladder cancer: surgical and pathological outcomes in 100 consecutive cases.
Q55427608Robotic radical cystectomy for the management of bladder cancer: Analysis of operative and pathological outcomes of eighteen patient.
Q41113235Robotic radical cystectomy with intracorporeal neobladder: Initial experience and outcomes
Q46218333Robotic radical cystectomy with intracorporeal neobladder: ready for prime time?
Q95262016Robotic radical cystectomy with intracorporeal urinary diversion: beyond the initial experience
Q46692973Robotic radical cystectomy--is the diversion the Achilles' heel?
Q56928487Robotic radical cystectomy: Medium-term oncologic follow-up
Q47826370Robotic radical cystectomy: intracorporeal versus extracorporeal versus orthotopic neobladder-Which is better?
Q46002326Robotic radical cystectomy: so far, so good--what next?
Q87004663Robotic radical cystectomy: technical tips and tricks
Q51631256Robotic radical cystectomy: where are we today, where will we be tomorrow?
Q24186826Robotic versus open radical cystectomy for bladder cancer in adults
Q91915467Robotic versus open radical cystectomy for bladder cancer in adults
Q67404550Robotic versus open radical cystectomy for bladder cancer in adults.
Q91264184Robotic versus open radical cystectomy throughout the learning phase: insights from a real-life multicenter study
Q27014781Robotic versus open radical cystectomy: an updated systematic review and meta-analysis
Q42658635Robotic versus open radical cystectomy: identification of patients who benefit from the robotic approach
Q42648156Robotic versus open radical cystectomy: prospective comparison of perioperative and pathologic outcomes in Japan
Q34691842Robotic vs open radical cystectomy: prospective comparison of perioperative outcomes and pathological measures of early oncological efficacy.
Q35157819Robotic vs. open radical cystectomy in bladder cancer: A systematic review and meta-analysis
Q26782249Robotic-Assisted Radical Cystectomy
Q51833362Robotic-assisted laparoscopic radical cystectomy and intra-abdominal formation of an orthotopic ileal neobladder.
Q47572626Robotic-assisted laparoscopic radical cystectomy in the octogenarian
Q51888164Robotic-assisted laparoscopic radical cystectomy with extracorporeal urinary diversion: initial experience.
Q38091333Robotic-assisted laparoscopic radical cystectomy: history, techniques and outcomes
Q51327471Robotic-assisted laparoscopic radical cystectomy: surgical and oncological outcomes.
Q51852836Robotic-assisted laparoscopic radical cystectomy: where do we stand?
Q37252123Robotic-assisted radical cystectomy
Q51683099Robotic-assisted radical cystectomy and orthotopic ileal neobladder using a modified Pfannenstiel incision.
Q38666683Robotic-assisted radical cystectomy versus open radical cystectomy for management of bladder cancer: review of literature and randomized trials
Q57471720Robotic-assisted radical cystectomy vs open radical cystectomy: systematic review and meta-analysis
Q44893721Robotic-assisted radical cystectomy with extracorporeal urinary diversion for urothelial carcinoma of the bladder: analysis of complications and oncologic outcomes in 175 patients with a median follow-up of 3 years
Q47743164Robotic-assisted radical cystectomy with intracorporeal urinary diversion versus open: early Australian experience.
Q99553026Robotic-assisted radical cystectomy with intracorporeal urinary diversion: A new standard of urinary diversion?
Q38030591Robotic-assisted radical cystectomy: current technique and outcomes
Q89460162Robotic-assisted radical cystectomy: the first multicentric Brazilian experience
Q48192956Robotic-assisted versus open radical cystectomy in bladder cancer: A meta-analysis of four randomized controlled trails.
Q51889307Robotically assisted radical cystectomy.
Q37983515Role and extent of lymphadenectomy during radical cystectomy for invasive bladder cancer
Q49420756Role of Radical Cystectomy in Non-Organ Confined Bladder Cancer: A Systematic Review
Q64235301Role of adjuvant cisplatin-based chemotherapy following radical cystectomy in locally advanced muscle-invasive bladder cancer: Systematic review and meta-analysis of randomized trials
Q88557874Role of bowel suspension technique to prevent early intestinal obstruction after radical cystectomy with ileal orthotopic neobladder: A retrospective cohort study
Q38059257Role of immediate radical cystectomy in the treatment of patients with residual T1 bladder cancer on restaging transurethral resection
Q44472637Role of lymph node density in predicting survival of patients with lymph node metastases after radical cystectomy: a multi-institutional study
Q96606523Role of lymph node dissection in radical cystectomy
Q87904051Role of routine computed tomography scan in the oncological follow up of patients treated by radical cystectomy for bladder cancer
Q86177739Role of ultrasound in management of long-term complications after to radical cystectomy and orthotopic neobladder construction: case report
Q40336022Root Causes and Modifiability of 30-Day Hospital Readmissions after Radical Cystectomy for Bladder Cancer.
Q74471151Rotundovaginopexy in orthotopic ileal neobladder following radical cystectomy in women
Q103035641Round ligament suspending treatment in orthotopic ileal-neobladder after radical cystectomy in women: A single centre prospective randomized trial
Q44784583Routine postoperative intensive care monitoring is not necessary after radical cystectomy
Q73589208Routine stentograms are not necessary before stent removal following radical cystectomy
Q46026810Routine use of nasogastric tubes after radical cystectomy.
Q104482334Rural Medicare patients less likely to undergo penile prosthesis implantation following radical cystectomy
Q33909943STOP smoking and alcohol drinking before OPeration for bladder cancer (the STOP-OP study), perioperative smoking and alcohol cessation intervention in relation to radical cystectomy: study protocol for a randomised controlled trial
Q51826346Safety and Effectiveness of Robot-Assisted Versus Open Radical Cystectomy for Bladder Cancer: A Systematic Review and Meta-Analysis.
Q38107986Safety and feasibility of laparoscopic radical cystectomy for the treatment of bladder cancer
Q92026654Safety of decreasing ureteral stent duration following radical cystectomy
Q90783618Sanctuary Testicular Bladder Cancer Metastasis 10 Years After Radical Cystectomy and Adjuvant Chemotherapy
Q51434666Sarcopenia as a Novel Preoperative Prognostic Predictor for Survival in Patients with Bladder Cancer Undergoing Radical Cystectomy.
Q55343308Sarcopenia as a comorbidity-independent predictor of survival following radical cystectomy for bladder cancer.
Q44125461Sarcopenia as a predictor of complications and survival following radical cystectomy
Q60622176Sarcopenia in patients with bladder cancer undergoing radical cystectomy: Impact on cancer-specific and all-cause mortality
Q61454769Sarcopenia is a reliable predictor of outcomes following radical cystectomy for bladder cancer
Q57210275Sarcopenia predicts 90-day mortality and postoperative complications after radical cystectomy for bladder cancer
Q96342183Sarcopenia predicts prognosis of bladder cancer patients after radical cystectomy: A study based on the Chinese population
Q53081590Scoring system for prediction of lymph node metastasis in radical cystectomy cohort.
Q91060389Screening logs from a pilot randomized controlled trial of radical cystectomy versus chemoradiation therapy for muscle-invasive bladder cancer
Q80450581Secondary malignant involvement of gynecologic organs in radical cystectomy specimens in women: is it mandatory to remove these organs routinely?
Q55040059Selecting candidates for early discharge after radical cystectomy for bladder cancer.
Q88627400Selection Effects May Explain Smoking-related Outcome Differences After Radical Cystectomy
Q63984741Selection of patients and benefit of immediate radical cystectomy for non-muscle invasive bladder cancer
Q44648476Selection of the type of urinary diversion in conjunction with radical cystectomy
Q57823507Semi-competing risk model to predict perioperative and oncologic outcomes after radical cystectomy
Q35663298Sensitivity of initial biopsy or transurethral resection of bladder tumor(s) for detecting histological variants on radical cystectomy.
Q45106800Separated pyelocolocutaneous diversion after bilateral ureterectomy and radical cystectomy for transitional cell carcinoma
Q84551001Sequential resection of malignant ureteral margins at radical cystectomy: a critical assessment of the value of frozen section analysis
Q89861698Sex-Sparing Robot-Assisted Radical Cystectomy with Intracorporeal Padua Ileal Neobladder in Female: Surgical Technique, Perioperative, Oncologic and Functional Outcomes
Q68198885Sexual Function In Men After Radical Cystectomy With or Without Urethrectomy
Q45112722Sexual function after male radical cystectomy in a sexually active population
Q43516456Sexual rehabilitation and male radical cystectomy
Q44185472Sharpening the focus on causes and timing of readmission after radical cystectomy for bladder cancer
Q78834002Shockwave lithotripsy for urinary stones in patients with urinary diversion after radical cystectomy
Q97563637Short- and Long-Term Evaluation of Renal Function after Radical Cystectomy and Cutaneous Ureterostomy in High-Risk Patients
Q92668765Short- and long-term survival has improved after radical cystectomy for bladder cancer in Québec during the years 2000-2015
Q40301356Short-Form Charlson Comorbidity Index for Assessment of Perioperative Mortality After Radical Cystectomy
Q92089709Short-term Mortality Associated with Definitive Chemoradiotherapy Versus Radical Cystectomy for Muscle-invasive Bladder Cancer
Q44101567Short-term morbidity and mortality of Indiana pouch, ileal conduit, and neobladder urinary diversion following radical cystectomy.
Q43360024Short-term patient reported health-related quality of life (HRQL) outcomes after robot-assisted radical cystectomy (RARC).
Q48452611Short-term patient-reported quality of life after robot-assisted radical cystectomy using the Convalescence and Recovery Evaluation
Q34436028Short-term perioperative outcomes of patients treated with radical cystectomy for bladder cancer included in the National Surgical Quality Improvement Program (NSQIP) database
Q51862787Short-term quality-of-life assessed after robot-assisted radical cystectomy: a prospective analysis.
Q87866549Should We Use Adjuvant Chemotherapy for Muscle-Invasive Bladder Cancer After Radical Cystectomy?
Q52997167Should we Refrain from Performing Oophorectomy in Conjunction with Radical Cystectomy for Bladder Cancer?
Q92487456Should we spare neoadjuvant chemotherapy in low-risk muscle-invasive bladder cancer patients scheduled for radical cystectomy?
Q73635640Sigmoid neobladder in women after radical cystectomy
Q51120471Sigmoid orthotopic neobladder after radical cystectomy for bladder tumour: an Indian experience.
Q48141343Significance of a frozen section analysis of the ureteral margin in bladder cancer patients treated with radical cystectomy and neoadjuvant chemotherapy.
Q45359897Significance of anaerobic bacteria in postoperative infection after radical cystectomy and urinary diversion or reconstruction
Q79852480Significance of cancer involvement at the ureteral margin detected on routine frozen section analysis during radical cystectomy
Q84902422Significance of distal ureteral margin at radical cystectomy for urothelial carcinoma
Q36601038Significance of intraoperative ureteral evaluation at radical cystectomy for urothelial cancer
Q38252649Significance of perivesical lymph nodes in radical cystectomy for bladder cancer
Q88124559Significance of preoperative butyrylcholinesterase as an independent predictor of survival in patients with muscle-invasive bladder cancer treated with radical cystectomy
Q99204373Significance of prophylactic urethrectomy at the time of radical cystectomy for bladder cancer
Q79327199Significance of radical cystectomy for bladder cancer in patients over 80 years old
Q80215499Significance of the time period between diagnosis of muscle invasion and radical cystectomy with regard to the prognosis of transitional cell carcinoma of the urothelium in the bladder
Q52852837Similar treatment outcomes for radical cystectomy and radical radiotherapy in invasive bladder cancer treated at a United Kingdom specialist treatment center.
Q81669163Similar treatment outcomes for radical cystectomy and radical radiotherapy in invasive bladder cancer treated at a United Kingdom specialist treatment center: in regard to Kotwal et al. (Int J Radiat Oncol Biol Phys 2008;70:456-463)
Q51843225Simplified laparoscopic radical cystectomy with orthotopic ileal neobladder creation in a porcine model.
Q37839400Simplified technique for parastomal hernia repair after radical cystectomy and ileal conduit creation
Q38827749Simultaneous en-bloc robot-assisted radical cystectomy and nephro-ureterectomy: technique description, outcomes, and literature summary
Q73698933Simultaneous prepubic urethrectomy with radical cystectomy for transitional cell carcinoma of the bladder
Q34761127Simultaneous radical cystectomy and colorectal cancer resection for synchronous muscle invasive bladder cancer and cT3 colorectal cancer: Our initial experience in five patients
Q34195098Simultaneous robot assisted laparoscopic radical nephroureterectomy; genital tract and paravaginal nerve sparing radical cystectomy; superextended lymph node dissection and intracorporeal Studer pouch reconstruction for bladder cancer: Robotic hat-t
Q50989882Single Center Experience with Secondary Urinary Diversion after Initial Radical Cystectomy and Primary Urinary Diversion.
Q95262006Single port robotic radical cystectomy with intracorporeal urinary diversion: a case series and review
Q47230254Single stage pancreaticoduodenectomy (Whipple's procedure), radical cystectomy and bladder substitution with the urethral Kock reservoir. Case report
Q92011335Single-center experience of robot-assisted radical cystectomy (RARC) and extended pelvic lymph node dissection
Q92970693Single-port Robotic Intracorporeal Ileal Conduit Urinary Diversion During Radical Cystectomy Using the SP Surgical System: Step-by-step Technique
Q47433212Size and volume of metastatic and non-metastatic lymph nodes in pelvis and lower abdomen in patients with carcinoma of the bladder undergoing radical cystectomy
Q93098835Skeletal Muscle and Fat Mass Indexes Predict Discharge Disposition after Radical Cystectomy
Q89038183Small bowel obstruction due to internal hernia caused by the ureter after laparoscopic radical cystectomy and ileal conduit: A case report
Q47107056Smoking and alcohol cessation intervention in relation to radical cystectomy: a qualitative study of cancer patients' experiences
Q87417530Smoking and survival after radical cystectomy for bladder cancer
Q90875839Socioeconomic Status-Related Parameters as Predictors of Competing (Non-Bladder Cancer) Mortality after Radical Cystectomy
Q39328902Socioeconomic status is associated with urinary diversion utilization after radical cystectomy for bladder cancer
Q84072813Soft tissue surgical margin status is a powerful predictor of outcomes after radical cystectomy: a multicenter study of more than 4,400 patients
Q83569855Solitary skin metastasis adjacent to ureterocutaneostomy 4 years after radical cystectomy for bladder cancer
Q35756004Sources of variation in follow-up expenditure after radical cystectomy
Q35921559Sparing radical cystectomy - How much is enough?
Q88545804Speeding up recovery from radical cystectomy: how low can we go?
Q91219811Spillover Effects of the Hospital Readmissions Reduction Program on Radical Cystectomy Readmissions
Q100993328Spontaneous bladder rupture due to bladder carcinoma: A case report required emergency radical cystectomy
Q67758755Squamous carcinoma of the bladder: treatment by radical cystectomy
Q67722037Stage B () transitional cell carcinoma of bladder highly curable by radical cystectomy
Q64998827Stage pT0 after radical cystectomy: are all patients equal?
Q51552001Stage pT0 at radical cystectomy confers improved survival: an international study of 4,430 patients.
Q79907964Stage specific lymph node metastasis mapping in radical cystectomy specimens
Q45083997Stage-specific impact of extended versus standard pelvic lymph node dissection in radical cystectomy
Q59649538Stage-specific impact of pelvic lymph node dissection on survival in patients with non-metastatic bladder cancer treated with radical cystectomy
Q36606951Staged based directed surveillance of invasive bladder cancer following radical cystectomy: valuable and effective?
Q92114411Staging the Host: Personalizing Risk Assessment for Radical Cystectomy Patients
Q84797055Standard or extended lymphadenectomy in radical cystectomy: what metric of surgical quality for lymph node dissections matters in improving patient outcomes?
Q43686707Standardization of pelvic lymphadenectomy performed at radical cystectomy: can we establish a minimum number of lymph nodes that should be removed?
Q79907956Standardization of radical cystectomy and pelvic lymph node dissection for bladder cancer: a collaborative group report
Q80491711Standardization of radical cystectomy: time to count and be counted
Q34962483Standardized analysis of complications after robot-assisted radical cystectomy: Korea University Hospital experience
Q47567424Standardized analysis of frequency and severity of complications after robot-assisted radical cystectomy
Q46128940Standardized assessment of complications in a contemporary series of European patients undergoing radical cystectomy
Q40990493Stapled orthotopic ileal neobladder after radical cystectomy for bladder cancer: Functional results and complications over a 20-year period.
Q101478517Stapled versus robot-sewn ileo-ileal anastomosis during robot-assisted radical cystectomy: a review of outcomes in urinary bladder cancer patients
Q51414933Stapleless laparoscopic assisted radical cystectomy with ileal neobladder in a male and with ileal loop in a female: initial report from Brazil.
Q39408804Status of Robot-Assisted Radical Cystectomy (RARC) in 2012.
Q37692565Status of robot-assisted radical cystectomy.
Q92348716Step-by-step technique for single-port robot-assisted radical cystectomy and pelvic lymph nodes dissection using the da Vinci® SP™ surgical system
Q48263400Stomal varices: a cause for intermittent haematuria post-radical cystectomy
Q98181820Strangulated internal hernia beneath the obturator nerve after laparoscopic radical cystectomy with extended pelvic lymph node dissection
Q92487518Studying the impact of comorbidity on post radical cystectomy survival: have we come a full circle?
Q37003991Suboptimal use of neoadjuvant chemotherapy in radical cystectomy patients: A population-based study
Q74322493Subtotal radical cystectomy after radical prostatectomy: a source of pelvic recurrence of bladder cancer with life threatening bleeding
Q41233325Successful Treatment with Paclitaxel, Carboplatin, and Gemcitabine as Second-line Chemotherapy for Recurrent Urothelial Carcinoma of the Bladder with Glandular Differentiation After Radical Cystectomy: A Case Report
Q91944706Successful transitional cell carcinoma of bladder underwent laparoscopic radical cystectomy with orthotopic intracorporeal Y pouch neobladder using a 3D digital printing model for surgical post op pouch evaluation
Q41458011Summary of complications of ureteroileal conduit with radical cystectomy: review of 336 cases (by Jerry W. Sullivan, MD, Harry Grabstald, MD, and Willet F. Whitmore, Jr). 1980.
Q44818814Super extended versus extended pelvic lymph node dissection in patients undergoing radical cystectomy for bladder cancer: a comparative study
Q46448114Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy
Q91193427Superior efficacy of neoadjuvant chemotherapy and radical cystectomy in cT3-4aN0M0 compared to cT2N0M0 bladder cancer
Q57108355Superior functional outcome after radical cystectomy and orthotopic bladder substitution with restrictive intraoperative fluid management: a followup study of a randomized clinical trial
Q38012243Surgeon controlled robot-assisted laparoscopic radical cystectomy: current review of oncologic and functional outcomes
Q49076859Surgery illustrated--Surgical Atlas. Robotic radical cystectomy in the male.
Q36872303Surgery insight: advantages and disadvantages of laparoscopic radical cystectomy to treat invasive bladder cancer
Q44907736Surgery-related complications of robot-assisted radical cystectomy with intracorporeal urinary diversion
Q47549011Surgical Factors Associated With Male and Female Sexual Dysfunction After Radical Cystectomy: What Do We Know and How Can We Improve Outcomes?
Q57099466Surgical High-risk Patients With ASA ≥ 3 Undergoing Radical Cystectomy: Morbidity, Mortality, and Predictors for Major Complications in a High-volume Tertiary Center
Q101052588Surgical Outcomes of Transvaginal Neobladder-Vaginal Fistula Repair After Radical Cystectomy with Ileal Orthotopic Neobladder: A Case-Control Study
Q96644226Surgical Pathology Findings in Patients Who Have Undergone Radical Cystectomy/Cystoprostatectomy With Extended Versus Standard Lymph Node Dissection for Urothelial Carcinoma of the Bladder: A Contemporary Analysis
Q92476927Surgical Safety of Radical Cystectomy and Pelvic Lymph Node Dissection Following Neoadjuvant Pembrolizumab in Patients with Bladder Cancer: Prospective Assessment of Perioperative Outcomes from the PURE-01 Trial
Q38610919Surgical and pathological outcomes of robotic-assisted radical cystectomy for bladder cancer in the community setting
Q44788553Surgical apgar outcome score: perioperative risk assessment for radical cystectomy
Q91719984Surgical approach as a determinant factor of clinical outcome following radical cystectomy: Does Enhanced Recovery After Surgery (ERAS) level the playing field?
Q46046308Surgical atlas. Radical cystectomy
Q44284097Surgical caseload is an important determinant of continent urinary diversion rate at radical cystectomy: a population-based study
Q46658638Surgical complications following radical cystectomy and orthotopic neobladders in women.
Q46892902Surgical complications of radical cystectomy in a teaching hospital
Q88171821Surgical landscape of radical cystectomy for bladder cancer in France over the last 10 years
Q51697311Surgical margin status after robot assisted radical cystectomy: results from the International Robotic Cystectomy Consortium.
Q89943601Surgical outcomes and learning curve of totally intracorporeal ileal conduit urinary diversion following laparoscopic radical cystectomy at a single institution
Q92762780Surgical safety in radical cystectomy: the anesthetist's point of view-how to make a safe procedure safer
Q41548059Surgical site infections in patients who undergo radical cystectomy: Excess mortality, stay prolongation and hospital cost overruns
Q73688686Surgical treatment after radical cystectomy
Q49720931Surgical treatment for clinical node-positive bladder cancer patients treated with radical cystectomy without neoadjuvant chemotherapy
Q40582698Surgical waiting time for radical cystectomy: a New Zealand experience
Q83883699Surveillance guidelines based on recurrence patterns after radical cystectomy for bladder cancer: the Canadian Bladder Cancer Network experience
Q38002454Surveillance guidelines based on recurrence patterns after radical cystectomy for bladder cancer: the Canadian Bladder Cancer Network experience.
Q92752570Survival Benefit Persists With Delayed Initiation of Adjuvant Chemotherapy Following Radical Cystectomy for Locally Advanced Bladder Cancer
Q96682013Survival Outcomes of Patients with Pathologically Proven Positive Lymph Nodes at Time of Radical Cystectomy with or without Neoadjuvant Chemotherapy
Q40918085Survival after Radical Cystectomy for Bladder Cancer in Relation to Prior Non-Muscle Invasive Disease in Quebec
Q45109470Survival after bladder-preservation with brachytherapy versus radical cystectomy; a single institution experience
Q84152353Survival after pelvic lymphadenectomy and radical cystectomy in patients with lymph-node metastatic transitional-cell carcinoma of the bladder
Q98190665Survival after radical cystectomy for bladder cancer: Multicenter comparison between minimally invasive and open approaches
Q70710625Survival after radical cystectomy for invasive transitional cell carcinoma of bladder
Q59649540Survival after radical cystectomy of non-bilharzial squamous cell carcinoma vs urothelial carcinoma: a competing-risks analysis
Q104469059Survival after radical cystectomy: Progressive versus De novo muscle invasive bladder cancer
Q92778018Survival after radiotherapy versus radical cystectomy for primary muscle-invasive bladder cancer: A Swedish nationwide population-based cohort study
Q38710592Survival differences among patients with bladder cancer according to sex: Critical evaluation of radical cystectomy use and delay to treatment
Q37495636Survival impact of followup care after radical cystectomy for bladder cancer.
Q43861990Survival in patients treated with radical cystectomy for bladder carcinoma
Q52946719Survival rates after radical cystectomy according to tumor stage of bladder carcinoma at first presentation.
Q35921521Survival up to 5-15 years in young women following genital sparing radical cystectomy and neobladder: oncological outcome and quality of life. Single-surgeon and single-institution experience
Q38611346Symptom clusters and related factors in bladder cancer patients three months after radical cystectomy
Q100728146Systematic Review and Meta-Analysis of the Efficacy and Safety of Enhanced Recovery After Surgery vs. Conventional Recovery After Surgery on Perioperative Outcomes of Radical Cystectomy
Q90264529Systematic Review of Factors Associated with the Utilization of Radical Cystectomy for Bladder Cancer
Q38976435Systematic Review on the Fate of the Remnant Urothelium after Radical Cystectomy
Q86015304Systematic assessment of complications and outcome of radical cystectomy undertaken with curative intent in patients with comorbidity and over 75 years of age
Q26785757Systematic methods for measuring outcomes: How they may be used to improve outcomes after Radical cystectomy
Q38308227Systematic review and cumulative analysis of oncologic and functional outcomes after robot-assisted radical cystectomy.
Q38308230Systematic review and cumulative analysis of perioperative outcomes and complications after robot-assisted radical cystectomy.
Q34527111Systematic review and meta-analysis of comparative studies reporting early outcomes after robot-assisted radical cystectomy versus open radical cystectomy.
Q38653852Systematic review and meta-analysis of non RCT's on health related quality of life after radical cystectomy using validated questionnaires: Better results with orthotopic neobladder versus ileal conduit
Q36143668Systematic review and meta-analysis of randomised trials of perioperative outcomes comparing robot-assisted versus open radical cystectomy
Q64082534Systematic review and meta-analysis on trimodal therapy versus radical cystectomy for muscle-invasive bladder cancer: Does the current quality of evidence justify definitive conclusions?
Q100384269Systematic review of neoadjuvant therapy by Immune checkpoint inhibitors before radical cystectomy: where do we stand?
Q39026360Systematic review of perioperative outcomes and complications after open, laparoscopic and robot-assisted radical cystectomy
Q38950782Systematic review of the oncological and functional outcomes of pelvic organ-preserving radical cystectomy (RC) compared with standard RC in women who undergo curative surgery and orthotopic neobladder substitution for bladder cancer.
Q91177661Systemic immune-inflammation index predicts prognosis of bladder cancer patients after radical cystectomy
Q81941900Systemic treatment for invasive bladder cancer: neoadjuvant chemotherapy and laparoscopic radical cystectomy
Q95477424T1 high-grade bladder cancer recurring after BCG therapy: a curative alternative to radical cystectomy exists. Con
Q45126392T1 high-grade bladder cancer recurring after BCG therapy: radical cystectomy is still the best approach. Pro.
Q61454762T1G3 bladder cancer, bacillus Calmette-Guerin and radical cystectomy: continued debate
Q35710421T1G3 bladder tumours: the case for radical cystectomy
Q39577347THE FIRST REPORT OF LAPAROSCOPIC RADICAL CYSTECTOMY IN GEORGIA.
Q93368125TROY expression is associated with pathological stage and poor prognosis in patients treated with radical cystectomy
Q41240378Taking it to the HILT: High-intensity local treatment with radical cystectomy for metastatic bladder cancer.
Q40796362Takotsubo stress-induced cardiomyopathy following robotic radical cystectomy
Q42370134Technical steps of open radical cystectomy and orthotopic neobladder to achieve the goals of "minimally invasive surgery"?
Q42839374Technical steps of open radical cystectomy and orthotopic neobladder to achieve the goals of "minimally invasive surgery"?
Q33724289Technique and results in total laparoscopic radical cystectomy with sigmoidorectal pouch (Mainz pouch II) - an initial experience
Q46555284Technique for radical cystectomy
Q70377735Technique of radical cystectomy
Q70891129Technique of radical cystectomy
Q45958409Technique of radical cystectomy and simultaneous repair of an abdominal aortic aneurysm.
Q50510641Temporal trends in perioperative morbidity for radical cystectomy using the National Surgical Quality Improvement Program database.
Q89050645Temporal trends in venous thromboembolism after radical cystectomy
Q92682851Ten-Year Oncologic Outcomes Following Robot-Assisted Radical Cystectomy: Results from the International Robotic Cystectomy Consortium
Q88950615The Association of Aspirin Use with Survival Following Radical Cystectomy
Q98724495The CanMoRe trial - evaluating the effects of an exercise intervention after robotic-assisted radical cystectomy for urinary bladder cancer: the study protocol of a randomised controlled trial
Q97517535The Cancer of the Bladder Risk Assessment (COBRA) score for Estimating Cancer-Specific Survival after Radical Cystectomy: External Validation in a Large Bi-institutional Cohort
Q92763332The Cancer of the Bladder Risk Assessment (COBRA) score for predicting cancer-specific survival after radical cystectomy for urothelial carcinoma of the bladder: External validation in a cohort of Korean patients
Q40053390The Cancer of the Bladder Risk Assessment (COBRA) score: Estimating mortality after radical cystectomy
Q87621622The Charlson comorbidity index predicts survival after disease recurrence in patients following radical cystectomy for urothelial carcinoma of the bladder
Q91284984The Complexity of Complications: How Do We Estimate Morbidity and Target Improvements Following Radical Cystectomy?
Q40499120The Correlation of Media Ranking's "Best" Hospitals and Surgical Outcomes Following Radical Cystectomy for Urothelial Cancer
Q100938559The Effect of Body Mass Index on Oncological and Surgical Outcomes in Patients Undergoing Radical Cystectomy for Bladder Cancer: A Multicenter Study of the Association of Urooncology, Turkey
Q92018064The Effect of Complexity of the Surgical Field on Perioperative Outcomes of Robot-Assisted Radical Cystectomy
Q89728018The Effect of Surgical Experience on Perioperative and Oncological Outcomes After Robot-assisted Radical Cystectomy with Intracorporeal Urinary Diversion: Evidence from a Referral Centre with Extensive Experience in Robotic Surgery
Q91213384The Endo GIA stapler in the paravaginal dissection during radical cystectomy
Q40932384The Estrogen Pathway: Estrogen Receptor-α, Progesterone Receptor, and Estrogen Receptor-β Expression in Radical Cystectomy Urothelial Cell Carcinoma Specimens
Q54958097The Extent of Lymphadenectomy at the Time of Radical Cystectomy for Bladder Cancer and its Impact on Prognosis and Survival.
Q91315128The Factors Significantly affecting the Quality of Life of Patients Who undergo Radical Cystectomy due to Bladder Cancer
Q40045710The Fate of Radical Cystectomy Patients after Hospital Discharge: Understanding the Black Box of the Pre-readmission Interval
Q93174764The Feasibility and Safety of Reproductive Organ Preserving Radical Cystectomy for Elderly Female Patients With Muscle-Invasive Bladder Cancer: A Retrospective Propensity Score-matched Study
Q91266634The Feasibility of a Health Care Application in the Treatment of Patients Undergoing Radical Cystectomy
Q38831046The Future of Enhanced Recovery for Radical Cystectomy: Current Evidence, Barriers to Adoption and Next Steps
Q66892968The Ileocecal Bladder: A New Method for Urinary Diversion After Radical Cystectomy (A Preliminary Report)
Q101129890The Impact of Circulating Tumor Cells on Venous Thromboembolism and Cardiovascular Events in Bladder Cancer Patients Treated with Radical Cystectomy
Q38843683The Impact of Health Literacy and Clinicodemographic Factors on Use of Discharge Services after Radical Cystectomy
Q41582174The Impact of Health Literacy on Surgical Outcomes Following Radical Cystectomy
Q98163998The Impact of Histological Variant on Oncological Outcomes in Patients With Urothelial Carcinoma of the Bladder Treated With Radical Cystectomy
Q57297392The Impact of Lymphovascular Invasion on Risk of Upstaging and Lymph Node Metastasis at the Time of Radical Cystectomy
Q41596016The Impact of Pelvic Venous Pressure on Blood Loss during Open Radical Cystectomy and Urinary Diversion: Results of a Secondary Analysis of a Randomized Clinical Trial
Q88555459The Impact of Perioperative Blood Transfusion on Survival of Bladder Cancer Patients Submitted to Radical Cystectomy: Role of Anemia Status
Q40103969The Impact of Plasmacytoid Variant Histology on the Survival of Patients with Urothelial Carcinoma of Bladder after Radical Cystectomy.
Q40198256The Impact of Radical Cystectomy and Urinary Diversion on Suicidal Death in Patients With Bladder Cancer
Q41687794The Impact of Tumor Diameter and Tumor Necrosis on Oncologic Outcomes in Patients With Urothelial Carcinoma of the Bladder Treated With Radical Cystectomy
Q92184013The Importance of Hospital and Surgeon Volume as Major Determinants of Morbidity and Mortality After Radical Cystectomy for Bladder Cancer: A Systematic Review and Recommendations by the European Association of Urology Muscle-invasive and Metastatic
Q37530382The July Effect in Radical Cystectomy: Mortality, Morbidity, and Efficiency
Q58124380The LACE Score as a Tool to Identify Radical Cystectomy Patients at Increased Risk of 90-Day Readmission and Mortality
Q39445173The Neutrophil-to-lymphocyte Ratio as a Prognostic Factor for Patients with Urothelial Carcinoma of the Bladder Following Radical Cystectomy: Validation and Meta-analysis
Q89986153The PT2D-Score: a novel tool to predict complications and economic outcome after radical cystectomy
Q85551705The Prognostic Significance of the Early Postoperative Neutrophil-to-Lymphocyte Ratio in Patients with Urothelial Carcinoma of the Bladder Undergoing Radical Cystectomy
Q90528049The Prognostic Value of Tumor Regression Grades Combined With TNM Classification in Patients With Muscle-Invasive Bladder Cancer Who Underwent Neoadjuvant Chemotherapy Followed by Radical Cystectomy
Q91244732The Role and Importance of Timely Radical Cystectomy for High-Risk Non-muscle-Invasive Bladder Cancer
Q40094310The Role of Surgery in Local Recurrences after Radical Cystectomy for Bladder Cancer.
Q38114718The SPARC score: a multifactorial outcome prediction model for patients undergoing radical cystectomy for bladder cancer.
Q90798882The Safety and Short-term Outcomes of Leukocyte Depleted Autologous Transfusions During Radical Cystectomy
Q57634284The Timing of Radical Cystectomy after Recent Myocardial Infarction
Q87153533The Timing of Radical Cystectomy for bacillus Calmette-Guérin Failure: Comparison of Outcomes and Risk Factors for Prognosis
Q39448663The Treatment of Recurrent Urothelial Tumors of the Upper Urinary System and at Urostomy Site following Radical Cystectomy with Intraureteral Bacillus Calmette-Guérin and Cryotherapy
Q47632287The Upper Limits of Hopeful Application of Radical Cystectomy for Vesical Carcinoma: Does Nodal Metastasis Always Indicate Incurability?
Q52571489The Use of a Metal Stent in the Treatment of Ureteral Stricture in a Patient Who Had Undergone Radical Cystectomy with the Creation of an Ileal Conduit.
Q98292479The Use of a Polytetrafluoroethylene Membrane-Covered Stent in the Management of Urine Extravasation After Radical Cystectomy and Ileal Conduit Formation
Q94601445The Usefulness of the Modified Frailty Index for Muscle-Invasive Bladder Cancer Patients Treated with Radical Cystectomy
Q96591915The Utility and Efficacy of Laparoscopic Radical Cystectomy in Patients with Muscle-Invasive Bladder Cancer at a Single Institution
Q83167971The Z-shaped ileal neobladder after radical cystectomy: an 18 years experience with 329 patients
Q83956307The adverse consequences of delaying radical cystectomy
Q89770695The association between N-methylnaltrexone, a peripherally acting mu-opioid receptor antagonist, and clinical outcomes in patients undergoing robotic-assisted radical cystectomy
Q44085530The association between extent of lymphadenectomy and survival among patients with lymph node metastases undergoing radical cystectomy
Q49331695The association between intraoperative fluid intake and postoperative complications in patients undergoing radical cystectomy with an enhanced recovery protocol
Q90729979The association between patient body mass index and perioperative outcomes following radical cystectomy: An analysis using the American College of Surgeons National Surgical Quality Improvement Program database
Q41432872The association of ABO blood type with disease recurrence and mortality among patients with urothelial carcinoma of the bladder undergoing radical cystectomy
Q45935262The association of preoperative serum albumin level and American Society of Anesthesiologists (ASA) score on early complications and survival of patients undergoing radical cystectomy for urothelial bladder cancer.
Q42004216The case for prostate capsule-sparing radical cystectomy in selected patients
Q73485953The changing pattern of mortality and morbidity from radical cystectomy
Q92487440The clinical and economic burden of perioperative complications of radical cystectomy
Q38438246The clinical significance of intra-operative ureteral frozen section analysis at radical cystectomy for urothelial carcinoma of the bladder
Q84009579The clinical significance of urine cytology after a radical cystectomy for urothelial cancer
Q45201281The clinical study of radical cystectomy for lymph node positive bladder cancer
Q71886863The colonic neobladder: a stoma-free bladder substitute after radical cystectomy--preliminary results in six patients
Q95523057The comparative effectiveness of quadratus lumborum blocks and paravertebral blocks in radical cystectomy patients
Q100524972The comprehensive complication index is associated with a significant increase in complication severity between 30 and 90 days after radical cystectomy for bladder cancer
Q44043763The connection between selective referrals for radical cystectomy and radical prostatectomy and volume-outcome effects: an instrumental variables analysis
Q97068548The cost of obesity in radical cystectomy
Q71238218The curability if invasive bladder cancer treated by radical cystectomy
Q40310251The diagnosis and treatment of urethral recurrence after radical cystectomy
Q90211510The effect of age and comorbidities on early postoperative complications after radical cystectomy: A contemporary population-based analysis
Q38634440The effect of broader, directed antimicrobial prophylaxis including fungal coverage on perioperative infectious complications after radical cystectomy.
Q72923055The effect of intermittent pneumatic compression devices on intraoperative blood loss during radical prostatectomy and radical cystectomy
Q50479490The effect of intra- and postoperative allogenic blood transfusion on patients' survival undergoing radical cystectomy for urothelial carcinoma of the bladder.
Q57108042The effect of length of ureteral resection on benign ureterointestinal stricture rate in ileal conduit or ileal neobladder urinary diversion following radical cystectomy
Q41652070The effect of metformin on cancer-specific survival outcomes in diabetic patients undergoing radical cystectomy for urothelial carcinoma of the bladder
Q87211852The effect of neoadjuvant chemotherapy on perioperative outcomes in patients who have bladder cancer treated with radical cystectomy: a population-based study
Q70328796The effect of nutritional status and support on morbidity and mortality of bladder cancer patients treated by radical cystectomy
Q35643316The effect of preoperative clinical variables on the 30- and 90-day morbidity and mortality after radical cystectomy: A single-centre study
Q90342476The effect of radical cystectomy on survival in patients with metastatic urothelial carcinoma of the urinary bladder
Q100511761The effect of sex on disease stage and survival after radical cystectomy: a population-based analysis
Q40170786The effect of the time interval between diagnosis of muscle-invasive bladder cancer and radical cystectomy on staging and survival: A Netherlands Cancer Registry analysis
Q44321234The effects of a physical exercise programme after radical cystectomy for urinary bladder cancer. A pilot randomized controlled trial
Q80212558The effects of adjusting for case mix on mortality and length of stay following radical cystectomy
Q81712644The effects of stage divergence on survival after radical cystectomy for urothelial cancer
Q77666583The experiences of rectosigmoid pouch as a continent urinary diversion after radical cystectomy
Q50533060The feasibility and effectiveness of robot-assisted radical cystectomy after neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer.
Q35994006The feasibility of radical cystectomy in elderly patients
Q82258546The frequency of prostatic involvement in radical cystectomy specimens for transitional cell carcinoma of the bladder
Q44228564The impact of co-morbid disease on cancer control and survival following radical cystectomy
Q92618802The impact of completeness of last transurethral resection of bladder tumors on the outcomes of radical cystectomy
Q51031663The impact of female gender on bladder cancer-specific death risk after radical cystectomy: a meta-analysis of 27,912 patients.
Q97646933The impact of histological variants on outcomes after open radical cystectomy for muscle-invasive urothelial bladder cancer: results from a single tertiary referral centre
Q37371241The impact of lymphadenectomy and lymph node metastasis on the outcomes of radical cystectomy for bladder cancer
Q91356196The impact of minimal invasive surgery on early complications and mortality after radical cystectomy for muscle-invasive urothelial bladder cancer
Q91445231The impact of non-urothelial variant histology on oncological outcomes following radical cystectomy
Q60054615The impact of patient-related nonmodifiable factors on perioperative outcomes following radical cystectomy with enhanced recovery protocol
Q50496600The impact of perioperative blood transfusion on cancer recurrence and survival following radical cystectomy.
Q50502382The impact of perioperative blood transfusion on survival following radical cystectomy for urothelial carcinoma.
Q49407223The impact of perioperative blood transfusion on survival outcomes in radical cystectomy patients
Q92665251The impact of perivesical lymph node metastasis on clinical outcomes of bladder cancer patients undergoing radical cystectomy
Q46426113The impact of positive soft tissue surgical margins following radical cystectomy for high-grade, invasive bladder cancer
Q40951362The impact of preoperative anemia on oncologic outcome in patients undergoing radical cystectomy for urothelial carcinoma of the bladder
Q96232924The impact of preoperative nutritional status on post-surgical complication and mortality rates in patients undergoing radical cystectomy for bladder cancer: a systematic review of the literature
Q45055946The impact of running versus interrupted anastomosis on ureterointestinal stricture rate after radical cystectomy.
Q104558313The impact of smoking on radical cystectomy complications increases in elderly patients
Q39014520The impact of socioeconomic status on perioperative complications and oncologic outcomes in patients undergoing radical cystectomy
Q84389717The impact of squamous and glandular differentiation on survival after radical cystectomy for urothelial carcinoma
Q40217833The impact of stapling devices use on patients with increased body mass index treated with radical cystectomy
Q53574858The impact of the AB0 and the Rhesus blood group system on outcomes in bladder cancer patients treated with radical cystectomy.
Q38235228The impact of the extent of lymphadenectomy on oncologic outcomes in patients undergoing radical cystectomy for bladder cancer: a systematic review
Q92243767The impact of variant histological differentiation on extranodal extension and survival in node positive bladder cancer treated with radical cystectomy
Q51382687The implications of hospital acquired adverse events on mortality, length of stay and costs for patients undergoing radical cystectomy for bladder cancer.
Q38760806The importance of clinical stage among patients with a complete pathologic response at radical cystectomy after neoadjuvant chemotherapy
Q45110574The importance of lymphovascular invasion in patients undergoing radical cystectomy for bladder cancer
Q50714743The importance of surgeon characteristics on impacting oncologic outcomes for patients undergoing radical cystectomy.
Q46005364The invasive T1 bladder tumor: contemporary issues and rationale for radical cystectomy.
Q30433190The learning curve for robot-assisted radical cystectomy
Q37740535The learning curve of robot-assisted radical cystectomy: results from the International Robotic Cystectomy Consortium.
Q91305866The long-term efficacy of one-shot neoadjuvant intra-arterial chemotherapy combined with radical cystectomy versus radical cystectomy alone for bladder cancer: a propensity-score matching study
Q42647608The lymph node yield during robot-assisted radical cystectomy
Q41524268The management of deeply infiltrating (T3) bladder carcinoma: controlled trial of radical radiotherapy versus preoperative radiotherapy and radical cystectomy (first report).
Q41058954The management of locally recurrent invasive bladder cancer following radical cystectomy
Q46084165The management of urethral transitional cell carcinoma after radical cystectomy for invasive bladder cancer
Q40775537The morbidity of laparoscopic radical cystectomy: analysis of postoperative complications in a multicenter cohort by the European Association of Urology (EAU)-Section of Uro-Technology
Q52853811The motion: Radical cystectomy in the elderly is becoming a standard treatment for bladder cancer.
Q53193063The motion: Radical cystectomy in the elderly is becoming a standard treatment for bladder cancer.
Q43770148The number of nodes removed as well as the template of the dissection is independently correlated to cancer-specific survival after radical cystectomy for muscle-invasive bladder cancer
Q91406662The occurrence of high-grade complications after radical cystectomy worsens oncological outcomes in patients with bladder cancer
Q37529160The oncologic results of laparoscopic radical cystectomy are not (yet) equivalent to open cystectomy
Q81174187The optimum timing of radical cystectomy for patients with recurrent high-risk superficial bladder tumour
Q89639833The perils of using registry data to compare the survival and cost of radical cystectomy and trimodality therapy in bladder cancer
Q46051123The potency-sparing radical cystectomy: does it compromise the completeness of the cancer resection?
Q81305143The predictors of local recurrence after radical cystectomy in patients with invasive bladder cancer
Q42500371The preoperative activity of Th1 and Th17 cytokine axes in prediction of sepsis after radical cystectomy.
Q52946591The presence of carcinoma in situ at radical cystectomy increases the risk of urothelial recurrence: Implications for follow-up schemes.
Q82222981The presence of circulating tumor cells does not predict extravesical disease in bladder cancer patients prior to radical cystectomy
Q33335296The presence of lymphovascular invasion in radical cystectomy specimens from patients with urothelial carcinoma portends a poor clinical prognosis
Q74259334The present position of radical cystectomy in the surgical management of carcinoma of the urinary bladder
Q91571268The prognostic impact of hexaminolevulinate-based bladder tumor resection in patients with primary non-muscle invasive bladder cancer treated with radical cystectomy
Q35348927The prognostic impact of perioperative blood transfusion on survival in patients with bladder urothelial carcinoma treated with radical cystectomy
Q90235552The prognostic role of preoperative circulating neutrophil-lymphocyte ratio in primary bladder cancer patients undergoing radical cystectomy: a meta-analysis
Q39657030The prognostic role of preoperative serum albumin/globulin ratio in patients with bladder urothelial carcinoma undergoing radical cystectomy
Q79805517The prognostic significance of advanced age in patients with bladder cancer treated with radical cystectomy
Q35591618The prognostic significance of metastatic perivesical lymph nodes identified in radical cystectomy specimens for transitional cell carcinoma of the bladder
Q53521807The prognostic significance of pathologic stage T0 on organ-confined bladder transitional cell carcinoma following radical cystectomy.
Q36264797The prognostic significance of preoperative leukocytosis and neutrophil-to-lymphocyte ratio in patients who underwent radical cystectomy for bladder cancer
Q38698128The prognostic significance of preoperatively assessed AST/ALT (De Ritis) ratio on survival in patients underwent radical cystectomy
Q80967866The prognostic value of E-cadherin, alpha-, beta- and gamma-catenin in bladder cancer patients who underwent radical cystectomy
Q73393234The prognostic value of angiogenesis factor expression for predicting recurrence and metastasis of bladder cancer after neoadjuvant chemotherapy and radical cystectomy
Q37859664The prognostic value of hydronephrosis in bladder cancer treated by radical cystectomy.
Q47296178The prognostic value of preoperative serum albumin-globulin ratio for high-grade bladder urothelial carcinoma treated with radical cystectomy: A propensity score-matched analysis
Q35677849The prognostic value of pretreatment of systemic inflammatory responses in patients with urothelial carcinoma undergoing radical cystectomy
Q91060380The prognostic value of the neutrophil-to-lymphocyte ratio in patients with muscle-invasive bladder cancer treated with neoadjuvant chemotherapy and radical cystectomy
Q90627464The prognostic value of the urokinase-plasminogen activator system (uPA) in bladder cancer patients treated with radical cystectomy (RC)
Q51041030The quality of life in men after radical cystectomy with a continent cutaneous diversion or orthotopic bladder substitution: is there a difference?
Q95761529The quality of life in men after radical cystectomy with a continent cutaneous diversion or orthotopic bladder substitution: is there a difference?
Q80382927The rationale for radical cystectomy as primary therapy for T4 bladder cancer
Q39729147The regionalization of radical cystectomy to specific medical centers
Q35659154The relationship between perioperative blood transfusion and overall mortality in patients undergoing radical cystectomy for bladder cancer
Q85529210The results of implementing a fast-track protocol in radical cystectomy in a tertiary hospital
Q37480548The risk factor for urethral recurrence after radical cystectomy in patients with transitional cell carcinoma of the bladder
Q38866956The risk of radical cystectomy
Q68006975The risk of urethral recurrence after radical cystectomy
Q37852269The role of FISH and cytology in upper urinary tract surveillance after radical cystectomy for bladder cancer.
Q58804638The role of antibiotic prophylaxis after radical cystectomy in preventing urinary tract infections and readmission for sepsis
Q100537039The role of extended lymph node dissection in patients undergoing radical cystectomy
Q36790175The role of lymphadenectomy in patients undergoing radical cystectomy for bladder cancer
Q92318183The role of metastatic burden in cytoreductive/consolidative radical cystectomy
Q37832899The role of pelvic lymph node dissection during radical cystectomy for bladder cancer.
Q52883937The role of pelvic lymphadenectomy and radical cystectomy for lymph node positive bladder cancer. The Memorial Sloan-Kettering Cancer Center experience.
Q40717335The role of perioperative blood transfusion on postoperative outcomes and overall survival in patients after laparoscopic radical cystectomy
Q50693158The role of preoperative prostatic urethral biopsy in clinical decision-making at the time of radical cystectomy.
Q104470906The role of radical cystectomy in patients with T1 variant histology bladder cancer
Q34180038The role of radical cystectomy in patients with clinical T4b bladder cancer
Q46430607The role of radical cystectomy in the management of high grade superficial bladder cancer (PA, P1, PIS and P2)
Q53541209The role of squamous differentiation in patients with transitional cell carcinoma of the bladder treated with radical cystectomy.
Q101131351The role of surgical experience in patient selection, surgical quality, and outcomes in robot-assisted radical cystectomy
Q85240152The sensitivity of initial transurethral resection or biopsy of bladder tumor(s) for detecting bladder cancer variants on radical cystectomy
Q90657670The significance of preoperative estimated glomerular filtration rate on survival outcomes in patients who underwent radical cystectomy and non-continent urinary diversion
Q58113023The surgical technique and initial outcomes of Anatolian neobladder: a novel technique of ileal neobladder after radical cystectomy
Q35028256The time from diagnosis of bladder cancer to radical cystectomy in Polish urological centres - results of CysTiming Poland study
Q61454775The timing of radical cystectomy following neoadjuvant chemotherapy
Q53530261The type of urinary diversion after radical cystectomy significantly impacts on the patient's quality of life.
Q91632875The use of perioperative chemotherapy in patients undergoing radical cystectomy for bladder cancer in Quebec (Canada), 2000-2016
Q52944650The utility of CT and MRI in detecting male urethral recurrence after radical cystectomy.
Q39480721The utility of neoadjuvant gemcitabine plus carboplatin followed by immediate radical cystectomy in patients with muscle-invasive bladder cancer who are ineligible for cisplatin-based chemotherapy
Q79205729The value of frozen-section analysis of ureteric margins on surgical decision-making in patients undergoing radical cystectomy for bladder cancer
Q40915250The value of pathologic factors in predicting cancer-specific survival among patients treated with radical cystectomy for transitional cell carcinoma of the bladder and prostate
Q33743740The volume-mortality relation for radical cystectomy in England: retrospective analysis of hospital episode statistics
Q45101898The volume-outcome relationship for radical cystectomy in England: an analysis of outcomes other than mortality
Q50077471Therapeutic strategies for organ-confined and non-organ-confined bladder cancer after radical cystectomy
Q86320999There is a place for radical cystectomy and urinary diversion, including orthotopic bladder substitution, in patients aged 75 and older: Results of a retrospective observational analysis from a high-volume center
Q41598640Thoracic epidural analgesia for radical cystectomy improves bowel function even in traditional perioperative care: a retrospective study in eighty-five patients.
Q91458144Threading the cost-outcome needle after radical cystectomy
Q43780562Thromboembolic events in patients with urothelial carcinoma undergoing neoadjuvant chemotherapy and radical cystectomy
Q92759460Time to Move On: The Impending Need for a New Disease-specific Comorbidity Index for Bladder Cancer Patients Undergoing Robot-assisted Radical Cystectomy
Q38123652Timing and outcomes for radical cystectomy in nonmuscle invasive bladder cancer
Q92176272Timing of adjuvant chemotherapy and overall survival following radical cystectomy
Q53185271Timing of blood transfusion and not ABO blood type is associated with survival in patients treated with radical cystectomy for nonmetastatic bladder cancer: Results from a single high-volume institution.
Q104135736Timing of lymphadenectomy during robot-assisted radical cystectomy: before or after cystectomy? Fifteen cases with totally intracorporeal urinary diversions
Q35533822Timing of radical cystectomy in Central Europe - multicenter study on factors influencing the time from diagnosis to radical treatment of bladder cancer patients
Q100508693Timing, Patterns and Predictors of 90-days Readmission Rate after Robotic Radical Cystectomy
Q45234655Timing, incidence and risk factors for venous thromboembolism in patients undergoing radical cystectomy for malignancy: a case for extended duration pharmacological prophylaxis
Q38064272Tips and tricks to robot-assisted radical cystectomy and intracorporeal diversion
Q44673534Tissue-engineered tubular graft for urinary diversion after radical cystectomy in rabbits
Q36422857Total Psoas Area Predicts Complications following Radical Cystectomy
Q91820830Totally intracorporeal 3D laparoscopic orthotopic neobladder reconstruction following radical cystectomy for infiltrative bladder tumors: the experience of modified Studer and modified Y-shaped ileal reconstruction techniques
Q38162247Totally intracorporeal robot-assisted radical cystectomy: optimizing total outcomes
Q38028591Towards bloodless cystectomy: a 10-year experience of intra-operative cell salvage during radical cystectomy
Q37983494Toxicity comparison of neoadjuvant versus adjuvant methotrexate, vinblastine, doxorubicin, and cisplatin (M-VAC) in radical cystectomy patients
Q52714988Tranexamic Acid versus Placebo to Prevent Blood Transfusion during Radical Cystectomy for Bladder Cancer (TACT): Study Protocol for a Randomized Controlled Trial.
Q91630106Trans-Fascial Placement of a High, Sub Muscular Reservoir in Patients Following Radical Cystectomy: Safety, Efficacy, and Predictability of Final Reservoir Location Verified With Abdominal Imaging
Q68463980Transitional Cell Carcinoma of the Urethra in Men after Radical Cystectomy for Bladder Cancer. Is Prophylactic Urethrectomy Indicated?
Q73638168Transitional cell carcinoma in a prostatic remnant 10 years after radical cystectomy
Q43449548Transitional cell carcinoma in orthotopic ileal neobladder 12 years after radical cystectomy
Q77435739Transitional cell carcinoma in the ileal conduit following radical cystectomy and nephroureterectomy
Q45423885Transitional infiltrating carcinoma of the bladder. Local recurrence and metastases. Analysis of 175 cases treated with radical cystectomy
Q35642963Transobturator vaginal tape (inside-out) for stress urinary incontinence after radical cystectomy and orthotopic reconstruction in women
Q94584806Transperitoneal uretercutaneostomy with use of mesosigmoid colon peritoneum in patients with bladder cancer after radical cystectomy
Q47344752Transperitoneal vs. extraperitoneal radical cystectomy for bladder cancer: A retrospective study
Q82416460Transurethral prostate biopsy before radical cystectomy remains clinically relevant for decision-making on urethrectomy in patients with bladder cancer
Q96120870Transurethral resection of bladder and radical cystectomy: Concordance of histology. Are we good enough?
Q92518189Transurethral-Assisted Transumbilical Laparoendoscopic Single-Site Radical Cystectomy: Initial Short-Term Experience
Q96430225Transvaginal Enterocele and Evisceration Repair After Radical Cystectomy Using Porcine Xenograft
Q37319840Transvaginal bowel evisceration following robot-assisted radical cystectomy
Q85825964Transvaginal neobladder vaginal fistula repair after radical cystectomy with orthotopic urinary diversion in women
Q55054251Transversus Abdominis Plane Blockade as Part of a Multimodal Postoperative Analgesia Plan in Patients Undergoing Radical Cystectomy.
Q53461353Treatment and outcomes of urethral recurrence of urinary bladder cancer in women after radical cystectomy and orthotopic neobladder: a series of 12 cases.
Q40331821Treatment of T3 bladder cancer: controlled trial of pre-operative radiotherapy and radical cystectomy versus radical radiotherapy
Q73160695Treatment of advanced bladder cancer with combined preoperative irradiation and radical cystectomy versus radical cystectomy alone: a phase III intergroup study
Q44687557Treatment of invasive bladder cancer: robot-assisted radical cystectomy and intracorporeal urinary diversion
Q51631315Treatment of urethral recurrence following radical cystectomy and ileal bladder substitution.
Q43727130Treatment outcome of radical cystectomy during a 10-year period (June 1984-September 1994) at Department of Urology, Fukui Medical School
Q90504189Trends in Adherence to Thromboprophylaxis Guideline in Patients Undergoing Radical Cystectomy
Q91246135Trends in Extended-Duration Venous Thromboembolism Prophylaxis Following Radical Cystectomy
Q91957816Trends in Management and Outcomes Among Patients with Urothelial Carcinoma Undergoing Radical Cystectomy from 1995 to 2015: The Memorial Sloan Kettering Experience
Q91951260Trends in Regionalization of Care and Mortality For Patients Treated With Radical Cystectomy
Q90643590Trends in epidural anesthesia use at the time of radical cystectomy and its association with perioperative and survival outcomes: a population-based analysis
Q41661097Trends in operative caseload and mortality rates after radical cystectomy for bladder cancer in England for 1998-2010.
Q46118519Trends in pelvic lymphadenectomy at the time of radical cystectomy: 1988 to 2004.
Q93136319Trends in quality of life reporting for radical cystectomy and urinary diversion over the last four decades: A systematic review of the literature
Q39604746Trends in regionalization of radical cystectomy in three large northeastern states from 1996 to 2009.
Q50993637Trends in renal function after radical cystectomy and ileal conduit diversion: new insights regarding estimated glomerular filtration rate variations.
Q35905142Trends in the Use of Chemotherapy before and after Radical Cystectomy in Patients with Muscle-invasive Bladder Cancer in Korea.
Q47211582Trends in urinary diversion after radical cystectomy for urothelial carcinoma.
Q44258882Trimodal Therapy is Inferior to Radical Cystectomy for Muscle-invasive Bladder Cancer using Population-level Data: Is There Evidence in the (Lack of) Details?
Q101403876Trimodal Therapy vs. Radical Cystectomy for Muscle-Invasive Bladder Cancer: A Meta-Analysis
Q38540660Trimodal therapy for invasive bladder cancer: is it really equal to radical cystectomy?
Q41743687Tube gastrostomy after radical cystectomy and urinary diversion: surgical technique and experience in 709 patients
Q44018497Tumor recurrence in the remnant urothelium of females undergoing radical cystectomy for transitional cell carcinoma of the bladder: long-term results from a single center
Q42378252Tumor-infiltrating CD8+ lymphocytes predict different clinical outcomes in organ- and non-organ-confined urothelial carcinoma of the bladder following radical cystectomy
Q45948761Twenty-year experience of radical cystectomy for bladder cancer in a medium-volume centre.
Q77449304Two cases of nonocclusive mesenteric ischemia after radical cystectomy
Q40793039Two-Port Approach Compared to Standard Laparoscopic Radical Cystectomy
Q86098856Two-port laparoscopic radical cystectomy with reusable umbilical system: a feasibility study
Q81170790Two-surgeon versus single-surgeon radical cystectomy and urinary diversion: impact on patient outcomes and costs
Q43645973Two-surgeon versus single-surgeon radical cystectomy and urinary diversion: impact on patient outcomes and costs.
Q36956211UBE2C is a marker of unfavorable prognosis in bladder cancer after radical cystectomy
Q38152780USANZ: Time-trends in use and impact on outcomes of perioperative chemotherapy in patients treated with radical cystectomy for urothelial bladder cancer
Q39397592Unaltered oncological outcomes of radical cystectomy with extended lymphadenectomy over three decades
Q41752954Understanding hospital readmission intensity after radical cystectomy
Q90255224Understanding physical activity behavior in patients with bladder cancer before and after radical cystectomy: a qualitative interview study
Q98775666Understanding psychosocial and sexual health concerns among women with bladder cancer undergoing radical cystectomy
Q38655139Underutilization of Radical Cystectomy Among Patients Diagnosed with Clinical Stage T2 Muscle-invasive Bladder Cancer
Q90348106Unexpected Early Oncologic Mortality after Open Radical Cystectomy for Bladder Cancer: Who Is to Be Blamed?
Q90116681Unfavorable Cancer-specific Survival After Neoadjuvant Chemotherapy and Radical Cystectomy in Patients With Bladder Cancer and Squamous Cell Variant: A Multi-institutional Study
Q91421685Unmarried men have worse oncologic outcomes after radical cystectomy for nonmetastatic urothelial bladder cancer
Q51609548Unpredicted neurological complications after robotic laparoscopic radical cystectomy and ileal conduit formation in steep trendelenburg position: two case reports.
Q55502151Unusual complication of bladder prolapse with subsequent diagnosis of urothelial carcinoma leading to a necrotizing soft tissue infection after radical cystectomy.
Q64093363Unusual lymphocele following radical cystectomy with orthotopic neobladder
Q83176749Unusual occurrence of neuroleptic malignant syndrome in urological surgery: a case report following radical cystectomy for invasive bladder cancer
Q37179666Updated assessment of neobladder utilization and morbidity according to urinary diversion after radical cystectomy: A contemporary US-population-based cohort
Q46348087Upholding Rigorous Standards: Comparable Patterns and Rates of Recurrence Between Open and Robot-assisted Radical Cystectomy
Q73091086Upper tract recurrences following radical cystectomy: an analysis of prognostic factors, recurrence pattern and stage at presentation
Q35914225Upper tract tumour after radical cystectomy for transitional cell carcinoma of the bladder: incidence and risk factors
Q46980038Upper tract urothelial recurrence following radical cystectomy for transitional cell carcinoma of the bladder: an analysis of 1,069 patients with 10-year followup
Q38027302Upper urinary tract and urethral recurrences following radical cystectomy: review of risk factors and outcomes between centres with different follow-up protocols
Q44703119Upper urinary tract recurrence after radical cystectomy for bladder cancer--who is at risk?
Q82702566Upper urinary tract recurrence after radical cystectomy for bladder cancer: incidence and risk factors
Q36860951Upper urinary tract recurrence following radical cystectomy for bladder cancer
Q38053552Upper urinary tract recurrence following radical cystectomy for bladder cancer: a meta-analysis on 13,185 patients.
Q71252237Upper urinary tract transitional cell cancer after radical cystectomy for bladder cancer
Q36788586Upper urinary tract tumour after radical cystectomy for transitional cell carcinoma of the bladder: an update on the risk factors, surveillance regimens and treatments
Q50967045Upstaging of urothelial cancer at the time of radical cystectomy: factors associated with upstaging and its effect on outcome.
Q77299574Ureter and bladder replacement following radical cystectomy
Q85208591Ureteral and urethral frozen sections during radical cystectomy or cystoprostatectomy: an analysis of denudation and atypia
Q90807515Ureteral and urethral recurrence after radical cystectomy: a systematic review
Q73589206Ureteral carcinoma in situ at radical cystectomy: does the margin matter?
Q37291060Ureteral frozen section analysis during radical cystectomy: Do margins matter?
Q42116093Ureteral frozen sections at the time of radical cystectomy: reliability and clinical implications
Q83205099Ureteric frozen sections during radical cystectomy for transitional cell carcinoma of the bladder--to do or not to do?
Q90922477Ureteric stricture rates and management after robot-assisted radical cystectomy: a single-centre observational study
Q97551613Uretero-Enteric Anastomotic Stricture Following Radical Cystectomy: A Comparison of Open, Robotic Extracorporeal, And Robotic Intracorporeal Approaches
Q56973698Uretero-caval fistula after radical cystectomy with bricker ileal conduit: a case report
Q41253604Ureteroarterial Fistulas After Robotic and Open Radical Cystectomy
Q38490370Ureteroenteric Strictures After Open Radical Cystectomy and Urinary Diversion: The University of Southern California Experience
Q85764965Ureteroenteric anastomotic strictures after radical cystectomy-does operative approach matter?
Q86141150Ureteronenteric Anastomotic Strictures After Radical Cystectomy - Does Operative Approach Matter?
Q35830361Urethral 'recurrence' found 14 years after radical cystectomy
Q100466648Urethral Recurrence of Urothelial Carcinoma of the Bladder Following Radical Cystectomy: An Unusual Imaging Pattern
Q51231387Urethral pressure profile following orthotopic neobladder: differences between nerve sparing and standard radical cystectomy techniques.
Q49357528Urethral recurrence after radical cystectomy for urothelial carcinoma: A systematic review and meta-analysis
Q44661985Urethral recurrence following radical cystectomy
Q72768695Urethral recurrences following radical cystectomy for invasive transitional cell carcinoma of the bladder
Q68550814Urethrectomy is harmful for preserving potency after radical cystectomy
Q69128561Urethrogluteal fistula occurring after radical cystectomy for bladder cancer
Q51368435Urinary Diversion After Radical Cystectomy for Bladder Cancer: Comparing Trends in the US and Germany from 2006 to 2014.
Q92297144Urinary Diversion Disparity Following Radical Cystectomy for Bladder Cancer in the Hispanic Population
Q87921054Urinary Reconstruction after Radical Cystectomy
Q39189375Urinary bladder cancer treated with radical cystectomy: perioperative parameters and early complications prospectively registered in a national population-based database.
Q34795731Urinary diversion after radical cystectomy
Q38170537Urinary diversion after radical cystectomy for bladder cancer: options, patient selection, and outcomes.
Q34670583Urinary diversion and morbidity after radical cystectomy for bladder cancer
Q43509975Urinary diversion following radical cystectomy: ileal conduit or ileal replacement bladder?
Q33605475Urinary diversion-related outcome in patients with pelvic recurrence after radical cystectomy for bladder cancer
Q55474720Urinary function following radical cystectomy and orthotopic neobladder urinary reconstruction.
Q89639814Urinary tract infection after radical cystectomy: a vexing problem despite prophylactic antibiotics
Q49670710Urinary tract infections following radical cystectomy and urinary diversion: a review of 1133 patients
Q92756450Urinary tract infections following radical cystectomy with enhanced recovery protocol: A prospective study
Q90292333Urinary tract infections in patients undergoing radical cystectomy and urinary diversion: challenges and considerations in antibiotic prophylaxis
Q51289799Urinary tract management after radical cystectomy for rhabdomyosarcoma in children--what is the best option?
Q91671603Urinary undiversion from a sigma-rectum pouch to a cutaneous urinary stoma as a treatment for severe metabolic disorders post-radical cystectomy: A case report
Q40324182Urine cytology in monitoring recurrence in urothelial carcinoma after radical cystectomy and urinary diversion
Q34538937Urodynamic and continence assessment of orthotropic neobladder reconstruction following radical cystectomy in bladder cancer; a prospective, blinded North Indian tertiary care experience
Q51563453Urodynamic features of the gastric pouch after radical cystectomy and the relationship to oral intake.
Q67560022Urodynamic findings in patients with a urethral Kock pouch after radical cystectomy
Q89079286Urological outcomes following pelvic exenteration for advanced pelvic cancer are not inferior to those following radical cystectomy
Q35072460Urologist referral delay and its impact on survival after radical cystectomy for bladder cancer
Q39065861Urothelial carcinoma in bladder diverticula: outcomes after radical cystectomy
Q86514957Urothelial carcinoma involving the prostate: the association of revised tumour stage and coexistent bladder cancer with survival after radical cystectomy
Q71013831Urothelial lesions associated with bladder carcinoma. Histological study of 18 radical cystectomy specimens
Q92679522Usage of Intravenous Lidocaine Infusion with Enhanced Recovery Pathway in Patients Scheduled for Open Radical Cystectomy: A Randomized Trial
Q92367387Use and duration of antibiotic prophylaxis and the rate of urinary tract infection after radical cystectomy for bladder cancer: Results of a multicentric series
Q40412278Use of adjuvant chemotherapy in radical cystectomy patients aged >65 years: a population-based study from the surveillance epidemiology and end results (SEER)-medicare database
Q44954690Use of combined apoptosis biomarkers for prediction of bladder cancer recurrence and mortality after radical cystectomy
Q91995005Use of indocyanine green to minimise uretero-enteric strictures after robotic radical cystectomy
Q40833210Use of preoperative performance status and hemoglobin concentration to predict overall survival for patients aged ≥ 75 years after radical cystectomy for treatment of bladder cancer
Q84928196Use of radical cystectomy as initial therapy for the treatment of high-grade T1 urothelial carcinoma of the bladder: a SEER database analysis
Q35632786Use of radical cystectomy for patients with invasive bladder cancer.
Q74783099Use of the endoscopic gastrointestinal anastomosis stapler in radical cystectomy
Q48309063Use of urostomy bags in the management of perioperative urine leakage after radical cystectomy
Q46953676Usefulness of 18F-fluorodeoxyglucose positron emission tomography/computerized tomography in diagnosis and treatment of pelvic recurrence of bladder cancer after radical cystectomy: a case report
Q40735589Usefulness of catheter pyelography in ileal diversions and continent bladder replacement after radical cystectomy
Q38162637Usefulness of the Memorial Sloan Kettering Cancer Center nomogram in the prognosis of patients treated with radical cystectomy for invasive bladder cancer
Q41844308Usefulness of transurethral biopsy for staging the prostatic urethra before radical cystectomy
Q37053787Using Analytic Morphomics to Understand Short-Term Convalescence after Radical Cystectomy
Q38076927Using preoperative albumin levels as a surrogate marker for outcomes after radical cystectomy for bladder cancer
Q41432488Utility and significance of ureteric frozen section analysis during radical cystectomy
Q93375375Utility of Bladder-Sparing Therapy vs Radical Cystectomy for Muscle-Invasive Bladder Cancer
Q93375184Utility of Bladder-Sparing Therapy vs Radical Cystectomy for Muscle-Invasive Bladder Cancer-Reply
Q64113942Utility of Routine Intraoperative Ureteral Frozen Section Analysis at Radical Cystectomy: Outcomes from a Regional Australian Center
Q90062227Utility of Routine Preoperative 18F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography (18F-FDG PET/CT) in Identifying Pathologic Lymph Node Metastases at Radical Cystectomy
Q85273738Utility of biomarkers in the prediction of oncologic outcome after radical cystectomy for squamous cell carcinoma
Q91253490Utility of robot-assisted radical cystectomy with intracorporeal urinary diversion for muscle-invasive bladder cancer
Q93049952Utility technique of a totally intracorporeal ileal conduit after robot-assisted radical cystectomy
Q89256162Utilization Trends and Short-term Outcomes of Robotic Versus Open Radical Cystectomy for Bladder Cancer
Q38606579Utilization and Outcomes of Radical Cystectomy for High-grade Non-muscle-invasive Bladder Cancer in Elderly Patients.
Q104288842Utilizing time-driven activity-based costing to determine open radical cystectomy and ileal conduit surgical episode cost drivers
Q41400238VIP neobladder (Padovana) reconstruction following radical cystectomy for bladder cancer Complications, functional outcome and quality of life evaluation in 95 cases
Q90330991Vaginal Dehiscence and Evisceration After Robotic-assisted Radical Cystectomy: A Case Series and Review of the Literature
Q47564539Vaginal cuff recurrence after radical cystectomy: an under - studied site of bladder cancer relapse
Q98614241Vaginal sparing in laparoscopic radical cystectomy for females: feasibility and technical notes
Q57020336Validating the predictors of outcomes after radical cystectomy for bladder cancer
Q89017427Validating the role of ABO blood type in risk of perioperative venous thromboembolism after radical cystectomy
Q53035018Validation of Preoperative Risk Grouping of the Selection of Patients Most Likely to Benefit From Neoadjuvant Chemotherapy Before Radical Cystectomy.
Q96429875Validation of a Questionnaire-Suitable Comorbidity Index in Patients Undergoing Radical Cystectomy
Q102218497Validation of the Khorona Score for Prediction of Venous Thromboembolism After Robot- Assisted Radical Cystectomy
Q38654958Validation of the Preoperative Score to Predict Postoperative Mortality in Patients Undergoing Radical Cystectomy
Q88437593Validation of the nomogram for predicting 90-day mortality after radical cystectomy in a Japanese cohort
Q34629576Valrubicin: an alternative to radical cystectomy for carcinoma in situ of the bladder.
Q68325166Value of Radical Cystectomy in Bladder Cancer with Pelvic Node Involvement
Q47124306Value of evaluating procalcitonin kinetics in diagnosis of infections in patients undergoing laparoscopic radical cystectomy
Q84958595Value of routine frozen section analysis of urethral margin in male patients undergoing radical cystectomy in predicting prostatic involvement
Q39471762Variability in complications and operative mortality after radical cystectomy in Spain
Q36149365Variability in surgical quality in a phase III clinical trial of radical cystectomy in patients with organ-confined, node-negative urothelial carcinoma of the bladder
Q82823020Variation in use of lymph node dissection during radical cystectomy for bladder cancer
Q38941333Variations in Preoperative Use of Bone Scan Among Medicare Beneficiaries Undergoing Radical Cystectomy
Q35622834Variations in reconstruction after radical cystectomy
Q88762895Variations in the Costs of Radical Cystectomy for Bladder Cancer in the USA
Q91923963Venous thromboembolism after radical cystectomy and urinary diversion: a single-center experience with 1737 consecutive patients
Q36620325Venous thromboembolism after radical cystectomy: Experience with screening ultrasonography.
Q39140746Venous thromboembolism following radical cystectomy: significant predictors, comparison of different anticoagulants and timing of events.
Q34275009Videoendoscopically assisted transvaginal radical cystectomy
Q49579746Vigorous intensity aerobic interval exercise in bladder cancer patients prior to radical cystectomy: a feasibility randomised controlled trial.
Q87250339Visceral obesity predicts adverse pathological features in urothelial bladder cancer patients undergoing radical cystectomy: a retrospective cohort study
Q50726763W-pouch With Modified Non-isolated Extra Limb for Continence in Cutaneous Diversion After Radical Cystectomy.
Q46396554Weight Loss Following Radical Cystectomy for Bladder Cancer: Characterization and Effect on Survival
Q42624859What about conventional laparoscopic radical cystectomy? Cost-analysis of open versus laparoscopic radical cystectomy
Q53370054What can be more prognostic than the pTNM category assessed on radical cystectomy specimens?
Q90927783What is the Standard of Care for Pelvic Lymphadenectomy Performed at the Time of Radical Cystectomy?
Q41453791What is the best urinary diversion after laparoscopic radical cystectomy?
Q42039017What is the role of adjuvant chemotherapy in locally advanced and lymph node-positive bladder cancer after radical cystectomy?
Q46386437What is the role of risk-adjusted funnel plots in the analysis of radical cystectomy volume-outcome relationships?
Q37391921What should be the patient's preference regarding the choice of hospital in the case of radical cystectomy? Evaluation of early complications after open radical cystectomy in a medium and high volume setting in one hospital
Q78319842When should quality of life be measured after radical cystectomy?
Q91566367Which comorbidity classification is best suited to identify patients at risk for 90-day and long-term non-bladder cancer mortality after radical cystectomy?
Q49464739Which is better in patients with hydronephrosis before radical cystectomy-percutaneous nephrostomy versus internal ureteral stents.
Q36867886Which urinary diversion is best after radical cystectomy? The case for "incontinent" diversion.
Q92444574Who should record surgical complications? Results from a third-party assessment of complications after radical cystectomy
Q45189701Will Rogers and the results of radical cystectomy for invasive bladder cancer
Q61454782Will long term oncologic follow-up make the case for robotic assisted radical cystectomy?
Q87449138Words of Wisdom. Re: Radical Cystectomy vs. Chemoradiation in T2-4aN0M0 Bladder Cancer: A Case-control Study
Q83637774Words of Wisdom. Re: potential impact of postoperative early complications on the timing of adjuvant chemotherapy in patients undergoing radical cystectomy: a high-volume tertiary cancer center experience
Q87248844Words of Wisdom. Re: robotic intracorporeal orthotopic neobladder during radical cystectomy in 132 patients
Q85236392Words of Wisdom. Re: urinary diversion and morbidity after radical cystectomy for bladder cancer
Q83637769Words of Wisdom. Re: use of radical cystectomy for patients with invasive bladder cancer
Q85754753Words of wisdom. Re: A new concept for early recovery after surgery in patients undergoing radical cystectomy for bladder cancer: results of a prospective randomized study
Q50991777Words of wisdom. Re: A randomized trial of robot-assisted laparoscopic radical cystectomy.
Q51929034Words of wisdom. Re: Evaluating the learning curve for robot- assisted laparoscopic radical cystectomy.
Q80183996Words of wisdom. Re: Lymphatic invasion is a prognostic factor for bladder cancer treated with radical cystectomy
Q83009539Words of wisdom. Re: Outcome after radical cystectomy with limited or extended pelvic lymph node dissection
Q84708783Words of wisdom. Re: Trends in pelvic lymphadenectomy at the time of radical cystectomy: 1988 to 2004. Hellenthal NJ, Ramirez ML, Evans CP, deVere White RW, Koppie TM
Q80951986Words of wisdom. Re: Use of combined apoptosis biomarkers for prediction of bladder cancer recurrence and mortality after radical cystectomy
Q80184001Words of wisdom. Re: radical cystectomy with extended lymphadenectomy: evaluating separate package versus en bloc submission for node positive bladder cases
Q80607834Words of wisdom. Re: the role of squamous differentiation in patients with transitional cell carcinoma of the bladder treated with radical cystectomy
Q84028534Words of wisdom: Re: Super extended versus extended pelvic lymph node dissection in patients undergoing radical cystectomy for bladder cancer: a comparative study
Q51280476Working capacity and well-being after radical cystectomy with continent cutaneous diversion.
Q96126841Xanthogranulomatous Ureteritis Mimicking Ureteral Involvement by Cancer in a Radical Cystectomy Specimen
Q53028971[(18)F]Fluorodeoxyglucose - positron emission tomography/computed tomography improves staging in patients with high-risk muscle-invasive bladder cancer scheduled for radical cystectomy.
Q67994908[10 years' experience with radical cystectomy in malignant tumors of the urinary bladder]
Q91165227[A Case Of cT3bN2M0 Pleomorphic Giant Cell Carcinoma of the Bladder without Recurrence after Neoadjuvant Chemotherapy and Radical Cystectomy for 4 Years]
Q73662869[A case of bilateral upper urinary tract tumors after radical cystectomy]
Q50514384[A case of late recurrence of urothelial carcinoma in an ileal conduit after radical cystectomy and ileal conduit diversion for bladder cancer].
Q57109427[A case of percutaneous BCG perfusion therapy for CIS of upper urinary tract CIS after radical cystectomy with ileal neobladder]
Q40469982[A case of ureteral carcinoma at 11 years after radical cystectomy and rectal bladder reconstruction: a case report].
Q50915382[A clinicopathological study of 218 patients with bladder carcinoma treated by radical cystectomy]
Q85241898[A method for forming a urinary bladder from the sigmoid after radical cystectomy in patients with bladder cancer]
Q81643148[A stage-dependent follow-up strategy after radical cystectomy for bladder carcinoma]
Q69552469[A study on 52 patients with bladder cancer treated with radical cystectomy--pathological findings, lymph node metastasis and prognosis]
Q74762868[Abdominal pain in patients undergoing radical cystectomy for bladder cancer]
Q83375682[Acute normovolemic hemodilution to reduce allogenic blood transfusion in patients undergoing radical cystectomy]
Q81442664[Acute peritonitis after radical cystectomy. Experience at our hospital and bibliographic review]
Q73822207[Adenocarcinoma of the renal pelvis and transitional cell carcinoma of the ureter occurring 11 years after radical cystectomy for bladder cancer: a case report]
Q71594008[Adjuvant chemotherapy after radical cystectomy in bladder carcinoma]
Q69574834[Adjuvant chemotherapy for high-stage and/or high-grade bladder cancer following radical cystectomy. A preliminary report]
Q72399340[Adjuvant polychemotherapy after radical cystectomy of metastatic bladder cancer]
Q104568740[Adjuvant radiotherapy after radical cystectomy for muscle-invasive bladder cancer]
Q83040407[An analysis of upper urinary tract recurrence following radical cystectomy for bladder cancer]
Q91885626[Analysis of influencing factors of ureteral anastomotic stenosis following urinary diversion after laparoscopic radical cystectomy]
Q84773207[Analysis of perioperative complications of laparoscopic radical cystectomy for bladder cancer]
Q89461897[Analysis of the results of ERAS protocol in real-life clinical practice AFTER radical cystectomy (the first prospective multicenter study in Russia)]
Q84894120[Application of tube gastrostomy in radical cystectomy with ileal conduit: a retrospective, comparative study]
Q98949314[Applying the ERAS (Enhanced Recovery After Surgery) protocol in radical cystectomy.]
Q71517399[Benefits and adverse effects of post-operative radiation therapy after radical cystectomy for patients with advanced bladder cancer]
Q77589390[Bilateral ureter within single nipple for cutaneous ureterostomy after radical cystectomy]
Q71831800[Bladder tumors treated with radical cystectomy. Results of 78 cases]
Q87271814[C-reactive protein prior to radical cystectomy: preoperative determination of CRP]
Q79670215[Cae of double cancer involving of the bladder and prostate which was treated by radical cystectomy 8 years after radical prostatectomy]
Q95486605[Characteristics of lymph node metastasis in patients undergoing radical cystectomy for bladder cancer: a retrospective single-center study of 522 cases]
Q69806391[Chemotherapy for advanced bladder cancer: clinical evaluation of chemotherapy for locally advanced or metastatic bladder cancer and adjuvant chemotherapy for deeply invasive bladder cancer following radical cystectomy]
Q69192173[Clinical experience on the use of total parenteral nutrition in patients subjected to radical cystectomy intervention for infiltrating neoplasms of the bladder]
Q93078329[Clinical experiences of laparoscopic radical cystectomy and urinary diversion in the elderly patients with bladder cancer]
Q84276430[Clinical outcomes after modified radical cystectomy in the treatment of 188 patients with invasive bladder cancer]
Q84773220[Clinical significance of radical cystectomy with extended lymphadenectomy]
Q74623027[Clinical study of radical cystectomy and urinary reconstruction in elderly patients with bladder cancer]
Q83464257[Comment to: "Robotic-assisted laparoscopic radical cystectomy: evaluation of functional and oncological results"]
Q84629232[Comment: «laparoendoscopic radical cystectomy with orthotopic ileal neobladder through umbilical single port»]
Q83964546[Comments on radical cystectomy - laparoscopic versus robotic]
Q92651183[Comparative analysis of results in laparoscopic radical cystectomy with extracorporeal and intracorporeal neobladder formation]
Q57131625[Compare of laparoscopic and open surgery for radical cystectomy with orthotopic ileal neobladder]
Q74400724[Complications after radical cystectomy in patients with bladder carcinoma]
Q54728767[Complications and late sequelae following radical cystectomy and supravesicle urinary diversion]
Q83758575[Critical analysis on risk factors of postoperative in-hospital complications in radical cystectomy of bladder cancer]
Q89461935[Current trends in the method used for urine derivation after radical cystectomy for muscle-invasive bladder cancer]
Q84706212[Diagnosis and treatment of urethral recurrence after radical cystectomy in the male]
Q50522625[Does chewing gum improve postoperative results in patients undergoing radical cystectomy? A systematic review of literature and meta-analysis].
Q83623410[Ductal Adenocarcinoma of the prostate with infiltration of the bladder. Can radical cystectomy and antiandrogen therapy cure the disease?]
Q90910605[Early complications after robot-assisted laparoscopic radical cystectomy and their risk factors]
Q81306491[Early postoperative complications of radical cystectomy and urinary diversion in elderly patients]
Q82497956[Early vs delayed radical cystectomy compared in highgrade superficial bladder tumors]
Q84446186[Editorial comment on: Laparoscopic radical cystectomy. The new gold standard for bladder carcinoma?]
Q54084114[Editorial comment on: Laparoscopic radical cystectomy. Where do we stand?].
Q84622180[Editorial comment: robotic assisted radical cystectomy: oncological safety]
Q51767178[Effect of gum chewing on bowel function recovery in patients after radical cystectomy with urinary diversion].
Q85467795[Effects of age, gender and urinary diversion category on perioperative complications of radical cystectomy]
Q95495409[Effects of performing pelvic lymph node dissection before versus after radical cystectomy]
Q81410216[Evaluation of 126 radical cystectomy with orthotopic ileal or sigmoidocolic neobladder]
Q90719675[Evaluation of the learning curve of laparoscopic radical cystectomy for cancer: Morbidity and oncological results]
Q83160689[Experience of laparoscopic nerve-sparing radical cystectomy and construction of ileal neobladder at Kansai Medical University]
Q79274528[Experiences with radical cystectomy combined with urinary diversion by ureteral sigmapouch (Mainz-pouch II) in bladder cancer patients]
Q80060250[Extended lymphadenectomy in radical cystectomy: margins, scope, methodology]
Q83239221[Extending the limits of lymphadenectomy during radical cystectomy: pitfalls in the interpretation of contemporary study results]
Q70833629[Extensive rectal cancer--preserved intestinal and urinary continence after en-block rectal resection and radical cystectomy]
Q85465127[Factors associated with increased blood loss in patients undergoing radical cystectomy in a contemporary series]
Q70482191[Factors determining the survival rate after radical cystectomy]
Q84617771[Fast track approach in radical cystectomy]
Q83183731[Fast-track concepts in the perioperative management of patients undergoing radical cystectomy and urinary diversion: review of the literature and research results]
Q81672029[First experience with the laparoscopic radical cystectomy]
Q86641310[First experiences of laparoscopic radical cystectomy]
Q73830076[Follow up of patients with bladder cancer treated with radical cystectomy]
Q68828254[Four cases of bladder replacement by enterocystoplasty after radical cystectomy for bladder cancer]
Q68010089[Four cases of upper urinary tract transitional cell carcinoma after radical cystectomy in bladder cancer]
Q96768842[Frequency of occurrence and risk factors for acute kidney injury after radical cystectomy]
Q95474636[Henoch-Schönlein purpura developed after radical cystectomy]
Q80623047[Hyperammonaemic encephalopathy, possible complication after urinary diversion in radical cystectomy. Review of the literature with regard to a clinical case]
Q92052067[INITIAL EXPERIENCE WITH ROBOT-ASSISTED RADICAL CYSTECTOMY AND INTRACORPOREAL URINARY DIVERSION ~COMPARISON WITH THE CONVENTIONAL METHOD~]
Q54117561[Immediate complications of radical cystectomy. Intestinal fistula: our experience in the treatment with somatostatin]
Q81272122[Impact of comorbidity on perioperative mortality after radical cystectomy]
Q95440299[Impact of different surgical methods of radical cystectomy on the perioperative complications in patients over 75 years]
Q95513802[Impact of different surgical methods of radical cystectomy on the perioperative complications in patients over 75 years]
Q89573600[Impact of neoadjuvant chemotherapy on the peri-operative morbidity of radical cystectomy for muscle invasive bladder cancer]
Q95451072[Impact of preoperative nutritional risk on complications after radical cystectomy]
Q69806394[Implant operation of penile inflatable prosthesis for a patient with erectile impotence due to radical cystectomy: a case report]
Q70816759[Indication of neobladder replacement in patients undergoing radical cystectomy for bladder cancer]
Q81109381[Indications and current results of substitution enteroplasty following radical cystectomy]
Q79348228[Indications for one-stage and delayed urethrectomy after radical cystectomy in patients with invasive cancer of the urinary bladder]
Q68002580[Indications for urethrectomy in male patients undergoing radical cystectomy in bladder carcinoma]
Q67881235[Infiltrating transitional carcinoma of the bladder (I). Comparison of 2 groups treated with preoperative radiotherapy (long-term protocol and short-term protocol) + radical cystectomy versus radical cystectomy only. Analysis of local recurrence and
Q77623119[Influence of neoadjuvant treatment on bladder infiltrating tumors treated with radical cystectomy]
Q83459805[Influence of older age on survival after radical cystectomy due to urothelial carcinoma of the bladder: survival analysis of a German multi-centre study after curative treatment of urothelial carcinoma of the bladder]
Q91566010[Intraoperative complications of radical cystectomy with various types of urinary diver- sions]
Q80082473[Invasive bladder carcinoma after prostatic carcinoma -- radical cystectomy has high morbidity rate]
Q84390665[Is it possible to predict postoperative ileus following radical cystectomy?]
Q70219182[Is radical cystectomy indicated for the treatment of patients with bladder carcinoma N+ M0?]
Q81359876[Is radical cystectomy justified in patients over 75 years old?]
Q77734747[Is there still a role for radical cystectomy in localized, infiltrating bladder cancers in 1998?]
Q95343104[Is total parenteral nutrition necessary in patients subjected to radical cystectomy?]
Q91130353[LAPAROSCOPIC RADICAL CYSTECTOMY AT HIROSHIMA CITY ASA HOSPITAL]
Q57115536[Laparoendoscopic radical cystectomy with orthotopic ileal neobladder through umbilical single port]
Q51905438[Laparoendoscopic single-site surgery radical cystectomy with orthotopic taenia myectomy sigmoid neobladder: initial report].
Q50618541[Laparoscopic radical cystectomy and detenial sigmoid colon orthotopic neobladder reconstruction for bladder tumor in a 3-year-old boy].
Q83843205[Laparoscopic radical cystectomy and orthotopic urinary diversion in the male patient: technique]
Q50775268[Laparoscopic radical cystectomy and sigmoid colon orthotopic neobladder reconstruction: report of 26 cases].
Q82247162[Laparoscopic radical cystectomy for 43 patients with invasive bladder carcinoma]
Q81558681[Laparoscopic radical cystectomy in clinically localized (T2) bladder tumors]
Q83192375[Laparoscopic radical cystectomy in elderly patients with bladder cancer: feasibility and evaluation of morbidity]
Q81614217[Laparoscopic radical cystectomy with enteric urinary diversion. Alternative to open cystectomy?]
Q52957715[Laparoscopic radical cystectomy with intracorporeal creation of a continent urinary diversion. Future or present?]
Q82993195[Laparoscopic radical cystectomy with orthotopic ileal neobladder: report of 108 cases]
Q84490923[Laparoscopic radical cystectomy with vaginal specimen extraction. Case report]
Q51921280[Laparoscopic radical cystectomy. The new gold standard for bladder carcinoma?].
Q50789935[Laparoscopic radical cystectomy: analysis of a single-surgeon learning curve of 60 cases].
Q79894729[Laparoscopic radical cystectomy: initial experience]
Q89461893[Laparoscopic radical cystectomy: novel technique with late dividing of the ureters]
Q74803283[Local recurrence after radical cystectomy for cancer of the bladder]
Q81484043[Local recurrence following radical cystectomy for bladder cancer. Diagnostic and therapeutic options]
Q82532837[Local recurrence of micropapillary bladder tumor after radical cystectomy : successful treatment with radiation therapy : a case report]
Q53777548[Long-term outcome of radical cystectomy in urinary bladder carcinoma]
Q77346741[Long-term results and quality of life of hemi-Kock orthotopic ileal neobladder after radical cystectomy]
Q73418347[Long-term results of short-course preoperative radiotherapy and radical cystectomy for bladder cancer]
Q82777642[Lymphatic dissection in radical cystectomy]
Q78118334[Lymphatic metastases in bladder carcinoma. Is radical cystectomy indicated?]
Q95549899[MARKERS OF KIDNEY DAMAGE AND NEPHROPROTECTIVE THERAPY IN RADICAL CYSTECTOMY]
Q78867031[Modified intestinal in situ neobladder in functional reconstruction of lower urinary tract after radical cystectomy: report of 15 cases]
Q87140905[Morbidity, mortality, and overall survival after radical cystectomy: comparison of single-center results with the literature and a nomogram]
Q82765032[Mortality and morbidity of radical cystectomy for bladder cancer in patients over the age of 75]
Q77773180[Necrotizing pancreatitis following radical cystectomy for infiltrating bladder carcinoma]
Q87132644[Negative prognostic impact of female gender on oncological outcomes following radical cystectomy]
Q64911967[Neoadjuvant cisplatin chemotherapy and radical cystectomy in bladder carcinoma]
Q53026798[Neoadjuvant therapy before radical cystectomy for muscle-invasive bladder cancer].
Q90789759[Nerve-sparing robot-assisted laparoscopic radical cystectomy: Clinical application and effect]
Q80953340[On 10-year experience in the use of direct and antireflux techniques of anastomosis of ureter and orthotopic intestinal neobladder after radical cystectomy]
Q50489633[Oncologic and perioperative outcomes of robot-assisted radical cystectomy: A single-center prospective series].
Q86874624[Oncological outcome of radical cystectomy for BCG failure compared to primary invasive disease]
Q92724164[Open vs Laparoscopic Radical Cystectomy: Comparison of perioperative and Mid-term oncological outcomes.]
Q74150625[Orthotopic bladder from the small intestine following radical cystectomy according to Studer's procedure]
Q86606702[Orthotopic ileal neobladder - robot-assisted radical cystectomy standard soon?]
Q93021435[Orthotopic neobladder reconstruction for bladder cancer: robotic-assisted versus open-radical cystectomy for perioperative outcomes, functional results and quality of life]
Q68054590[Partial bladder resection--truly an alternative to radical cystectomy?]
Q81769048[Pelvic recurrence after radical cystectomy for bladder cancer]
Q68694466[Penile implantation surgery for organic impotence due to radical cystectomy or prostatectomy]
Q84523047[Peritoneal carcinomatosis after robotic-assisted radical cystectomy]
Q81254559[Place of laparoscopic radical cystectomy in the treatment of invasive bladder urothelial carcinoma]
Q69183460[Planned preoperative radiotherapy and radical cystectomy in the management of bladder cancer]
Q86492623[Prediction of local-regional failures in urothelial carcinoma of the bladder after radical cystectomy. A novel risk stratification]
Q81786063[Prevalence of lymph node metastases in non-muscle-invasive bladder cancer. Delay of radical cystectomy and upstaging in the cystectomy specimen as risk factors]
Q84572133[Prognosis of local recurrence after radical cystectomy for bladder cancer]
Q84083343[Prognostic factors for survival in patients with transitional bladder cancer treated with radical cystectomy]
Q51030221[Prognostic factors of survival in infiltrating urothelial bladder carcinoma. A retrospective study of 158 patients treated by radical cystectomy].
Q84962051[Prognostic significance of vascular invasion in patients with urothelial carcinoma treated with radical cystectomy]
Q81466029[Prognostic value of lymph node dissections in bladder cancer treated with radical cystectomy]
Q92669129[Propensity-matched comparison of laparoscopic and open radical cystectomy for female patients with bladder cancer]
Q84341374[Quality of life after radical cystectomy - an overview and analysis of a contemporary series]
Q83987314[Radical cystectomy - pro laparoscopic]
Q51790967[Radical cystectomy - pro robotic].
Q72606227[Radical cystectomy and laparoscopic ileal conduit]
Q80347910[Radical cystectomy and urinary diversion in elderly patients with increased comorbidity]
Q57100841[Radical cystectomy and urinary diversion-what is important ?]
Q83220209[Radical cystectomy and urinary diversion: assistance to patient choice]
Q81959535[Radical cystectomy as a muscle-invasive bladder cancer treatment in elderly patients]
Q81437631[Radical cystectomy early postoperative complications and mortality rate]
Q81219506[Radical cystectomy for invasive bladder carcinoma in patients 75 years old or older]
Q77953777[Radical cystectomy for superficial tumors in the BCG era]
Q69552490[Radical cystectomy for transitional cell carcinoma of the bladder]
Q85014199[Radical cystectomy for urothelial bladder cancer: prognostic impact of lymph node metastasis and soft tissue surgical margins]
Q72753231[Radical cystectomy in bladder carcinoma]
Q83178939[Radical cystectomy in patients with non-muscle invasive bladder cancer who fail BCG therapy]
Q95440277[Radical cystectomy in patients with pathological non-muscle invasive bladder cancer]
Q53033127[Radical cystectomy in patients with pathological non-muscle invasive bladder cancer].
Q74396886[Radical cystectomy in superficial bladder carcinoma]
Q53738113[Radical cystectomy in the therapy of bladder tumors].
Q79893717[Radical cystectomy in the treatment for bladder carcinoma: results of 125 operated patients]
Q80738355[Radical cystectomy in the treatment of bladder cancer always in due time?]
Q73092134[Radical cystectomy in the treatment of cancer of the bladder]
Q76380994[Radical cystectomy in the treatment of invasive bladder cancer]
Q88303984[Radical cystectomy vs. chemoradiation for the treatment of T2-4a N0 M0 bladder cancer]
Q73612041[Radical cystectomy with ileoneocystoplasty]
Q53053796[Radical cystectomy with orthotopic neobladder replacement: Comparison of robotic assisted and open surgical route].
Q73976462[Radical cystectomy with orthotopic urinary diversion in patients older than 70 years of age]
Q68713424[Radical cystectomy with preservation of sexual function]
Q45942269[Radical cystectomy with secondary epithelialization. Considerations and personal experience]
Q78876468[Radical cystectomy. Bladder substitution (in women)]
Q75237415[Radical cystectomy. Comparison of "Hautmann" and "Studer-neobladder"]
Q90176076[Radical cystectomy: therapeutic aspects of preoperative and early postoperative management]
Q90240907[Relationship between Early Complications after Radical Cystectomy and Psoas Muscle Mass]
Q80342308[Reliable surgical procedure. Orthotopic bladder replacement in radical cystectomy]
Q83168488[Research of laparoscopic radical cystectomy and urinary diversion]
Q72390589[Results of radical cystectomy for bladder cancer]
Q77186681[Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion]
Q53965629[Retrograde radical cystectomy. Advantages of our "vesico-rectal tunnel" method].
Q83041443[Retrospetive analysis of early postoperative complications of radical cystectomy and urinary diversion performed during a 17-year period]
Q84773215[Risk factor analysis of post-operative complications in radical cystectomy for bladder transitional cell cancer: retrospective assessment from 208 consecutive cases]
Q84587568[Robot-assisted laparoscopic radical cystectomy with extracorporeal urinary diversion]
Q80855622[Robot-assisted laparoscopic radical cystectomy]
Q102055283[Robot-assisted radical cystectomy with neobladder formation]
Q50536877[Robot-assisted radical cystectomy. Pilot study for the prospective evaluation of perioperative parameters compared to open radical cystectomy].
Q83326727[Robot-assisted radical cystectomy: do we actually need a robot?]
Q91747236[Robotic versus open radical cystectomy for adults with bladder cancer]
Q83464259[Robotic-assisted laparoscopic radical cystectomy: evaluation of functional and oncological results]
Q79406140[Sexual-nerve-Sparing radical cystectomy: experience with 32 cases]
Q73868569[Short-term results of radical cystectomy]
Q74366752[Significance of pelvic lymphadenectomy for the prognosis after radical cystectomy]
Q79321299[Stage pT0 bladder tumors after radical cystectomy: a review of our series]
Q83706880[Stress urinary incontinence after radical cystectomy: neobladder construction and placement of the functional retrourethral sling]
Q68424012[Substitute bladder following radical cystectomy]
Q81306524[Surgical site infection by bacillus Calmette-Guerin (BCG) after radical cystectomy, occurring after intravesical bcg therapy: a case report]
Q73413334[Survival in stage T2-T3A bladder cancer treated with radical cystectomy]
Q68841751[Technical comparison: uretero-ureterocutaneostomy with Y and ileal shunt after radical cystectomy]
Q86214188[Technique of the urethral anastomosis in orthotopic neo-bladder following robot-assisted radical cystectomy (RARC)]
Q92614623[The Development of the Preoperative Nomogram Predicting Major Perioperative Complications after Radical Cystectomy with Ileal Conduit or Orthotopic Neobladder]
Q92418602[The Safety of Laparoscopic Radical Cystectomy during Initial Phases in a Japanese Multicenter Cohort]
Q80935980[The Studer orthotopic bladder after radical cystectomy--observation of more than 40 patients]
Q68711812[The alternative of substitution enterocystoplasty after radical cystectomy]
Q85869527[The analysis of perioperative complications during radical cystectomy using a standardized reporting system]
Q96689141[The impact of radical cystectomy on health-related quality of life and potential for optimisation]
Q68539724[The quality of life in patients with bladder cancer after radical cystectomy with ileal conduit: I. Results of questionnaire surveys]
Q68539727[The quality of life in patients with bladder cancer after radical cystectomy with ileal conduit: II. Results of questionnaire surveys to compare the impact of treatments]
Q82229329[The radical cystectomy with different methods of the urine derivation in urinary bladder carcinoma]
Q69479780[The role of radical cystectomy in the treatment of invasive bladder carcinoma]
Q84743707[The urethral anastomosis in orthotopic neobladder following robot-assisted radical cystectomy (RARC) at German-speaking centres]
Q87705450[The value of surgical margins for clinical predictions and decisions following radical cystectomy for bladder cancer]
Q81699520[Transitional cell carcinoma relapse in uretero-ileal conduit after radical cystectomy]
Q77489331[Treatment of locally advanced carcinoma of the urinary bladder with preoperative radiotherapy and radical cystectomy versus radical cystectomy alone]
Q50711833[Treatment outcome of laparoscopic radical cystectomy at a single institution].
Q73808357[Unusual complications after radical cystectomy]
Q50648276[Upper urothelium tumor in patients treated with radical cystectomy for transitional carcinoma of the bladder]
Q85741289[Urinary diversion after radical cystectomy - What is the long-term renal function after ileal conduit and neobladder?]
Q95563865[Urine derivation after radical cystectomy]
Q95578516[Usefulness of cold ureteral biopsy during radical cystectomy as a predictor of recurrence risk: Review of our series.]
Q92019367[Usefulness of frozen section exams during radical cystectomy for urothelial carcinoma]
Q68044088[Value of radical cystectomy in the treatment of infiltrating bladder cancer]
Q83329890[Wound complications after radical cystectomy]
Q42373335miR-199a-3p and miR-214-3p improve the overall survival prediction of muscle-invasive bladder cancer patients after radical cystectomy
Q59649613p53 Predictive Value for pT1-2 N0 Disease at Radical Cystectomy

Search more.